Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Habitual
Mapping themes trends and knowledge structure of trophoblastic invasion, a bibliometric analysis from 2012-2021.
Abortion, Spontaneous
Detection of MMP-9 and TIMP-3 mRNA expression in the villi of patients undergoing early spontaneous abortion: A report of 30 cases.
Abortion, Spontaneous
Genetic variation in matrix metalloproteinase MMP2 and MMP9 as a risk factor for idiopathic recurrent spontaneous abortions in an Indian population.
Abortion, Spontaneous
Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Abortion, Spontaneous
Spontaneous abortion is preceded by an altered serum concentration of matrix metalloproteinases.
Acantholysis
The specific proteolysis hypothesis of pemphigus: does the song remain the same?
Acidosis
An in-silico strategy to explore neuroprotection by quercetin in cerebral ischemia: a novel hypothesis based on inhibition of matrix metalloproteinase (MMPs) and acid sensing ion channel 1a (ASIC1a).
Acne Vulgaris
Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
Acquired Immunodeficiency Syndrome
A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.
Acquired Immunodeficiency Syndrome
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
Acquired Immunodeficiency Syndrome
Matrix metalloproteinase-7, -8, -9, -25, and -26 and CD43, -45, and -68 cell-markers in HIV-infected patients' saliva and gingival tissue.
Acquired Immunodeficiency Syndrome
Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
Acquired Immunodeficiency Syndrome
The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis (Review).
Acute Coronary Syndrome
Association of calcium channel blocker use and pregnancy-associated plasma protein-A among older adults with hypertension: results from the ilSIRENTE study.
Acute Coronary Syndrome
Clinical significance of leukotriene b4 and extracellular matrix metalloproteinase inducer in acute coronary syndrome.
Acute Coronary Syndrome
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
Acute Coronary Syndrome
Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices.
Acute Coronary Syndrome
Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome.
Acute Coronary Syndrome
Matrix metalloproteinases in acute coronary syndromes: A new therapeutic target?
Acute Coronary Syndrome
Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
Acute Coronary Syndrome
Metalloproteinases in Diabetics and Nondiabetics during Acute Coronary Syndromes and after 3 Months.
Acute Coronary Syndrome
Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.
Acute Coronary Syndrome
Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.
Acute Coronary Syndrome
Practical implications of novel serum ELISA-assay for matrix metalloproteinase-8 in acute cardiac diagnostics.
Acute Coronary Syndrome
Role of matrix metalloproteinases in coronary artery disease.
Acute Coronary Syndrome
Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-? Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis.
Acute Coronary Syndrome
Systemic versus coronary levels of inflammation in acute coronary syndromes.
Acute Coronary Syndrome
The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence.
Acute Coronary Syndrome
The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome.
Acute Coronary Syndrome
Usefulness of Plasma Matrix Metalloproteinase-3 Levels to Predict Myocardial Infarction in Men With and Without Acute Coronary Syndrome.
Acute Coronary Syndrome
[Expression of extracellular matrix metalloproteinase inducer in the unstable plaque of patients with acute coronary syndrome].
Acute Coronary Syndrome
[Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome]
Acute Coronary Syndrome
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
Acute Coronary Syndrome
[Intravascular ultrasound study of coronary remodeling and determination of matrix metalloproteinase and hypersensitive C-reactive protein]
Acute Kidney Injury
Matrix metalloproteinase-9, 10, and stress hyperglycaemia in acute kidney injury.
Acute Kidney Injury
[Application value of urinary IGFBP7 and TIMP-2 in acute kidney injury with decompensated hepatitis B virus-related liver cirrhosis].
Acute Lung Injury
Effects of Mesenchymal Stem Cell Therapy on the Time Course of Pulmonary Remodeling Depend on the Etiology of Lung Injury in Mice.
Acute Lung Injury
Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells.
Acute Lung Injury
Matrix metalloproteinase activity in pediatric acute lung injury.
Acute Lung Injury
Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs.
Acute Lung Injury
Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass.
Acute Lung Injury
Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice.
Acute Lung Injury
Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.
Acute Lung Injury
Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase.
Acute Lung Injury
Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice.
Acute Lung Injury
The role of neutrophil collagenase in endotoxic acute lung injury.
Acute Lung Injury
Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat.
Acute Lung Injury
[Current progress of matrix metalloproteinase in acute lung injury following cardiopulmonary bypass]
Acute Lung Injury
[Effects of unfractionated heparin on expression of metalloproteinase-2 and -9 in acute lung injury rats].
Acute Lung Injury
[Expression of various matrix metalloproteinases in mice with hyperoxia induced acute lung injury.]
Adenocarcinoma
Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China.
Adenocarcinoma
Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.
Adenocarcinoma
Clinicopathologic significance of fascin, extracellular matrix metalloproteinase inducer, and ezrin expressions in colorectal adenocarcinoma.
Adenocarcinoma
Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells.
Adenocarcinoma
Comparative Role of Matrixins in Diagnostics of Parotid Gland Tumors.
Adenocarcinoma
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
Adenocarcinoma
Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Adenocarcinoma
COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
Adenocarcinoma
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Adenocarcinoma
Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung.
Adenocarcinoma
EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma.
Adenocarcinoma
Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Adenocarcinoma
Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung.
Adenocarcinoma
Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas.
Adenocarcinoma
Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.
Adenocarcinoma
Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa.
Adenocarcinoma
High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
Adenocarcinoma
Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture.
Adenocarcinoma
Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
Adenocarcinoma
Ingestion of proteoglycan fraction from shark cartilage increases serum inhibitory activity against matrix metalloproteinase-9 and suppresses development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic duct carcinogenesis in hamster.
Adenocarcinoma
Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
Adenocarcinoma
Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model.
Adenocarcinoma
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial.
Adenocarcinoma
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
Adenocarcinoma
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.
Adenocarcinoma
Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget's disease by receptor activator of nuclear factor kappa-B ligand (RANKL)/ RANK pathways.
Adenocarcinoma
Prognostic significance of expression of matrix metalloproteinase in colorectal adenocarcinomas and their metastases.
Adenocarcinoma
Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.
Adenocarcinoma
Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.
Adenocarcinoma
Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.
Adenocarcinoma
Relationship between biomarker expression and allelic alteration in esophageal carcinoma.
Adenocarcinoma
Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.
Adenocarcinoma
The Effect of Oral Administration of PUFAs on the Matrix Metalloproteinase Expression in Gastric Adenocarcinoma Patients Undergoing Chemotherapy.
Adenocarcinoma
The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.
Adenocarcinoma of Lung
Allicin inhibits the invasion of lung adenocarcinoma cells by altering tissue inhibitor of metalloproteinase/matrix metalloproteinase balance via reducing the activity of phosphoinositide 3-kinase/AKT signaling.
Adenocarcinoma of Lung
Anti-angiogenic, apoptotic and matrix metalloproteinase inhibitory activity of Withania somnifera (ashwagandha) on lung adenocarcinoma cells.
Adenocarcinoma of Lung
Changes in tissue metalloproteinase inhibitor-1 and matrix metalloproteinases during tumor development and metastasizing in mice.
Adenocarcinoma of Lung
Curcumol inhibits lung adenocarcinoma growth and metastasis via inactivation of PI3K/AKT and Wnt/ß-catenin pathway.
Adenocarcinoma of Lung
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide.
Adenocarcinoma of Lung
Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
Adenocarcinoma of Lung
Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells.
Adenocarcinoma of Lung
PKC?, MMP?2 and MMP?9 expression in lung adenocarcinoma and association with a metastatic phenotype.
Adenocarcinoma of Lung
Sevoflurane inhibits invasion and migration of lung cancer cells by inactivating the p38 MAPK signaling pathway.
Adenocarcinoma of Lung
Significance of interstitial tumor-associated macrophages in the progression of lung adenocarcinoma.
Adenoma
Comparative Role of Matrixins in Diagnostics of Parotid Gland Tumors.
Adenoma
Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction.
Adenoma
Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity.
Adenoma
Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon.
Adenoma
Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes.
Adenoma
Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
Adenoma
The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion.
Adenoma
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Adenoma
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Adenoma, Liver Cell
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Adenoma, Pleomorphic
Comparative Role of Matrixins in Diagnostics of Parotid Gland Tumors.
Adenoma, Pleomorphic
Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Adenomatous Polyposis Coli
Relationship among expression of basic-fibroblast growth factor, MTDH/Astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas.
Adenomyosis
A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice.
Adenomyosis
Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.
Adenomyosis
Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-2 in Adenomyosis and Endometrial Polyps and its Correlation With Angiogenesis.
Adenomyosis
Increased invasion activity of endometrial stromal cells and elevated expression of matrix metalloproteinase messenger RNA in the uterine tissues of mice with experimentally induced adenomyosis.
Adenomyosis
Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice.
Adenomyosis
[Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis]
Adenomyosis
[Expression of the small molecular weight matrix metalloproteinase in adenomyosis of the mouse uterus]
Adrenal Cortex Neoplasms
Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
Adrenocortical Carcinoma
Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas.
Aggressive Periodontitis
Collagenase activity in gingival crevicular fluid of patients with juvenile periodontitis.
Aggressive Periodontitis
Concentration of MMP-8 and IL-1? in gingival crevicular fluid in patients with chronic and aggressive periodontitis.
Aggressive Periodontitis
Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis.
Aggressive Periodontitis
Effects of cranberry components on human aggressive periodontitis gingival fibroblasts.
Aggressive Periodontitis
Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis.
Aggressive Periodontitis
Implant-safe test in patients with peri-implantitis.
Aggressive Periodontitis
Matrix Metalloproteinase (MMP)-8 and Tissue Inhibitors of Metalloproteinases (TIMP)-1 Gene Polymorphisms in Generalized Aggressive Periodontitis: GCF MMP-8 and TIMP-1 Levels and Outcome of Periodontal Therapy.
Aggressive Periodontitis
Matrix metalloproteinase levels in children with aggressive periodontitis.
Aggressive Periodontitis
MMP-8 -799 C>T genetic polymorphism is associated with the susceptibility to chronic and aggressive periodontitis in Taiwanese.
Aggressive Periodontitis
Periodontal Treatment Reduces Matrix Metalloproteinase Levels in Localized Aggressive Periodontitis.
Aggressive Periodontitis
Salivary collagenase, elastase- and trypsin-like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis.
Aggressive Periodontitis
Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis.
Aggressive Periodontitis
Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo.
Aggressive Periodontitis
The effect of topical doxycycline usage on gingival crevicular fluid MMP-8 levels of chronic and aggressive periodontitis patients: a pilot study.
Aggressive Periodontitis
The Utility of Gingival Crevicular Fluid Matrix Metalloproteinase-8 Response Patterns in Prediction of Site Level Clinical Treatment Outcome.
Airway Obstruction
Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma.
Airway Obstruction
In vitro inhibition of matrix metalloproteinase activity in tracheal epithelial lining fluid from horses with recurrent airway obstruction.
Albuminuria
8D.08: MATRIX METALLOPROTEINASE (MMP) 2 AND MMP9 ACTIVITY IS INCREASED IN CONDITIONS OF ALBUMINURIA ESCAPE UNDER CHRONIC RENIN-ANGIOTENSIN SYSTEM SUPPRESSION.
Albuminuria
CTGF inhibits BMP-7 signaling in diabetic nephropathy.
Albuminuria
Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease.
Alveolar Bone Loss
Effects of Low Dose Doxycycline and Bisphosphonate Clodronate on Gingival Levels of Matrix Metalloproteinase -9, Interleukin -1B and Alveolar Bone Loss in Diabetic Rats. A Histomorphometric and Immunohistochemical Study.
Alveolar Bone Loss
Gelatinases and extracellular matrix metalloproteinase inducer are associated with cyclosporin-A-induced attenuation of periodontal degradation in rats.
Alveolar Bone Loss
Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease.
Alveolar Bone Loss
Local administration of Tiludronic Acid downregulates important mediators involved in periodontal tissue destruction in experimental periodontitis in rats.
Alveolar Bone Loss
Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis.
Alveolar Bone Loss
Morphometric and histopathological evaluation of the effect of grape seed proanthocyanidin on alveolar bone loss in experimental diabetes and periodontitis.
Alveolitis, Extrinsic Allergic
MMP2 Polymorphism Affects Plasma Matrix Metalloproteinase (MMP)-2 Levels, and Correlates with the Decline in Lung Function in Hypersensitivity Pneumonitis Positive to Autoantibodies Patients.
Alzheimer Disease
Disturbed Matrix Metalloproteinase Pathway in Both Age-Related Macular Degeneration and Alzheimer's Disease.
Alzheimer Disease
Expression of the type 1 metalloproteinase in the rat hippocampus after the intracerebroventricular injection of ?-amyloid peptide (25-35).
Alzheimer Disease
Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease.
Alzheimer Disease
Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database.
Alzheimer Disease
Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
Alzheimer Disease
Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.
Alzheimer Disease
Understanding the complexity of the matrix metalloproteinase system and its relevance to age-related diseases: Age-related macular degeneration and Alzheimer's disease.
Ameloblastoma
Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors.
Ameloblastoma
Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma.
Ameloblastoma
Invadopodia proteins, cortactin and membrane type I matrix metalloproteinase (MT1-MMP) are expressed in ameloblastoma.
Ameloblastoma
MMP-7, -8, -9, E-cadherin, and beta-catenin expression in 34 ameloblastoma cases.
Ameloblastoma
[Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma]
Amyloidosis
Doxycycline decreases amyloidogenic light chain-induced autophagy in isolated primary cardiac myocytes.
Aneurysm
A failure of matrix metalloproteinase inhibition in the prevention of rat intracranial aneurysm formation.
Aneurysm
Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm.
Aneurysm
Aneurysm growth, elastinolysis, and attempted doxycycline inhibition of elastase-induced aneurysms in rabbits.
Aneurysm
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Aneurysm
Associations between serum relaxin 2, aneurysm formation/size and severity of atherosclerosis: a preliminary prospective analysis.
Aneurysm
Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
Aneurysm
Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?
Aneurysm
Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases.
Aneurysm
Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.
Aneurysm
Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation.
Aneurysm
Differences in Elastin and Elastolytic Enzymes between Men and Women with Abdominal Aortic Aneurysm.
Aneurysm
Differential expression of genes in elastase-induced saccular aneurysms with high and low aspect ratios.
Aneurysm
Does lipoprotein(a) inhibit elastolysis in abdominal aortic aneurysms?
Aneurysm
Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices.
Aneurysm
Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9 activity in patients with Kawasaki disease.
Aneurysm
Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury.
Aneurysm
Elastin-Derived Peptides Promote Abdominal Aortic Aneurysm Formation by Modulating M1/M2 Macrophage Polarization.
Aneurysm
Enhanced embryonic nonmuscle myosin heavy chain isoform and matrix metalloproteinase expression in aortic abdominal aneurysm with rapid progression.
Aneurysm
Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin II in vitro.
Aneurysm
Extracellular proteolysis in the development and progression of atherosclerosis.
Aneurysm
Heterogeneity of tensile strength and matrix metalloproteinase activity in the wall of abdominal aortic aneurysms.
Aneurysm
Inflammatory Smooth Muscle Cells Induce Endothelial Cell Alterations to Influence Cerebral Aneurysm Progression via Regulation of Integrin and VEGF Expression.
Aneurysm
Licochalcone A attenuates abdominal aortic aneurysm induced by angiotensin II via regulating the miR-181b/SIRT1/HO-1 signaling.
Aneurysm
Long-term miR-29b suppression reduces aneurysm formation in a Marfan mouse model.
Aneurysm
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Aneurysm
Matrix Metalloproteinase -2 and -9 Expression in the Wall of Saccular Cerebral Artery Aneurysm: Paper 54.
Aneurysm
Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Aneurysm
Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.
Aneurysm
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease.
Aneurysm
Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.
Aneurysm
Molecular imaging of matrix metalloproteinase activation to predict murine aneurysm expansion in vivo.
Aneurysm
Nitric oxide in experimental aneurysm formation: early events and consequences of nitric oxide inhibition.
Aneurysm
Optical imaging of MMP-12 active form in inflammation and aneurysm.
Aneurysm
Paracrine secretion of transforming growth factor-beta1 in aneurysm healing and stabilization with endovascular smooth muscle cell therapy.
Aneurysm
Peroxisome Proliferator-Activated Receptor ? Level Contributes to Structural Integrity and Component Production of Elastic Fibers in the Aorta.
Aneurysm
Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair.
Aneurysm
Relationship Between Circulating Plasma Matrix Metalloproteinase-9 (gelatinase-B) Concentration and Aortic Root Dilatation.
Aneurysm
Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms.
Aneurysm
Role of matrix metalloproteinases in abdominal aortic aneurysms.
Aneurysm
Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.
Aneurysm
Systemic Administration of Ribbon-type Decoy Oligodeoxynucleotide Against Nuclear Factor ?B and Ets Prevents Abdominal Aortic Aneurysm in Rat Model.
Aneurysm
The role of matrix metalloproteinases in vascular disease.
Aneurysm
Thoracic aortic aneurysm: reading the enemy's playbook.
Aneurysm
TIMP?3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP?2 and MMP?9 activity, and reduced TNF?? expression.
Aneurysm
[The role of estrogen in the formation and development of abdominal aortic aneurysm: experiment with rats]
Aneurysm, Dissecting
Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection.
Aneurysm, Dissecting
Impact of matrix metalloproteinase-8 gene variations on the risk of thoracic aortic dissection in a Chinese Han population.
Aneurysm, Dissecting
Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection.
Aneurysm, Dissecting
Matrix metalloproteinase levels in acute aortic dissection, acute pancreatitis and other abdominal pain.
Aneurysm, Dissecting
Matrix metalloproteinase levels in chronic thoracic aortic dissection.
Aneurysm, Dissecting
Relationship Between Circulating Plasma Matrix Metalloproteinase-9 (gelatinase-B) Concentration and Aortic Root Dilatation.
Aneurysm, Dissecting
Rule out of acute aortic dissection with plasma matrix metalloproteinase 8 in the emergency department.
Aneurysm, Dissecting
The multitasking role of macrophages in Stanford type A acute aortic dissection.
Aneurysm, Dissecting
The prominent expression of plasma matrix metalloproteinase-8 in acute thoracic aortic dissection.
Aneurysm, Dissecting
Variants of genes encoding collagens and matrix metalloproteinase system increased the risk of aortic dissection.
Aneurysm, Ruptured
Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms.
Angina, Stable
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
Angina, Stable
Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.
Angina, Stable
Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
Angina, Stable
Role of matrix metalloproteinases in coronary artery disease.
Angina, Stable
Serum tissue inhibitor of metalloproteinases-1 and higher risk features of coronary plaque: a volumetric multivessel intravascular ultrasound study.
Angina, Stable
[Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome]
Angina, Stable
[Intravascular ultrasound study of coronary remodeling and determination of matrix metalloproteinase and hypersensitive C-reactive protein]
Angina, Stable
[Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance]
Angina, Unstable
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
Angina, Unstable
High plasma levels of matrix metalloproteinase-8 in patients with unstable angina.
Angina, Unstable
[Comparison of right atrial matrix metalloproteinase expression between patients with unstable angina and myocardial infarction]
Angina, Unstable
[Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome]
Angina, Unstable
[Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance]
Angiofibroma
Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Angiokeratoma
A case of angiokeratoma circumscriptum: immunolocalization of matrix metalloproteinase (MMP)-9.
Ankylosis
An extract from Myracrodruon urundeuva inhibits matrix mineralization in human osteoblasts.
Ankylosis
Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study.
Anthrax
Studies in mice reveal a role for anthrax toxin receptors in matrix metalloproteinase function and extracellular matrix homeostasis.
Aortic Aneurysm
Characterization of serum matrix metalloproteinase 2/9 levels in patients with ascending aortic aneurysms.
Aortic Aneurysm
Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Modulate Matrix Metalloproteinase Immunoreactivity in a Mouse Model of Pre-abdominal Aortic Aneurysm.
Aortic Aneurysm
Effect of miR-21 on rat thoracic aortic aneurysm model by regulating the expressions of MMP-2 and MMP-9.
Aortic Aneurysm
Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms.
Aortic Aneurysm
Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.
Aortic Aneurysm
Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
Aortic Aneurysm
Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Aortic Aneurysm
Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.
Aortic Aneurysm
Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice.
Aortic Aneurysm
SP600125 Attenuates Nicotine-Related Aortic Aneurysm Formation by Inhibiting Matrix Metalloproteinase Production and CC Chemokine-Mediated Macrophage Migration.
Aortic Aneurysm
Systemic Delivery of Nanoparticles Loaded with Pentagalloyl Glucose Protects Elastic Lamina and Prevents Abdominal Aortic Aneurysm in Rats.
Aortic Aneurysm
[Effect of nifedipine on organ protection: potential application in patients with aortic aneurysm]
Aortic Aneurysm, Abdominal
A Novel Histone Deacetylase Inhibitor Reduces Abdominal Aortic Aneurysm Formation in Angiotensin II-Infused Apolipoprotein E-Deficient Mice.
Aortic Aneurysm, Abdominal
Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines.
Aortic Aneurysm, Abdominal
Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.
Aortic Aneurysm, Abdominal
Association of Matrix Metalloproteinase Levels with Collagen Degradation in the Context of Abdominal Aortic Aneurysm.
Aortic Aneurysm, Abdominal
Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
Aortic Aneurysm, Abdominal
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events.
Aortic Aneurysm, Abdominal
Cross-talk between macrophages, smooth muscle cells, and endothelial cells in response to cigarette smoke: the effects on MMP2 and 9.
Aortic Aneurysm, Abdominal
Different drugs effect on mesenchimal stem cells isolated from abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Does lipoprotein(a) inhibit elastolysis in abdominal aortic aneurysms?
Aortic Aneurysm, Abdominal
Early growth response factor-1 DNA enzyme 1 inhibits the formation of abdominal aortic aneurysm in rats.
Aortic Aneurysm, Abdominal
Effect of hyperbaric oxygen treatment in a rat model of abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice.
Aortic Aneurysm, Abdominal
Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.
Aortic Aneurysm, Abdominal
Genotype-phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion.
Aortic Aneurysm, Abdominal
Heterogeneity of tensile strength and matrix metalloproteinase activity in the wall of abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Hypoxia in Abdominal Aortic Aneurysm Supports a Role for HIF-1? and Ets-1 as Drivers of Matrix Metalloproteinase Upregulation in Human Aortic Smooth Muscle Cells.
Aortic Aneurysm, Abdominal
Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.
Aortic Aneurysm, Abdominal
In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate.
Aortic Aneurysm, Abdominal
Increased angiogenesis at the site of abdominal aortic aneurysm rupture.
Aortic Aneurysm, Abdominal
Inhibition of EP4 signaling attenuates aortic aneurysm formation.
Aortic Aneurysm, Abdominal
Isoflavone Ameliorated Oxidative Stress and Vascular Damages in Nicotine-Administrated Mice.
Aortic Aneurysm, Abdominal
Levo-Tetrahydropalmatine Attenuates Progression of Abdominal Aortic Aneurysm in an Elastase Perfusion Rat Model via Suppression of Matrix Metalloproteinase and Monocyte Chemotactic Protein-1.
Aortic Aneurysm, Abdominal
Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall.
Aortic Aneurysm, Abdominal
Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
Aortic Aneurysm, Abdominal
Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection.
Aortic Aneurysm, Abdominal
Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Aortic Aneurysm, Abdominal
Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
Aortic Aneurysm, Abdominal
Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline.
Aortic Aneurysm, Abdominal
MMP-12 has a role in abdominal aortic aneurysms in mice.
Aortic Aneurysm, Abdominal
Monocyte activity is linked with abdominal aortic aneurysm diameter.
Aortic Aneurysm, Abdominal
Multiple sites of vascular dilation or aneurysmal disease and matrix metalloproteinase genetic variants in patients with abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN.
Aortic Aneurysm, Abdominal
Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells.
Aortic Aneurysm, Abdominal
Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair.
Aortic Aneurysm, Abdominal
Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Presence of Chlamydia pneumoniae in abdominal aortic aneurysms is not associated with increased activity of matrix metalloproteinases.
Aortic Aneurysm, Abdominal
Preservation of rabbit aorta elastin from degradation by gingival fibroblasts in an ex vivo model.
Aortic Aneurysm, Abdominal
Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles.
Aortic Aneurysm, Abdominal
Putative targeting of matrix metalloproteinase-8 in atherosclerosis.
Aortic Aneurysm, Abdominal
RANKL-mediated osteoclastogenic differentiation of macrophages in the abdominal aorta of angiotensin II-infused apolipoprotein E knockout mice.
Aortic Aneurysm, Abdominal
Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.
Aortic Aneurysm, Abdominal
Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Significance of Matrix Metalloproteinase-9 Inhibition by Imidapril for Prevention of Abdominal Aortic Aneurysms in Angiotensin II Type 1 Receptor-Knockout Mice.
Aortic Aneurysm, Abdominal
Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).
Aortic Aneurysm, Abdominal
The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: a case-control study.
Aortic Aneurysm, Abdominal
Validated UHPLC-MS/MS method for quantification of doxycycline in abdominal aortic aneurysm patients.
Aortic Aneurysm, Thoracic
A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2.
Aortic Aneurysm, Thoracic
Correlation between MMP and TIMP levels and elastic moduli of ascending thoracic aortic aneurysms.
Aortic Aneurysm, Thoracic
Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves.
Aortic Aneurysm, Thoracic
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
Aortic Aneurysm, Thoracic
Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.
Aortic Aneurysm, Thoracic
Low transcriptional activity haplotype of matrix metalloproteinase 1 is less frequent in bicuspid aortic valve patients.
Aortic Aneurysm, Thoracic
Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
Aortic Aneurysm, Thoracic
Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.
Aortic Aneurysm, Thoracic
Regulation of membrane type-1 matrix metalloproteinase activity and intracellular localization in clinical thoracic aortic aneurysms.
Aortic Aneurysm, Thoracic
Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms.
Aortic Aneurysm, Thoracic
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation.
Aortic Diseases
Blocking the ERK1/2 signal pathway can inhibit S100A12 induced human aortic smooth muscle cells damage.
Aortic Diseases
Medical treatment for thoracic aortic aneurysm - much more work to be done.
Aortic Valve Disease
Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice.
Aortic Valve Disease
Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
Aortic Valve Stenosis
Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis.
Aortic Valve Stenosis
Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model.
Aortic Valve Stenosis
Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis.
Aortic Valve Stenosis
Matrix metalloproteinase expression in nonrheumatic aortic stenosis.
Appendicitis
Biomarkers to estimate the probability of complicated appendicitis.
Appendicitis
Can new inflammatory markers improve the diagnosis of acute appendicitis?
Appendicitis
Matrix metalloproteinase levels in peritoneal effluents were increased in a patient with appendicitis undergoing continuous ambulatory peritoneal dialysis.
Appendicitis
Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis.
Arrhythmias, Cardiac
Anti-arrhythmic and anti-heart failure effects of low-level electrical stimulation on aortic root ventricular ganglionated plexi.
Arteriovenous Fistula
Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model.
Arteriovenous Fistula
Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats.
Arteriovenous Fistula
Vein tissue expression of matrix metalloproteinase as biomarker for hemodialysis arteriovenous fistula maturation.
Arteriovenous Malformations
Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.
Arteriovenous Malformations
Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations.
Arteriovenous Malformations
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage.
Arteritis
Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease.
Arteritis
MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis.
Arthralgia
A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors.
Arthralgia
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer.
Arthralgia
The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura.
Arthritis
A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities.
Arthritis
A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis.
Arthritis
A Randomized Phase II Trial of the Matrix Metalloproteinase Inhibitor BMS-275291 in Hormone-Refractory Prostate Cancer Patients with Bone Metastases.
Arthritis
Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
Arthritis
Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview.
Arthritis
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.
Arthritis
Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase.
Arthritis
Baicalein Attenuates Oxidative Stress-Induced Expression of Matrix Metalloproteinase-1 by Regulating the ERK/JNK/AP-1 Pathway in Human Keratinocytes.
Arthritis
Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.
Arthritis
BRAF splice variants in rheumatoid arthritis synovial fibroblasts activate MAPK through CRAF.
Arthritis
CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway.
Arthritis
Celastrus-derived Celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses.
Arthritis
Changes in the concentration of plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis.
Arthritis
Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
Arthritis
Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
Arthritis
Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis.
Arthritis
Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8.
Arthritis
Crocin exerts anti-inflammatory and anti-arthritic effects on type II collagen-induced arthritis in rats.
Arthritis
Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.
Arthritis
Curcumin: a potential candidate for matrix metalloproteinase inhibitors.
Arthritis
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
Arthritis
Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Arthritis
Development of temporomandibular joint arthritis: The use of animal models.
Arthritis
Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-?B Pathway.
Arthritis
Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe.
Arthritis
Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis.
Arthritis
Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases.
Arthritis
Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.
Arthritis
Expression of Cannabinoid Receptors in Human Osteoarthritic Cartilage: Implications for Future Therapies.
Arthritis
Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Arthritis
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
Arthritis
Impressic acid from Acanthopanax koreanum, possesses matrix metalloproteinase-13 down-regulating capacity and protects cartilage destruction.
Arthritis
Inhibition of Matrix Metalloproteinase-3 and -13 Synthesis Induced by IL-1{beta} in Chondrocytes from Mice Lacking Microsomal Prostaglandin E Synthase-1.
Arthritis
Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer.
Arthritis
Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Arthritis
Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.
Arthritis
Interleukin-1 beta induction of c-fos and collagenase expression in articular chondrocytes: involvement of reactive oxygen species.
Arthritis
Intraarticular induction of interleukin-1beta expression in the adult mouse, with resultant temporomandibular joint pathologic changes, dysfunction, and pain.
Arthritis
Involvement of 15-lipoxygenase in the inflammatory arthritis.
Arthritis
JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis.
Arthritis
Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
Arthritis
Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls.
Arthritis
Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
Arthritis
Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression.
Arthritis
Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.
Arthritis
Matrix metalloproteinase inhibitors in arthritis.
Arthritis
Matrix metalloproteinase inhibitors in the treatment of arthritis: comment on the article by Vincenti et al.
Arthritis
Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.
Arthritis
Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors.
Arthritis
NADPH-oxidase-driven oxygen radical production determines chondrocyte death and partly regulates metalloproteinase-mediated cartilage matrix degradation during interferon-gamma-stimulated immune complex arthritis.
Arthritis
New biochemical insight of conserved water molecules at catalytic and structural Zn(2+) ions in human matrix metalloproteinase-I: a study by MD-simulation.
Arthritis
Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritis.
Arthritis
Novel Potent Proline-Based Metalloproteinase Inhibitors: Design, (Radio)Synthesis, and First in Vivo Evaluation as Radiotracers for Positron Emission Tomography.
Arthritis
Orally active MMP-1 sparing ?-tetrahydropyranyl and ?-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.
Arthritis
PEP-1-FK506BP12 inhibits matrix metalloproteinase expression in human articular chondrocytes and in a mouse carrageenan-induced arthritis model.
Arthritis
Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity.
Arthritis
Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840.
Arthritis
Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-Terminal kinase pathway.
Arthritis
Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells.
Arthritis
Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis.
Arthritis
Rheumatoid arthritis and salivary biomarkers of periodontal disease.
Arthritis
Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases.
Arthritis
Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages.
Arthritis
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Arthritis
Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes.
Arthritis
Structural insights on druggable hotspots in CD147: A bull's eye view.
Arthritis
Sulphonamides: Deserving class as MMP inhibitors?
Arthritis
Suppression of hyaluronan synthesis alleviates inflammatory response in murine arthritis and in human rheumatoid synovial fibroblasts.
Arthritis
Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.
Arthritis
The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis.
Arthritis
The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction.
Arthritis
Thioredoxin fusion construct enables high-yield production of soluble, active matrix metalloproteinase-8 (MMP-8) in Escherichia coli.
Arthritis
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1.
Arthritis
Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.
Arthritis
[Diagnostic utility of anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis]
Arthritis, Experimental
Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis.
Arthritis, Experimental
Astilbin suppresses collagen-induced arthritis via the dysfunction of lymphocytes.
Arthritis, Experimental
Blockade of integrin VLA-4 prevents inflammation and matrix metalloproteinase expression in a murine model of accelerated collagen-induced arthritis.
Arthritis, Experimental
Correction to: Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis.
Arthritis, Experimental
Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe.
Arthritis, Experimental
Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis.
Arthritis, Experimental
Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.
Arthritis, Experimental
Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway.
Arthritis, Experimental
Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031.
Arthritis, Experimental
Tenidap and flurbiprofen enhance uptake of matrix metalloproteinase inhibitor 4-dedimethylaminotetracycline in inflamed joints of adjuvant arthritic rats.
Arthritis, Experimental
Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage.
Arthritis, Experimental
Tumor necrosis factor receptor pre-ligand assembly domain is an important therapeutic target in inflammatory arthritis.
Arthritis, Juvenile
Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis.
Arthritis, Juvenile
Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
Arthritis, Juvenile
Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls.
Arthritis, Juvenile
Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.
Arthritis, Psoriatic
Increased serum TWEAK levels in Psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels.
Arthritis, Reactive
In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis.
Arthritis, Reactive
Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis.
Arthritis, Rheumatoid
A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Arthritis, Rheumatoid
A high throughput fluorogenic substrate for stromelysin (MMP-3).
Arthritis, Rheumatoid
A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies.
Arthritis, Rheumatoid
A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.
Arthritis, Rheumatoid
Active matrix metalloproteinase-8 and periodontal bacteria depending on periodontal status in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Age at onset of rheumatoid arthritis: association with polymorphisms in the vascular endothelial growth factor A(VEGFA) gene and an intergenic locus between matrix metalloproteinase (MMP) 1 and 3 genes.
Arthritis, Rheumatoid
Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.
Arthritis, Rheumatoid
Andrographolide inhibits the migration, invasion and matrix metalloproteinase expression of rheumatoid arthritis fibroblast-like synoviocytes via inhibition of HIF-1? signaling.
Arthritis, Rheumatoid
Annexin-1 mediates TNF-alpha-stimulated matrix metalloproteinase secretion from rheumatoid arthritis synovial fibroblasts.
Arthritis, Rheumatoid
Anti-inflammatory activities of light emitting diode irradiation on collagen-induced arthritis in mice (a secondary publication).
Arthritis, Rheumatoid
Anti-rheumatic medication and salivary MMP-8, a biomarker for periodontal disease.
Arthritis, Rheumatoid
Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.
Arthritis, Rheumatoid
Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes.
Arthritis, Rheumatoid
Bioinformatics analysis reveals different gene expression patterns in the annulus fibrosis and nucleus pulpous during intervertebral disc degeneration.
Arthritis, Rheumatoid
BRAF splice variants in rheumatoid arthritis synovial fibroblasts activate MAPK through CRAF.
Arthritis, Rheumatoid
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease.
Arthritis, Rheumatoid
Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis.
Arthritis, Rheumatoid
CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.
Arthritis, Rheumatoid
CD147 induces up-regulation of vascular endothelial growth factor in U937-derived foam cells through PI3K/AKT pathway.
Arthritis, Rheumatoid
CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
Arthritis, Rheumatoid
Correlation among macrophage inflammatory protein 1alpha levels, matrix metalloproteinase 8 levels, and systemic inflammation in rheumatoid arthritis: comment on the articles by Yamanaka et al and Mattey et al.
Arthritis, Rheumatoid
Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification.
Arthritis, Rheumatoid
Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Arthritis, Rheumatoid
Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Arthritis, Rheumatoid
Doxycycline protects serum alpha-1-antitrypsin from human neutrophil collagenase.
Arthritis, Rheumatoid
Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs.
Arthritis, Rheumatoid
Effects of celecoxib on human chondrocytes--enhanced production of chemokines.
Arthritis, Rheumatoid
Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
Arthritis, Rheumatoid
Enhanced expression of mRNA for nuclear factor kappaB1 (p50) in CD34+ cells of the bone marrow in rheumatoid arthritis.
Arthritis, Rheumatoid
Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes.
Arthritis, Rheumatoid
Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Arthritis, Rheumatoid
Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis.
Arthritis, Rheumatoid
Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Arthritis, Rheumatoid
Expression of membrane-type matrix metalloproteinases in synovial tissue from patients with rheumatoid arthritis or osteoarthritis.
Arthritis, Rheumatoid
Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells.
Arthritis, Rheumatoid
Gadd45beta deficiency in rheumatoid arthritis: Enhanced synovitis through JNK signaling.
Arthritis, Rheumatoid
Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease.
Arthritis, Rheumatoid
Gold sodium thiomalate activates latent human leukocyte collagenase.
Arthritis, Rheumatoid
Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway.
Arthritis, Rheumatoid
Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
Arthritis, Rheumatoid
Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts.
Arthritis, Rheumatoid
Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38.
Arthritis, Rheumatoid
Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).
Arthritis, Rheumatoid
Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium.
Arthritis, Rheumatoid
In vivo model of cartilage degradation--effects of a matrix metalloproteinase inhibitor.
Arthritis, Rheumatoid
Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium.
Arthritis, Rheumatoid
Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
Arthritis, Rheumatoid
Increased soluble CD4 in serum of rheumatoid arthritis patients is generated by matrix metalloproteinase (MMP)-like proteinases.
Arthritis, Rheumatoid
Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status.
Arthritis, Rheumatoid
Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Knockdown of sphingosine kinase 1 inhibits the migration and invasion of human rheumatoid arthritis fibroblast-like synoviocytes by down-regulating the PI3K/AKT activation and MMP-2/9 production in vitro.
Arthritis, Rheumatoid
Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients.
Arthritis, Rheumatoid
Ligand-dependent release of active neutrophil collagenase.
Arthritis, Rheumatoid
Lysis of fibrillar collagen by neutrophils in synovial fluid. A role for surface-bound immunoglobulins.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.
Arthritis, Rheumatoid
Matrix metalloproteinase 28/epilysin expression in cartilage from patients with rheumatoid arthritis and osteoarthritis: comment on the article by Kevorkian et al.
Arthritis, Rheumatoid
Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase inhibitors in rheumatic diseases.
Arthritis, Rheumatoid
Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface.
Arthritis, Rheumatoid
Matrix metalloproteinase-8 in sera and from polymorphonuclear leucocytes in rheumatoid arthritis: in vitro characterization and correlation with disease activity.
Arthritis, Rheumatoid
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline.
Arthritis, Rheumatoid
Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis.
Arthritis, Rheumatoid
Mechanical stretch regulates the expression of matrix metalloproteinase in rheumatoid arthritis fibroblast-like synoviocytes.
Arthritis, Rheumatoid
Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cells under mechanical stimuli.
Arthritis, Rheumatoid
MMP-8 and TIMP-1 are associated to periodontal inflammation in patients with rheumatoid arthritis under methotrexate immunosuppression - First results of a cross-sectional study.
Arthritis, Rheumatoid
Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement.
Arthritis, Rheumatoid
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.
Arthritis, Rheumatoid
Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis.
Arthritis, Rheumatoid
Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840.
Arthritis, Rheumatoid
Promoter competition assay for analyzing gene regulation in joint tissue engineering.
Arthritis, Rheumatoid
Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP.
Arthritis, Rheumatoid
Proteases as drug targets.
Arthritis, Rheumatoid
Protective Effect of Withania somnifera and Cardiospermum halicacabum Extracts Against Collagenolytic Degradation of Collagen.
Arthritis, Rheumatoid
Protein isoprenylation regulates secretion of matrix metalloproteinase 1 from rheumatoid synovial fibroblasts: effects of statins and farnesyl and geranylgeranyl transferase inhibitors.
Arthritis, Rheumatoid
Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.
Arthritis, Rheumatoid
Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission.
Arthritis, Rheumatoid
Reduction of interleukin-1? induced matrix metalloproteinase-3 release by extracts of six plants: inhibitory screening of 35 traditional medicinal plants.
Arthritis, Rheumatoid
Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
Arthritis, Rheumatoid
Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-Terminal kinase pathway.
Arthritis, Rheumatoid
Regulation of JNK by MKK-7 in fibroblast-like synoviocytes.
Arthritis, Rheumatoid
Relationship between matrix metalloproteinase-3 serum level and pulmonary artery systolic pressure in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.
Arthritis, Rheumatoid
Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease.
Arthritis, Rheumatoid
Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-? Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis.
Arthritis, Rheumatoid
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Arthritis, Rheumatoid
Synovial IL-21/TNF-producing CD4(+) T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes.
Arthritis, Rheumatoid
Synoviocyte innate immune responses: I. Differential regulation of interferon responses and the JNK pathway by MAPK kinases.
Arthritis, Rheumatoid
Targeted knockout of TNF-? by injection of lentivirus-mediated siRNA into the subacromial bursa for the treatment of subacromial bursitis in rats.
Arthritis, Rheumatoid
The effects of periodontal therapy on gingival crevicular fluid matrix metalloproteinase-8, interleukin-6 and prostaglandin E2 levels in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
The effects of pulse methylprednisolone on matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis.
Arthritis, Rheumatoid
The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient.
Arthritis, Rheumatoid
The oral administration effect of drug mannuronic acid (M2000) on gene expression of matrix and tissue inhibitor of metalloproteinases in rheumatoid arthritis patients.
Arthritis, Rheumatoid
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors.
Arthritis, Rheumatoid
Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study.
Arthritis, Rheumatoid
Tumor necrosis factor receptor-associated factor 6 (TRAF6) inhibition modulates bone loss and matrix metalloproteinase expression levels in collagen-induced rheumatoid arthritis rat.
Arthritis, Rheumatoid
[Application of NFkappaB inhibitor for arthritis]
Arthritis, Rheumatoid
[Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis]
Arthritis, Rheumatoid
[Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis]
Arthritis, Rheumatoid
[Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis]
Arthritis, Rheumatoid
[Matrix metalloproteinase 2, 3, and 9 gene polymorphisms in women with rheumatoid arthritis].
Arthritis, Rheumatoid
[Polymorphism of gene promotor region for MMP-2 in rheumatoid arthritis]
Aspergillosis
Cytoskeletal Alteration Is an Early Cellular Response in Pulmonary Epithelium Infected with Aspergillus fumigatus Rather than Scedosporium apiospermum.
Asthma
A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor.
Asthma
Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma.
Asthma
An extract of Crataegus pinnatifida fruit attenuates airway inflammation by modulation of matrix metalloproteinase-9 in ovalbumin induced asthma.
Asthma
Association of matrix metalloproteinase 8 genetic polymorphisms with bronchial asthma in a Japanese population.
Asthma
Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.
Asthma
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
Asthma
Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis.
Asthma
Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.
Asthma
Effect of selective cysteinyl leukotriene receptor antagonists on airway inflammation and matrix metalloproteinase expression in a mouse asthma model.
Asthma
Effect of Xiaochuanping powder on the inflammatory response and airway remodeling in asthmatic rats.
Asthma
Effects of Inhaled Corticosteroids on Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinase-1 in the Airways of Asthmatic Children.
Asthma
Expression of matrix metalloproteinases MMP-9 within the airways in asthma.
Asthma
Human Rhinovirus Infection Upregulates MMP-9 Production in Airway Epithelial Cells via NF-{kappa}B.
Asthma
Immune responses of airway neutrophils are impaired in asthma.
Asthma
Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma.
Asthma
Increased angiogenic factors in exhaled breath condensate of children with severe asthma - New markers of disease progression?
Asthma
Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma.
Asthma
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
Asthma
Inhaled corticosteroids do not reduce initial high activity of matrix metalloproteinase (MMP)-9 in exhaled breath condensates of children with asthma exacerbation: a proof of concept study.
Asthma
Localization of Matrix Metalloproteinase (MMP)-9 in Lung Tissue of a Murine Model of Allergic Asthma.
Asthma
Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma.
Asthma
Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma.
Asthma
Matrix metalloproteinase-1 polymorphism is associated with persistent airway obstruction in asthma in the Taiwanese population.
Asthma
Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults.
Asthma
Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation.
Asthma
Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.
Asthma
Matrix metalloproteinase-9 in lung remodeling.
Asthma
Mechanical stress is communicated between different cell types to elicit matrix remodeling.
Asthma
Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1.
Asthma
Neovastat (AE-941) inhibits the airway inflammation and hyperresponsiveness in a murine model of asthma.
Asthma
Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids.
Asthma
Polymorphic Variants 279R and 668Q Augment Activity of Matrix Metalloproteinase-9 in Breath Condensates of Children with Asthma.
Asthma
Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma.
Asthma
Proteomics: is it an approach to understand the progression of chronic lung disorders?
Asthma
Salmeterol or doxycycline do not inhibit acute bronchospasm and airway inflammation in cats with experimentally-induced asthma.
Asthma
Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: Relationship to disease severity.
Asthma
Sulphonamides: Deserving class as MMP inhibitors?
Asthma
The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity.
Asthma
The effects of interleukin-33 on airways collagen deposition and matrix metalloproteinase expression in a murine surrogate of asthma.
Asthma
Thioredoxin fusion construct enables high-yield production of soluble, active matrix metalloproteinase-8 (MMP-8) in Escherichia coli.
Asthma
Use of a three dimensional cell culture model to study airway smooth muscle / mast cell interactions in airway remodelling.
Asthma
Zingiber cassumunar ROXb. and its active constituent inhibit MMP-9 direct activation by house dust mite allergens and MMP-9 expression in PMA-stimulated human airway epithelial cells.
Astrocytoma
Activated leukocyte cell adhesion molecule is expressed in neuroepithelial neoplasms and decreases with tumor malignancy, matrix metalloproteinase 2 expression, and absence of IDH1R132H mutation.
Astrocytoma
Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells.
Astrocytoma
Exogenous C2 Ceramide Suppresses Matrix Metalloproteinase Gene Expression by Inhibiting ROS Production and MAPK Signaling Pathways in PMA-Stimulated Human Astroglioma Cells.
Astrocytoma
Matrix metalloproteinase expression in childhood astrocytomas.
Astrocytoma
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Astrocytoma
Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Astrocytoma
Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.
Ataxia Telangiectasia
Simian virus 40 transformation alters the actin cytoskeleton, expression of matrix metalloproteinases and inhibitors of metalloproteinases, and invasive behavior of normal and ataxia-telangiectasia human skin fibroblasts.
Atherosclerosis
A fluorescence lifetime spectroscopy study of matrix metalloproteinases-2 and -9 in human atherosclerotic plaque.
Atherosclerosis
A Role of Matrix Metalloproteinase-8 in Atherosclerosis.
Atherosclerosis
Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates.
Atherosclerosis
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells.
Atherosclerosis
Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.
Atherosclerosis
An Important Role of Matrix Metalloproteinase-8 in Angiogenesis in Vitro and in Vivo.
Atherosclerosis
Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
Atherosclerosis
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Atherosclerosis
Associations between serum relaxin 2, aneurysm formation/size and severity of atherosclerosis: a preliminary prospective analysis.
Atherosclerosis
Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation.
Atherosclerosis
Atherosclerotic plaque vulnerability is increased in mouse model of lupus.
Atherosclerosis
Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway.
Atherosclerosis
C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
Atherosclerosis
Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?
Atherosclerosis
Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9.
Atherosclerosis
Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.
Atherosclerosis
Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1.
Atherosclerosis
Cocoa procyanidins inhibit expression and activation of MMP-2 in vascular smooth muscle cells by direct inhibition of MEK and MT1-MMP activities.
Atherosclerosis
Cordycepin inhibits vascular smooth muscle cell proliferation.
Atherosclerosis
Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo.
Atherosclerosis
Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.
Atherosclerosis
Dietary flax seed in prevention of hypercholesterolemic atherosclerosis.
Atherosclerosis
Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
Atherosclerosis
Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8.
Atherosclerosis
Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.
Atherosclerosis
Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury.
Atherosclerosis
Effects of matrix metalloproteinase 13 on vascular smooth muscle cells migration via Akt-ERK dependent pathway.
Atherosclerosis
Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
Atherosclerosis
Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
Atherosclerosis
Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.
Atherosclerosis
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.
Atherosclerosis
Familial abdominal aortic aneurysm: a systematic review of a genetic background.
Atherosclerosis
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Atherosclerosis
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.
Atherosclerosis
Genetics of ultrasonographic carotid atherosclerosis.
Atherosclerosis
Genistein inhibits Ang II-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPAR?-NF-?B signaling pathway in rat vascular smooth muscle cells.
Atherosclerosis
Ghrelin inhibits atherosclerotic plaque angiogenesis and promotes plaque stability in a rabbit atherosclerotic model.
Atherosclerosis
Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling.
Atherosclerosis
Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice.
Atherosclerosis
High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.
Atherosclerosis
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis.
Atherosclerosis
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
Atherosclerosis
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
Atherosclerosis
Inhibition of endogenous nitric oxide in the heart enhances matrix metalloproteinase-2 release.
Atherosclerosis
Inhibitory effect of Uncaria sinensis on human aortic smooth muscle cell migration is based on matrix metalloproteinase-9 inhibitory activity.
Atherosclerosis
Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function.
Atherosclerosis
Intracoronary upregulation of platelet extracellular matrix metalloproteinase inducer (CD147) in coronary disease.
Atherosclerosis
Investigation of RNA interference suppression of matrix metalloproteinase-9 in mouse model of atherosclerosis.
Atherosclerosis
Involvement of integrins, MAPK, and NF-kappaB in regulation of the shear stress-induced MMP-9 expression in endothelial cells.
Atherosclerosis
Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis.
Atherosclerosis
Lithium chloride suppresses LPS-mediated matrix metalloproteinase-9 expression in macrophages through phosphorylation of GSK-3?.
Atherosclerosis
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Atherosclerosis
Macrophage-derived MMP-8 determines smooth muscle cell differentiation from adventitia stem/progenitor cells and promotes neointima hyperplasia.
Atherosclerosis
Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Atherosclerosis
Mast cells promote atherosclerosis by releasing proinflammatory cytokines.
Atherosclerosis
Matrix metalloproteinase inhibition in atherosclerosis and stroke.
Atherosclerosis
Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction.
Atherosclerosis
Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques.
Atherosclerosis
Mechanisms of aortic valve calcification.
Atherosclerosis
Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.
Atherosclerosis
MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs.
Atherosclerosis
MMP-9 inhibition by ACE inhibitor reduces oxidized LDL-mediated foam-cell formation.
Atherosclerosis
Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy.
Atherosclerosis
Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide.
Atherosclerosis
Novel Potent Proline-Based Metalloproteinase Inhibitors: Design, (Radio)Synthesis, and First in Vivo Evaluation as Radiotracers for Positron Emission Tomography.
Atherosclerosis
Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction--is it associated with depressive symptomatology?
Atherosclerosis
Pimaric acid from Aralia cordata has an inhibitory effect on TNF-?-induced MMP-9 production and HASMC migration via down-regulated NF-?B and AP-1.
Atherosclerosis
Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
Atherosclerosis
Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells.
Atherosclerosis
Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.
Atherosclerosis
Potential role of proteasome on c-jun related signaling in hypercholesterolemia induced atherosclerosis.
Atherosclerosis
Practical implications of novel serum ELISA-assay for matrix metalloproteinase-8 in acute cardiac diagnostics.
Atherosclerosis
Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.
Atherosclerosis
Proprotein convertase subtilisin/kexin type 3 promotes adipose tissue-driven macrophage chemotaxis and is increased in obesity.
Atherosclerosis
Putative targeting of matrix metalloproteinase-8 in atherosclerosis.
Atherosclerosis
RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population.
Atherosclerosis
Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
Atherosclerosis
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly.
Atherosclerosis
Role of matrix metalloproteinase-8 in atherosclerosis.
Atherosclerosis
Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.
Atherosclerosis
Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
Atherosclerosis
Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.
Atherosclerosis
The feedback loop of "EMMPRIN/NF-?B" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
Atherosclerosis
Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis.
Atherosclerosis
Thrombin-thrombomodulin activation of protein C facilitates the activation of progelatinase A.
Atherosclerosis
Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.
Atherosclerosis
Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.
Atherosclerosis
Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice.
Atherosclerosis
Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
Atherosclerosis
Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.
Atherosclerosis
[Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease]
Atherosclerosis
[Effect of Dracocephalum moldavica total flavones on expression of TGF-?1/Smad signaling pathway and matrix metalloproteinase of atherosclerosis ApoE-/- mice].
Atherosclerosis
[Influence of periodontal therapy on serum interleukin-6 and carotid metalloproteinases in animals with chronic periodontitis associated with atherosclerosis].
Atherosclerosis
[Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance]
Atherosclerosis
[Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function]
Atrial Fibrillation
Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences.
Atrial Fibrillation
Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation.
Atrial Fibrillation
Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure.
Atrial Fibrillation
Matrix Metalloproteinase Neutrophil Gelatinase-Associated Lipocalin Complex Predicts Atrial Fibrillation Recurrence after Electrical Cardioversion in Obese Patients.
Atrial Fibrillation
MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese.
Atrial Fibrillation
Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.
Atrial Fibrillation
[Metalloproteinase activity of the blood in patients with arterial hypertension with paroxysmal form of atrial fibrillation.]
Atrial Fibrillation
[Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation]
Autoimmune Diseases
A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys alpha B-crystallin and generates a promiscuous T cell epitope.
Autoimmune Diseases
Matrix metalloproteinase and G protein coupled receptors: Co-conspirators in the pathogenesis of autoimmune disease and cancer.
Autoimmune Diseases
Tear Matrix Metalloproteinases and Myeloperoxidase Levels in Patients With Boston Keratoprosthesis Type I.
Axial Spondyloarthritis
Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix?
Bacteremia
Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
Bacteremia
Potential Co-Relation Between Chronic Periodontitis And Cancer - An Emerging Concept.
Bacterial Infections
Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor.
Bacterial Infections
Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histiocytes.
Barrett Esophagus
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
beta-Thalassemia
Association of thalassemia major and gingival inflammation: A pilot study.
Bicuspid Aortic Valve Disease
Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis.
Bicuspid Aortic Valve Disease
Enlarged Size and Impaired Elastic Properties of the Ascending Aorta are Associated with Endothelial Dysfunction and Elevated Plasma Matrix Metalloproteinase-2 Level in Patients with Bicuspid Aortic Valve.
Bicuspid Aortic Valve Disease
Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves.
Bicuspid Aortic Valve Disease
Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation.
Blister
A case of anaphylactoid purpura with multiple blister formation: possible pathophysiological role of gelatinase (MMP-9).
Blister
A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
Blister
Effect of smoking, abstention, and nicotine patch on epidermal healing and collagenase in skin transudate.
Blister
Matrix metalloproteinase gelatinase B (MMP-9) is associated with leaking glaucoma filtering blebs.
Blister
Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Blister
Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.
Blister
Smoking affects collagen synthesis and extracellular matrix turnover in human skin.
Bone Cysts
TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB.
Bone Diseases
Matrix Metalloproteinase Inspired Therapeutic Strategies for Bone Diseases.
Bone Diseases
Metastatic bone disease: pathogenesis and new strategies for treatment.
Bone Diseases
Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
Bone Resorption
A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
Bone Resorption
A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts.
Bone Resorption
A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis.
Bone Resorption
Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis.
Bone Resorption
Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells.
Bone Resorption
Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development.
Bone Resorption
Effect of local hIL-10 gene therapy on experimental periodontitis in ovariectomized rats.
Bone Resorption
Effects of matrix metalloproteinase inhibitors on bone resorption and orthodontic tooth movement.
Bone Resorption
Expression of MMP-8 and MMP-13 in the development of periradicular lesions.
Bone Resorption
Gene expression analyses in malformed skeletal structures of gilthead sea bream (Sparus aurata).
Bone Resorption
In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation.
Bone Resorption
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
Bone Resorption
Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts.
Bone Resorption
miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway.
Bone Resorption
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
Bone Resorption
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Bone Resorption
T cells stimulate catabolic gene expression by the stromal cells from giant cell tumor of bone.
Bone Resorption
The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction.
Bone Resorption
The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts.
Bone Resorption
The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitis.
Bone Resorption
The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.
Bone Resorption
The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.
Bone Resorption
Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
Bone Resorption
Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis.
Bone Resorption
[Bone and bone related biochemical examinations. Bone and collagen related metabolites. Urinary and serum NTX as bone resorption markers]
Brain Diseases
Lipopolysaccharide-Induced Matrix Metalloproteinase-9 Expression Associated with Cell Migration in Rat Brain Astrocytes.
Brain Edema
Basic Fibroblast Growth Factor (bFGF) Protects the Blood-Brain Barrier by Binding of FGFR1 and Activating the ERK Signaling Pathway After Intra-Abdominal Hypertension and Traumatic Brain Injury.
Brain Edema
Brain pericytes are the most thrombin-sensitive matrix metalloproteinase-9-releasing cell type constituting the blood-brain barrier in vitro.
Brain Edema
Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage.
Brain Edema
Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.
Brain Edema
Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs.
Brain Edema
Galangin Inhibits Thrombin-Induced MMP-9 Expression in SK-N-SH Cells via Protein Kinase-Dependent NF-?B Phosphorylation.
Brain Edema
Matrix metalloproteinase inhibition attenuates brain edema after surgical brain injury.
Brain Edema
MATRIX METALLOPROTEINASE INHIBITION ATTENUATES BRAIN EDEMA IN AN IN VIVO MODEL OF SURGICALLY-INDUCED BRAIN INJURY.
Brain Edema
Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury.
Brain Edema
MATRIX METALLOPROTEINASE INHIBITION ATTENUATES BRAIN EDEMA IN AN IN VIVO MODEL OF SURGICALLY-INDUCED BRAIN INJURY.
Brain Edema
Memantine protects blood-brain barrier integrity and attenuates neurological deficits through inhibiting nitric oxide synthase ser1412 phosphorylation in intracerebral hemorrhage rats: involvement of peroxynitrite-related matrix metalloproteinase-9/NLRP3 inflammasome activation.
Brain Edema
Mito-Tempo prevents nicotine-induced exacerbation of ischemic brain damage.
Brain Edema
Monoacylglycerol Lipase Inhibitor is Safe when Combined with Delayed r-tPA Administration in Treatment of Stroke.
Brain Edema
Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats.
Brain Edema
Reduced brain edema and matrix metalloproteinase (MMP) expression by pre-reperfusion infusion into ischemic territory in rat.
Brain Edema
Selective MMP-inhibition with Ro 28-2653 in acute experimental stroke - a magnetic resonance imaging efficacy study.
Brain Edema
Simvastatin in traumatic brain injury: Effect on brain edema mechanisms.
Brain Edema
TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure.
Brain Edema
Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats.
Brain Edema
Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Brain Injuries
A Prospective Evaluation of the Temporal Matrix Metalloproteinase Response after Severe Traumatic Brain Injury in Humans.
Brain Injuries
Cerebroprotection by the neuronal PGE2 receptor EP2 after intracerebral hemorrhage in middle-aged mice.
Brain Injuries
Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
Brain Injuries
Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat.
Brain Injuries
Flavonoids targeting of I?B phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells.
Brain Injuries
Inhibition of matrix metalloproteinases-2/-9 transiently reduces pre-oligodendrocyte loss during lipopolysaccharide- but not tumour necrosis factor-alpha-induced inflammation in fetal ovine glial culture.
Brain Injuries
Matrix metalloproteinase inhibition attenuates brain edema after surgical brain injury.
Brain Injuries
MATRIX METALLOPROTEINASE INHIBITION ATTENUATES BRAIN EDEMA IN AN IN VIVO MODEL OF SURGICALLY-INDUCED BRAIN INJURY.
Brain Injuries
Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury.
Brain Injuries
MATRIX METALLOPROTEINASE INHIBITION ATTENUATES BRAIN EDEMA IN AN IN VIVO MODEL OF SURGICALLY-INDUCED BRAIN INJURY.
Brain Injuries
Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.
Brain Injuries
Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice.
Brain Injuries
Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage.
Brain Injuries
Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection.
Brain Injuries
Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery.
Brain Injuries
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis.
Brain Injuries
[Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients]
Brain Injuries, Traumatic
A Prospective Evaluation of the Temporal Matrix Metalloproteinase Response after Severe Traumatic Brain Injury in Humans.
Brain Injuries, Traumatic
Association between the Cerebral Inflammatory and Matrix Metalloproteinase Responses after Severe Traumatic Brain Injury in Humans.
Brain Injuries, Traumatic
Blood-brain barrier dysfunction significantly correlates with serum matrix metalloproteinase-7 (MMP-7) following traumatic brain injury.
Brain Injuries, Traumatic
Influence of therapeutic hypothermia on matrix metalloproteinase activity after traumatic brain injury in rats.
Brain Injuries, Traumatic
Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study.
Brain Injuries, Traumatic
Prognostic utility of early plasma matrix metalloproteinases -2 and -9 concentrations after severe traumatic brain injury.
Brain Injuries, Traumatic
Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats.
Brain Injuries, Traumatic
Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.
Brain Ischemia
A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia.
Brain Ischemia
An in-silico strategy to explore neuroprotection by quercetin in cerebral ischemia: a novel hypothesis based on inhibition of matrix metalloproteinase (MMPs) and acid sensing ion channel 1a (ASIC1a).
Brain Ischemia
Analysis of regulatory effect of miR-149-5p on Sphingosine-1-phosphate receptor 2 of pericytes and its neuroprotective molecular mechanism after acute cerebral ischemia reperfusion in rats.
Brain Ischemia
Blockade of Apoptosis Signal-Regulating Kinase 1 Attenuates Matrix Metalloproteinase 9 Activity in Brain Endothelial Cells and the Subsequent Apoptosis in Neurons after Ischemic Injury.
Brain Ischemia
Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Brain Ischemia
Comparison of matrix metalloproteinase activation after focal cortical ischemia in young adult and aged mice.
Brain Ischemia
Crocin protects against cerebral- ischemia-induced damage in aged rats through maintaining the integrity of blood-brain barrier.
Brain Ischemia
Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia.
Brain Ischemia
Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke.
Brain Ischemia
Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke.
Brain Ischemia
In Vivo Evidence that the Increase in Matrix Metalloproteinase Activity Occurs Early after Cerebral Ischemia.
Brain Ischemia
In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia.
Brain Ischemia
Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia.
Brain Ischemia
Lithium chloride suppresses LPS-mediated matrix metalloproteinase-9 expression in macrophages through phosphorylation of GSK-3?.
Brain Ischemia
Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
Brain Ischemia
Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia.
Brain Ischemia
Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia.
Brain Ischemia
Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice.
Brain Ischemia
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice.
Brain Ischemia
Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia.
Brain Ischemia
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
Brain Ischemia
Neuroprotective effects of N-acetylcysteine via inhibition of matrix metalloproteinase in a mouse model of transient global cerebral ischemia.
Brain Ischemia
Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats.
Brain Ischemia
PPARgamma agonist pioglitazone rescues neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.
Brain Ischemia
Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats.
Brain Ischemia
The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
Brain Ischemia
The neuroprotective effect of MicroRNA-149-5p and coenzymeQ10 by reducing levels of inflammatory cytokines and metalloproteinases following focal brain ischemia in rats.
Brain Ischemia
Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Brain Neoplasms
Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells.
Brain Neoplasms
Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Brain Neoplasms
Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo.
Brain Neoplasms
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro.
Brain Neoplasms
Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy cell index of high-grade glioblastoma.
Brain Neoplasms
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Brain Neoplasms
In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture.
Brain Neoplasms
Increased expression of intracystic matrix metalloproteinases in brain tumors: relationship to the pathogenesis of brain tumor-associated cysts and peritumoral edema.
Brain Neoplasms
Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells.
Brain Neoplasms
Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Brain Neoplasms
Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Brain Neoplasms
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Brain Neoplasms
[The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in invasion of tumours of neuroepithelial tissue]
Breast Neoplasms
A drug-delivering-drug strategy for combined treatment of metastatic breast cancer.
Breast Neoplasms
A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma.
Breast Neoplasms
A matrix metalloproteinase gene expressed in human T lymphocytes is identical with collagenase 3 from breast carcinomas.
Breast Neoplasms
A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment.
Breast Neoplasms
A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice.
Breast Neoplasms
A Multiwell-Based Detection Platform with Integrated PDMS Concentrators for Rapid Multiplexed Enzymatic Assays.
Breast Neoplasms
A novel role for the SUMO E3 ligase PIAS1 in cancer metastasis.
Breast Neoplasms
A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.
Breast Neoplasms
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer.
Breast Neoplasms
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.
Breast Neoplasms
Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.
Breast Neoplasms
Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells.
Breast Neoplasms
Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancer orthotopic model.
Breast Neoplasms
alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells.
Breast Neoplasms
Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression.
Breast Neoplasms
Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway.
Breast Neoplasms
An assessment of MMP and TIMP gene expression in cell lines and stroma - tumour differences in microdissected breast cancer biopsies.
Breast Neoplasms
Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery.
Breast Neoplasms
Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells.
Breast Neoplasms
Applications of Hairpin DNA-Functionalized Gold Nanoparticles for Imaging mRNA in Living Cells.
Breast Neoplasms
Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-?B activation in TPA-induced breast cancer cells.
Breast Neoplasms
Aryl Hydrocarbon Receptor in Breast Cancer-A Newly Defined Prognostic Marker.
Breast Neoplasms
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
Breast Neoplasms
Assignment of the human stromelysin 3 (STMY3) gene to the q11.2 region of chromosome 22.
Breast Neoplasms
Association between Expression of Tissue Inhibitors of Metalloproteinases-1, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Genes and Axillary Lymph Nodes Metastasis in Patients with Breast Cancer.
Breast Neoplasms
Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis.
Breast Neoplasms
Association of matrix metalloproteinases 3 and 9 single nucleotide polymorphisms with breast cancer risk: A case-control study.
Breast Neoplasms
Augmented release of matrix metalloproteinase-9 by PKC activation in organotypic cultures of human breast cancer and adjacent normal breast tissue and fibroadenoma.
Breast Neoplasms
Biochemical characterization of human collagenase-3.
Breast Neoplasms
Body fluid MMP-2 as a putative biomarker in metastatic breast cancer.
Breast Neoplasms
Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing.
Breast Neoplasms
Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines.
Breast Neoplasms
CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
Breast Neoplasms
CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
Breast Neoplasms
Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.
Breast Neoplasms
Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories.
Breast Neoplasms
Cleavage of Syndecan-1 Promotes the Proliferation of the Basal-Like Breast Cancer Cell Line BT-549 Via Akt SUMOylation.
Breast Neoplasms
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
Breast Neoplasms
Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta.
Breast Neoplasms
Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor.
Breast Neoplasms
Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development.
Breast Neoplasms
Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx.
Breast Neoplasms
Common matrix metalloproteinase-2 gene variants and altered susceptibility to breast cancer and associated features in Tunisian women.
Breast Neoplasms
Correction: The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.
Breast Neoplasms
Crosstalk between TGF-? signaling and miRNAs in breast cancer metastasis.
Breast Neoplasms
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Breast Neoplasms
Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.
Breast Neoplasms
Determining the dynamics of cancer cell secretion.
Breast Neoplasms
Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection.
Breast Neoplasms
Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts.
Breast Neoplasms
Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas.
Breast Neoplasms
Downregulation of caveolin-1 promotes murine breast cancer cell line progression by highly glycosylated CD147.
Breast Neoplasms
Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Breast Neoplasms
Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery.
Breast Neoplasms
Dynamics of internalization and recycling of the prometastatic membrane type 4 matrix metalloproteinase (MT4-MMP) in breast cancer cells.
Breast Neoplasms
Dysregulation of adenosine kinase isoforms in breast cancer.
Breast Neoplasms
Effect of GnT-V knockdown on the proliferation, migration and invasion of the SMMC7721/R human hepatocellular carcinoma drug-resistant cell line.
Breast Neoplasms
Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
Breast Neoplasms
Effect of methanolic and water extract of Leucobryum bowringii Mitt. on growth, migration and invasion of MCF 7 human breast cancer cells in vitro.
Breast Neoplasms
Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.
Breast Neoplasms
Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells.
Breast Neoplasms
Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors.
Breast Neoplasms
Expression of collagenase-3 in the rat ovary during the ovulatory process.
Breast Neoplasms
Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells.
Breast Neoplasms
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Breast Neoplasms
Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model.
Breast Neoplasms
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Breast Neoplasms
Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.
Breast Neoplasms
Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
Breast Neoplasms
Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways.
Breast Neoplasms
Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Breast Neoplasms
Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis.
Breast Neoplasms
Hsa-miR-206 represses the proliferation and invasion of breast cancer cells by targeting Cx43.
Breast Neoplasms
Human brain endothelial cell-derived COX-2 facilitates extravasation of breast cancer cells across the blood-brain barrier.
Breast Neoplasms
Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity.
Breast Neoplasms
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
Breast Neoplasms
Imaging Matrix Metalloproteinase Activity Implicated in Breast Cancer Progression.
Breast Neoplasms
Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells.
Breast Neoplasms
Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Breast Neoplasms
In situ injection of dual-delivery PEG based MMP-2 sensitive hydrogels for enhanced tumor penetration and chemo-immune combination therapy.
Breast Neoplasms
Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes.
Breast Neoplasms
Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol.
Breast Neoplasms
Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells.
Breast Neoplasms
Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study.
Breast Neoplasms
Inhibition of cell invasion and migration by CEACAM1-4S in breast cancer.
Breast Neoplasms
Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.
Breast Neoplasms
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen.
Breast Neoplasms
Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells.
Breast Neoplasms
Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness?
Breast Neoplasms
KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9.
Breast Neoplasms
Loquat (Eriobotrya japonica) extracts suppress the adhesion, migration and invasion of human breast cancer cell line.
Breast Neoplasms
Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Breast Neoplasms
Low serum MMP-1 in breast cancer: a negative prognostic factor?
Breast Neoplasms
Matrix metalloproteinase (MMP)-1 and MMP-3 gene variations affect MMP-1 and -3 serum concentration and associates with breast cancer.
Breast Neoplasms
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
Breast Neoplasms
Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
Breast Neoplasms
Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells.
Breast Neoplasms
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database.
Breast Neoplasms
Matrix metalloproteinase expression in breast cancer.
Breast Neoplasms
Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
Breast Neoplasms
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Breast Neoplasms
Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Breast Neoplasms
Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
Breast Neoplasms
Matrix metalloproteinase inhibitors: past lessons and future prospects in breast cancer.
Breast Neoplasms
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Breast Neoplasms
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
Breast Neoplasms
Matrix metalloproteinase?2 regulates MDA?MB?231 breast cancer cell invasion induced by active mammalian diaphanous-related formin 1.
Breast Neoplasms
Matrix metalloproteinases and metastatic cancer.
Breast Neoplasms
Matrix metalloproteinases are involved in both type I (apoptosis) and type II (autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells.
Breast Neoplasms
Matrix metalloproteinases as breast cancer drivers and therapeutic targets.
Breast Neoplasms
MBP-1 inhibits breast cancer growth and metastasis in immunocompetent mice.
Breast Neoplasms
Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.
Breast Neoplasms
Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumor vascular architecture.
Breast Neoplasms
Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.
Breast Neoplasms
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model.
Breast Neoplasms
Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: the role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.
Breast Neoplasms
Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells.
Breast Neoplasms
Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.
Breast Neoplasms
Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.
Breast Neoplasms
Monoclonal anti?MUC1 antibody with novel octahydropyrazino[2,1?a:5,4?a']diisoquinoline derivative as a potential multi?targeted strategy in MCF?7 breast cancer cells.
Breast Neoplasms
Myricetin suppresses breast cancer metastasis through down-regulating the activity of matrix metalloproteinase (MMP)-2/9.
Breast Neoplasms
Novel strategy in breast cancer therapy: Revealing the bright side of ginsenosides.
Breast Neoplasms
Oldenlandia diffusa suppresses metastatic potential through inhibiting matrix metalloproteinase-9 and intercellular adhesion molecule-1 expression via p38 and ERK1/2 MAPK pathways and induces apoptosis in human breast cancer MCF-7 cells.
Breast Neoplasms
Oleuropein induces anti-metastatic effects in breast cancer.
Breast Neoplasms
Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Breast Neoplasms
Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer.
Breast Neoplasms
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196.
Breast Neoplasms
Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
Breast Neoplasms
Potential Role of Phytochemicals Against Matrix Metalloproteinase Induced Breast Cancer; An Explanatory Review.
Breast Neoplasms
Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
Breast Neoplasms
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Breast Neoplasms
Protein kinase D1 inhibits breast cancer cell invasion via regulating matrix metalloproteinase expression.
Breast Neoplasms
Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Breast Neoplasms
Proteinases As Biomarkers In Breast Cancer Prognosis And Diagnosis.
Breast Neoplasms
Proteomic validation of protease drug targets: pharmacoproteomics of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tag labelling and tandem mass spectrometry.
Breast Neoplasms
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.
Breast Neoplasms
Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
Breast Neoplasms
Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Breast Neoplasms
Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions.
Breast Neoplasms
Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells.
Breast Neoplasms
Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.
Breast Neoplasms
Replication study for reported SNP associations with breast cancer survival.
Breast Neoplasms
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis.
Breast Neoplasms
Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
Breast Neoplasms
Serum cytokine profile in patients with breast cancer.
Breast Neoplasms
Serum TIMP-1 predicts survival outcomes of invasive breast carcinoma patients: a meta-analysis.
Breast Neoplasms
Short-hairpin RNA-mediated MTA2 silencing inhibits human breast cancer cell line MDA-MB231 proliferation and metastasis.
Breast Neoplasms
SKA2 mediates invasion and metastasis in human breast cancer via EMT.
Breast Neoplasms
SPIONs embedded in polyamino acid nanogels to synergistically treat tumor microenvironment and breast cancer cells.
Breast Neoplasms
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.
Breast Neoplasms
Statins and breast cancer: may matrix metalloproteinase be the missing link.
Breast Neoplasms
Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Breast Neoplasms
Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts.
Breast Neoplasms
Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13).
Breast Neoplasms
Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Breast Neoplasms
Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.
Breast Neoplasms
Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.
Breast Neoplasms
TAK1-TAB2 Signaling Contributes to Bone Destruction by Breast Carcinoma Cells.
Breast Neoplasms
Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
Breast Neoplasms
Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.
Breast Neoplasms
The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.
Breast Neoplasms
The Association of Matrix Metalloproteinase-8 Promoter Genotypes in Breast Cancer.
Breast Neoplasms
The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis.
Breast Neoplasms
The effect of opine on matrix metalloproteinase expression in mice with breast cancer.
Breast Neoplasms
The effect of tomatine on metastasis related matrix metalloproteinase (MMP) activities in breast cancer cell model.
Breast Neoplasms
The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer.
Breast Neoplasms
The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain.
Breast Neoplasms
The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family.
Breast Neoplasms
The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
Breast Neoplasms
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
Breast Neoplasms
Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer.
Breast Neoplasms
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells.
Breast Neoplasms
Toll-Like Receptor 9 Agonists Promote Cellular Invasion by Increasing Matrix Metalloproteinase Activity.
Breast Neoplasms
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
Breast Neoplasms
Transcriptional control of cell density dependent regulation of matrix metalloproteinase and TIMP expression in breast cancer cell lines.
Breast Neoplasms
Two-photon laser-generated microtracks in 3D collagen lattices: principles of MMP-dependent and -independent collective cancer cell invasion.
Breast Neoplasms
Up-regulation of miR-182 by ?-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.
Breast Neoplasms
Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis.
Breast Neoplasms
USP4 promotes invasion of breast cancer cells via Relaxin/TGF-?1/Smad2/MMP-9 signal.
Breast Neoplasms
Valproic acid modulates radiation-enhanced matrix metalloproteinase activity and invasion of breast cancer cells.
Breast Neoplasms
Wortmannin Reduces Metastasis and Angiogenesis of Human Breast Cancer Cells via Nuclear Factor- B-dependent Matrix Metalloproteinase-9 and Interleukin-8 Pathways.
Breast Neoplasms
Zinc stable isotope analysis reveals Zn dyshomeostasis in benign tumours, breast cancer, and adjacent histologically normal tissue.
Breast Neoplasms
ZKSCAN3 promotes breast cancer cell proliferation, migration and invasion.
Breast Neoplasms
[A Simple Medical Research Microdevice for Analyzing Three-dimensional Migration of Tumor Cells in Vitro].
Breast Neoplasms
[Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer]
Breast Neoplasms
[Expression of matrix metalloproteinase (MMP-2) and extracellular matrix metalloproteinases inducer (EMMPRIN) in benign and advanced breast cancer tissue samples]
Breast Neoplasms
[Relationship between LKB1 gene and invasion-related factors of breast cancer cells]
Breast Neoplasms
[Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma]
Breast Neoplasms
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Bronchiectasis
Collagenase-2 and -3 are inhibited by doxycycline in the chronically inflamed lung in bronchiectasis.
Bronchiectasis
Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease.
Bronchiectasis
In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis.
Bronchiectasis
Lack of association between matrix metalloproteinase 8 promoter polymorphism and bronchiectasis in Koreans.
Bronchiectasis
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Bronchiectasis
Matrix Metalloproteinases Vary with Airway Microbiota Composition and Lung Function in Non-Cystic Fibrosis Bronchiectasis.
Bronchiectasis
Potentiative effects of neutral proteinases in an inflamed lung: relationship of neutrophil procollagenase (proMMP-8) to plasmin, cathepsin G and tryptase in bronchiectasis in vivo.
Bronchiectasis
Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications.
Bronchiolitis
Editorial: leukocyte trafficking and matrix metalloproteinase-8 in obliterative bronchiolitis.
Bronchiolitis
Matrix metalloproteinase induction in post-transplant obliterative bronchiolitis.
Bronchiolitis
MMP-8 promotes polymorphonuclear cell migration through collagen barriers in obliterative bronchiolitis.
Bronchitis, Chronic
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
Bronchopulmonary Dysplasia
Angiogenesis-related genes may be a more important factor than matrix metalloproteinases in bronchopulmonary dysplasia development.
Bronchopulmonary Dysplasia
Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development.
Bronchopulmonary Dysplasia
Matrix Metalloproteinase-9 Deficiency Worsens Lung Injury in a Model of Bronchopulmonary Dysplasia.
Bursitis
Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor.
Bursitis
Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise.
Calcinosis
GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity.
Capsule Opacification
[Experimental study on effects of matrix metalloproteinase inhibitor on posterior capsule opacification in rabbits].
Carcinogenesis
A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.
Carcinogenesis
Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis.
Carcinogenesis
Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Carcinogenesis
Cell Specific Matrix Metalloproteinase-1 Regulates Lung Metastasis Synergistically with Smoke Exposure.
Carcinogenesis
Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.
Carcinogenesis
Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Carcinogenesis
Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma.
Carcinogenesis
Different Role of Caveolin-1 Gene in the Progression of Gynecological Tumors.
Carcinogenesis
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Carcinogenesis
Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Carcinogenesis
Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model.
Carcinogenesis
Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis.
Carcinogenesis
Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse.
Carcinogenesis
Fli?1 promotes metastasis by regulating MMP2 signaling in hepatocellular carcinoma.
Carcinogenesis
Galangin and Kaempferol Suppress Phorbol-12-Myristate-13-Acetate-Induced Matrix Metalloproteinase-9 Expression in Human Fibrosarcoma HT-1080 Cells.
Carcinogenesis
Glycoprotein non-metastatic melanoma protein B promotes glioma motility and angiogenesis through the Wnt/?-catenin signaling pathway.
Carcinogenesis
High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
Carcinogenesis
Inflammatory and tumorigenic effects of environmental pollutants found in particulate matter on lung epithelial cells.
Carcinogenesis
Influence of HPV16 E2 and its localisation on the expression of matrix metalloproteinase-9.
Carcinogenesis
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
Carcinogenesis
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
Carcinogenesis
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Carcinogenesis
Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis.
Carcinogenesis
Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
Carcinogenesis
Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.
Carcinogenesis
Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
Carcinogenesis
miR?378a?3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.
Carcinogenesis
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.
Carcinogenesis
MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
Carcinogenesis
MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
Carcinogenesis
New target therapies in advanced pancreatic cancer.
Carcinogenesis
No Association of Matrix Metalloproteinase [MMP]-2 (-735C > T) and Tissue Inhibitor of Metalloproteinase [TIMP]-2 (-418G > C) Gene Polymorphisms with Cervical Cancer Susceptibility.
Carcinogenesis
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism.
Carcinogenesis
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Carcinogenesis
Pirfenidone inhibits TGF-beta expression in malignant glioma cells.
Carcinogenesis
Pivotal involvement of the CX3CL1-CX3CR1 axis for the recruitment of M2 tumor-associated macrophages in skin carcinogenesis.
Carcinogenesis
Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
Carcinogenesis
Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix.
Carcinogenesis
Role of matrix metalloproteinases in colorectal carcinogenesis.
Carcinogenesis
STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
Carcinogenesis
Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery.
Carcinogenesis
Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
Carcinogenesis
Testosterone-induced matrix metalloproteinase activation is a checkpoint for neuronal addition to the adult songbird brain.
Carcinogenesis
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Carcinogenesis
The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 gene promoter region in invasion and prognosis of meningiomas.
Carcinogenesis
Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression.
Carcinogenesis
Upregulated expression of MMP-9 in gingival epithelial cells induced by prolonged stimulation with arecoline.
Carcinogenesis
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma.
Carcinogenesis
[Expression and clinical significance of matrix metalloproteinase-26 in non-small cell lung cancer.]
Carcinogenesis
[The matrix metalloproteinase in oral and oropharyngeol cancer - literature review].
Carcinoid Tumor
Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Carcinoma
(-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells.
Carcinoma
A circular RNA derived from MMP9 facilitates oral squamous cell carcinoma metastasis through regulation of MMP9 mRNA stability.
Carcinoma
A novel functional site of extracellular matrix metalloproteinase inducer (EMMPRIN) that limits the migration of human uterine cervical carcinoma cells.
Carcinoma
A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.
Carcinoma
Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas.
Carcinoma
Acid-electrolyzed functional water induces extracellular matrix metalloproteinase inducer, a possible novel alarmin, secretion from oral squamous cell carcinoma cell lines.
Carcinoma
Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells.
Carcinoma
An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma.
Carcinoma
Analysis of the gene-expression profile regarding the progression of human gastric carcinoma.
Carcinoma
Annexin A1 expression is correlated with malignant potential of renal cell carcinoma.
Carcinoma
Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model.
Carcinoma
Anti-invasive activities of anthocyanins through modulation of tight junctions and suppression of matrix metalloproteinase activities in HCT-116 human colon carcinoma cells.
Carcinoma
Anti-invasive activity of ethanol extracts of Ganoderma lucidum through tightening of tight junctions and inhibition of matrix metalloproteinase activities in human gastric carcinoma cells.
Carcinoma
Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
Carcinoma
Anti-invasive effects of decitabine, a DNA methyltransferase inhibitor, through tightening of tight junctions and inhibition of matrix metalloproteinase activities in AGS human gastric carcinoma cells.
Carcinoma
Antibody microarray-based technology to rapidly define matrix metalloproteinase (MMP) signatures in patients undergoing resection for primary gastric carcinoma.
Carcinoma
Anticancer Efficacy of Polyphenols and Their Combinations.
Carcinoma
Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Carcinoma
Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China.
Carcinoma
Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Carcinoma
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
Carcinoma
Caveolin-1 promotes an invasive phenotype and predicts poor prognosis in large cell lung carcinoma.
Carcinoma
Caveolin-1 regulating the invasion and expression of matrix metalloproteinase (MMPs) in pancreatic carcinoma cells.
Carcinoma
Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells.
Carcinoma
Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry.
Carcinoma
Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
Carcinoma
Cleavage of beta 4 integrin by matrilysin.
Carcinoma
Clinicopathologic significance of fascin, extracellular matrix metalloproteinase inducer, and ezrin expressions in colorectal adenocarcinoma.
Carcinoma
Clinicopathological Significance of Matrix Metalloproteinase-2 Protein Expression in Renal Cell Carcinoma Patients.
Carcinoma
Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation.
Carcinoma
Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.
Carcinoma
Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas.
Carcinoma
Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
Carcinoma
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
Carcinoma
Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas.
Carcinoma
Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma.
Carcinoma
Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Carcinoma
Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.
Carcinoma
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Carcinoma
Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification.
Carcinoma
Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Carcinoma
Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Carcinoma
Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon.
Carcinoma
Differential expression of degradome components in cutaneous squamous cell carcinomas.
Carcinoma
Differential expression of matrix metalloproteinase-2 by fibroblasts in co-cultures with keratinocytes, basal cell carcinoma and melanoma.
Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Carcinoma
Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung.
Carcinoma
Divergent Matrix-Remodeling Strategies Distinguish Developmental from Neoplastic Mammary Epithelial Cell Invasion Programs.
Carcinoma
Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma.
Carcinoma
DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cells.
Carcinoma
Dual regulation of stromelysin-3 by fibroblast growth factor-2 in murine osteoblasts.
Carcinoma
Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor.
Carcinoma
Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma.
Carcinoma
Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses.
Carcinoma
Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
Carcinoma
Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines.
Carcinoma
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Carcinoma
EMMPRIN expression in oral SCC is regulated by FYN kinase.
Carcinoma
EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.
Carcinoma
EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome.
Carcinoma
EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
Carcinoma
Endosomal WASH and exocyst complexes control exocytosis of MT1-MMP at invadopodia.
Carcinoma
Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
Carcinoma
Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion.
Carcinoma
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model.
Carcinoma
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
Carcinoma
Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.
Carcinoma
Estimation of serum and salivary matrix metalloproteinase levels in oral squamous cell carcinoma patients: a systematic review and meta-analysis.
Carcinoma
Euterpe oleracea extract inhibits tumorigenesis effect of the chemical carcinogen DMBA in breast experimental cancer.
Carcinoma
Exercise modulates platelet-nasopharyngeal carcinoma cell aggregation and subsequent tissue factor and matrix metalloproteinase activities.
Carcinoma
Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.
Carcinoma
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
Carcinoma
Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas.
Carcinoma
Expression levels of matrix metalloproteinase-9 in human gastric carcinoma.
Carcinoma
Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase.
Carcinoma
Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.
Carcinoma
Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
Carcinoma
Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
Carcinoma
Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma.
Carcinoma
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Carcinoma
Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Carcinoma
Expression of matrix metalloproteinases in feline vaccine site-associated sarcomas.
Carcinoma
Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis.
Carcinoma
Expression of matrix metalloproteinases in gastric carcinoma and possibility of clinical application of matrix metalloproteinase inhibitor in vivo.
Carcinoma
Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Carcinoma
Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma.
Carcinoma
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Carcinoma
Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines.
Carcinoma
Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.
Carcinoma
Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma.
Carcinoma
Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Carcinoma
Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication.
Carcinoma
Extracellular matrix metalloproteinase inducer expression in histological grades of oral squamous cell carcinoma - An immunohistochemical study.
Carcinoma
Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Carcinoma
Extracellular vesicles originating from glioblastoma cells increase metalloproteinase release by astrocytes: the role of CD147 (EMMPRIN) and ionizing radiation.
Carcinoma
Fusobacteria modulate oral carcinogenesis and promote cancer progression.
Carcinoma
Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography.
Carcinoma
Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes.
Carcinoma
High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Carcinoma
High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.
Carcinoma
Human collagenase-3 is expressed in malignant squamous epithelium of the skin.
Carcinoma
Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer.
Carcinoma
Human neutrophil peptide-1 affects matrix metalloproteinase-2, -8 and -9 secretions of oral squamous cell carcinoma cell lines in vitro.
Carcinoma
Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts.
Carcinoma
Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities.
Carcinoma
Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Carcinoma
Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
Carcinoma
Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths.
Carcinoma
Immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma.
Carcinoma
Immunohistochemical expression of MMP-2 and MMP-8 in oral squamous cell carcinoma.
Carcinoma
Immunohistochemical predictors in squamous cell carcinoma of the tongue and floor of the mouth.
Carcinoma
Impedimetric toxicity assay in microfluidics using free and liposome-encapsulated anticancer drugs.
Carcinoma
In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors and human papillomavirus transcripts in cervical carcinoma cell lines.
Carcinoma
Increased expression of matrix metalloproteinase-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma.
Carcinoma
Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.
Carcinoma
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Carcinoma
Inducing regulated necrosis and shifting macrophage polarization with anti-EMMPRIN antibody (161-pAb) and complement factors.
Carcinoma
Inhibiting Invasion into Human Bladder Carcinoma 5637 Cells with Diallyl Trisulfide by Inhibiting Matrix Metalloproteinase Activities and Tightening Tight Junctions.
Carcinoma
Inhibition of Matrix Metalloproteinase Activities and Tightening of Tight Junctions by Diallyl Disulfide in AGS Human Gastric Carcinoma Cells.
Carcinoma
Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
Carcinoma
Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model.
Carcinoma
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Carcinoma
Interleukin-6 as a potential molecular target in esophageal squamous cell carcinoma.
Carcinoma
Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
Carcinoma
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
Carcinoma
Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
Carcinoma
Lysyl oxidase-like-1 enhances lung metastasis when lactate accumulation and monocarboxylate transporter expression are involved.
Carcinoma
Mast cells and matrix metalloproteinase 9 expression in actinic cheilitis and lip squamous cell carcinoma.
Carcinoma
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Carcinoma
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Carcinoma
Matrilysins may not predict the metastatic potential in squamous cell carcinoma of the tongue.
Carcinoma
Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines.
Carcinoma
Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
Carcinoma
Matrix metalloproteinase activity in urine of patients with renal cell carcinoma leads to degradation of extracellular matrix proteins: possible use as a screening assay.
Carcinoma
Matrix metalloproteinase expression in basal cell carcinoma: relationship between enzyme profile and collagen fragmentation pattern.
Carcinoma
Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients.
Carcinoma
Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
Carcinoma
Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice.
Carcinoma
Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma.
Carcinoma
Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.
Carcinoma
Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
Carcinoma
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Carcinoma
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
Carcinoma
Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.
Carcinoma
Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation.
Carcinoma
Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Carcinoma
MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts.
Carcinoma
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Carcinoma
MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus.
Carcinoma
Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines.
Carcinoma
Molecular docking of alkaloid compounds with the matrix metalloproteinase 2.
Carcinoma
Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B.
Carcinoma
MT1?MMP promotes the proliferation and invasion of gastric carcinoma cells via regulating vimentin and E?cadherin.
Carcinoma
MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells.
Carcinoma
NF-kappaB involvement in tumor-stroma interaction of squamous cell carcinoma.
Carcinoma
Non-invasive methods of bladder cancer detection.
Carcinoma
Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma.
Carcinoma
Overexpression of the thrombospondin 2 (TSP2) gene modulated by the matrix metalloproteinase family expression and production in human colon carcinoma cell line.
Carcinoma
Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Carcinoma
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Carcinoma
Phenotypes of human esophageal squamous cell carcinoma based on matrix metalloproteinase production.
Carcinoma
Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.
Carcinoma
PKM2 enhances cancer invasion via ETS-1-dependent induction of matrix metalloproteinase in oral squamous cell carcinoma cells.
Carcinoma
Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
Carcinoma
Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
Carcinoma
Potentiation of cell invasion and matrix metalloproteinase production by alpha3beta1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5.
Carcinoma
Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin.
Carcinoma
Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.
Carcinoma
Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Carcinoma
Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma.
Carcinoma
Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma.
Carcinoma
Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.
Carcinoma
Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.
Carcinoma
Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression.
Carcinoma
Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.
Carcinoma
Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.
Carcinoma
Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.
Carcinoma
Relationship among expression of basic-fibroblast growth factor, MTDH/Astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas.
Carcinoma
Relationship between the Expression of Matrix Metalloproteinase and Clinicopathologic Features in Oral Squamous Cell Carcinoma.
Carcinoma
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis.
Carcinoma
Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
Carcinoma
Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Carcinoma
Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake.
Carcinoma
Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
Carcinoma
Serum metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in lung carcinoma patients.
Carcinoma
Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction.
Carcinoma
Significance of matrix metalloproteinase 9 and CD34 expressions in esophageal carcinoma: correlation with DNA content.
Carcinoma
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
Carcinoma
Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts.
Carcinoma
Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer.
Carcinoma
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Carcinoma
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Carcinoma
Stromelysin-3 expression promotes tumor take in nude mice.
Carcinoma
Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.
Carcinoma
Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression.
Carcinoma
Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
Carcinoma
Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Carcinoma
Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line.
Carcinoma
The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
Carcinoma
The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma.
Carcinoma
The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Carcinoma
The IGF-I Receptor Can Alter the Matrix Metalloproteinase Repertoire of Tumor Cells through Transcriptional Regulation of PKC-{alpha}
Carcinoma
The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
Carcinoma
The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma.
Carcinoma
The interplay of matrix metalloproteinase-8, transforming growth factor-?1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Carcinoma
The matrix metalloproteinase system in oral squamous cell carcinoma.
Carcinoma
The prognostic values of matrix metalloproteinases in ovarian cancer.
Carcinoma
The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma.
Carcinoma
The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas.
Carcinoma
Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1.
Carcinoma
TIMP-1 Overexpression in Lung Carcinoma Enhances Tumor Kinetics and Angiogenesis in Brain Metastasis.
Carcinoma
Tissue inhibitors of matrix metalloproteinases 1 and 2 and matrix metalloproteinase activity in the serum and lungs of mice with lewis lung carcinoma.
Carcinoma
Transcriptional induction of stromelysin-3 in mesodermal cells is mediated by an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive site.
Carcinoma
Transcriptional regulation of the Xenopus laevis Stromelysin-3 gene by thyroid hormone is mediated by a DNA element in the first intron.
Carcinoma
Trypsin-2 Enhances Carcinoma Invasion by Processing Tight Junctions and Activating ProMT1-MMP.
Carcinoma
Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.
Carcinoma
Up-regulation of matrix metalloproteinase family gene involvement in ursolic acid-induced human lung non-small carcinoma cell apoptosis.
Carcinoma
Up-regulation of matrix metalloproteinase-8 by betel quid extract and arecoline and its role in 2D motility.
Carcinoma
Upregulated expression and activation of membrane?associated proteases in esophageal squamous cell carcinoma.
Carcinoma
Urinary matrix metalloproteinase activity is not significantly altered in patients with renal cell carcinoma.
Carcinoma
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Carcinoma
WNT-5A, but not matrix metalloproteinase 3 or beta-catenin protein, expression is related to early stages of lip carcinogenesis.
Carcinoma
[An experimental study of matrix metalloproteinase inhibitor BB-94 inhibits the invasion and metastasis of the human salivary adenoid cystic carcinoma in vitro and in vivo]
Carcinoma
[Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma]
Carcinoma
[Collagenase-3 (MMP-13) expression in epithelial cancers of the eyelids]
Carcinoma
[Correlation of membrane type I matrix metalloproteinase (MT1-MMP) expression with clinicomorphological features of tumor front in squamous cell carcinoma of the larynx]
Carcinoma
[Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization]
Carcinoma
[Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
Carcinoma
[Expression of extracellular matrix metalloproteinase inducer in human bladder transitional cell carcinoma]
Carcinoma
[Expression of extracellular matrix metalloproteinase inducer in laryngeal squamous cell carcinoma]
Carcinoma
[Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance]
Carcinoma
[Expressions of discoidin domain receptor 1 and matrix metalloproteinase 2 in salivary gland adenoid cystic carcinoma and clinical significance].
Carcinoma
[Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3]
Carcinoma
[Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis]
Carcinoma
[Matrix metalloproteinase in human gastric carcinoma]
Carcinoma
[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]
Carcinoma
[Relationship between expression of MMP-2 and prognosis in human laryngeal squamous cell carcinoma].
Carcinoma
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]
Carcinoma
[The expression of EMMPRIN and the matrix metalloproteinase MMP-1 in the cervix uteri and corpus uteri in cervical squamous cell carcinoma].
Carcinoma, Adenoid Cystic
Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Carcinoma, Adenoid Cystic
[An experimental study of matrix metalloproteinase inhibitor BB-94 inhibits the invasion and metastasis of the human salivary adenoid cystic carcinoma in vitro and in vivo]
Carcinoma, Adenoid Cystic
[Expressions of discoidin domain receptor 1 and matrix metalloproteinase 2 in salivary gland adenoid cystic carcinoma and clinical significance].
Carcinoma, Basal Cell
Differential expression of matrix metalloproteinase-2 by fibroblasts in co-cultures with keratinocytes, basal cell carcinoma and melanoma.
Carcinoma, Basal Cell
Matrix metalloproteinase expression in basal cell carcinoma: relationship between enzyme profile and collagen fragmentation pattern.
Carcinoma, Basal Cell
Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients.
Carcinoma, Basal Cell
MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts.
Carcinoma, Basal Cell
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Carcinoma, Ductal
Intracystic papillary carcinoma of breast: interrelationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases.
Carcinoma, Ductal
Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Carcinoma, Ductal
Tissue inhibitor of metalloproteinase-4 is elevated in early-stage breast cancers with accelerated progression and poor clinical course.
Carcinoma, Embryonal
Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel.
Carcinoma, Hepatocellular
A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines.
Carcinoma, Hepatocellular
Antrodia cinnamomea Inhibits Migration in Human Hepatocellular Carcinoma Cells: The Role of ERp57 and PGK-1.
Carcinoma, Hepatocellular
Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas.
Carcinoma, Hepatocellular
BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
Carcinoma, Hepatocellular
Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model.
Carcinoma, Hepatocellular
Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner.
Carcinoma, Hepatocellular
c-Met identifies a population of matrix metalloproteinase 9-producing monocytes in peritumoural stroma of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B.
Carcinoma, Hepatocellular
Chemotherapy-Enriched THBS2-Deficient Cancer Stem Cells Drive Hepatocarcinogenesis through Matrix Softness Induced Histone H3 Modifications.
Carcinoma, Hepatocellular
Des-?-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
Carcinoma, Hepatocellular
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Carcinoma, Hepatocellular
Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20.
Carcinoma, Hepatocellular
Elevated expression levels of androgen receptors and matrix metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and staging.
Carcinoma, Hepatocellular
Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.
Carcinoma, Hepatocellular
High Mobility Group Box-1 promotes hepatocellular carcinoma progression through miR-21-mediated matrix metalloproteinase activity.
Carcinoma, Hepatocellular
Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1.
Carcinoma, Hepatocellular
Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells.
Carcinoma, Hepatocellular
Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Leukocyte function-associated antigen-1-dependent adhesion of rat ascites hepatoma AH66F to mesentery-derived mesothelial cells.
Carcinoma, Hepatocellular
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
Carcinoma, Hepatocellular
MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
Carcinoma, Hepatocellular
Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.
Carcinoma, Hepatocellular
No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
Carcinoma, Hepatocellular
Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)?2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
Carcinoma, Hepatocellular
Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase.
Carcinoma, Hepatocellular
Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.
Carcinoma, Hepatocellular
Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator twist1.
Carcinoma, Hepatocellular
Reciprocal activation between MMP-8 and TGF-?1 stimulates EMT and malignant progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival.
Carcinoma, Hepatocellular
Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
Carcinoma, Hepatocellular
The role of serum response factor in hepatocellular carcinoma: An association with matrix metalloproteinase.
Carcinoma, Hepatocellular
[Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization]
Carcinoma, Intraductal, Noninfiltrating
Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Carcinoma, Intraductal, Noninfiltrating
Tissue inhibitor of metalloproteinase-4 is elevated in early-stage breast cancers with accelerated progression and poor clinical course.
Carcinoma, Large Cell
Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Carcinoma, Lewis Lung
Tissue inhibitors of matrix metalloproteinases 1 and 2 and matrix metalloproteinase activity in the serum and lungs of mice with lewis lung carcinoma.
Carcinoma, Lobular
Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.
Carcinoma, Medullary
Expression of stromelysin-3 in medullary carcinoma of the breast.
Carcinoma, Mucoepidermoid
Comparative expression of matrix metalloproteinases in low-grade mucoepidermoid carcinoma and typical lung cancer.
Carcinoma, Mucoepidermoid
Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Carcinoma, Non-Small-Cell Lung
Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Caveolin-1 promotes an invasive phenotype and predicts poor prognosis in large cell lung carcinoma.
Carcinoma, Non-Small-Cell Lung
Changes in angiogenic growth factor levels after gefitinib treatment in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Carcinoma, Non-Small-Cell Lung
Dysregulation of FURIN by prostaglandin-endoperoxide synthase 2 in lung epithelial NCI-H292 cells.
Carcinoma, Non-Small-Cell Lung
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.
Carcinoma, Non-Small-Cell Lung
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
Carcinoma, Non-Small-Cell Lung
Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma.
Carcinoma, Non-Small-Cell Lung
Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Negative correlation of cytoplasm TIMP3 with miR-222 indicates a good prognosis for NSCLC.
Carcinoma, Non-Small-Cell Lung
Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential.
Carcinoma, Non-Small-Cell Lung
Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
Carcinoma, Non-Small-Cell Lung
Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Serum metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in lung carcinoma patients.
Carcinoma, Non-Small-Cell Lung
Study on Invadopodia Formation for Lung Carcinoma Invasion with a Microfluidic 3D Culture Device.
Carcinoma, Non-Small-Cell Lung
Video-assisted thoracic surgery lobectomy for lung cancer is associated with less immunochemokine disturbances than thoracotomy.
Carcinoma, Non-Small-Cell Lung
[Expression and significance of MIF and CD147 in non-small cell lung cancer]
Carcinoma, Non-Small-Cell Lung
[Expression of adiponectin in non-small cell lung cancer and its relationship with MMP-9 and angiogenesis].
Carcinoma, Ovarian Epithelial
Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.
Carcinoma, Ovarian Epithelial
Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Matrix metalloproteinase-1 promoter polymorphism and epithelial ovarian cancer: does ethnicity matter?
Carcinoma, Ovarian Epithelial
Prognostic Significance of Extracellular Matrix Metalloproteinase Inducer and Matrix Metalloproteinase 2 in Epithelial Ovarian Cancer.
Carcinoma, Ovarian Epithelial
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Carcinoma, Papillary
Intracystic papillary carcinoma of breast: interrelationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases.
Carcinoma, Renal Cell
Annexin A1 expression is correlated with malignant potential of renal cell carcinoma.
Carcinoma, Renal Cell
Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Carcinoma, Renal Cell
Clinicopathological Significance of Matrix Metalloproteinase-2 Protein Expression in Renal Cell Carcinoma Patients.
Carcinoma, Renal Cell
Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma.
Carcinoma, Renal Cell
Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704.
Carcinoma, Renal Cell
Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Carcinoma, Renal Cell
Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
Carcinoma, Renal Cell
Inducing regulated necrosis and shifting macrophage polarization with anti-EMMPRIN antibody (161-pAb) and complement factors.
Carcinoma, Renal Cell
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Carcinoma, Renal Cell
Matrix metalloproteinase activity in urine of patients with renal cell carcinoma leads to degradation of extracellular matrix proteins: possible use as a screening assay.
Carcinoma, Renal Cell
Modifications of the radiosensitivity of a renal cancer cell line as a consequence of stable TIMP-1 overexpression.
Carcinoma, Renal Cell
PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration.
Carcinoma, Renal Cell
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Carcinoma, Renal Cell
The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma.
Carcinoma, Renal Cell
Urinary matrix metalloproteinase activity is not significantly altered in patients with renal cell carcinoma.
Carcinoma, Small Cell
Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Carcinoma, Squamous Cell
A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops.
Carcinoma, Squamous Cell
Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells.
Carcinoma, Squamous Cell
Anticancer Efficacy of Polyphenols and Their Combinations.
Carcinoma, Squamous Cell
Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas.
Carcinoma, Squamous Cell
Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Carcinoma, Squamous Cell
Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Carcinoma, Squamous Cell
Differential expression of degradome components in cutaneous squamous cell carcinomas.
Carcinoma, Squamous Cell
Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung.
Carcinoma, Squamous Cell
Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
Carcinoma, Squamous Cell
Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
Carcinoma, Squamous Cell
Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.
Carcinoma, Squamous Cell
Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas.
Carcinoma, Squamous Cell
Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase.
Carcinoma, Squamous Cell
Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Carcinoma, Squamous Cell
Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Carcinoma, Squamous Cell
Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication.
Carcinoma, Squamous Cell
High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Carcinoma, Squamous Cell
Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Carcinoma, Squamous Cell
Immunohistochemical predictors in squamous cell carcinoma of the tongue and floor of the mouth.
Carcinoma, Squamous Cell
Increased expression of matrix metalloproteinase-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma.
Carcinoma, Squamous Cell
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Carcinoma, Squamous Cell
Mast cells and matrix metalloproteinase 9 expression in actinic cheilitis and lip squamous cell carcinoma.
Carcinoma, Squamous Cell
Matrilysins may not predict the metastatic potential in squamous cell carcinoma of the tongue.
Carcinoma, Squamous Cell
Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines.
Carcinoma, Squamous Cell
Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
Carcinoma, Squamous Cell
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Carcinoma, Squamous Cell
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Carcinoma, Squamous Cell
MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells.
Carcinoma, Squamous Cell
NF-kappaB involvement in tumor-stroma interaction of squamous cell carcinoma.
Carcinoma, Squamous Cell
Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma.
Carcinoma, Squamous Cell
Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
Carcinoma, Squamous Cell
Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.
Carcinoma, Squamous Cell
Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.
Carcinoma, Squamous Cell
Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.
Carcinoma, Squamous Cell
Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line.
Carcinoma, Squamous Cell
The interplay of matrix metalloproteinase-8, transforming growth factor-?1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
The prognostic value of CXCR4, MMP-2 and MMP-9 in tongue squamous carcinoma.
Carcinoma, Squamous Cell
The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas.
Carcinoma, Squamous Cell
TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal squamous carcinoma cells.
Carcinoma, Squamous Cell
WNT-5A, but not matrix metalloproteinase 3 or beta-catenin protein, expression is related to early stages of lip carcinogenesis.
Carcinoma, Squamous Cell
[Collagenase-3 (MMP-13) expression in epithelial cancers of the eyelids]
Carcinoma, Squamous Cell
[Correlation of membrane type I matrix metalloproteinase (MT1-MMP) expression with clinicomorphological features of tumor front in squamous cell carcinoma of the larynx]
Carcinoma, Squamous Cell
[Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
Carcinoma, Squamous Cell
[The expression of EMMPRIN and the matrix metalloproteinase MMP-1 in the cervix uteri and corpus uteri in cervical squamous cell carcinoma].
Carcinoma, Transitional Cell
Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Carcinoma, Transitional Cell
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
Carcinoma, Transitional Cell
Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
Carcinoma, Transitional Cell
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
Carcinoma, Transitional Cell
[Expression of extracellular matrix metalloproteinase inducer in human bladder transitional cell carcinoma]
Carcinosarcoma
Walker 256 tumor cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species.
Cardiomegaly
?1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
Cardiomegaly
Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats.
Cardiomegaly
Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-? in renovascular hypertension-induced cardiac hypertrophy.
Cardiomegaly
The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension.
Cardiomegaly
TRAF3IP2 Mediates Aldosterone/Salt-Induced Cardiac Hypertrophy and Fibrosis.
Cardiomegaly
[Alterations in sympathoadrenal system in congestive heart failure]
Cardiomyopathies
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.
Cardiomyopathies
EMMPRIN and its ligand Cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy.
Cardiomyopathies
Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model.
Cardiomyopathies
Inhibiting matrix metalloproteinase by cell-based TIMP-3 gene transfer effectively treats acute and chronic ischemic cardiomyopathy.
Cardiomyopathies
Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy.
Cardiomyopathies
Interrelation between Expression of ADAM 10 and MMP 9 and Synthesis of Peroxynitrite in Doxorubicin Induced Cardiomyopathy.
Cardiomyopathies
Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
Cardiomyopathies
Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Cardiomyopathy, Dilated
Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy.
Cardiomyopathy, Dilated
Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy.
Cardiomyopathy, Dilated
Defects in matrix metalloproteinase inhibitory stoichiometry and selective MMP induction in patients with nonischemic or ischemic dilated cardiomyopathy.
Cardiomyopathy, Dilated
EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes.
Cardiomyopathy, Dilated
Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation.
Cardiomyopathy, Dilated
Immunoexpression of MMP-8, MMP-9 and TIMP-2 in dilated cardiomyopathy.
Cardiomyopathy, Dilated
Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
Cardiomyopathy, Dilated
Inverse relationship between raft LRP1 localization and non-raft ERK1,2/MMP9 activation in idiopathic dilated cardiomyopathy: potential impact in ventricular remodeling.
Cardiomyopathy, Dilated
Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
Cardiomyopathy, Dilated
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.
Cardiomyopathy, Dilated
Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
Cardiomyopathy, Dilated
Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy.
Cardiomyopathy, Dilated
Structural insights into the binding of MMP9 inhibitors.
Cardiomyopathy, Hypertrophic
Impact of metalloproteinases on left ventricular remodeling and heart failure events in patients with hypertrophic cardiomyopathy.
Cardiomyopathy, Hypertrophic
Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Cardiomyopathy, Restrictive
Collagen subtypes and matrix metalloproteinase in idiopathic restrictive cardiomyopathy.
Cardiotoxicity
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.
Cardiovascular Diseases
Association between serum and oral matrix metalloproteinase-8 levels and periodontal health status.
Cardiovascular Diseases
Cellular fibronectin response to supervised moderate aerobic training in patients with type 2 diabetes.
Cardiovascular Diseases
Coconut oil consumption improves fat-free mass, plasma HDL-cholesterol and insulin sensitivity in healthy men with normal BMI compared to peanut oil.
Cardiovascular Diseases
Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines.
Cardiovascular Diseases
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease.
Cardiovascular Diseases
Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Cardiovascular Diseases
Environmental arsenic exposure and serum matrix metalloproteinase-9.
Cardiovascular Diseases
Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine.
Cardiovascular Diseases
Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
Cardiovascular Diseases
Genetic variability of matrix metalloproteinase genes in cardiovascular disease.
Cardiovascular Diseases
Genetic Variants Contributing to Circulating Matrix Metalloproteinase 8 Levels and Their Association With Cardiovascular Diseases: A Genome-Wide Analysis.
Cardiovascular Diseases
Genetics of ultrasonographic carotid atherosclerosis.
Cardiovascular Diseases
Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels.
Cardiovascular Diseases
Hypothesis: Metalloproteinase Inhibitors Decrease Risks of Cardiovascular Disease.
Cardiovascular Diseases
Immediate Postnatal Overfeeding in Rats Programs Aortic Wall Structure Alterations and Metalloproteinases Dysregulation in Adulthood.
Cardiovascular Diseases
Increased Matrix Metalloproteinase 2 Activity in the Human Internal Mammary Artery Is Associated with Ageing, Hypertension, Diabetes and Kidney Dysfunction.
Cardiovascular Diseases
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.
Cardiovascular Diseases
Matrix metalloproteinase inhibitor properties of tetracyclines: Therapeutic potential in cardiovascular diseases.
Cardiovascular Diseases
Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.
Cardiovascular Diseases
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
Cardiovascular Diseases
Modulation of macrophage function and metabolism.
Cardiovascular Diseases
Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NF?B-mediated mechanisms.
Cardiovascular Diseases
Orally active MMP-1 sparing ?-tetrahydropyranyl and ?-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.
Cardiovascular Diseases
Plasma matrix metalloproteinase (MMP)-9 levels are reduced following low-calorie cranberry juice supplementation in men.
Cardiovascular Diseases
Practical implications of novel serum ELISA-assay for matrix metalloproteinase-8 in acute cardiac diagnostics.
Cardiovascular Diseases
Provitamin A carotenoids are independently associated with matrix metalloproteinase-9 in plasma samples from a general population.
Cardiovascular Diseases
Recent insights into natural product inhibitors of matrix metalloproteinases.
Cardiovascular Diseases
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly.
Cardiovascular Diseases
Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells.
Cardiovascular Diseases
Role of Salivary Biomarkers in Detection of Cardiovascular Diseases (CVD).
Cardiovascular Diseases
Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.
Cardiovascular Diseases
Serum or Plasma Matrix Metalloproteinase (MMP)-9 Levels and Cardiovascular Diseases.
Cardiovascular Diseases
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Cardiovascular Diseases
Taurine inhibits increased MMP-2 expression in a model of oxidative stress induced by glutathione depletion in rabbit heart.
Cardiovascular Diseases
The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies.
Cardiovascular Diseases
[The role of changes of matrix metalloproteinase in cardiovascular diseases]
Carotid Artery Diseases
Association of MMP-8 promoter gene polymorphisms with carotid atherosclerosis: preliminary study.
Carotid Artery Diseases
Correlations of MMP-1, MMP-3, and MMP-12 with the degree of atherosclerosis, plaque stability and cardiovascular and cerebrovascular events.
Carotid Artery Diseases
Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis.
Carotid Artery Diseases
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis.
Carotid Artery Diseases
Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis.
Carotid Stenosis
Neutrophil Gelatinase Associated Lipocalin (NGAL) for Identification of Unstable Plaques in Patients with Asymptomatic Carotid Stenosis.
Carpal Tunnel Syndrome
Matrix metalloproteinase genes on chromosome 11q22 and risk of carpal tunnel syndrome.
Cataract
Higher TGF-?1, TGF-?2, MMP-2 and TIMP-1 Levels in the Aqueous Humor of the Patients with Acute Primary Angle Closure.
Cataract
Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.
Cataract
Matrix metalloproteinase inhibitors suppress transforming growth factor-beta-induced subcapsular cataract formation.
Cataract
Matrix metalloproteinase-2 and -9 activities in the human lens epithelial cells and serum of steroid induced posterior subcapsular cataracts.
cathepsin s deficiency
Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
Central Nervous System Infections
CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features.
Cerebral Amyloid Angiopathy
Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy.
Cerebral Amyloid Angiopathy
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.
Cerebral Hemorrhage
Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
Cerebral Hemorrhage
Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.
Cerebral Hemorrhage
Erythropoietin attenuates intracerebral hemorrhage by diminishing matrix metalloproteinases and maintaining blood-brain barrier integrity in mice.
Cerebral Hemorrhage
High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.
Cerebral Hemorrhage
Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy.
Cerebral Hemorrhage
Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
Cerebral Hemorrhage
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage.
Cerebral Hemorrhage
Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study.
Cerebral Hemorrhage
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
Cerebral Hemorrhage
[Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients]
Cerebral Infarction
Associations between matrix metalloproteinase gene polymorphisms and the development of cerebral infarction.
Cerebral Infarction
Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum MMP-2 and MMP-9 were associated with acute cerebral infarction.
Cerebral Infarction
Delayed Gelatinase Inhibition Induces Reticulon 4 Receptor Expression in the Peri-Infarct Cortex.
Cerebral Infarction
Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats.
Cerebral Infarction
Relationship between lysophosphatidic acid and matrix metalloproteinase-9 plasma concentrations and carotid atheromatous plaque stability in patients with cerebral infarction.
Cerebral Infarction
[Association between -1296T/C and -915A/G polymorphisms of matrix metalloproteinase inhibitor-3 gene and atherosclerotic cerebral infarction in an ethnic Han Chinese population].
Cerebral Palsy
A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.
Cerebral Palsy
Amniotic fluid matrix metalloproteinase-8 and the development of cerebral palsy.
Chagas Disease
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.
Cheilitis
Mast cells and matrix metalloproteinase 9 expression in actinic cheilitis and lip squamous cell carcinoma.
Cheilitis
WNT-5A, but not matrix metalloproteinase 3 or beta-catenin protein, expression is related to early stages of lip carcinogenesis.
Chlamydophila Infections
Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
Cholangiocarcinoma
A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma.
Cholangiocarcinoma
Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing.
Cholangiocarcinoma
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Cholangiocarcinoma
Expression of Matrix Metalloproteinase 2 and Extracellular Matrix Metalloproteinase Inducer are Unfavorable Postoperative Prognostic Factors in Intrahepatic Cholangiocarcinoma.
Cholangiocarcinoma
Expression pattern of matrix metalloproteinases in human liver.
Cholangiocarcinoma
Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-? Pathway.
Cholera
Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes.
Cholestasis
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis.
Cholestasis
Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity.
Cholestasis, Intrahepatic
Celastrol Attenuates Intrahepatic Cholestasis of Pregnancy by Inhibiting Matrix Metalloproteinases-2 and 9.
Cholestasis, Intrahepatic
Epigallocatechin-3-gallate ameliorates intrahepatic cholestasis of pregnancy by inhibiting matrix metalloproteinase-2 and matrix metalloproteinase-9.
Cholestasis, Intrahepatic
Resveratrol reduces matrix metalloproteinases and alleviates intrahepatic cholestasis of pregnancy in rats.
Cholesteatoma
Evaluation of significant gene expression changes in congenital and acquired cholesteatoma.
Cholesteatoma
Expression of matrix metalloproteinase in cholesteatoma epithelium of patients with cholesteatoma otitis media.
Cholesteatoma
Suppressive activity of vitamin D3 on matrix metalloproteinase production from cholesteatoma keratinocytes in vitro.
Cholesteatoma
The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: a comparative analysis.
Cholesteatoma
TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation.
Cholesteatoma
Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma--correlations with growth factor expression in vivo?
Cholesteatoma, Middle Ear
Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma--correlations with growth factor expression in vivo?
Chondroma
Immunohistochemical analysis of matrix metalloproteinase-1, -3, and -13 in naturally occurring cartilaginous tumors of dogs.
Chondrosarcoma
AMP-activated protein kinase activation mediates CCL3-induced cell migration and matrix metalloproteinase-2 expression in human chondrosarcoma.
Chondrosarcoma
Antitumor effect of resveratrol on chondrosarcoma cells via phosphoinositide 3-kinase/AKT and p38 mitogen-activated protein kinase pathways.
Chondrosarcoma
Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Chondrosarcoma
CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-?B signaling pathway.
Chondrosarcoma
CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin dependent pathway.
Chondrosarcoma
Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
Chondrosarcoma
Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor.
Chondrosarcoma
Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours.
Chondrosarcoma
CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chondrosarcoma
Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells.
Chondrosarcoma
Effect of pulsed electromagnetic field on MMP-9 and TIMP-1 levels in chondrosarcoma cells stimulated with IL-1?.
Chondrosarcoma
Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways.
Chondrosarcoma
Expression of membrane type 1 matrix metalloproteinase in human articular cartilage.
Chondrosarcoma
HGF and c-Met interaction promotes migration in human chondrosarcoma cells.
Chondrosarcoma
Icariin inhibits MMP?1, MMP?3 and MMP?13 expression through MAPK pathways in IL?1??stimulated SW1353 chondrosarcoma cells.
Chondrosarcoma
Immunohistochemical analysis of matrix metalloproteinase-1, -3, and -13 in naturally occurring cartilaginous tumors of dogs.
Chondrosarcoma
Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chondrosarcoma
Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.
Chondrosarcoma
Production of matrix metalloproteinases and a metalloproteinase inhibitor by swarm rat chondrosarcoma.
Chondrosarcoma
Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells.
Chondrosarcoma
Spatholobus suberectus inhibits osteoclastogenesis and stimulates chondrogenesis.
Chondrosarcoma
The differential effects of IL-1 and TNF-alpha on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells.
Chondrosarcoma
Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway.
Chondrosarcoma
WISP-1 increases MMP-2 expression and cell motility in human chondrosarcoma cells.
Chordoma
Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma.
Chordoma
Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas.
Chorioamnionitis
A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.
Chorioamnionitis
A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes.
Chorioamnionitis
An elevated amniotic fluid prostaglandin F2? concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes.
Chorioamnionitis
Chorioamnionitis increases matrix metalloproteinase-8 concentrations in bronchoalveolar lavage fluid from preterm babies.
Chorioamnionitis
Clinical chorioamnionitis at term VIII: a rapid MMP-8 test for the identification of intra-amniotic inflammation.
Chorioamnionitis
Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes().
Chorioamnionitis
Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency.
Chorioamnionitis
Gastric fluid versus amniotic fluid analysis for the identification of intra-amniotic infection due to Ureaplasma species.
Chorioamnionitis
Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model.
Chorioamnionitis
Performance characteristics of putative tests for subclinical chorioamnionitis.
Chorioamnionitis
Persistence after birth of systemic inflammation associated with umbilical cord inflammation.
Chorioamnionitis
Prognostic Markers for Chorioamnionitis: IL-6, TNF-?, and MMP-8 in Vaginally Obtained Amniotic Fluid.
Chorioamnionitis
SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitis.
Chorioamnionitis
The antenatal identification of funisitis with a rapid MMP-8 bedside test.
Chorioamnionitis
The frequency and clinical significance of intra-uterine infection and inflammation in patients with placenta previa and preterm labor and intact membranes.
Chorioamnionitis
The inflammatory milieu of amniotic fluid in acute-chorioamnionitis decreases with increasing gestational age.
Chorioamnionitis
The Inflammatory Milieu of Amniotic Fluid Increases with Chorio-Deciduitis Grade in Inflammation-Restricted to Choriodecidua, but Not Amnionitis, of Extra-Placental Membranes.
Chorioamnionitis
The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications.
Chorioamnionitis
The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis.
Chorioamnionitis
The Relationship Between Matrix Metalloproteinase-8 in After Birth Oral Fluid and Acute Histologic Chorioamnionitis in Preterm Delivery.
Chorioamnionitis
Umbilical cord blood concentrations of IL-6, IL-8, and MMP-8 in pregnancy complicated by preterm premature rupture of the membranes and histological chorioamnionitis.
Chorioamnionitis
Vaginal Fluid Inflammatory Biomarkers and the Risk of Adverse Neonatal Outcomes in Women with PPROM.
Chorioamnionitis
[Clinical significance of matrix metalloproteinase-9/tissue inhibitors of matrix metalloproteinase -1 imbalance in maternal serum, amniotic fluid, umbilical cord serum in patients with premature rupture of the membranes]
Choriocarcinoma
The effect of serum from women with preeclampsia on JAR (trophoblast-like) cell line.
Choroidal Neovascularization
Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization.
Choroidal Neovascularization
Preventive versus treatment effect of AG3340, a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization.
Choroidal Neovascularization
Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice.
Chronic Periodontitis
A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis.
Chronic Periodontitis
Analysis of matrix metalloproteinase-8 levels in gingival crevicular fluid and whole mouth fluid among smokers and nonsmokers using enzyme-linked immune-sorbent assay and a novel chair-side test.
Chronic Periodontitis
Association of matrix metalloproteinase (MMP)-1, 3, 9, interleukin (IL)-2, 8 and cyclooxygenase (COX)-2 gene polymorphisms with chronic periodontitis in a Chinese population.
Chronic Periodontitis
Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis.
Chronic Periodontitis
Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study.
Chronic Periodontitis
Cellular source and tetracycline-inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus.
Chronic Periodontitis
Clinical Correlates of A Lateral Flow Immunoassay Oral Risk Indicator.
Chronic Periodontitis
Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue.
Chronic Periodontitis
Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis.
Chronic Periodontitis
Effect of 1,064-nm Nd:YAG laser therapy on GCF IL-1? and MMP-8 levels in patients with chronic periodontitis.
Chronic Periodontitis
Effect of scaling and root planing on interleukin-1?, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients.
Chronic Periodontitis
Effect of smoking on periodontal health.
Chronic Periodontitis
Effectiveness of Probiotic Lozenges in Periodontal Management of Chronic Periodontitis Patients: Clinical and Immunological Study.
Chronic Periodontitis
Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease.
Chronic Periodontitis
EFFECTS OF SRP AND SUB-ANTIMICROBIAL DOSE DOXYCYCLINE ON GCF LEVELS OF MMPs -8, -13 AND SERUM LEVELS OF HsCRP IN PATIENTS WITH CHRONIC PERIODONTITIS.
Chronic Periodontitis
Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis.
Chronic Periodontitis
Evaluation of Systemic Levels of Neutrophilic Enzymes in Hypertensive Patients With Chronic Periodontitis.
Chronic Periodontitis
Evaluation of the inhibitory effect of triphala on PMN-type matrix metalloproteinase (MMP-9).
Chronic Periodontitis
Expression of ?-catenin and MMP-8 in gingival crevicular fluid and gingival tissue indicates the disease severity of patients with chronic periodontitis.
Chronic Periodontitis
Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus.
Chronic Periodontitis
GCF MMP-8 levels in smokers and non-smokers with chronic periodontitis following scaling and root planing accompanied by systemic use of flurbiprofen.
Chronic Periodontitis
Gingival Crevicular Fluid (GCF) Matrix Metalloproteinase -8 Levels Predict Treatment Outcome Among Smoking Chronic Periodontitis Patients.
Chronic Periodontitis
Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis.
Chronic Periodontitis
Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy.
Chronic Periodontitis
Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy.
Chronic Periodontitis
Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis.
Chronic Periodontitis
Importance of MMP-8 in Salivary and Gingival Crevicular Fluids of Periodontitis Patients.
Chronic Periodontitis
Matrix metalloproteinase 8 (MMP8) gene polymorphisms in chronic periodontitis.
Chronic Periodontitis
Matrix metalloproteinase gene polymorphisms in chronic periodontitis: a case-control study in the Indian population.
Chronic Periodontitis
Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients.
Chronic Periodontitis
MMP-8-Responsive Polyethylene Glycol Hydrogel for Intraoral Drug Delivery.
Chronic Periodontitis
Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test.
Chronic Periodontitis
Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade.
Chronic Periodontitis
Reduced expression of lipopolysaccharide-induced CXC chemokine in Porphyromonas gingivalis-induced experimental periodontitis in matrix metalloproteinase-8 null mice.
Chronic Periodontitis
Relationship of collagenase and cathepsin G activity in gingival crevicular fluid.
Chronic Periodontitis
Role of salivary matrix metalloproteinase-8 (MMP-8) in chronic periodontitis diagnosis.
Chronic Periodontitis
Salivary biomarkers: Relationship between oxidative stress and alveolar bone loss in chronic periodontitis.
Chronic Periodontitis
Salivary IgA, Interleukin-1? and MMP-8 as Salivary Biomarkers in Chronic Periodontitis Patients.
Chronic Periodontitis
Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis.
Chronic Periodontitis
Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
Chronic Periodontitis
Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article.
Chronic Periodontitis
Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo.
Chronic Periodontitis
Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases.
Chronic Periodontitis
The adjunctive effect of tenoxicam during non-surgical periodontal treatment on clinical parameters and gingival crevicular fluid levels of MMP-8 and TNF-? in patients with chronic periodontitis - randomized, double-blind clinical trial.
Chronic Periodontitis
The effect of adjunctive low-dose doxycycline and licorice therapy on gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.
Chronic Periodontitis
The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.
Chronic Periodontitis
The effect of adjunctive subantimicrobial dose doxycycline therapy on GCF EMMPRIN levels in chronic periodontitis.
Chronic Periodontitis
The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid.
Chronic Periodontitis
The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis.
Chronic Periodontitis
The impact of smoking on levels of chronic periodontitis-associated biomarkers.
Chronic Periodontitis
The influence of smoking on the levels of matrix metalloproteinase-8 and periodontal parameters in smoker and nonsmoker patients with chronic periodontitis: A clinicobiochemical study.
Chronic Periodontitis
The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitis.
Chronic Periodontitis
Whole Salivary Interleukin-6 and Matrix Metalloproteinase-8 Levels in Chronic Periodontitis Patients With and Without Prediabetes.
Chronic Periodontitis
[Analysis of salivary protease spectrum in chronic periodontitis].
Chronic Periodontitis
[Effect of photodynamic therapy on IL-1beta and MMP-8 in gingival crevicular fluid of chronic periodontitis.]
Chronic Periodontitis
[Influence of periodontal therapy on serum interleukin-6 and carotid metalloproteinases in animals with chronic periodontitis associated with atherosclerosis].
Chronic Periodontitis
[MMP-3 and MMP-8 levels in patients with chronic periodontitis before and after nonsurgical periodontal therapy].
Chronic Urticaria
Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients?
Coinfection
Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis.
Colic
Detecting early kidney damage in horses with colic by measuring matrix metalloproteinase -9 and -2, other enzymes, urinary glucose and total proteins.
Colitis
Acrylamide exposure aggravates the development of ulcerative colitis in mice through activation of NF-?B, inflammatory cytokines, iNOS, and oxidative stress.
Colitis
An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Colitis
Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways.
Colitis
Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.
Colitis
Effect of methylprednisolone on the ulceration, matrix metalloproteinase distribution and eicosanoid production in a model of colitis in the rabbit.
Colitis
Fumigaclavine C, an fungal metabolite, improves experimental colitis in mice via downregulating Th1 cytokine production and matrix metalloproteinase activity.
Colitis
Inhibition of Plasmin Protects Against Colitis in Mice by Suppressing Matrix Metalloproteinase 9-Mediated Cytokine Release From Myeloid Cells.
Colitis
Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium.
Colitis
Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia.
Colitis
Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
Colitis
Matrix Metalloproteinase MMP-12 promotes macrophage transmigration across intestinal epithelial tight junctions and increases severity of experimental colitis.
Colitis
Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer.
Colitis
Matrix metalloproteinase-9 regulates MUC-2 expression through its effect on goblet cell differentiation.
Colitis
Notch1 Regulates the Effects of Matrix Metalloproteinase-9 on Colitis-Associated Cancer in Mice.
Colitis
Role of chymase-dependent matrix metalloproteinase-9 activation in mice with dextran sodium sulfate-induced colitis.
Colitis
The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease.
Colitis, Ulcerative
Changes in MMP-2, MMP-9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis.
Colitis, Ulcerative
Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
Colitis, Ulcerative
P081. Matrix Metalloproteinase Degraded Biglycan (BGM) and Citrullinated and MMP-degraded Vimentin (VICM) differentiates Crohn's disease from ulcerative colitis.
Colitis, Ulcerative
Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.
Colitis, Ulcerative
Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats.
Colitis, Ulcerative
The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis.
Colitis-Associated Neoplasms
Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer.
Colonic Neoplasms
Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.
Colonic Neoplasms
Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice.
Colonic Neoplasms
Assessment of MMP29 Gene Expression and Silver Nanoparticles Effects on Colon Cancer Cell Line (HT29).
Colonic Neoplasms
Auraptene decreases the activity of matrix metalloproteinases in dextran sulfate sodium-induced ulcerative colitis in ICR mice.
Colonic Neoplasms
CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases.
Colonic Neoplasms
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Colonic Neoplasms
Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: association with reduced cancer cell migration.
Colonic Neoplasms
Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma.
Colonic Neoplasms
Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
Colonic Neoplasms
Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.
Colonic Neoplasms
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Colonic Neoplasms
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Colonic Neoplasms
Gefitinib decreases the synthesis of matrix metalloproteinase and the adhesion to extracellular matrix proteins of colon cancer cells.
Colonic Neoplasms
Inhibition of metalloproteinase and proteasome activities in colon cancer cells by citrus peel extracts.
Colonic Neoplasms
Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells.
Colonic Neoplasms
Keeping Out the Bad Guys: Gateway to Cellular Target Therapy.
Colonic Neoplasms
Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line CaCo-2.
Colonic Neoplasms
Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
Colonic Neoplasms
Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
Colonic Neoplasms
Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.
Colonic Neoplasms
microRNA-4429-5p suppresses the malignant development of colon cancer by targeting matrix metalloproteinase 16.
Colonic Neoplasms
Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells.
Colonic Neoplasms
NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.
Colonic Neoplasms
Plasma MMP-1 Expression as a Prognostic Factor in Colon Cancer.
Colonic Neoplasms
Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line.
Colonic Neoplasms
Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166.
Colonic Neoplasms
Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels.
Colonic Neoplasms
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Colonic Neoplasms
Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Colonic Neoplasms
Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelial?mesenchymal transition mediated by the FAK/AKT/MMPs axis.
Colonic Neoplasms
Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
Colonic Neoplasms
The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells.
Colonic Neoplasms
The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage.
Colonic Neoplasms
[Increased expression of extracellular matrix metalloproteinase inducer through interaction between fibroblasts and colonic cancer cells]
Colorectal Neoplasms
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Colorectal Neoplasms
Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.
Colorectal Neoplasms
Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer.
Colorectal Neoplasms
Beta-catenin--a linchpin in colorectal carcinogenesis?
Colorectal Neoplasms
Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo.
Colorectal Neoplasms
Chemotherapy in colorectal cancer: new options and new challenges.
Colorectal Neoplasms
Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Colorectal Neoplasms
Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.
Colorectal Neoplasms
Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Colorectal Neoplasms
Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.
Colorectal Neoplasms
Corrigendum to "Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity" [Cancer Lett. 416 (2018) 31-41].
Colorectal Neoplasms
Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Colorectal Neoplasms
Dimerumic Acid Inhibits SW620 Cell Invasion by Attenuating H(2)O(2)-Mediated MMP-7 Expression via JNK/C-Jun and ERK/C-Fos Activation in an AP-1-Dependent Manner.
Colorectal Neoplasms
Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients.
Colorectal Neoplasms
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Colorectal Neoplasms
High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
Colorectal Neoplasms
High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
Colorectal Neoplasms
How the matrix metalloproteinase MMP14 contributes to the progression of colorectal cancer.
Colorectal Neoplasms
Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
Colorectal Neoplasms
In vivo optical molecular imaging of matrix metalloproteinase activity following celecoxib therapy for colorectal cancer.
Colorectal Neoplasms
Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
Colorectal Neoplasms
Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Colorectal Neoplasms
Knockdown of lncRNA CCEPR suppresses colorectal cancer progression.
Colorectal Neoplasms
Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis.
Colorectal Neoplasms
Macroscopic portal vein tumor thrombi of liver metastasis from colorectal cancer.
Colorectal Neoplasms
Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer.
Colorectal Neoplasms
Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Colorectal Neoplasms
Matrix metalloproteinase 9 -1562C/T polymorphism increased protein levels in patients with colorectal cancer in a sample from southeastern Brazil.
Colorectal Neoplasms
Matrix Metalloproteinase Responsive Nanoparticles for Synergistic Treatment of Colorectal Cancer via Simultaneous Anti-Angiogenesis and Chemotherapy.
Colorectal Neoplasms
Matrix metalloproteinase-8 rs11225395 polymorphism correlates with colorectal cancer risk and survival in a Chinese Han population: a case-control study.
Colorectal Neoplasms
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
Colorectal Neoplasms
Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.
Colorectal Neoplasms
Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes.
Colorectal Neoplasms
MMP-9 Expression after Metallic Stent Placement in Patients with Colorectal Cancer: Association with In-Stent Restenosis.
Colorectal Neoplasms
Monitoring cell endocytosis of liposomes by real-time electrical impedance spectroscopy.
Colorectal Neoplasms
No associations of a set of SNPs in the Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase (MMP) genes with survival of colorectal cancer patients.
Colorectal Neoplasms
Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.
Colorectal Neoplasms
Plasma gelatinase activity does not reflect disease activity after operation for colorectal cancer.
Colorectal Neoplasms
Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
Colorectal Neoplasms
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.
Colorectal Neoplasms
Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
Colorectal Neoplasms
Prognostic significance of serum MMP-8, -9, and TIMP-1 in colorectal cancer.
Colorectal Neoplasms
Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
Colorectal Neoplasms
Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion.
Colorectal Neoplasms
Raf and PI3K are the Molecular Targets for the Anti-metastatic Effect of Luteolin.
Colorectal Neoplasms
Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
Colorectal Neoplasms
Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors.
Colorectal Neoplasms
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Colorectal Neoplasms
The association of matrix metalloproteinase-1 genetic polymorphism (-1607 1G>2G) with colorectal cancer: a meta-analysis.
Colorectal Neoplasms
The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.
Colorectal Neoplasms
The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Colorectal Neoplasms
The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology.
Colorectal Neoplasms
Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.
Colorectal Neoplasms
Tumor associated proteases -- prognostic markers of colorectal cancer.
Colorectal Neoplasms
[Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colorectal cancer cell line HT-29]
Colorectal Neoplasms
[Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer]
Coma
Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.
Communicable Diseases
Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis.
Congenital Abnormalities
Histopathological changes in collagen and matrix metalloproteinase levels in articular condyle of experimental model rats with jaw deformity.
Conjunctivitis
Tear fluid concentration of mmp-8 is elevated in non-allergic eosinophilic conjunctivitis and correlates with conjunctival inflammatory cell infiltration.
Conjunctivitis, Allergic
Activation of corneal fibroblast-derived matrix metalloproteinase-2 by tryptase.
Conjunctivitis, Allergic
Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.
Contracture
A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Contracture
Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src.
Corneal Injuries
Altered expression of matrix metalloproteinases and their tissue inhibitors as possible contributors to corneal droplet formation in climatic droplet keratopathy.
Corneal Injuries
Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.
Corneal Neovascularization
Role of senescent fibroblasts on alkali-induced corneal neovascularization.
Corneal Neovascularization
[Inhibitory effects of matrix metalloproteinase inhibitor on corneal neovascularization]
Corneal Opacity
An intact complement system dampens cornea inflammation during acute primary HSV-1 infection.
Corneal Ulcer
Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis.
Coronary Aneurysm
Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with kawasaki disease.
Coronary Aneurysm
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
Coronary Artery Disease
Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease.
Coronary Artery Disease
Causal associations of serum matrix metalloproteinase-8 level with ischaemic stroke and ischaemic stroke subtypes: a Mendelian randomization study.
Coronary Artery Disease
Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling.
Coronary Artery Disease
Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatin.
Coronary Artery Disease
Doxycycline Reduces Cardiac Matrix Metalloproteinase-2 Activity but Does not Ameliorate Myocardial Dysfunction During Reperfusion in Coronary Artery Bypass Patients Undergoing Cardiopulmonary Bypass.
Coronary Artery Disease
Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease.
Coronary Artery Disease
Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
Coronary Artery Disease
High plasma levels of matrix metalloproteinase-8 in patients with unstable angina.
Coronary Artery Disease
Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
Coronary Artery Disease
Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
Coronary Artery Disease
Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease.
Coronary Artery Disease
Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.
Coronary Artery Disease
Meta-analysis: matrix metalloproteinase family gene polymorphisms and risk for coronary artery disease.
Coronary Artery Disease
Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
Coronary Artery Disease
Plasma EMMPRIN levels in acute myocardial infarction and stable coronary artery disease.
Coronary Artery Disease
Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease.
Coronary Artery Disease
Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
Coronary Artery Disease
Practical implications of novel serum ELISA-assay for matrix metalloproteinase-8 in acute cardiac diagnostics.
Coronary Artery Disease
Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9.
Coronary Artery Disease
Role of matrix metalloproteinases in coronary artery disease.
Coronary Artery Disease
The Co-Existence of the IL-18+183 A/G and MMP-9 -1562 C/T Polymorphisms Is Associated with Clinical Events in Coronary Artery Disease Patients.
Coronary Artery Disease
The effects of nanomicelle of curcumin on the matrix metalloproteinase (MMP-2, 9) activity and expression in patients with coronary artery disease (CAD): A randomized controlled clinical trial.
Coronary Artery Disease
Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease.
Coronary Artery Disease
Variant in GALNT3 Gene Linked with Reduced Coronary Artery Disease Risk in Chinese Population.
Coronary Artery Disease
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
Coronary Disease
Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?
Coronary Disease
Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.
Coronary Disease
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Coronary Disease
Genetic polymorphism of MMP family and coronary disease susceptibility: a meta-analysis.
Coronary Disease
Intracoronary upregulation of platelet extracellular matrix metalloproteinase inducer (CD147) in coronary disease.
Coronary Disease
Lack of an association between matrix metalloproteinase polymorphisms and coronary heart disease in a Han Chinese population.
Coronary Disease
Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease.
Coronary Disease
Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.
Coronary Disease
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
Coronary Disease
The Association Between Extracellular Matrix Metalloproteinase Inducer Polymorphisms and Coronary Heart Disease: A Potential Way to Predict Disease.
Coronary Disease
[Matrix metalloproteinase-1 gene -519A/G polymorphism and the risk of coronary heart disease in Northern Chinese Han population]
Coronary Disease
[Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance]
Coronary Disease
[Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease].
Coronavirus Infections
Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion.
Cough
Effect of Xiaochuanping powder on the inflammatory response and airway remodeling in asthmatic rats.
COVID-19
Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
Creutzfeldt-Jakob Syndrome
Matrix metalloproteinase profile in patients with Creuztfeldt-Jakob disease.
Crohn Disease
An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn's Disease.
Crohn Disease
Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values.
Crohn Disease
Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
Crohn Disease
Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease.
Crohn Disease
Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
Crohn Disease
P081. Matrix Metalloproteinase Degraded Biglycan (BGM) and Citrullinated and MMP-degraded Vimentin (VICM) differentiates Crohn's disease from ulcerative colitis.
Crohn Disease
Ramiprilate inhibits functional matrix metalloproteinase activity in Crohn's disease fistulas.
Cryptorchidism
Plasma concentration of MMP-1 and MMP-2 in boys with cryptorchidism and its lack of correlation with INSL3 and inhibin B.
Cutis Laxa
Regulation of matrix metalloproteinase (MMP) expression in cutis laxa fibroblasts: upregulation of MMP-1, MMP-3 and MMP-9 genes but not of the MMP-2 gene.
Cystic Fibrosis
An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosis.
Cystic Fibrosis
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Cystic Fibrosis
Neutrophil collagenase in sputum from patients with cystic fibrosis.
Cysts
Characterization of interstitial collagenases in jaw cyst wall.
Cysts
Cystic vestibular schwannomas: a possible role of matrix metalloproteinase-2 in cyst development and unfavorable surgical outcome.
Cysts
Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade.
Cysts
Expression of matrix metalloproteinase in the fluids of renal cystic lesions.
Cysts
Increased expression of intracystic matrix metalloproteinases in brain tumors: relationship to the pathogenesis of brain tumor-associated cysts and peritumoral edema.
Cysts
Novel matrix metalloproteinase from the cyst nematodes Heterodera glycines and Globodera rostochiensis.
Dementia
Impact of the matrix metalloproteinase MMP-3 on dementia.
Dementia
Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia.
Dementia
Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia.
Dementia
Possible relationship between periodontitis and dementia in a North Indian old age population: a pilot study.
Demyelinating Diseases
Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).
Demyelinating Diseases
Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan.
Demyelinating Diseases
Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter.
Demyelinating Diseases
Steroids and brain atrophy in multiple sclerosis.
Dengue
MMP cellular responses to dengue virus infection-induced vascular leakage.
Dental Caries
Dentin degradonomics - The potential role of salivary MMP-8 in dentin caries.
Dental Caries
Effect of sealing infected dentin with glass ionomer cement on the abundance and localization of MMP-2, MMP-8, and MMP-9 in young permanent molars in vivo.
Dental Caries
Matrix metalloproteinases (MMPs) in oral diseases.
Dental Caries
[A preliminary study of saliva matrix metalloproteinases (MMP-2 and MMP-9) in children with caries].
Dental Plaque
Chlamydia pneumoniae together with collagenase-2 (MMP-8) in periodontal lesions.
Dental Plaque
Effect of smoking cessation for 1 year on periodontal biomarkers in gingival crevicular fluid.
Dentigerous Cyst
Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors.
Dermatitis, Atopic
A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis.
Dermatitis, Atopic
Beneficial effects of marine algal compounds in cosmeceuticals.
Dermatitis, Contact
In vivo optical imaging of matrix metalloproteinase activity detects acute and chronic contact hypersensitivity reactions and enables monitoring of the antiinflammatory effects of N-acetylcysteine.
Dermatitis, Contact
In vivo Optical Imaging of Matrix Metalloproteinase Activity Detects Acute and Chronic Contact Hypersensitivity Reactions and Enables Monitoring of the Antiinflammatory Effects of N-Acetylcysteine.
Dermatitis, Contact
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
Diabetes Complications
Matrix metalloproteinase-2 dysregulation in type 1 diabetes.
Diabetes Complications
Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction.
Diabetes Mellitus
Circulating serum matrix metalloproteinase-3 and metalloproteinase-9 are not associated with echocardiographic parameters of diastolic function in asymptomatic type 2 diabetic patients.
Diabetes Mellitus
Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics.
Diabetes Mellitus
Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress.
Diabetes Mellitus
Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients.
Diabetes Mellitus
Hyperhomocysteinemic diabetic cardiomyopathy: oxidative stress, remodeling, and endothelial-myocyte uncoupling.
Diabetes Mellitus
Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.
Diabetes Mellitus
Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients : MMPs in tear samples from type 1 diabetes.
Diabetes Mellitus
Matrix metalloproteinase-8 analysis in patients with periodontal disease with prediabetes or type 2 diabetes mellitus: A systematic review.
Diabetes Mellitus
Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus.
Diabetes Mellitus
Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
Diabetes Mellitus
The effect of type 2 diabetes mellitus and smoking on periodontal parameters and salivary matrix metalloproteinase-8 levels.
Diabetes Mellitus
The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8.
Diabetes Mellitus
The influence of type 2 diabetes mellitus on salivary matrix metalloproteinase-8 levels and periodontal parameters: A study in an Indian population.
Diabetes Mellitus
The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitis.
Diabetes Mellitus
The Short-Term Effectiveness of Non-Surgical Treatment in Reducing Levels of Interleukin-1? and Proteases in Gingival Crevicular Fluid From Patients With Type 2 Diabetes Mellitus and Chronic Periodontitis.
Diabetes Mellitus
The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis.
Diabetes Mellitus, Type 1
A close relationship between type 1 diabetes and vitamin A-deficiency and matrix metalloproteinase and hyaluronidase activities in skin tissues.
Diabetes Mellitus, Type 1
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes.
Diabetes Mellitus, Type 1
Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.
Diabetes Mellitus, Type 1
Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1.
Diabetes Mellitus, Type 1
Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.
Diabetes Mellitus, Type 1
Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients : MMPs in tear samples from type 1 diabetes.
Diabetes Mellitus, Type 1
Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis.
Diabetes Mellitus, Type 2
A case of 14q11.2 microdeletion with autistic features, severe obesity and facial dysmorphisms suggestive of Wolf-Hirschhorn syndrome.
Diabetes Mellitus, Type 2
Circulating serum matrix metalloproteinase-3 and metalloproteinase-9 are not associated with echocardiographic parameters of diastolic function in asymptomatic type 2 diabetic patients.
Diabetes Mellitus, Type 2
Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics.
Diabetes Mellitus, Type 2
Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Diabetes Mellitus, Type 2
Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients.
Diabetes Mellitus, Type 2
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes.
Diabetes Mellitus, Type 2
Glycemic control prevents microvascular remodeling and increased tone in Type 2 diabetes: link to endothelin-1.
Diabetes Mellitus, Type 2
Influence of Type 2 Diabetes on Prevalence of Key Periodontal Pathogens, Salivary Matrix Metalloproteinases, and Bone Remodeling Markers in Sudanese Adults with and without Chronic Periodontitis.
Diabetes Mellitus, Type 2
Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes.
Diabetes Mellitus, Type 2
Low Levels of Serum Soluble Receptors for Advanced Glycation End Products, Biomarkers for Disease State: Myth or Reality.
Diabetes Mellitus, Type 2
Matrix metalloproteinase-8 analysis in patients with periodontal disease with prediabetes or type 2 diabetes mellitus: A systematic review.
Diabetes Mellitus, Type 2
Monocyte matrix metalloproteinase production in Type 2 diabetes and controls--a cross sectional study.
Diabetes Mellitus, Type 2
Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes.
Diabetes Mellitus, Type 2
Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes.
Diabetes Mellitus, Type 2
Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes.
Diabetes Mellitus, Type 2
Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
The effect of type 2 diabetes mellitus and smoking on periodontal parameters and salivary matrix metalloproteinase-8 levels.
Diabetes Mellitus, Type 2
The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8.
Diabetes Mellitus, Type 2
The influence of type 2 diabetes mellitus on salivary matrix metalloproteinase-8 levels and periodontal parameters: A study in an Indian population.
Diabetes Mellitus, Type 2
The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitis.
Diabetes Mellitus, Type 2
The Short-Term Effectiveness of Non-Surgical Treatment in Reducing Levels of Interleukin-1? and Proteases in Gingival Crevicular Fluid From Patients With Type 2 Diabetes Mellitus and Chronic Periodontitis.
Diabetes Mellitus, Type 2
The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis.
Diabetes Mellitus, Type 2
[Polymorphisms in Genes of Cytokines and Matrix Metalloproteinases Associated With Ischemic Heart Disease in Patients With Type 2 Diabetes].
Diabetes, Gestational
Proteolytic Mediators in Gestational Diabetes Mellitus and Gingivitis.
Diabetic Cardiomyopathies
Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism.
Diabetic Cardiomyopathies
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
Diabetic Foot
Alleviating neuropathy of diabetic foot ulcer by co-delivery of venlafaxine and matrix metalloproteinase drug-loaded cellulose nanofiber sheets: production, in vitro characterization and clinical trial.
Diabetic Foot
Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers.
Diabetic Foot
High matrix metalloproteinase levels are associated with dermal graft failure in diabetic foot ulcers.
Diabetic Foot
Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers.
Diabetic Foot
Nitric oxide donors selectively reduce the expression of matrix metalloproteinases-8 and -9 by human diabetic skin fibroblasts.
Diabetic Foot
The role of matrix metalloproteinases in wound healing.
Diabetic Nephropathies
C-peptide exhibits a late induction effect on matrix metallopeptidase-9 in high glucose-stimulated rat mesangial cells.
Diabetic Nephropathies
Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
Diabetic Nephropathies
Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Diabetic Nephropathies
Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.
Diabetic Nephropathies
Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.
Diabetic Nephropathies
Evaluation of role of doxycycline (a matrix metalloproteinase inhibitor) on renal functions in patients of diabetic nephropathy.
Diabetic Nephropathies
Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.
Diabetic Nephropathies
Insulin-mediated activation of activator protein-1 through the mitogen-activated protein kinase pathway stimulates collagenase-1 gene transcription in the MES 13 mesangial cell line.
Diabetic Nephropathies
Periodontal Inflammatory Burden and Salivary Matrix Metalloproteinase-8 Concentration Among Patients With Chronic Kidney Disease at the Predialysis Stage.
Diabetic Nephropathies
Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats.
Diabetic Nephropathies
Study on the relationship between the methylation of the MMP-9 gene promoter region and diabetic nephropathy.
Diabetic Nephropathies
The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulation.
Diabetic Nephropathies
Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy.
Diabetic Nephropathies
Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression.
Diabetic Neuropathies
Mechanistic investigations of matrix metalloproteinase-8 inhibition by metal abstraction peptide.
Diabetic Retinopathy
Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.
Diabetic Retinopathy
Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
Diabetic Retinopathy
Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture.
Diabetic Retinopathy
Investigation of Ocular Neovascularization-Related Genes and Oxidative Stress in Diabetic Rat Eye Tissues After Resveratrol Treatment.
Diabetic Retinopathy
Matrix metalloproteinase-2 dysregulation in type 1 diabetes.
Diabetic Retinopathy
Matrix metalloproteinases in human diabetic and nondiabetic vitreous.
Diabetic Retinopathy
Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.
Diabetic Retinopathy
Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.
Diabetic Retinopathy
Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy.
Diabetic Retinopathy
Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.
Diabetic Retinopathy
The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage.
Diphtheria
Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.
Diphtheria
Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
Disseminated Intravascular Coagulation
Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.
Diverticular Diseases
Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease.
Diverticulosis, Colonic
Genetic variants of tissue inhibitors of matrix metalloproteinase 1 (rs4898) and 2 (rs8179090) in diverticulosis.
Down Syndrome
Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down's syndrome.
Down Syndrome
Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down's syndrome.
Down Syndrome
Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome.
Down Syndrome
Enhancement of matrix metalloproteinase (MMP)-2 activity in gingival tissue and cultured fibroblasts from Down's syndrome patients.
Dry Eye Syndromes
Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease.
Dry Eye Syndromes
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
Dry Eye Syndromes
EMMPRIN Modulates Epithelial Barrier Function through a MMP-Mediated Occludin Cleavage Implications in Dry Eye Disease.
Dry Eye Syndromes
Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye.
Dry Eye Syndromes
MMP-8 Is Critical for Dexamethasone Therapy in Alkali-Burned Corneas Under Dry Eye Conditions.
Dry Eye Syndromes
Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye.
Dupuytren Contracture
Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor.
Dupuytren Contracture
Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.
Dyspnea
Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.
Embolic Stroke
Causal associations of serum matrix metalloproteinase-8 level with ischaemic stroke and ischaemic stroke subtypes: a Mendelian randomization study.
Embolic Stroke
Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.
Embolic Stroke
Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
Embolic Stroke
Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
Embolic Stroke
MMP-9-Related microRNAs as Prognostic Markers for Hemorrhagic Transformation in Cardioembolic Stroke Patients.
Embolic Stroke
Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke.
Embolism
Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization.
Embolism
The relationship between plasma MMP-1, -7, -8 and -13 levels and embolic potential during carotid endoluminal intervention.
Empyema
Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
Empyema
Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions.
Encephalitis
Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-delta-dependent ERK/Elk-1 pathway in astrocytes.
Encephalitis
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis.
Encephalitis
Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus.
Encephalitis
Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells.
Encephalitis
Doxycycline and meloxicam can treat neuroinflammation by increasing activity of antioxidant enzymes in rat brain.
Encephalitis
Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-?B pathway in human astroglia infected with Toxoplasma gondii.
Encephalitis, Japanese
Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage.
Encephalomyelitis
An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization.
Encephalomyelitis
Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice.
Encephalomyelitis
Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro.
Encephalomyelitis
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
Encephalomyelitis
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Encephalomyelitis
Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis.
Encephalomyelitis
Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.
Encephalomyelitis
Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation.
Encephalomyelitis
MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity.
Encephalomyelitis
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
Encephalomyelitis
Treatment of experimental autoimmune encephalomyelitis with a neurotropic alphavirus vector expressing tissue inhibitor of metalloproteinase-2.
Encephalomyelitis
Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization.
Encephalomyelitis, Autoimmune, Experimental
Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice.
Encephalomyelitis, Autoimmune, Experimental
Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro.
Encephalomyelitis, Autoimmune, Experimental
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
Encephalomyelitis, Autoimmune, Experimental
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Encephalomyelitis, Autoimmune, Experimental
Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.
Encephalomyelitis, Autoimmune, Experimental
Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation.
Encephalomyelitis, Autoimmune, Experimental
MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity.
Encephalomyelitis, Autoimmune, Experimental
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
Encephalomyelitis, Autoimmune, Experimental
Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790.
Encephalomyelitis, Autoimmune, Experimental
Treatment of experimental autoimmune encephalomyelitis with a neurotropic alphavirus vector expressing tissue inhibitor of metalloproteinase-2.
Encephalomyelitis, Autoimmune, Experimental
Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis.
Endocarditis
[Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function]
Endoleak
Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms.
Endoleak
The association between plasma matrix metalloproteinase-9 concentration and endoleak after endovascular aortic aneurysm repair: a meta-analysis.
Endometrial Hyperplasia
Enhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding.
Endometrial Hyperplasia
Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium.
Endometrial Neoplasms
Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3.
Endometrial Neoplasms
Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
Endometrial Neoplasms
Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes.
Endometrial Neoplasms
Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.
Endometrial Neoplasms
G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth.
Endometrial Neoplasms
Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2.
Endometrial Neoplasms
Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium.
Endometrial Neoplasms
Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Endometrial Neoplasms
Matrix metalloproteinase (MMP)-2 and MMP-9 Expression in Tumor Infiltrating CD3 Lymphocytes From Women With Endometrial Cancer.
Endometrial Neoplasms
No Association between Matrix Metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and Endometrial Cancer Risk.
Endometrial Neoplasms
Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Endometrial Neoplasms
Progestin suppresses matrix metalloproteinase production in endometrial cancer.
Endometrial Neoplasms
The association of transforming growth factor-beta 1 with myometrial invasion of endometrial carcinomas through effects on matrix metalloproteinase.
Endometrial Neoplasms
[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma]
Endometrial Neoplasms
[The factors involved in invasive ability of endometrial carcinoma cells]
Endometriosis
Could statins constitute a novel treatment for endometriosis? Systematic review of the literature.
Endometriosis
Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium.
Endometriosis
Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.
Endometriosis
Elevated serum chemokines are independently associated with both endometriosis and uranium exposure.
Endometriosis
Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9.
Endometriosis
Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis.
Endometriosis
Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis.
Endometriosis
Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis.
Endometriosis
Extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the baboon endometrium: menstrual cycle and endometriosis.
Endometriosis
Future perspectives in the medical treatment of endometriosis.
Endometriosis
Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis?
Endometriosis
Increased Circulating MMP-2 Levels in Infertile Patients With Moderate and Severe Pelvic Endometriosis.
Endometriosis
Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis.
Endometriosis
Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis.
Endometriosis
Matrix metalloproteinase messenger RNA expression in human endometriosis grafts cultured on a chicken chorioallantoic membrane.
Endometriosis
Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium.
Endometriosis
Medical treatment of endometriosis.
Endometriosis
mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay.
Endometriosis
Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis.
Endometriosis
Paracrine regulation of matrix metalloproteinase expression in endometriosis.
Endometriosis
Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis.
Endometriosis
Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice.
Endometriosis
Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis.
Endometriosis
Survivin gene expression in endometriosis.
Endometriosis
Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues.
Endometriosis
The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis.
Endometriosis
[Association of matrix metalloproteinases' polymorphisms of MMP3 and MMP9 with development of genital endometriosis].
Endometriosis
[Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis]
Endometriosis
[Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 mRNA in endometriosis]
Endotoxemia
Administration of a matrix metalloproteinase inhibitor after hemorrhage improves cardiovascular and hepatocellular function.
Endotoxemia
Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia.
Endotoxemia
Inflammation and lung injury in an ovine model of fluid resuscitated endotoxemic shock.
Endotoxemia
Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia.
Endotoxemia
Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia.
Endotoxemia
Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
Endotoxemia
Matrix metalloproteinase-2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats.
Endotoxemia
Metalloproteinase inhibitor prevents hepatic injury in endotoxemic mice.
Endotoxemia
MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia.
Endotoxemia
MMP-8 Genotypes Influence the Inflammatory Response in Human Endotoxemia.
Endotoxemia
Simultaneous Inhibition of Tumor Necrosis Factor Receptor 1 and Matrix Metalloproteinase 8 Completely Protects Against Acute Inflammation and Sepsis.
Endotoxemia
[The activity of components of system of matrix metalloproteinase and tissue inhibitors of metalloproteinase on different stages of chronic cardiac failure].
Epidermolysis Bullosa Dystrophica
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Epilepsy
Different circulating metalloproteinases profiles in women with migraine with and without aura.
Epilepsy
Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations.
Epilepsy
Important role of matrix metalloproteinase 9 in epileptogenesis.
Epilepsy
Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura.
Epiretinal Membrane
The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinase, on a new animal model of epiretinal membrane.
Erythema
Improvement of Skin Barrier Dysfunction by Phenolic-containing Extracts of Lycium barbarum via Nrf2/HO-1 Regulation.
Erythema
Terminalia Chebulanin Attenuates Psoriatic Skin Lesion via Regulation of Heme Oxygenase-1.
Erythema
Time course of lesion development in the hairless guinea-pig model of sulfur mustard-induced dermal injury.
Erythema
Ultraviolet irradiation increases matrix metalloproteinase-8 protein in human skin in vivo.
Esophageal Achalasia
Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia.
Esophageal Neoplasms
Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18.
Esophageal Neoplasms
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Esophageal Neoplasms
Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.
Esophageal Neoplasms
Neoadjuvant radiochemotherapy increases matrix metalloproteinase activity in healthy tissue in esophageal cancer patients.
Esophageal Neoplasms
Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.
Esophageal Neoplasms
Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells in vitro and in vivo.
Esophageal Neoplasms
Upregulated expression and activation of membrane?associated proteases in esophageal squamous cell carcinoma.
Esophageal Neoplasms
Upregulation of extracellular matrix metalloproteinase inducer promotes hypoxia-induced epithelial-mesenchymal transition in esophageal cancer.
Esophageal Squamous Cell Carcinoma
Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China.
Esophageal Squamous Cell Carcinoma
Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.
Esophageal Squamous Cell Carcinoma
Phenotypes of human esophageal squamous cell carcinoma based on matrix metalloproteinase production.
Esophageal Squamous Cell Carcinoma
Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.
Esophageal Squamous Cell Carcinoma
Upregulated expression and activation of membrane?associated proteases in esophageal squamous cell carcinoma.
Essential Hypertension
Abnormalities of the extracellular degradation of collagen type I in essential hypertension.
Essential Hypertension
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Essential Hypertension
Polymorphisms of the matrix metalloproteinase genes are associated with essential hypertension in a Caucasian population of Central Russia.
Exostoses
Evidence of genetic underexpression in chorionic villi samples of euploid fetuses with increased nuchal translucency at 10-11 weeks' gestation.
Exotropia
MMPs, TIMPs and BMP-4 in medial rectus muscle obtained from intermittent exotropia patients and their clinical correlations.
Extranodal Extension
Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.
Eye Diseases
The role and function of matrix metalloproteinase-8 in rhegmatogenous retinal detachment.
Fanconi Anemia
Anticancer Efficacy of Polyphenols and Their Combinations.
Fanconi Anemia
Repression of matrix metalloproteinases and inhibition of cell invasion by a nutrient mixture, containing ascorbic acid, lysine, proline, and green tea extract on human fanconi anemia fibroblast cell lines.
Fasciitis
Gastroesophageal cancer, palmar fasciitis and a matrix metalloproteinase inhibitor.
Fetal Growth Retardation
Differences in Brain-Derived Neurotrophic Factor and Matrix Metalloproteinase-9 between Appropriate Neonates between Normal Birth Weight and Intrauterine Growth Restriction.
Fetal Growth Retardation
Immediate Postnatal Overfeeding in Rats Programs Aortic Wall Structure Alterations and Metalloproteinases Dysregulation in Adulthood.
Fetal Growth Retardation
Matrix metalloproteinase release from placental explants of pregnancies complicated by intrauterine growth restriction.
Fetal Growth Retardation
MiR-590-3p and its targets VEGF, PIGF, and MMP9 in early, middle, and late pregnancy: their longitudinal changes and correlations with risk of fetal growth restriction.
Fetal Growth Retardation
Presenting Twins Are Exposed to Higher Levels of Inflammatory Mediators than Nonpresenting Twins as Early as the Midtrimester of Pregnancy.
Fibroadenoma
Augmented release of matrix metalloproteinase-9 by PKC activation in organotypic cultures of human breast cancer and adjacent normal breast tissue and fibroadenoma.
Fibroma
MMP-1 and MMP-8 expression in giant-cell fibroma and inflammatory fibrous hyperplasia.
Fibromatosis, Aggressive
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.
Fibromatosis, Gingival
Effect of transforming growth factor-beta1, interleukin-6, and interferon-gamma on the expression of type I collagen, heat shock protein 47, matrix metalloproteinase (MMP)-1 and MMP-2 by fibroblasts from normal gingiva and hereditary gingival fibromatosis.
Fibrosarcoma
A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells.
Fibrosarcoma
A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
Fibrosarcoma
Anti-tumor effects of Rubratoxin B on cell toxicity, inhibition of cell proliferation, cytotoxic activity and matrix metalloproteinase-2,9.
Fibrosarcoma
Antimetastatic activity of pinosylvin, a natural stilbenoid, is associated with the suppression of matrix metalloproteinases.
Fibrosarcoma
Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Fibrosarcoma
Characterization of Normal Murine Carpal Bone Development Prompts Re-Evaluation of Pathologic Osteolysis as the Cause of Human Carpal-Tarsal Osteolysis Disorders.
Fibrosarcoma
Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells.
Fibrosarcoma
Effect of Lapachol on the Inhibition of Matrix Metalloproteinase Related to the Invasion of Human Fibrosarcoma Cells.
Fibrosarcoma
Effect of phloroglucinol on oxidative stress and inflammation.
Fibrosarcoma
Effects of genistein on invasion and matrix metalloproteinase activities of HT1080 human fibrosarcoma cells.
Fibrosarcoma
Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis.
Fibrosarcoma
Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Fibrosarcoma
Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Fibrosarcoma
Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model.
Fibrosarcoma
Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis.
Fibrosarcoma
Production of M2000 (?-d-mannuronic acid) and its therapeutic effect on experimental nephritis.
Fibrosarcoma
Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion.
Fibrosarcoma
Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
Fibrosarcoma
Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells.
Fibrosarcoma
Salinomycin causes migration and invasion of human fibrosarcoma cells by inducing MMP-2 expression via PI3-kinase, ERK-1/2 and p38 kinase pathways.
Fibrosarcoma
Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.
Fibrosarcoma
Therapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritis.
Fibrosarcoma
Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.
Foot Ulcer
Alleviating neuropathy of diabetic foot ulcer by co-delivery of venlafaxine and matrix metalloproteinase drug-loaded cellulose nanofiber sheets: production, in vitro characterization and clinical trial.
Foot Ulcer
Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers.
Foot Ulcer
High matrix metalloproteinase levels are associated with dermal graft failure in diabetic foot ulcers.
Foot Ulcer
Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers.
Fragile X Syndrome
Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.
Furunculosis
Matrix metalloproteinase mRNA expression in canine anal furunculosis lesions.
Gallbladder Neoplasms
Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Gallbladder Neoplasms
Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer.
Gastritis
Assessment of systemic matrix metalloproteinase and their regulator response in children with Helicobacter pylori gastritis.
Gastritis
Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
Gastritis
Increased expression of matrix metalloproteinase-9 associated with gastric ulcer recurrence.
Gastritis
Transforming Growth Factor-B1 and Matrix Metalloproteinase-7 Promoter Variants Induce Risk for Helicobacter pylori-Associated Gastric Precancerous Lesions.
Gastroesophageal Reflux
Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma.
Gastrointestinal Diseases
Differential expression and processing of matrix metalloproteinase 19 marks progression of gastrointestinal diseases.
Gastrointestinal Neoplasms
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
Gastrointestinal Neoplasms
CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
Gastrointestinal Neoplasms
Inhibition of invasion and lymph node metastasis of gastrointestinal cancer cells by R-94138, a matrix metalloproteinase inhibitor.
Gastrointestinal Neoplasms
Prognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies.
Gastrointestinal Neoplasms
Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.
Gastrointestinal Neoplasms
Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.
Gastrointestinal Neoplasms
Translational research in pancreatic adenocarcinoma.
Gastrointestinal Stromal Tumors
[Correlation between expressions of matrix metalloproteinase-2 & 9 and vasculogenic mimicry in gastrointestinal stromal tumors]
Gastroschisis
Can levels of interleukins and matrix metalloproteinases in the amniotic fluid predict postnatal bowel function in fetuses with gastroschisis?
gelatinase b deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
gelatinase b deficiency
Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling.
Genetic Diseases, Inborn
An investigation into the MMP1 gene promoter region polymorphism--1607 2G with recessive dystrophic epidermolysis bullosa disease severity in northeastern Mexican patients.
Genetic Diseases, Inborn
Thoracic aortic aneurysm: reading the enemy's playbook.
Genetic Diseases, Inborn
Thoracic Aortic Aneurysm: Reading ttable he Enemy's Playbook.
Giant Cell Arteritis
MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis.
Giant Cell Tumor of Bone
Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Giant Cell Tumor of Bone
Matrix Metalloproteinase Activity in the Stromal Cell of Giant Cell Tumor of Bone.
Giant Cell Tumor of Bone
Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
Giant Cell Tumors
Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Giant Cell Tumors
Matrix Metalloproteinase Activity in the Stromal Cell of Giant Cell Tumor of Bone.
Giant Cell Tumors
Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
Gingival Overgrowth
Gingival crevicular fluid and serum matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 levels in renal transplant patients undergoing different immunosuppressive therapy.
Gingival Overgrowth
Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth.
Gingival Pocket
Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood.
Gingival Pocket
Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
Gingival Recession
Adjunctive effect of antimicrobial photodynamic therapy to nonsurgical periodontal treatment in smokers: a randomized clinical trial.
Gingival Recession
Cytokine (interleukin-1beta) and MMP levels in gingival crevicular fluid after use of platelet-rich fibrin or connective tissue graft in the treatment of localized gingival recessions.
Gingival Recession
Effects of Photodynamic Therapy on the Clinical and Gingival Crevicular Fluid Inflammatory Biomarkers in Chronic Periodontitis: A Split-Mouth Randomized Clinical Trial.
Gingivitis
A Prototype Antibody-based Biosensor for Measurement of Salivary MMP-8 in Periodontitis using Surface Acoustic Wave Technology.
Gingivitis
Activation of neutrophil collagenase in periodontitis.
Gingivitis
Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down's syndrome.
Gingivitis
Analysis of matrix metalloproteinase-8 levels in gingival crevicular fluid and whole mouth fluid among smokers and nonsmokers using enzyme-linked immune-sorbent assay and a novel chair-side test.
Gingivitis
Biomarkers of periodontitis in oral fluids.
Gingivitis
Characterizing the Subgingival Microbiome of Pregnant African American Women.
Gingivitis
Decreased salivary matrix metalloproteinase-8 reflecting a defensive potential in juvenile parotitis.
Gingivitis
Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods.
Gingivitis
Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease.
Gingivitis
Diagnostic sensitivity and specificity of host-derived salivary biomarkers in periodontal disease amongst adults: Systematic review.
Gingivitis
Elevated matrix metalloproteinase-8 in saliva and serum in polycystic ovary syndrome and association with gingival inflammation.
Gingivitis
Evaluation of salivary biomarkers for the diagnosis of periodontitis.
Gingivitis
Gingival crevicular fluid and serum matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 levels in renal transplant patients undergoing different immunosuppressive therapy.
Gingivitis
Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis.
Gingivitis
Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease.
Gingivitis
Implant-safe test in patients with peri-implantitis.
Gingivitis
Levels of myeloid-related proteins in saliva for screening and monitoring of periodontal disease.
Gingivitis
Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis.
Gingivitis
Longitudinal study of salivary proteinases during pregnancy and postpartum.
Gingivitis
Matrix metalloproteinase-1 and -8 in gingival crevicular fluid during orthodontic tooth movement: a pilot study during 1 month of follow-up after fixed appliance activation.
Gingivitis
Matrix metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients.
Gingivitis
Oral Fluid Biomarkers for Diagnosing Gingivitis in Human: A Cross-Sectional Study.
Gingivitis
Proteolytic Mediators in Gestational Diabetes Mellitus and Gingivitis.
Gingivitis
Salivary and Serum Markers Related to Innate Immunity in Generalized Aggressive Periodontitis.
Gingivitis
Salivary Biomarkers Associated with Gingivitis and Response to Therapy.
Gingivitis
Salivary Colony Stimulating Factor-1 and Interleukin-34 in Periodontal Disease.
Gingivitis
Salivary levels of MPO, MMP-8 and TIMP-1 are associated with gingival inflammation response patterns during experimental gingivitis.
Gingivitis
Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
Gingivitis
Targeted salivary biomarkers for discrimination of periodontal health and disease(s).
Gingivitis
The analysis of matrix metalloproteinase-8 in gingival crevicular fluid and periodontal diseases.
Gingivitis
The effect of adjunctive chlorhexidine mouthrinse on GCF MMP-8 and TIMP-1 levels in gingivitis: a randomized placebo-controlled study.
Gingivitis
The effect of Parodontax® on the MMP-8 concentration in gingivitis patients.
Glaucoma
Associations between matrix metalloproteinase gene polymorphisms and glaucoma susceptibility: a meta-analysis.
Glaucoma
Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.
Glaucoma
Characterisation of Ilomastat for Prolonged Ocular Drug Release.
Glaucoma
Floppy eyelid syndrome: ocular and systemic associations.
Glaucoma
Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma.
Glaucoma
Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.
Glaucoma
Lycium Barbarum Exerts Protection against Glaucoma-Like Injury Via Inhibition of MMP-9 Signaling In Vitro.
Glaucoma
Matrix metalloproteinase and cytokine expression in Tenon fibroblasts during scar formation after glaucoma filtration or implant surgery in rats.
Glaucoma
Matrix metalloproteinase gelatinase B (MMP-9) is associated with leaking glaucoma filtering blebs.
Glaucoma
Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery.
Glaucoma
Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients.
Glaucoma
Safety of Using Matrix Metalloproteinase Inhibitor in Experimental Glaucoma Filtration Surgery.
Glaucoma
Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.
Glaucoma
Trabodenoson on trabecular meshwork rejuvenation: a comprehensive review of clinical data.
Glaucoma, Angle-Closure
Differences in the Histopathology and Matrix Metalloproteinase Expression in Tenon's Tissue of Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma.
Glaucoma, Open-Angle
Differences in the Histopathology and Matrix Metalloproteinase Expression in Tenon's Tissue of Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma.
Glaucoma, Open-Angle
Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma.
Glaucoma, Open-Angle
Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.
Glioblastoma
A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.
Glioblastoma
Activated leukocyte cell adhesion molecule is expressed in neuroepithelial neoplasms and decreases with tumor malignancy, matrix metalloproteinase 2 expression, and absence of IDH1R132H mutation.
Glioblastoma
An Extensive Invasive Intracranial Human Glioblastoma Xenograft Model. Role of High Level Matrix Metalloproteinase 9.
Glioblastoma
BMAL1 Suppresses Proliferation, Migration, and Invasion of U87MG Cells by Downregulating Cyclin B1, Phospho-AKT, and Metalloproteinase-9.
Glioblastoma
Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
Glioblastoma
Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells.
Glioblastoma
Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo.
Glioblastoma
Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme.
Glioblastoma
Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors.
Glioblastoma
Extracellular vesicles originating from glioblastoma cells increase metalloproteinase release by astrocytes: the role of CD147 (EMMPRIN) and ionizing radiation.
Glioblastoma
Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
Glioblastoma
Inhibition of MMP-2 secretion from brain tumor cells suggests chemopreventive properties of a furanocoumarin glycoside and of chalcones isolated from the twigs of Dorstenia turbinata.
Glioblastoma
Ionizing radiation affects epidermal growth factor receptor signalling and metalloproteinase secretion in glioma cells.
Glioblastoma
Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
Glioblastoma
Luteolin reduces migration of human glioblastoma cell lines via inhibition of the p-IGF-1R/PI3K/AKT/mTOR signaling pathway.
Glioblastoma
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Glioblastoma
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.
Glioblastoma
Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells.
Glioblastoma
The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells.
Glioblastoma
Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
Glioma
A carcinogenic trigger to study the function of tumor suppressor genes in Schmidtea mediterranea.
Glioma
A complete compilation of matrix metalloproteinase expression in human malignant gliomas.
Glioma
A role of matrix metalloproteinases produced by glioma-cells.
Glioma
Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells.
Glioma
Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Glioma
Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cells.
Glioma
Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells.
Glioma
ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome.
Glioma
Bergamottin, a natural furanocoumarin abundantly present in grapefruit juice, suppresses the invasiveness of human glioma cells via inactivation of Rac1 signaling.
Glioma
Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity.
Glioma
Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
Glioma
Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.
Glioma
Detection of failure of bevacizumab treatment for malignant glioma based on urinary matrix metalloproteinase activity.
Glioma
Differential effects of photofrin, 5-aminolevulinic acid and calphostin C on glioma cells.
Glioma
Drug-induced apoptosis by a matrix metalloproteinase inhibitor, SI-27 on human malignant glioma cell lines; in vitro study.
Glioma
Effect of photodynamic therapy combined with torasemide on the expression of matrix metalloproteinase 2 and sodium-potassium-chloride cotransporter 1 in rat peritumoral edema and glioma.
Glioma
Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
Glioma
Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme.
Glioma
Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Glioma
Fluid shear stress regulates the invasive potential of glioma cells via modulation of migratory activity and matrix metalloproteinase expression.
Glioma
Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
Glioma
Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro.
Glioma
Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.
Glioma
Glycoprotein non-metastatic melanoma protein B promotes glioma motility and angiogenesis through the Wnt/?-catenin signaling pathway.
Glioma
HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
Glioma
High MMP-26 expression in glioma is correlated with poor clinical outcome of patients.
Glioma
In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture.
Glioma
Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells.
Glioma
Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of glioma cells in a 3-dimensional collagen matrix.
Glioma
Influence of bcl-2-related proteins on matrix metalloproteinase expression in a rat glioma cell line.
Glioma
Inhibition of EMMPRIN by microRNA-124 suppresses the growth, invasion and tumorigenicity of gliomas.
Glioma
Inhibition of glioma angiogenesis and invasion by SI-27, an anti-matrix metalloproteinase agent in a rat brain tumor model.
Glioma
Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation.
Glioma
Ionizing Radiation Enhances Matrix Metalloproteinase-2 Secretion and Invasion of Glioma Cells through Src/Epidermal Growth Factor Receptor-Mediated p38/Akt and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways.
Glioma
Irradiation of primary human gliomas triggers dynamic and aggressive survival responses involving microvesicle signaling.
Glioma
Long non-coding RNA FOXD2-AS1 promotes cell proliferation, metastasis and EMT in glioma by sponging miR-506-5p.
Glioma
Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
Glioma
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
Glioma
Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
Glioma
Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.
Glioma
Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM.
Glioma
Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
Glioma
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.
Glioma
Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility.
Glioma
Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKK?.
Glioma
Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways.
Glioma
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status.
Glioma
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.
Glioma
PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
Glioma
Quantitative analysis of glioma cell invasion by confocal laser scanning microscopy in a novel brain slice model.
Glioma
Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix.
Glioma
RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis.
Glioma
Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
Glioma
RNA interference?mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells.
Glioma
Role of hyaluronan in glioma invasion.
Glioma
Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Glioma
Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
Glioma
Suppression of cell invasion on human malignant glioma cell lines by a novel matrix-metalloproteinase inhibitor SI-27: in vitro study.
Glioma
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.
Glioma
Tanshinone IIA Suppresses Glioma Cell Proliferation, Migration and Invasion Both in vitro and in vivo Partially Through miR-16-5p/Talin-1 (TLN1) Axis.
Glioma
Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.
Glioma
Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models.
Glioma
Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
Glioma
Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Glioma
The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro.
Glioma
The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma.
Glioma
The function of MMP-28/TGF-? induced cell apoptosis in human glioma cells.
Glioma
The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
Glioma
The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Glioma
Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
Glioma
TLR9 expression is associated with prognosis in patients with glioblastoma multiforme.
Glioma
TNF-? respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma.
Glomerulonephritis
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis.
Glomerulonephritis
Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis.
Glomerulonephritis
Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases.
Gnathostomiasis
A dot-ELISA test using a Gnathostoma spinigerum recombinant matrix metalloproteinase protein for the serodiagnosis of human gnathostomiasis.
Graft vs Host Disease
A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation.
Graft vs Host Disease
Effect of a matrix metalloproteinase inhibitor on host resistance against Listeria monocytogenes infection.
Graft vs Host Disease
[Prophylactic effect of matrix metalloproteinase inhibitor on acute graft-versus-host disease in a murine model]
Granuloma
A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection.
Granuloma
Absence of circulating aldosterone attenuates foreign body reaction around surgical sutures.
Granuloma
Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
Granuloma
Cytokines, MMP-2, and MMP-9 levels in patients with a solitary cysticercus granuloma.
Granuloma
Improved abdominal wall wound healing by helium pneumoperitoneum.
Granuloma
Modulation of Matrix Metalloproteinase 14, Tissue Inhibitor of Metalloproteinase 3, Tissue Inhibitor of Metalloproteinase 4, and Inducible Nitric Oxide Synthase in the Development of Periapical Lesions.
Hajdu-Cheney Syndrome
Al-Aqeel Sewairi syndrome, a new autosomal recessive disorder with multicentric osteolysis, nodulosis and arthropathy. The first genetic defect of matrix metalloproteinase 2 gene.
Hajdu-Cheney Syndrome
Characterization of Normal Murine Carpal Bone Development Prompts Re-Evaluation of Pathologic Osteolysis as the Cause of Human Carpal-Tarsal Osteolysis Disorders.
Hantavirus Infections
Generation of plasma cells and CD27-IgD- B cells during hantavirus infection is associated with distinct pathological findings.
Head and Neck Neoplasms
Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.
Head and Neck Neoplasms
Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Head and Neck Neoplasms
Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
Head and Neck Neoplasms
Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Head and Neck Neoplasms
Ethanolic Extract of Ocimum sanctum Leaves Reduced Invasion and Matrix Metalloproteinase Activity of Head and Neck Cancer Cell Lines.
Head and Neck Neoplasms
Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer.
Head and Neck Neoplasms
The relationship between MMPs and pH in whole saliva of radiated head and neck cancer patients.
Head and Neck Neoplasms
Tumor-stroma interactions influence cytokine expression and matrix metalloproteinase activities in paired primary and metastatic head and neck cancer cells.
Healthcare-Associated Pneumonia
Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activity.
Heart Arrest
Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.
Heart Arrest
Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation.
Heart Arrest
Serum matrix metalloproteinases in patients resuscitated from cardiac arrest. The association with therapeutic hypothermia.
Heart Arrest
[Expression of mRNA of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase after cardiopulmonary resuscitation for asphyxial cardiac arrest in rat]
Heart Defects, Congenital
Circulating matrix metalloproteinase levels after ventricular septal defect repair in infants.
Heart Diseases
Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats.
Heart Diseases
Immobilization of matrix metalloproteinase 8 (MMP-8) for online drug screening.
Heart Diseases
Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations.
Heart Diseases
Matrix metalloproteinases in the pathogenesis of viral heart disease.
Heart Diseases
Role of matrix metalloproteinases in hypertension-associated cardiac fibrosis.
Heart Diseases
Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease.
Heart Diseases
Short-term disruption in regional left ventricular electrical conduction patterns increases interstitial matrix metalloproteinase activity.
Heart Failure
A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.
Heart Failure
Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength.
Heart Failure
Adrenoceptor blockade alters plasma gelatinase activity in patients with heart failure and MMP-9 promoter activity in a human cell line (ECV304).
Heart Failure
Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.
Heart Failure
Association between matrix metalloproteinase-9 and worsening heart failure events in patients with chronic heart failure.
Heart Failure
Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
Heart Failure
Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.
Heart Failure
Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction.
Heart Failure
Clinical significance of matrix metalloproteinase (MMP)-2 in patients with acute heart failure.
Heart Failure
Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
Heart Failure
Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
Heart Failure
Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism.
Heart Failure
Correlation between serum matrix metalloproteinase and myocardial fibrosis in heart failure patients with reduced ejection fraction: A retrospective analysis.
Heart Failure
Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling.
Heart Failure
Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.
Heart Failure
EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes.
Heart Failure
Enhanced matrix metalloproteinase activity in skeletal muscles of rats with congestive heart failure.
Heart Failure
Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Heart Failure
Heart failure alters matrix metalloproteinase gene expression and activity in rat skeletal muscle.
Heart Failure
Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure.
Heart Failure
Impact of metalloproteinases on left ventricular remodeling and heart failure events in patients with hypertrophic cardiomyopathy.
Heart Failure
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
Heart Failure
Intracoronary Delivery of Recombinant TIMP-3 Following Myocardial Infarction: Effects on Myocardial Remodeling and Function.
Heart Failure
Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.
Heart Failure
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.
Heart Failure
Matrix metalloproteinase and heart failure: is it time to move from research to clinical laboratories?
Heart Failure
Matrix metalloproteinase gene polymorphisms in heart failure: new pieces to the myocardial matrix puzzle.
Heart Failure
Matrix metalloproteinase in left ventricular remodeling and heart failure.
Heart Failure
Matrix metalloproteinase inhibition and the prevention of heart failure.
Heart Failure
Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure.
Heart Failure
Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
Heart Failure
Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function.
Heart Failure
Matrix metalloproteinase therapy in heart failure.
Heart Failure
Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia.
Heart Failure
MMP inhibition as a potential therapeutic strategy for CHF.
Heart Failure
MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
Heart Failure
Myocardial matrix metalloproteinase activity and abundance with congestive heart failure.
Heart Failure
Myocardial matrix metalloproteinase-3 and matrix metalloproteinase inhibitor-1 expression in congestive heart failure.
Heart Failure
Oxidative remodeling in pressure overload induced chronic heart failure.
Heart Failure
Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
Heart Failure
Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.
Heart Failure
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
Heart Failure
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.
Heart Failure
Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
Heart Failure
Prevention of incipient diabetic cardiomyopathy by high-dose thiamine.
Heart Failure
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction.
Heart Failure
Putative targeting of matrix metalloproteinase-8 in atherosclerosis.
Heart Failure
Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice.
Heart Failure
Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
Heart Failure
Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure.
Heart Failure
Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment.
Heart Failure
Signaling pathways that influence extracellular remodeling.
Heart Failure
The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome.
Heart Failure
Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.
Heart Failure
Translational Sciences in Cardiac Failure Secondary to Arteriovenous Fistula in Hemodialysis Patients.
Heart Failure
Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure.
Heart Failure
[Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases.]
Heart Failure
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
Heart Failure
[Microbiocenosis and activity of the inflammatory process in the colon of the patients with chronic cardiac failure].
Heart Failure
[The activity of components of system of matrix metalloproteinase and tissue inhibitors of metalloproteinase on different stages of chronic cardiac failure].
Heart Failure, Systolic
Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure.
Heart Rupture
Cardiac rupture complicating myocardial infarction.
Heart Rupture
Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture.
Heart Rupture
Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice.
Heart Septal Defects, Ventricular
Circulating matrix metalloproteinase levels after ventricular septal defect repair in infants.
Heart Valve Diseases
[Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function]
HELLP Syndrome
Proteases and their inhibitors are indicative in gestational disease.
Hemangioma
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
Hemangioma, Cavernous, Central Nervous System
Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.
Hemangiosarcoma
Activation of matrix metalloproteinase (MMP)-2 by membrane type 1-MMP and abnormal immunolocalization of the basement membrane components laminin and type IV collagen in canine spontaneous hemangiosarcomas.
Hematologic Neoplasms
Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview.
Hematoma, Subdural, Chronic
[Role of matrix metalloproteinase in transformation of subdural effusion into chronic subdural hematoma]
Hemorrhagic Stroke
Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient.
Hepatic Veno-Occlusive Disease
Chymase Inhibition Attenuates Monocrotaline-Induced Sinusoidal Obstruction Syndrome in Hamsters.
Hepatic Veno-Occlusive Disease
Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition.
Hepatitis
Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8.
Hepatitis
Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
Hepatitis
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.
Hepatitis
Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor.
Hepatitis
Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection.
Hepatitis
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis.
Hepatitis
Theoretical basis of a beneficial role for vitamin D in viral hepatitis.
Hepatitis B
Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
Hepatitis B
[Application value of urinary IGFBP7 and TIMP-2 in acute kidney injury with decompensated hepatitis B virus-related liver cirrhosis].
Hepatitis B, Chronic
Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma.
Hepatitis C
Association between matrix metalloproteinase (MMP)-2, MMP-9 and total antioxidant status of patients with asymptomatic hepatitis C virus infection.
Hepatitis C
Hepatitis C virus core protein promotes the migration and invasion of hepatocyte via activating transcription of extracellular matrix metalloproteinase inducer.
Hepatitis C
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hepatitis C, Chronic
Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.
Hepatitis C, Chronic
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hepatitis C, Chronic
Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-? in Chronic Hepatitis C Virus Patients.
Hepatitis, Chronic
Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
Hepatitis, Chronic
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hermanski-Pudlak Syndrome
Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome.
Hernias, Diaphragmatic, Congenital
Elastase and matrix metalloproteinase activities are associated with pulmonary vascular disease in the nitrofen rat model of congenital diaphragmatic hernia.
Hernias, Diaphragmatic, Congenital
Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery.
Herpes Zoster
Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain.
Herpes Zoster
Caspase-1 Inhibitor Prevents Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage in Mice.
Herpes Zoster
Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice.
Herpes Zoster
The Traditional Chinese Medicine Compound, GRS, Alleviates Blood-Brain Barrier Dysfunction.
Hidradenitis Suppurativa
Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by Regulating Macrophage Differentiation and Matrix Metalloproteinase Expression.
Hip Dislocation
Direct and indirect markers of cartilage metabolism in synovial fluid obtained from dogs with hip dysplasia and correlation with clinical and radiographic variables.
HIV Infections
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies.
HIV Infections
Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.
Hydrocephalus
Matrix metalloproteinases in infants with posthemorrhagic hydrocephalus.
Hydronephrosis
TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat.
Hyperalgesia
Absence of mechanical allodynia and Abeta-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase.
Hyperalgesia
Matrix Metalloproteinase Inhibitor COL-3 Prevents the Development of Paclitaxel-Induced Hyperalgesia in Mice.
Hyperalgesia
Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Hyperalgesia
Role of GPCR (mu-opioid)-receptor tyrosine kinase (epidermal growth factor) crosstalk in opioid-induced hyperalgesic priming (type II).
Hyperemia
Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease.
Hyperemia
Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients.
Hyperglycemia
Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histiocytes.
Hyperhomocysteinemia
Cardiac synchronous and dys-synchronous remodeling in diabetes mellitus.
Hyperhomocysteinemia
Four Weeks of Aerobic Training Affects Cardiac Tissue Matrix Metalloproteinase, Lactate Dehydrogenase and Malate Dehydrogenase Enzymes Activities, and Hepatorenal Biomarkers in Experimental Hyperhomocysteinemia in Rats.
Hyperhomocysteinemia
Homocysteine elicits an M1 phenotype in murine macrophages through an EMMPRIN-mediated pathway.
Hyperhomocysteinemia
Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.
Hyperhomocysteinemia
Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia.
Hyperhomocysteinemia
[Lower extremity varicose veins in childhood and at a young age: Mechanism of development and specific features].
Hyperlipidemias
Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia.
Hypersensitivity
What makes a chemical a respiratory sensitizer?
Hypertension
"Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
Hypertension
?1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
Hypertension
Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
Hypertension
Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.
Hypertension
Atorvastatin and sildenafil decrease vascular TGF-? levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
Hypertension
Cerebral microhemorrhages: mechanisms, consequences and prevention.
Hypertension
Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target.
Hypertension
Dermal pathology, cellular biology, and inflammation in chronic venous disease.
Hypertension
Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
Hypertension
Effects of androgen on vascular and inflammatory biomarkers in a female hypertensive population.
Hypertension
Effects of early and late chronic pressure overload on extracellular matrix remodeling.
Hypertension
Extracellular matrix remodeling in the vascular wall.
Hypertension
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Hypertension
Genetic variants of the matrix metalloproteinase family genes and risk for hypertension: a case-control study among northeastern Han Chinese.
Hypertension
Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling.
Hypertension
Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-?.
Hypertension
Inflammation in chronic venous ulcers.
Hypertension
Inhibition of matrix metalloproteinase and hypertension.
Hypertension
Leukocyte matrix metalloproteinase and tissue inhibitor gene expression patterns in children with primary hypertension.
Hypertension
Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension.
Hypertension
Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.
Hypertension
Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension.
Hypertension
Matrix metalloproteinase -2, -9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension.
Hypertension
Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension.
Hypertension
Matrix Metalloproteinase Inhibition Mitigates Renovascular Remodeling in Salt-Sensitive Hypertension.
Hypertension
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
Hypertension
Matrix Metalloproteinases and Arterial Hypertension: Role of Oxidative Stress and Nitric Oxide in Vascular Functional and Structural Alterations.
Hypertension
Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.
Hypertension
Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects.
Hypertension
Plasma matrix metalloproteinase (MMP)-9 levels are reduced following low-calorie cranberry juice supplementation in men.
Hypertension
Prediction of the early response to spironolactone in resistant hypertension by the combination of matrix metalloproteinase-9 activity and arterial stiffness parameters.
Hypertension
Pyrrolidine dithiocarbamate downregulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodeling in renovascular hypertension.
Hypertension
Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
Hypertension
Serum cardiovascular risk biomarkers in pre-pubertal obese children.
Hypertension
The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.
Hypertension
Venous ulcer: what is new?
Hypertension
Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats.
Hypertension
[Metalloproteinase activity of the blood in patients with arterial hypertension with paroxysmal form of atrial fibrillation.]
Hypertension, Portal
The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
Hypertension, Pregnancy-Induced
Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy.
Hypertension, Pregnancy-Induced
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Hypertension, Pregnancy-Induced
Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension.
Hypertension, Pulmonary
Changes of pulmonary pathology and gene expressions after simvastatin treatment in the monocrotaline-induced pulmonary hypertension rat model.
Hypertension, Pulmonary
L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9.
Hypertension, Pulmonary
The role of matrix metalloproteinase in the intimal sarcoma-like cells derived from endarterectomized tissues from a chronic thromboembolic pulmonary hypertension patient.
Hypertension, Pulmonary
Valsartan attenuates pulmonary hypertension via suppression of mitogen activated protein kinase signaling and matrix metalloproteinase expression in rodents.
Hypertriglyceridemia
Reduction in Secretion of Very Low Density Lipoprotein-Triacylglycerol by a Matrix Metalloproteinase Inhibitor in a Rat Model of Diet-Induced Hypertriglyceridemia.
Hypertrophy, Left Ventricular
Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
Hypertrophy, Left Ventricular
Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats.
Hypoalbuminemia
Effects of Albumin Infusion on Serum Levels of Albumin, Proinflammatory Cytokines (TNF-?, IL-1, and IL-6), CRP, and MMP-8; Tissue Expression of EGRF, ERK1, ERK2, TGF-?, Collagen, and MMP-8; and Wound Healing in Sprague Dawley Rats.
Hyponatremia
Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome.
Hypopharyngeal Neoplasms
Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma.
Idiopathic Interstitial Pneumonias
Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias.
Idiopathic Pulmonary Fibrosis
An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition.
Idiopathic Pulmonary Fibrosis
Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Idiopathic Pulmonary Fibrosis
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Idiopathic Pulmonary Fibrosis
Matrix metalloproteinase-9 in lung remodeling.
Idiopathic Pulmonary Fibrosis
Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF.
Idiopathic Pulmonary Fibrosis
MMP expression and abnormal lung permeability are important determinants of outcome in IPF.
Idiopathic Pulmonary Fibrosis
Mononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Profibrotic Activities for Matrix Metalloproteinase-8 during Bleomycin-Mediated Lung Injury.
Idiopathic Pulmonary Fibrosis
Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.
Infarction, Middle Cerebral Artery
Analysis of regulatory effect of miR-149-5p on Sphingosine-1-phosphate receptor 2 of pericytes and its neuroprotective molecular mechanism after acute cerebral ischemia reperfusion in rats.
Infarction, Middle Cerebral Artery
Crotalus atrox disintegrin reduces hemorrhagic transformation by attenuating matrix metalloproteinase-9 activity after middle cerebral artery occlusion in hyperglycemic male rats.
Infarction, Middle Cerebral Artery
Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats.
Infarction, Middle Cerebral Artery
Matrix metalloproteinase (MMP) induction and inhibition at different doses of recombinant tissue plasminogen activator following experimental stroke.
Infections
A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection.
Infections
A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes.
Infections
A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery.
Infections
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Infections
Activation of AMPK in human fetal membranes alleviates infection-induced expression of pro-inflammatory and pro-labour mediators.
Infections
Activation of neutrophil collagenase in periodontitis.
Infections
Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
Infections
Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes.
Infections
Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection.
Infections
Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes.
Infections
ATF3 is a negative regulator of inflammation in human fetal membranes.
Infections
Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans.
Infections
Batimastat reduces Mycobacterium tuberculosis-induced apoptosis in macrophages.
Infections
beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer.
Infections
Bi-layered nanocomposite bandages for controlling microbial infections and overproduction of matrix metalloproteinase activity.
Infections
Bovine herpesvirus-5 infection in a rabbit experimental model: Immunohistochemical study of the cellular response in the CNS.
Infections
Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube infection.
Infections
Clinical chorioamnionitis at term VIII: a rapid MMP-8 test for the identification of intra-amniotic inflammation.
Infections
Clinical Chorioamnionitis at Term: New Insights into the Etiology, Microbiology, and the Fetal, Maternal and Amniotic Cavity Inflammatory Responses.
Infections
Comparison of amniotic fluid matrix metalloproteinase-8 and cathelicidin in the diagnosis of intra-amniotic infection.
Infections
Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes().
Infections
Coxsackievirus A2 Leads to Heart Injury in a Neonatal Mouse Model.
Infections
Cryptococcus neoformans pulmonary granuloma formation is associated with matrix metalloproteinase-2 expression.
Infections
Dexamethasone prevents alteration of tight junction-associated proteins and barrier function in porcine choroid plexus epithelial cells after infection with Streptococcus suis in vitro.
Infections
Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis.
Infections
Downregulation of miR?29b?3p promotes ??tubulin deacetylation by targeting the interaction of matrix metalloproteinase?9 with integrin ?1 in nasal polyps.
Infections
Dual protective mechanisms of matrix metalloproteinases 2 and 9 in immune defense against Streptococcus pneumoniae.
Infections
Effect of a matrix metalloproteinase inhibitor on host resistance against Listeria monocytogenes infection.
Infections
Effect of E. faecalis on the release of serine proteases elastase and cathepsin G, and collagenase-2 (MMP-8) by human polymorphonuclear leukocytes (PMNs).
Infections
Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice.
Infections
Effects of the knockdown of hypoxia inducible factor-1? expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines.
Infections
Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
Infections
Evaluation of the Biological Effects of Lyophilized Hydrophilic Extract of Rhus coriaria on Myeloperoxidase (MPO) Activity, Wound Healing, and Microbial Infections of Skin Wound Tissues.
Infections
Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.
Infections
Expression of Interleukin-1? and Matrix Metalloproteinase-8 in Cytolytic and Noncytolytic Enterococcus faecalis-induced Persistent Apical Periodontitis: A Comparative Study in the Rat.
Infections
Extracellular matrix metalloproteinase inducer enhances host resistance against pseudomonas aeruginosa infection through MAPK signaling pathway.
Infections
Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. Pylori infection.
Infections
Global cytokine/chemokine profile identifies potential progression prediction indicators in hand-foot-and-mouth disease patients with Enterovirus A71 infections.
Infections
GM-CSF- and TNF-{alpha}-mediated matrix metalloproteinase production by human osteoblasts and monocytes upon infection with Brucella abortus.
Infections
Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.
Infections
High fat diet modulates inflammatory parameters in the heart and liver during acute Trypanosoma cruzi infection.
Infections
Host gene-encoded severe lung TB: from genes to the potential pathways.
Infections
Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.
Infections
Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response.
Infections
Human cytomegalovirus-induced inhibition of cytotrophoblast invasion in a first trimester extravillous cytotrophoblast cell line.
Infections
Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection.
Infections
Human parasitic meningitis caused by Angiostrongylus cantonensis infection in Taiwan.
Infections
Human polynucleotide phosphorylase (hPNPaseold-35): a potential link between aging and inflammation.
Infections
Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection.
Infections
Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Infections
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.
Infections
Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-?B pathway in human astroglia infected with Toxoplasma gondii.
Infections
Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections.
Infections
Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection.
Infections
KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction.
Infections
Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome.
Infections
Mast cell proteases as protective and inflammatory mediators.
Infections
Matrix metalloproteinase (MMP)-2 and MMP-9 as inflammation markers of Trichinella spiralis and Trichinella pseudospiralis infections in mice.
Infections
Matrix Metalloproteinase Activity in Infections by an Encephalitic Virus, Mouse Adenovirus Type 1.
Infections
Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection.
Infections
Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
Infections
Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation.
Infections
Matrix metalloproteinase-9 leads to blood-brain barrier leakage in mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis.
Infections
Matrix Metalloproteinase-9 Leads to Claudin-5 Degradation via the NF-?B Pathway in BALB/c Mice with Eosinophilic Meningoencephalitis Caused by Angiostrongylus cantonensis.
Infections
Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo.
Infections
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Infections
Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor.
Infections
Matrix Metalloproteinases Vary with Airway Microbiota Composition and Lung Function in Non-Cystic Fibrosis Bronchiectasis.
Infections
Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection.
Infections
Methicillin-Resistant Staphylococcus Aureus infection exacerbates NSCLC cell metastasis by up-regulating TLR4/MyD88 pathway.
Infections
Microbiological and biochemical findings in relation to clinical periodontal status in active smokers, non-smokers and passive smokers.
Infections
MMP cellular responses to dengue virus infection-induced vascular leakage.
Infections
Modified Profile of Matrix Metalloproteinase 2 and 9 Production by Human Fallopian Tube Epithelial Cells After Infection In Vitro With Neisseria gonorrhoeae.
Infections
Neisseria gonorrhoeae Challenge Increases Matrix Metalloproteinase-8 Expression in Fallopian Tube Explants.
Infections
Persistent Oral Human Papillomavirus (HPV) Infection is Associated with Low Salivary Levels of Matrix Metalloproteinase 8 (MMP-8).
Infections
Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.
Infections
Quantitative proteomics identify an association between extracellular matrix degradation and immunopathology of genotype VII Newcastle disease virus in the spleen in chickens.
Infections
Real-time quantification of matrix metalloproteinase and integrin ?v?3 expression during biomaterial-associated infection in a murine model.
Infections
Regulation of matrix metalloproteinase (MMP) and tissue inhibitor of matrix metalloproteinase (TIMP) genes during JHMV infection of the central nervous system.
Infections
Rhinovirus-induces progression of lung disease in a mouse model of COPD via IL-33/ST2 signaling axis.
Infections
Sendai virus infection up-regulates trypsin I and matrix metalloproteinase-9, triggering viral multiplication and matrix degradation in rat lungs and lung L2 cells.
Infections
Streptococcus pyogenes degrades extracellular matrix in chondrocytes via MMP-13.
Infections
T cell production of matrix metalloproteases and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain.
Infections
T-cell production of matrix metalloproteinases and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain.
Infections
Targeting extracellular cyclophilins ameliorates disease progression in experimental biliary atresia.
Infections
The antidepressant fluoxetine protects the hippocampus from brain damage in experimental pneumococcal meningitis.
Infections
The frequency and clinical significance of intra-uterine infection and inflammation in patients with placenta previa and preterm labor and intact membranes.
Infections
The intensity of the fetal inflammatory response in intraamniotic inflammation with and without microbial invasion of the amniotic cavity.
Infections
The matrix metalloproteinase gene GmMMP2 is activated in response to pathogenic infections in soybean.
Infections
The Relationship Between Matrix Metalloproteinase-8 in After Birth Oral Fluid and Acute Histologic Chorioamnionitis in Preterm Delivery.
Infections
The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis (Review).
Infections
The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori.
Infections
The Role of Matrix Metalloproteinases in Development, Repair, and Destruction of the Lungs.
Infections
Time-dependent matrix metalloproteinases and tissue inhibitor of metalloproteinases expression change in fusarium solani keratitis.
Infections
Truncated active matrix metalloproteinase-8 gene expression in HepG2 cells is active against native type I collagen.
Infections
Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
Infections
Urinary NGAL Measured after the First Year Post Kidney Transplantation Predicts Changes in Glomerular Filtration over One-Year Follow-Up.
Infections
Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections.
Infections
Value of amniotic fluid neutrophil collagenase concentrations in preterm premature rupture of membranes.
Infections
[The immunopathology mechanisms of matrix metalloproteinases in brain infection induced by parasites].
Infertility, Male
Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility.
Inflammatory Bowel Diseases
Focus issue: understanding mechanisms of inflammation.
Inflammatory Bowel Diseases
Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma2-chain expression in murine inflammatory bowel disease (ulcerative colitis).
Inflammatory Bowel Diseases
In vitro evaluation of compression-coated glycyl-l-histidyl-l-lysine-Cu(II) (GHK-Cu(2+))-loaded microparticles for colonic drug delivery.
Inflammatory Bowel Diseases
Increased expression of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: cross-sectional study.
Inflammatory Bowel Diseases
Matrix metalloproteinase levels are elevated in inflammatory bowel disease.
Inflammatory Bowel Diseases
Matrix metalloproteinase-9 regulates MUC-2 expression through its effect on goblet cell differentiation.
Inflammatory Bowel Diseases
Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.
Influenza in Birds
Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions.
Influenza, Human
Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection.
Influenza, Human
Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes?
Insulin Resistance
Association of MMP-8 with obesity, smoking and insulin resistance.
Insulin Resistance
Cellular fibronectin response to supervised moderate aerobic training in patients with type 2 diabetes.
Insulin Resistance
Countermeasures for pasture-associated laminitis in ponies and horses.
Insulin Resistance
Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women.
Insulin Resistance
Pioglitazone improves left ventricular diastolic function in patients with essential hypertension.
Insulin Resistance
Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes.
interstitial collagenase deficiency
MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing.
Intervertebral Disc Degeneration
ISSLS prize in basic science 2021: a novel inducible system to regulate transgene expression of TIMP1.
Intervertebral Disc Degeneration
Matrix metalloproteinase (MMP)-3 gene up-regulation in a rat tail compression loading-induced disc degeneration model.
Intervertebral Disc Degeneration
[Effect of electroacupuncture intervention on expression of extracellular matrix collagen and metabolic enzymes].
Intervertebral Disc Degeneration
[Effects of electroacupuncture at Jiaji (EX-B 2) on extracellular matrix MMP-1, MMP-3 and TIMP-1 levels in the degenerated cervical intervertebral disc in rats]
Intervertebral Disc Degeneration
[Study on yiqi huayu bushen recipe and its disassembled recipes in regulating mRNA expression of collagens and metabolic enzymes in extracellular matrix of cervical disc]
Intervertebral Disc Displacement
Analysis of cartilage oligomeric matrix protein and matrix metalloproteinase-9 in cerebrospinal fluid of miniature dachshund with intervertebral disc herniation.
Intervertebral Disc Displacement
Correlation of matrix metalloproteinases-1 and -3 with patient age and grade of lumbar disc herniation.
Intervertebral Disc Displacement
Effects of MMP-1 and MMP-3 gene polymorphisms on gene expression and protein level in lumbar disc herniation.
Intervertebral Disc Displacement
Matrix metalloprotease-9 activity in the cerebrospinal fluid and spinal injury severity in dogs with intervertebral disc herniation.
Intervertebral Disc Displacement
Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration.
Intervertebral Disc Displacement
Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc.
Intervertebral Disc Displacement
The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation.
Intervertebral Disc Displacement
Up-regulated expression of matrilysin and neutrophil collagenase in human herniated discs.
Intracranial Aneurysm
A failure of matrix metalloproteinase inhibition in the prevention of rat intracranial aneurysm formation.
Intracranial Aneurysm
Association of functional MMP-2 gene variant with intracranial aneurysms: case-control genetic association study and meta-analysis.
Intracranial Aneurysm
Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.
Intracranial Hemorrhages
Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.
Intracranial Hemorrhages
Reperfusion and Neurovascular Dysfunction in Stroke: from Basic Mechanisms to Potential Strategies for Neuroprotection.
Ischemic Stroke
Association between Inflammatory Biomarkers and Progression of Intracranial Large Artery Stenosis after Ischemic Stroke.
Ischemic Stroke
Association Between Matrix Metalloproteinase Family Gene Polymorphisms and Ischemic Stroke: a Meta-analysis.
Ischemic Stroke
Association between matrix metalloproteinase family gene polymorphisms and risk of ischemic stroke: A systematic review and meta-analysis of 29 studies.
Ischemic Stroke
Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke.
Ischemic Stroke
Association between the Matrix Metalloproteinase-9 rs3918242 Polymorphism and Ischemic Stroke Susceptibility: A Meta-Analysis.
Ischemic Stroke
Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice.
Ischemic Stroke
Causal associations of serum matrix metalloproteinase-8 level with ischaemic stroke and ischaemic stroke subtypes: a Mendelian randomization study.
Ischemic Stroke
Causal Effect of MMP-1 (Matrix Metalloproteinase-1), MMP-8, and MMP-12 Levels on Ischemic Stroke: A Mendelian Randomization Study.
Ischemic Stroke
Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke.
Ischemic Stroke
Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia.
Ischemic Stroke
Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound.
Ischemic Stroke
Meta-analysis of matrix metalloproteinase (MMP)-9 C1562T polymorphism and susceptibility to ischemic stroke in the Chinese population.
Ischemic Stroke
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Ischemic Stroke
Role of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonism.
Ischemic Stroke
Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke.
Ischemic Stroke
The Role of High Mobility Group Box 1 in Ischemic Stroke.
Ischemic Stroke
The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke.
Ischemic Stroke
The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke.
Joint Diseases
Al-Aqeel Sewairi syndrome, a new autosomal recessive disorder with multicentric osteolysis, nodulosis and arthropathy. The first genetic defect of matrix metalloproteinase 2 gene.
Joint Diseases
Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses.
Joint Diseases
Biological strategies for osteoarthritis: from early diagnosis to treatment.
Joint Diseases
cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis.
Joint Diseases
Characterization of Normal Murine Carpal Bone Development Prompts Re-Evaluation of Pathologic Osteolysis as the Cause of Human Carpal-Tarsal Osteolysis Disorders.
Joint Diseases
Effects of the antirheumatic remedy hox alpha--a new stinging nettle leaf extract--on matrix metalloproteinases in human chondrocytes in vitro.
Joint Diseases
Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs.
Joint Diseases
Matrix metalloproteinase, vitamin A and methylprednisolone effects on experimentally induced amyloid arthropathy.
Joint Diseases
MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1?-stimulated human articular chondrocyte C28/I2 cells.
Joint Diseases
Protein kinase C isoforms zeta and iota mediate collagenase expression and cartilage destruction via STAT3- and ERK-dependent c-fos induction.
Joint Diseases
Reduction of interleukin-1? induced matrix metalloproteinase-3 release by extracts of six plants: inhibitory screening of 35 traditional medicinal plants.
Joint Diseases
Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.
Joint Diseases
The role of IL-17-secreting mast cells in inflammatory joint disease.
Joint Diseases
[The matrix metalloproteinase gene family: structure, function, expression, and role in destructive joint disease]
Keloid
Correlation between Serum 25-Hydroxyvitamin D Levels with Keloid Severity.
Keloid
Effects of hepatocyte growth factor on collagen synthesis and matrix metalloproteinase production in keloids.
Keloid
Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
Keloid
Relaxin-expressing adenovirus decreases collagen synthesis and up-regulates matrix metalloproteinase expression in keloid fibroblasts: in vitro experiments.
Keloid
Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment.
Keloid
Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts.
Keloid
Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis.
Keratitis
Biofilm microenvironment activated supramolecular nanoparticles for enhanced photodynamic therapy of bacterial keratitis.
Keratitis
Correlation between matrix metalloproteinase expression and activation of the focal adhesion kinase signaling pathway in herpes stromal keratitis.
Keratitis
Elevated Expression and Activation of Matrix Metalloproteinase 8 in Tear Fluid in Atopic Blepharoconjunctivitis.
Keratitis
Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa-associated keratitis.
Keratitis
Expression of matrix metalloproteinases during experimental Candida albicans keratitis.
Keratitis
Inhibition of matrix metalloproteins 9 attenuated Candida albicans induced inflammation in mouse cornea.
Keratitis
Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
Keratitis
Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
Keratitis
Secretory Leukoprotease Inhibitor: A Native Antimicrobial Protein in the Innate Immune Response in a Rat Model of S. aureus Keratitis.
Keratitis
Testican-1 Promotes Resistance against Pseudomonas aeruginosa-Induced Keratitis through Regulation of MMP-2 Expression and Activation.
Keratitis
[The roles of gelatinases in pathological changes of fungal keratitis in experimental rabbits]
Keratoacanthoma
Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Keratoconus
Acute hypoxia influences collagen and matrix metalloproteinase expression by human keratoconus cells in vitro.
Keratoconus
Collagenolytic proteinases in keratoconus.
Keratoconus
EMMPRIN and MMP-1 in keratoconus.
Keratoconus
Expression of degradative enzymes and protease inhibitors in corneas with keratoconus.
Keratoconus
Induction of matrix metalloproteinase-1 by tumor necrosis factor-? is mediated by interleukin-6 in cultured fibroblasts of keratoconus.
Keratoconus
Keratoconus: an inflammatory disorder?
Keratoconus
Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
Keratoconus
Role of extracellular matrix remodelling gene SNPs in keratoconus.
Keratoconus
The Enigma of Environmental Factors in Keratoconus.
Kidney Diseases
Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
Kidney Failure, Chronic
Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Kidney Failure, Chronic
Inflammatory response and matrix metalloproteinases in chronic kidney failure: Modulation by adropin and spexin.
Kidney Failure, Chronic
Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease.
Kidney Neoplasms
Expression of thrombospondin-derived 4N1K peptide-containing proteins in renal cell carcinoma tissues is associated with a decrease in tumor growth and angiogenesis.
Kounis Syndrome
Extracellular matrix metalloproteinase inducer (EMMPRIN), acute myocardial infarction and the Kounis syndrome.
Laryngeal Neoplasms
Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.
Laryngeal Neoplasms
Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.
Laryngeal Neoplasms
Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
Laryngeal Neoplasms
The matrix metalloproteinase in larynx cancer.
Leg Ulcer
Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Leg Ulcer
Effect of collagen turnover and matrix metalloproteinase activity on healing of venous leg ulcers.
Leg Ulcer
Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers.
Leg Ulcer
Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Leg Ulcer
Hydroxyurea-induced leg ulcers treated with a protease-modulating matrix.
Leg Ulcer
Matrix Metalloproteinase Profiles in Chronic Venous Ulcer Wound Fluid of Inflammatory and Granulating Venous Leg Ulcers.
Leg Ulcer
Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers.
Leg Ulcer
Plasminogen activation in venous leg ulcers.
Leg Ulcer
The Impact of Differential Expression of Extracellular Matrix Metalloproteinase Inducer, Matrix Metalloproteinase-2, Tissue Inhibitor of Matrix Metalloproteinase-2 and PDGF-AA on the Chronicity of Venous Leg Ulcers.
Leg Ulcer
The role of matrix metalloproteinases in wound healing.
Leiomyoma
Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Leiomyoma
MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Leiomyoma
Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Leiomyoma
Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer.
Leiomyoma
The function role and synergic effect of syndecan-1 for mifepristone in uterine leiomyoma.
Leiomyoma
Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system.
Lentivirus Infections
Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity.
Leprosy
High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.
Leukemia
Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells
Leukemia
Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases.
Leukemia
Doxycycline induces apoptosis by way of caspase-3 activation with inhibition of matrix metalloproteinase in human T-lymphoblastic leukemia CCRF-CEM cells.
Leukemia
Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.
Leukemia
Expression of neutrophil collagenase (MMP-8) in Jurkat T leukemia cells and its role in invasion.
Leukemia
Growth of tyrosine kinase inhibitor-resistant Philadelphia-positive acute lymphoblastic leukemia: Role of bone marrow stromal cells.
Leukemia
High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
Leukemia
Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
Leukemia
Inhibition of matrix metalloproteinases expression in human dental pulp cells by all-trans retinoic acid.
Leukemia
Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
Leukemia
Orostachys japonicus inhibits the expression of MMP-2 and MMP-9 mRNA and modulates the expression of iNOS and COX-2 genes in human PMA-differentiated THP-1 cells via inhibition of NF-?B and MAPK activation.
Leukemia
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
Leukemia
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.
Leukemia
Recombinant Multivalent EMMPRIN Extracellular Domain Induces U937 Human Leukemia Cell Apoptosis by Downregulation of Monocarboxylate Transporter 1 and Activation of Procaspase-9.
Leukemia
The Contribution of MMP-8 Promoter Genotypes to Childhood Leukemia.
Leukemia
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Leukemia
[Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1].
Leukemia, Monocytic, Acute
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.
Leukemia, Monocytic, Acute
[Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1].
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Leukemia, Myeloid
A new matrix metalloproteinase inhibitor SI-27 induces apoptosis in several human myeloid leukemia cell lines and enhances sensitivity to TNF alpha-induced apoptosis.
Leukemia, Myeloid
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
Leukemia, Myeloid, Acute
Hispidulin induces mitochondrial apoptosis in acute myeloid leukemia cells by targeting extracellular matrix metalloproteinase inducer.
Leukemia, Myeloid, Acute
[Relationship between VEGF and MMP-2, MMP-9 in 82 Patients with Acute Myeloid Leukemia.]
Leukemia, Promyelocytic, Acute
Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases.
Leukemia, T-Cell
Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
Leukemia-Lymphoma, Adult T-Cell
Testican 3 expression in adult T-cell leukemia.
Leukocytosis
Factors affecting matrix metalloproteinase-8 levels in the vaginal and cervical fluids in the first and second trimester of pregnancy.
Leukoplakia
TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis.
Lichen Planus
MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus.
Lichen Planus, Oral
Matrix metalloproteinase gene expression in oral lichen planus: erosive vs. reticular forms.
Lichen Planus, Oral
MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus.
Lichen Planus, Oral
Zinc Therapy in Treatment of Symptomatic Oral Lichen Planus.
Lipedema
The MMP14-caveolin axis and its potential relevance for lipoedema.
Liver Cirrhosis
A cut above the rest? MMP-8 and liver fibrosis gene therapy.
Liver Cirrhosis
Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells.
Liver Cirrhosis
Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.
Liver Cirrhosis
Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
Liver Cirrhosis
Adenoviral delivery of truncated MMP-8 fused with the hepatocyte growth factor mutant 1K1 ameliorates liver cirrhosis and promotes hepatocyte proliferation.
Liver Cirrhosis
Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-?1/Smad signalling, MMPs and TIMPs.
Liver Cirrhosis
Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.
Liver Cirrhosis
Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice.
Liver Cirrhosis
CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis.
Liver Cirrhosis
Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients.
Liver Cirrhosis
Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet.
Liver Cirrhosis
Enhanced liver fibrosis (ELF) test in obese children with ultrasound-proven liver steatosis.
Liver Cirrhosis
Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
Liver Cirrhosis
Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
Liver Cirrhosis
Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.
Liver Cirrhosis
Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/?-Catenin Reduces Liver Fibrosis in Mice.
Liver Cirrhosis
Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells.
Liver Cirrhosis
Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis.
Liver Cirrhosis
Matrix metalloproteinase gene delivery for liver fibrosis.
Liver Cirrhosis
Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway.
Liver Cirrhosis
Mesenchymal stem cell infusion therapy in carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
Liver Cirrhosis
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.
Liver Cirrhosis
Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis.
Liver Cirrhosis
Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice.
Liver Cirrhosis
Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model.
Liver Cirrhosis
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon ? and ribavirin.
Liver Cirrhosis
The immunoreactivity of TGF-b1 in non-alcoholic fatty liver disease.
Liver Cirrhosis
Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.
Liver Cirrhosis
Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.
Liver Cirrhosis
Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis.
Liver Cirrhosis
[Application value of urinary IGFBP7 and TIMP-2 in acute kidney injury with decompensated hepatitis B virus-related liver cirrhosis].
Liver Cirrhosis
[Combined effects of antisense TBRI eukaryotic expressing plasmid and antisense TIMP-1 eukaryotic expressing plasmid on rat liver fibrosis]
Liver Cirrhosis, Alcoholic
Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.
Liver Cirrhosis, Alcoholic
Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study.
Liver Diseases
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Liver Diseases
Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C.
Liver Diseases
Matrix metalloproteinase (MMP)-3 polymorphism in patients with HBV related chronic liver disease.
Liver Diseases
Non-canonical role of matrix metalloprotease (MMP) in activation and migration of hepatic stellate cells (HSCs).
Liver Diseases
Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis.
Liver Diseases, Alcoholic
Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.
Liver Diseases, Alcoholic
Non-canonical role of matrix metalloprotease (MMP) in activation and migration of hepatic stellate cells (HSCs).
Liver Failure
Matrix metalloproteinase-9 in the initial injury after hepatectomy in mice.
Liver Failure, Acute
Chymase inhibition attenuates lipopolysaccharide/ d-galactosamine-induced acute liver failure in hamsters.
Liver Failure, Acute
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis.
Liver Neoplasms
Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.
Liver Neoplasms
Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20.
Liver Neoplasms
Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
Liver Neoplasms
Knockdown of ACTA2?AS1 promotes liver cancer cell proliferation, migration and invasion.
Liver Neoplasms
Sonic Hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Lung Diseases
Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice.
Lung Diseases
Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Lung Diseases
Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in pulmonary fibrosis.
Lung Diseases
Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha.
Lung Diseases
Matrix metalloproteinase-9 in lung remodeling.
Lung Diseases
Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8.
Lung Diseases
Structural insights into the binding of MMP9 inhibitors.
Lung Diseases, Interstitial
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Lung Diseases, Interstitial
Extracellular matrix metalloproteinase inducer in interstitial pneumonias.
Lung Diseases, Interstitial
Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in pulmonary fibrosis.
Lung Diseases, Interstitial
Neutrophil collagenase in rheumatoid interstitial lung disease.
Lung Diseases, Interstitial
Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease.
Lung Injury
Attenuation of oxidant-induced lung injury by the synthetic matrix metalloproteinase inhibitor BB-3103.
Lung Injury
BPD Following Preterm Birth: A Model for Chronic Lung Disease and a Substrate for ARDS in Childhood.
Lung Injury
Experimental hindlimb ischemia increases neutrophil-mediated matrix metalloproteinase activity: a potential mechanism for lung injury after limb ischemia.
Lung Injury
Gene expressions and roles of matrix metalloproteinases-8 and tissue inhibitor of metalloproteinases-1 in hyperoxia-induced pulmonary fibrosis in neonatal rats.
Lung Injury
High levels of extracellular matrix metalloproteinase inducer are expressed in lymphangioleiomyomatosis.
Lung Injury
Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils.
Lung Injury
Induction of pulmonary matrilysin expression by combustion and ambient air particles.
Lung Injury
Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress.
Lung Injury
Mobilization of Bone Marrow Cells by CSF3 Protects Mice from Bleomycin-Induced Lung Injury.
Lung Injury
Profibrotic Activities for Matrix Metalloproteinase-8 during Bleomycin-Mediated Lung Injury.
Lung Injury
Resuscitation of hypoxic piglets with 100% O2 increases pulmonary metalloproteinases and IL-8.
Lung Injury
Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis.
Lung Injury
Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases.
Lung Injury
Shedding of Syndecan-1/CXCL1 Complexes by MMP7 Functions as an Epithelial Checkpoint of Neutrophil Activation.
Lung Injury
Time-dependent inhibition of immune complex-induced lung injury by catalase: relationship to alterations in macrophage and neutrophil matrix metalloproteinase elaboration.
Lung Injury
Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease.
Lung Injury
Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat.
Lung Injury
[Feature changes of MMP-2/9 activities and TIMP-1/2 protein expressions during the progression of pulmonary fibrosis in rats]
Lung Injury
[Study on effect of dexamethasone on the expression of matrix metalloproteinase and its tissue inhibitors in hyperoxia-induced lung injury]
Lung Neoplasms
AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.
Lung Neoplasms
Alterations in gene expression of proprotein convertases in human lung cancer have a limited number of scenarios.
Lung Neoplasms
An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.
Lung Neoplasms
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.
Lung Neoplasms
Andrographolide inhibits the activation of NF-?B and MMP-9 activity in H3255 lung cancer cells.
Lung Neoplasms
Anti-metastatic effects of isolinderalactone via the inhibition of MMP-2 and up regulation of NM23-H1 expression in human lung cancer A549 cells.
Lung Neoplasms
Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway.
Lung Neoplasms
Association of matrix metalloproteinase family gene polymorphisms with lung cancer risk: logistic regression and generalized odds of published data.
Lung Neoplasms
Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
Lung Neoplasms
Bcl-X(L) and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells.
Lung Neoplasms
CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner.
Lung Neoplasms
Changes in angiogenic growth factor levels after gefitinib treatment in non-small cell lung cancer.
Lung Neoplasms
Comparative expression of matrix metalloproteinases in low-grade mucoepidermoid carcinoma and typical lung cancer.
Lung Neoplasms
Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases.
Lung Neoplasms
Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway.
Lung Neoplasms
Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Lung Neoplasms
Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment.
Lung Neoplasms
Differential Expressions Of Matrix Metalloproteinases, A Disintegrin And Metalloproteinases, And A Disintegrin And Metalloproteinases With Thrombospondin Motifs And Their Endogenous Inhibitors Among Histologic Subtypes Of Lung Cancers.
Lung Neoplasms
Dysregulation of FURIN by prostaglandin-endoperoxide synthase 2 in lung epithelial NCI-H292 cells.
Lung Neoplasms
Early combined treatment with carboplatin and the MMP inhibitor, prinomastat, prolongs survival and reduces systemic metastasis in an aggressive orthotopic lung cancer model.
Lung Neoplasms
Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
Lung Neoplasms
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Lung Neoplasms
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer.
Lung Neoplasms
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Lung Neoplasms
Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.
Lung Neoplasms
Feruloyl-L-arabinose attenuates migration, invasion and production of reactive oxygen species in H1299 lung cancer cells.
Lung Neoplasms
Gelatinolytic activity of matrix metalloproteinase in lung cancer studied using film in situ zymography stamp method.
Lung Neoplasms
Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression.
Lung Neoplasms
Hecogenin acetate inhibits reactive oxygen species production and induces cell cycle arrest and senescence in the A549 human lung cancer cell line.
Lung Neoplasms
High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
Lung Neoplasms
How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity.
Lung Neoplasms
IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
Lung Neoplasms
Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
Lung Neoplasms
Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
Lung Neoplasms
Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270.
Lung Neoplasms
Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies.
Lung Neoplasms
Matrix metalloproteinase activity in early-stage lung cancer.
Lung Neoplasms
Matrix metalloproteinase expression in lung cancer.
Lung Neoplasms
Matrix metalloproteinase family gene polymorphisms and lung cancer susceptibility: an updated meta-analysis.
Lung Neoplasms
Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression.
Lung Neoplasms
Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer.
Lung Neoplasms
Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses.
Lung Neoplasms
Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
Lung Neoplasms
Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.
Lung Neoplasms
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
Lung Neoplasms
Miltirone-induced apoptosis in cisplatin-resistant lung cancer cells through upregulation of p53 signaling pathways.
Lung Neoplasms
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.
Lung Neoplasms
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines.
Lung Neoplasms
Negative correlation of cytoplasm TIMP3 with miR-222 indicates a good prognosis for NSCLC.
Lung Neoplasms
NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
Lung Neoplasms
Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential.
Lung Neoplasms
Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
Lung Neoplasms
Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer.
Lung Neoplasms
Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway.
Lung Neoplasms
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.
Lung Neoplasms
Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Lung Neoplasms
Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer.
Lung Neoplasms
Pipoxolan inhibits CL1-5 lung cancer cells migration and invasion through inhibition of MMP-9 and MMP-2.
Lung Neoplasms
Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.
Lung Neoplasms
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
Lung Neoplasms
Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer.
Lung Neoplasms
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.
Lung Neoplasms
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18.
Lung Neoplasms
Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells.
Lung Neoplasms
Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.
Lung Neoplasms
Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.
Lung Neoplasms
Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Lung Neoplasms
Small cell lung cancer and targeted therapies.
Lung Neoplasms
SNPs in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis.
Lung Neoplasms
Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
Lung Neoplasms
Study on Invadopodia Formation for Lung Carcinoma Invasion with a Microfluidic 3D Culture Device.
Lung Neoplasms
Targeting ?-tubulin/CCT-? complex induces apoptosis and suppresses migration and invasion of highly metastatic lung adenocarcinoma.
Lung Neoplasms
TGF-?-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression.
Lung Neoplasms
The Contribution of MMP-8 Promoter Polymorphisms in Lung Cancer.
Lung Neoplasms
The relationship of metalloproteinase gene polymorphisms and lung cancer.
Lung Neoplasms
Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.
Lung Neoplasms
Transition from suspension to adherent growth is accompanied by tissue factor expression and matrix metalloproteinase secretion in a small cell lung cancer cell line.
Lung Neoplasms
Video-assisted thoracic surgery lobectomy for lung cancer is associated with less immunochemokine disturbances than thoracotomy.
Lung Neoplasms
[Effect of Src tyrosine kinase inhibition on secretion of MMP-2 and MMP-9 by non-small cell lung cancer cells].
Lung Neoplasms
[Expression and pathological mechanism of MMP-9 and HIF-2? in CD133(+) lung cancer stem cells].
Lung Neoplasms
[Expression and significance of MIF and CD147 in non-small cell lung cancer]
Lung Neoplasms
[Expression of adiponectin in non-small cell lung cancer and its relationship with MMP-9 and angiogenesis].
Lung Neoplasms
[MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells].
Lung Neoplasms
[Molecular therapy in lung cancer]
Lung Neoplasms
[Significance of caveolin-1 protein detected by quantum dots technique in human lung cancer invasiveness and metastasis.]
Lupus Erythematosus, Cutaneous
Ultraviolet radiation-induced cytokines promote mast cell accumulation and matrix metalloproteinase production: potential role in cutaneous lupus erythematosus.
Lupus Erythematosus, Systemic
Concentrations of circulating matrix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: implications for monitoring disease activity in systemic lupus erythematosus.
Lupus Nephritis
Increased glomerular matrix metalloproteinase activity in murine lupus nephritis.
Lyme Neuroborreliosis
Detection of a 130-kD matrix metalloproteinase in cerebrospinal fluid from a patient with Lyme neuroborreliosis.
Lymphangioleiomyomatosis
Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response.
Lymphangioleiomyomatosis
Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade.
Lymphangioleiomyomatosis
High levels of extracellular matrix metalloproteinase inducer are expressed in lymphangioleiomyomatosis.
Lymphangioleiomyomatosis
Rapamycin-insensitive Up-regulation of MMP2 and Other Genes in TSC2-deficient LAM-like Cells.
Lymphatic Metastasis
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Lymphatic Metastasis
Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis.
Lymphatic Metastasis
Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Lymphatic Metastasis
Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis.
Lymphatic Metastasis
Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
Lymphatic Metastasis
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Lymphatic Metastasis
Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Lymphatic Metastasis
Inhibition of invasion and lymph node metastasis of gastrointestinal cancer cells by R-94138, a matrix metalloproteinase inhibitor.
Lymphatic Metastasis
Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270.
Lymphatic Metastasis
Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
Lymphatic Metastasis
LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.
Lymphatic Metastasis
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
Lymphatic Metastasis
Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma.
Lymphatic Metastasis
Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Lymphatic Metastasis
Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique.
Lymphatic Metastasis
The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma.
Lymphatic Metastasis
[Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma]
Lymphatic Metastasis
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Lymphoma
Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences.
Lymphoma
Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
Lymphoma
Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.
Lymphoma
CTHRC1 mediates IL?1??induced apoptosis in chondrocytes via JNK1/2 signaling.
Lymphoma
Evaluation of extracellular matrix protein expression and apoptosis in the uterosacral ligaments of patients with or without pelvic organ prolapse.
Lymphoma
Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Lymphoma
Inhibitory effects of FKBP14 on human cervical cancer cells.
Lymphoma
Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.
Lymphoma
MicroRNA?15a?5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP?2 signaling pathway.
Lymphoma
Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
Lymphoma
Protective effects of psoralidin on IL?1??induced chondrocyte apoptosis.
Lymphoma
Punicalagin suppresses the proliferation and invasion of cervical cancer cells through inhibition of the ?-catenin pathway.
Lymphoma
Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Lymphoma
Type II cGMP?dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells.
Lymphoma, B-Cell
Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences.
Lymphoma, B-Cell
Effects of a nutrient mixture on immunohistochemical localization of cancer markers in human cervical cancer HeLa cell tumor xenografts in female nude mice.
Lymphoma, B-Cell
Evaluation of extracellular matrix protein expression and apoptosis in the uterosacral ligaments of patients with or without pelvic organ prolapse.
Lymphoma, B-Cell
Functions of endothelin-1 in apoptosis and migration in hepatocellular carcinoma.
Lymphoma, B-Cell
Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses.
Lymphoma, B-Cell
I157172, a novel inhibitor of cystathionine ?-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.
Lymphoma, B-Cell
Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-?B1.
Lymphoma, B-Cell
Miltirone-induced apoptosis in cisplatin-resistant lung cancer cells through upregulation of p53 signaling pathways.
Lymphoma, B-Cell
miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways
Lymphoma, B-Cell
Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage.
Lymphoma, B-Cell
Puerarin 6?-O-xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis.
Lymphoma, B-Cell
Trametes robiniophila may induce apoptosis and inhibit MMPs expression in the human gastric carcinoma cell line MKN-45.
Lymphoma, B-Cell
Treadmill exercise ameliorates impairment of spatial learning memory in pups born to old and obese mother rats.
Lymphoma, B-Cell
Wnt6 contributes tumorigenesis and development of colon cancer via its effects on cell proliferation, apoptosis, cell-cycle and migration.
Lymphoma, T-Cell
Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model.
Macular Degeneration
Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.
Macular Degeneration
Disturbed matrix metalloproteinase activity of Bruch's membrane in age-related macular degeneration.
Macular Degeneration
Disturbed Matrix Metalloproteinase Pathway in Both Age-Related Macular Degeneration and Alzheimer's Disease.
Macular Degeneration
Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration.
Macular Degeneration
Risk of macular degeneration affected by polymorphisms in Matrix metalloproteinase-2: A case-control study in Chinese Han population.
Macular Degeneration
The association of matrix metalloproteinases polymorphisms and interleukins in advanced age-related macular degeneration.
Macular Degeneration
Understanding the complexity of the matrix metalloproteinase system and its relevance to age-related diseases: Age-related macular degeneration and Alzheimer's disease.
Macular Edema
Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.
Malaria
Matrix metalloproteinase-9 polymorphism 1562 C > T (rs3918242) associated with protection against placental malaria.
Malaria
Matrix Metalloproteinases and Their Tissue Inhibitors (TIMPs) in Plasmodium falciparum Malaria: Serum Levels of TIMP-1 Are Associated with Disease Severity.
Malaria
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.
Malaria, Cerebral
Glial activation and matrix metalloproteinase release in cerebral malaria.
Malnutrition
The expression of matrix metalloproteinases 8 and 9 by neutrophils of Wistar albino rats with severe qualitative and quantitative protein malnutrition.
Marfan Syndrome
Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
Marfan Syndrome
Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.
Marfan Syndrome
RGD-containing fibrillin-1 fragments upregulate matrix metalloproteinase expression in cell culture: a potential factor in the pathogenesis of the Marfan syndrome.
Marfan Syndrome
Ulnar Artery Aneurysm as a Late Sequela of Marfan Syndrome.
Mastitis
Altered Leukocyte Responsiveness in Dairy Cows with Naturally Occurring Chronic Staphylococcus aureus Mastitis.
Mastitis
Increase in milk metalloproteinase activity and vascular permeability in bovine endotoxin-induced and naturally occurring Escherichia coli mastitis.
Mastocytoma
Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase.
Medulloblastoma
Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of beta1-integrin, ERK, and NF-kappaB.
Medulloblastoma
Extracellular Matrix Metalloproteinase Inducer is a Negative Prognostic Factor of Pediatric Medulloblastoma.
Medulloblastoma
Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients.
Melanoma
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells.
Melanoma
A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies.
Melanoma
A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells.
Melanoma
Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasion.
Melanoma
Analysis of Enzymatic Activity of Matrix Metalloproteinase (MMP) by Collagen Zymography in Melanoma.
Melanoma
Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.
Melanoma
Anti-tumor angiogenic effect of a matrix metalloproteinase inhibitor MMI270.
Melanoma
Assaying Wnt5A-mediated invasion in melanoma cells.
Melanoma
Astrocytes facilitate melanoma brain metastasis via secretion of IL-23.
Melanoma
Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agents.
Melanoma
Benefit of adjuvant interferon alfa-2b (IFN-?) therapy in melanoma patients with high serum MMP-8 levels.
Melanoma
Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study.
Melanoma
Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Melanoma
Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.
Melanoma
Differential expression of matrix metalloproteinase-2 by fibroblasts in co-cultures with keratinocytes, basal cell carcinoma and melanoma.
Melanoma
Direct and tumor microenvironment mediated influences of 5'-deoxy-5'-(methylthio)adenosine on tumor progression of malignant melanoma.
Melanoma
Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.
Melanoma
Exposure of the cryptic de-adhesive site FNIII14 in fibronectin molecule and its binding to membrane-type eEF1A induce migration and invasion of cancer cells via ?1-integrin inactivation.
Melanoma
Expression and Characterization of Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) and its Different Forms in Melanoma.
Melanoma
Expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of MMP (TIMP)-1 in conjunctival melanomas and clinical implications.
Melanoma
Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Melanoma
Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Melanoma
Glycoprotein non-metastatic melanoma protein B promotes glioma motility and angiogenesis through the Wnt/?-catenin signaling pathway.
Melanoma
Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity.
Melanoma
Helix aspersa maxima mucus exhibits antimelanogenic and antitumoral effects against melanoma cells.
Melanoma
IL-33/ST2 Axis Regulates Vasculogenic Mimicry via ERK1/2-MMP-2/9 Pathway in Melanoma.
Melanoma
Immunohistochemical expression of matrix metalloproteinase-2 and -9 in melanocytic nevi is altered by ultraviolet B.
Melanoma
Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines.
Melanoma
Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.
Melanoma
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.
Melanoma
Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
Melanoma
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
Melanoma
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Melanoma
Matrix metalloproteinases in human melanoma.
Melanoma
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
Melanoma
Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen.
Melanoma
Modulated Electro-Hyperthermia Facilitates NK-Cell Infiltration and Growth Arrest of Human A2058 Melanoma in a Xenograft Model.
Melanoma
Modulation of Activated Leukocyte Cell Adhesion Molecule-Mediated Invasion Triggers an Innate Immune Gene Response in Melanoma.
Melanoma
Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
Melanoma
Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKC? signalling: a potential candidate in melanoma cancer therapy.
Melanoma
Neutrophil collagenase (MMP-8) is expressed during early development in neural crest cells as well as in adult melanoma cells.
Melanoma
Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.
Melanoma
Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation.
Melanoma
Notch1-MAPK Signaling Axis Regulates CD133(+) Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis.
Melanoma
Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group.
Melanoma
Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
Melanoma
Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice.
Melanoma
Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Melanoma
Recent advances in melanoma research.
Melanoma
Recombinant human prothrombin kringle-2 inhibits B16F10 melanoma metastasis through inhibition of neovascularization and reduction of matrix metalloproteinase expression.
Melanoma
Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities.
Melanoma
Role of ING4 in human melanoma cell migration, invasion and patient survival.
Melanoma
RSK1 Activation Promotes Invasion in Nodular Melanoma.
Melanoma
S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis.
Melanoma
Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.
Melanoma
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
Melanoma
Silymarin Targets ?-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells.
Melanoma
Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo.
Melanoma
Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor.
Melanoma
Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor.
Melanoma
TGF-? signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.
Melanoma
The effect of ultraviolet radiation on choroidal melanocytes and melanoma cell lines: cell survival and matrix metalloproteinase production.
Melanoma
The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane.
Melanoma
The fibrinolytic factor tPA drives LRP1-mediated melanoma growth and metastasis.
Melanoma
The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice.
Melanoma
The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
Melanoma
The Melanoma Vascular Mimicry Phenotype Defined in Gene Expression and Microsome Sequencing Analysis.
Melanoma
The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis.
Melanoma
Therapeutic intervention of proanthocyanidins on the migration capacity of melanoma cells is mediated through PGE2 receptors and ?-catenin signaling molecules.
Melanoma
TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
Melanoma
Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
Melanoma
Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells.
Melanoma
Uveal melanocytes express high constitutive levels of MMP-8 which can be upregulated by TNF-? via the MAPK pathway.
Melanoma
Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.
Melanoma
Wild-type versus mutant MMP-8 in melanoma: 'When you come to a fork in the road, take it'*
Melanoma
[Non-specific immunotherapy inhibits angiogenesis - results of the monitoring of serum levels of vascular endothelial growth factor and matrix metalloproteinase 8 in patients with malignant melanoma receiving adjuvant high-dose interferon therapy].
Melanoma, Experimental
Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.
Melanoma, Experimental
Matrix metalloproteinase inhibitor, MMI270 (CGS27023A) inhibited hematogenic metastasis of B16 melanoma cells in both experimental and spontaneous metastasis models.
Meningeal Carcinomatosis
Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Meningioma
Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
Meningioma
Possible role of matrix metalloproteinase in osteolytic intracranial meningiomas.
Meningioma
The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas.
Meningitis
A case of idiopathic hypertrophic cranial pachymeningitis presenting high values of matrix metalloproteinase.
Meningitis
Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus.
Meningitis
Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae.
Meningitis
Dynamic changes of matrix metalloproteinase-9 in patients with Klebsiella pneumoniae meningitis.
Meningitis
Effects of purulent meningitis on the changes of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase inhibitor-1 (TIMP-1) in cerebrospinal fluid of neonates.
Meningitis
Human parasitic meningitis caused by Angiostrongylus cantonensis infection in Taiwan.
Meningitis, Aseptic
Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
Meningitis, Bacterial
Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Meningitis, Bacterial
The Potential Role of Matrix Metalloproteinases 8 and 9 and Myeloperoxidase in Predicting Outcomes of Bacterial Meningitis of Childhood.
Meningitis, Pneumococcal
Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Meningitis, Pneumococcal
Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
Meningitis, Pneumococcal
Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.
Meningitis, Pneumococcal
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis.
Meningococcal Infections
Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8.
Meningoencephalitis
Matrix metalloproteinase expression in sheep with listerial meningoencephalitis.
Menorrhagia
Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia.
Mesothelioma, Malignant
Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells.
Mesothelioma, Malignant
Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression.
Mesothelioma, Malignant
Inhibition of malignant mesothelioma cell matrix metalloproteinase production and invasion by a novel nutrient mixture.
Mesothelioma, Malignant
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines.
Mesothelioma, Malignant
Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Metabolic Diseases
Cleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the spontaneously hypertensive rat.
Metabolic Syndrome
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease.
Metabolic Syndrome
Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.
Metabolic Syndrome
Genetic variants of matrix metalloproteinase (MMP2) gene influence metabolic syndrome susceptibility.
Metabolic Syndrome
Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.
Metabolic Syndrome
Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Metabolic Syndrome
Interaction between Vascular Endothelial Growth Factor-A (rs2010963) Gene Polymorphisms and Dietary Diversity Score on Cardiovascular Risk Factors in Patients with Metabolic Syndrome.
Metabolic Syndrome
The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease.
Metabolic Syndrome
Validation of Periodontitis Screening Model Using Socio-Demographic, Systemic and Molecular Information in a Korean Population.
Metrorrhagia
Endometrial histology, microvascular density and caliber, and matrix metalloproteinase-3 in users of the Nestorone-releasing contraceptive implant with and without endometrial breakthrough bleeding.
Metrorrhagia
Enhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding.
Migraine Disorders
45(th) Annual Scientific Meeting of the American Headache Society June 19 -22, 2003, Chicago, IL, USA.
Migraine Disorders
Combined effects of ACE and MMP-3 polymorphisms on migraine development.
Migraine Disorders
Different circulating metalloproteinases profiles in women with migraine with and without aura.
Migraine Disorders
Increased matrix metalloproteinase activity is associated with migraine and migraine-related metabolic dysfunctions.
Migraine Disorders
Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura.
Migraine with Aura
Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura.
Mitral Valve Insufficiency
Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog.
Mouth Neoplasms
Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.
Mouth Neoplasms
Assessment of MicroRNA (miR)-365 Effects on Oral Squamous Carcinoma Cell Line Phenotypes.
Mouth Neoplasms
Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1?-induced matrix metalloproteinase expression in oral cancer.
Mouth Neoplasms
Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
Mouth Neoplasms
Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer.
Mouth Neoplasms
Matrix Metalloproteinase 20-Dentin Sialophosphoprotein Interaction in Oral Cancer.
Mouth Neoplasms
Matrix metalloproteinase gene polymorphisms and oral cancer.
Mouth Neoplasms
Matrix metalloproteinases (MMPs) in oral diseases.
Mouth Neoplasms
Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.
Mouth Neoplasms
Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells.
Mouth Neoplasms
The Contribution of Matrix Metalloproteinase-8 Promoter Polymorphism to Oral Cancer Susceptibility.
Mouth Neoplasms
The matrix metalloproteinase and insulin-like growth factor system in oral cancer - a prospective clinical study.
Moyamoya Disease
MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease.
Mucocele
Significant correlation between matrix metalloproteinase activity and tumor necrosis factor-alpha in salivary extravasation mucoceles.
Mucocutaneous Lymph Node Syndrome
Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9 activity in patients with Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
[Roles of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase and hs-CRP in Kawasaki disease]
Mucositis
Evaluation of Metalloproteinase-8 Levels in Crevicular Fluid of Patients with Healthy Implants or Periodontitis.
Mucositis
Histological evaluation of peri-implant mucosal and gingival tissues in peri-implantitis, peri-implant mucositis and periodontitis patients: a cross-sectional clinical study.
Mucositis
Use of IL-1 ?, IL-6, TNF-?, and MMP-8 biomarkers to distinguish peri-implant diseases: A systematic review and meta-analysis.
Multiple Myeloma
Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation.
Multiple Myeloma
Matrix metalloproteinase and cytokine production by bone marrow adherent cells from multiple myeloma patients.
Multiple Myeloma
Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
Multiple Myeloma
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease.
Multiple Myeloma
Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma.
Multiple Sclerosis
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
Multiple Sclerosis
Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
Multiple Sclerosis
An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization.
Multiple Sclerosis
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.
Multiple Sclerosis
Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice.
Multiple Sclerosis
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.
Multiple Sclerosis
Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.
Multiple Sclerosis
Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.
Multiple Sclerosis
Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing-remitting multiple sclerosis patients and their first-degree family.
Multiple Sclerosis
Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro.
Multiple Sclerosis
Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
Multiple Sclerosis
Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier.
Multiple Sclerosis
Immobilization of matrix metalloproteinase 8 (MMP-8) for online drug screening.
Multiple Sclerosis
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Multiple Sclerosis
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
Multiple Sclerosis
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment.
Multiple Sclerosis
Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Multiple Sclerosis
Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis.
Multiple Sclerosis
Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.
Multiple Sclerosis
Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation.
Multiple Sclerosis
Misuse of serum matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 as a biomarker in multiple sclerosis.
Multiple Sclerosis
MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?
Multiple Sclerosis
Once-weekly 22microg subcutaneous IFN-beta-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels.
Multiple Sclerosis
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
Multiple Sclerosis
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes.
Multiple Sclerosis, Chronic Progressive
Once-weekly 22microg subcutaneous IFN-beta-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels.
Multiple Sclerosis, Relapsing-Remitting
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.
Multiple Sclerosis, Relapsing-Remitting
Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.
Multiple Sclerosis, Relapsing-Remitting
Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
Multiple System Atrophy
Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy.
Muscular Atrophy
The mechanisms and treatments of muscular pathological changes in immobilization-induced joint contracture: A literature review.
Muscular Disorders, Atrophic
Matrix metalloproteinase imbalance in muscle disuse atrophy.
Muscular Dystrophies
Congenital Muscular Dystrophy 1D Causes Matrix Metalloproteinase Activation And Blood-Brain Barrier Impairment.
Muscular Dystrophy, Duchenne
Mitochondrial dysfunction causes Ca2+ overload and ECM degradation-mediated muscle damage in C. elegans.
Myalgia
A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors.
Myelodysplastic Syndromes
Increased intracellular activity of matrix metalloproteinases in neutrophils may be associated with delayed healing of infection without neutropenia in myelodysplastic syndromes.
Myelodysplastic Syndromes
Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Myocardial Infarction
Acute Myocardial Infarction is Reflected in Salivary Matrix Metalloproteinase-8 Activation Level.
Myocardial Infarction
Aliskiren and valsartan mediate left ventricular remodeling post-myocardial infarction in mice through MMP-9 effects.
Myocardial Infarction
Alteplase treatment affects circulating matrix metalloproteinase concentrations in patients with ST segment elevation acute myocardial infarction.
Myocardial Infarction
Analysis of protein fragmentation inhibition by an MMP-inhibitor in an in vivo model of heart failure using automated chromatography.
Myocardial Infarction
Association of R279Q and C1562T polymorphisms of matrix metalloproteinase 9 gene and increased risk for myocardial infarction in patients with premature coronary artery disease.
Myocardial Infarction
Attenuation of lipid metabolic abnormalities, proinflammatory cytokines, and matrix metalloproteinase expression by biochanin-A in isoproterenol-induced myocardial infarction in rats.
Myocardial Infarction
Bilateral sympathectomy improves postinfarction left ventricular remodeling and function.
Myocardial Infarction
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
Myocardial Infarction
Changes of Matrix Metalloproteinase-9 Level Is Associated With Left Ventricular Remodeling Following Acute Myocardial Infarction Among Patients Treated With Trandolapril, Valsartan or Both.
Myocardial Infarction
Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival.
Myocardial Infarction
Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.
Myocardial Infarction
Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation.
Myocardial Infarction
Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER.
Myocardial Infarction
Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction.
Myocardial Infarction
Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats.
Myocardial Infarction
Dynamic expression of the main related indicators of thrombosis, inflammatory reaction and tissue damage in a rat model of myocardial infarction.
Myocardial Infarction
Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction.
Myocardial Infarction
Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction.
Myocardial Infarction
Effects of mesenchymal stem cells on matrix metalloproteinase synthesis in cardiac fibroblasts.
Myocardial Infarction
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
Myocardial Infarction
Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction: clinical evidence from distal protection.
Myocardial Infarction
EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction.
Myocardial Infarction
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
Myocardial Infarction
Erratum: "Acute Myocardial Infarction is Reflected in Salivary Matrix Metalloproteinase-8 Activation Level".
Myocardial Infarction
Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Myocardial Infarction
Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
Myocardial Infarction
Extracellular matrix metalloproteinase inducer (EMMPRIN), acute myocardial infarction and the Kounis syndrome.
Myocardial Infarction
Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
Myocardial Infarction
Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat.
Myocardial Infarction
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Myocardial Infarction
Gingival crevicular fluid MMP-8-concentrations in patients after acute myocardial infarction.
Myocardial Infarction
Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study.
Myocardial Infarction
High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction.
Myocardial Infarction
Imidapril and enalapril similarly inhibit plasma matrix metalloproteinase activities and attenuate left ventricular remodeling in patients with acute myocardial infarction.
Myocardial Infarction
Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction.
Myocardial Infarction
Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture.
Myocardial Infarction
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.
Myocardial Infarction
Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction.
Myocardial Infarction
Intracoronary Delivery of Recombinant TIMP-3 Following Myocardial Infarction: Effects on Myocardial Remodeling and Function.
Myocardial Infarction
Intramyocardial injection of tannic acid attenuates postinfarction remodeling: a novel approach to stabilize the breaking extracellular matrix.
Myocardial Infarction
Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
Myocardial Infarction
Matrix metalloproteinase -9 polymorphism and outcome after acute myocardial infarction.
Myocardial Infarction
Matrix Metalloproteinase 3 Gene Polymorphism and Its Level Predict Morbidity After Acute Myocardial Infarction.
Myocardial Infarction
Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
Myocardial Infarction
Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit.
Myocardial Infarction
Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Myocardial Infarction
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.
Myocardial Infarction
Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs.
Myocardial Infarction
Matrix Metalloproteinase Mediated Type I Collagen Degradation is an Independent Predictor of Increased Risk of Acute Myocardial Infarction in Postmenopausal Women.
Myocardial Infarction
Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.
Myocardial Infarction
Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.
Myocardial Infarction
Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction.
Myocardial Infarction
Mesenchymal Stem Cells Promote Matrix Metalloproteinase Secretion By Cardiac Fibroblasts And Reduce Cardiac Ventricular Fibrosis After Myocardial Infarction.
Myocardial Infarction
Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
Myocardial Infarction
Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.
Myocardial Infarction
Myocardial infarct expansion and matrix metalloproteinase inhibition.
Myocardial Infarction
Myocardial infarction induces early increased remote ADAM8 expression of rat hearts after cardiac arrest.
Myocardial Infarction
Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization.
Myocardial Infarction
Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.
Myocardial Infarction
Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.
Myocardial Infarction
Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.
Myocardial Infarction
Plasma EMMPRIN levels in acute myocardial infarction and stable coronary artery disease.
Myocardial Infarction
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.
Myocardial Infarction
Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction.
Myocardial Infarction
Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction.
Myocardial Infarction
Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
Myocardial Infarction
Putative targeting of matrix metalloproteinase-8 in atherosclerosis.
Myocardial Infarction
Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
Myocardial Infarction
Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction.
Myocardial Infarction
Relation of plasma matrix metalloproteinase-8 levels late after myocardial infarction with left ventricular volumes and ejection fraction.
Myocardial Infarction
Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Myocardial Infarction
Role of matrix metalloproteinases in coronary artery disease.
Myocardial Infarction
Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
Myocardial Infarction
Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.
Myocardial Infarction
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Myocardial Infarction
Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.
Myocardial Infarction
Serum MMP-8: A Novel Indicator of Left Ventricular Remodeling and Cardiac Outcome in Patients after Acute Myocardial Infarction.
Myocardial Infarction
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Myocardial Infarction
Sesamol Attenuates Isoproterenol-induced Acute Myocardial Infarction via Inhibition of Matrix Metalloproteinase-2 and -9 Expression in Rats.
Myocardial Infarction
Significance of matrix metalloproteinase-9 in cardiac dysfunction during the very acute phase after myocardial infarction in hamsters.
Myocardial Infarction
Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
Myocardial Infarction
Systemic versus coronary levels of inflammation in acute coronary syndromes.
Myocardial Infarction
Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice.
Myocardial Infarction
The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction.
Myocardial Infarction
The Matrix Metalloproteinase 2-1575 gene Polymorphism is Associated with the Risk of Developing Myocardial Infarction in Mexican Patients.
Myocardial Infarction
Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction.
Myocardial Infarction
Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.
Myocardial Infarction
Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction.
Myocardial Infarction
[Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats]
Myocardial Infarction
[Comparison of right atrial matrix metalloproteinase expression between patients with unstable angina and myocardial infarction]
Myocardial Infarction
[Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats]
Myocardial Infarction
[Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome]
Myocardial Infarction
[In vivo interleukin-10 gene transfer down-regulates myocardial matrix metalloproteinase and myocardial collagen expressions in rats with acute myocardial infarction]
Myocardial Infarction
[Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance]
Myocardial Ischemia
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events.
Myocardial Ischemia
Disrupting the Extracellular Matrix Metalloproteinase Inducer-Cyclophilin A Interaction Reduces Infarct Size and Preserves Systolic Function After Myocardial Ischemia and Reperfusion.
Myocardial Ischemia
Tumor necrosis factor-alpha G(-308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C(-1562)T promoter polymorphism and risk and extent of ischemic heart disease.
Myocardial Ischemia
[Polymorphisms in Genes of Cytokines and Matrix Metalloproteinases Associated With Ischemic Heart Disease in Patients With Type 2 Diabetes].
Myocarditis
Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
Myocarditis
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
Myocarditis
Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction.
Myocarditis
Dynamic changes in myocardial matrix metalloproteinase activity in mice with viral myocarditis.
Myocarditis
Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity.
Myocarditis
Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
Myocarditis
Matrix metalloproteinases in the pathogenesis of viral heart disease.
Myocarditis
Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.
Myoma
Extracellular matrix metalloproteinase expression in endometrial tissue after arterial embolization of myomas.
Myoma
Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment.
Myopia
Anti-Inflammatory Effects of Resveratrol on Human Retinal Pigment Cells and a Myopia Animal Model.
Myopia
Changes of TGF-?2, MMP-2, and TIMP-2 levels in the vitreous of patients with high myopia.
Myopia
Gelatinase A and TIMP-2 expression in the fibrous sclera of myopic and recovering chick eyes.
Myopia
Inhibition of matrix metalloproteinase activity in the chick sclera and its effect on myopia development.
Myositis
Matrix Metalloproteinase Responsive Delivery of Myostatin Inhibitors.
Myositis
Specific matrix metalloproteinase expression in focal myositis: an immunopathological study.
Myxoma
The expression of apoptotic proteins and matrix metalloproteinases in odontogenic myxomas.
Nasal Polyps
Double-stranded RNA poly(I:C) enhances matrix metalloproteinase mRNA expression in human nasal polyp epithelial cells.
Nasal Polyps
Expression of extracellular matrix metalloproteinase inducer in nasal polyps.
Nasal Polyps
Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs.
Nasal Polyps
Matrix metalloproteinase-9 promoter gene polymorphism (-1562C>T) in nasal polyposis.
Nasal Polyps
Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Nasal Polyps
Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells.
Nasal Polyps
Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps.
Nasal Polyps
Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro.
Nasal Polyps
Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro.
Nasal Polyps
[Effects of double-stranded RNA poly(I:C) on matrix metalloproteinase mRNA expression in human nasal polyp epithelial cells]
Nasopharyngeal Carcinoma
Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Expression of bcl-2 correlates with poor prognosis and modulates migration of nasopharyngeal carcinoma cells.
Nasopharyngeal Carcinoma
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Nasopharyngeal Carcinoma
Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis.
Nasopharyngeal Carcinoma
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
Nasopharyngeal Carcinoma
Overexpression of Asparagine Synthetase and Matrix Metalloproteinase 19 Confers Cisplatin Sensitivity in Nasopharyngeal Carcinoma Cells.
Nasopharyngeal Carcinoma
[Study of the relation between MMP2, MMP9 and nasopharyngeal carcinoma]
Neonatal Sepsis
The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications.
Neoplasm Metastasis
"Locked" cancer cells are more sensitive to chemotherapy.
Neoplasm Metastasis
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Neoplasm Metastasis
-(-)Epigallocatechin-3-gallate downregulates EGFR, MMP-2, MMP-9 EMMPRIN and inhibits the invasion of MCF-7 tamoxifen resistant cells.
Neoplasm Metastasis
1?Palmitoyl?2?linoleoyl?3?acetyl?rac?glycerol ameliorates EGF?induced MMP?9 expression by promoting receptor desensitization in MDA?MB?231 cells.
Neoplasm Metastasis
A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid.
Neoplasm Metastasis
A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Neoplasm Metastasis
A high throughput fluorogenic substrate for stromelysin (MMP-3).
Neoplasm Metastasis
A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice.
Neoplasm Metastasis
A Model for the Solution Structure of Human Fe(II)-Bound Acireductone Dioxygenase and Interactions with the Regulatory Domain of Matrix Metalloproteinase I (MMP-I).
Neoplasm Metastasis
A new matrix metalloproteinase-9 inhibitor 3,4-dihydroxycinnamic acid (caffeic acid) from methanol extract of Euonymus alatus: isolation and structure determination.
Neoplasm Metastasis
A novel functional site of extracellular matrix metalloproteinase inducer (EMMPRIN) that limits the migration of human uterine cervical carcinoma cells.
Neoplasm Metastasis
A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells.
Neoplasm Metastasis
A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
Neoplasm Metastasis
A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Neoplasm Metastasis
A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
Neoplasm Metastasis
A phase II trial of marimastat in advanced pancreatic cancer.
Neoplasm Metastasis
A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis.
Neoplasm Metastasis
A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis.
Neoplasm Metastasis
A Randomized Phase II Trial of the Matrix Metalloproteinase Inhibitor BMS-275291 in Hormone-Refractory Prostate Cancer Patients with Bone Metastases.
Neoplasm Metastasis
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma.
Neoplasm Metastasis
Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.
Neoplasm Metastasis
Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.
Neoplasm Metastasis
Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients.
Neoplasm Metastasis
Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasion.
Neoplasm Metastasis
Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines.
Neoplasm Metastasis
alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells.
Neoplasm Metastasis
Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas.
Neoplasm Metastasis
Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation.
Neoplasm Metastasis
Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression.
Neoplasm Metastasis
An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma.
Neoplasm Metastasis
An in vivo model for screening peptidomimetic inhibitors of gelatinase A.
Neoplasm Metastasis
An Unusually Stable G-Quadruplex within the 5'-UTR of the MT3 Matrix Metalloproteinase mRNA Represses Translation in Eukaryotic Cells.
Neoplasm Metastasis
Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Neoplasm Metastasis
Anticancer effects of four varieties of muscadine grape.
Neoplasm Metastasis
Antimetastasis Effect of Anthraquinones from Marine Fungus, Microsporum sp.
Neoplasm Metastasis
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
Neoplasm Metastasis
Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells
Neoplasm Metastasis
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Neoplasm Metastasis
Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis.
Neoplasm Metastasis
Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Neoplasm Metastasis
Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Neoplasm Metastasis
Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer.
Neoplasm Metastasis
Association of matrix metalloproteinase (MMP)-2 and -9 expression with extra-gastrointestinal stromal tumor metastasis.
Neoplasm Metastasis
Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis.
Neoplasm Metastasis
Augment the efficacy of eradicating metastatic lesions and tumor proliferation in breast cancer by honokiol-loaded pH-sensitive targeted lipid nanoparticles.
Neoplasm Metastasis
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
Neoplasm Metastasis
Baicalein Attenuates Oxidative Stress-Induced Expression of Matrix Metalloproteinase-1 by Regulating the ERK/JNK/AP-1 Pathway in Human Keratinocytes.
Neoplasm Metastasis
Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.
Neoplasm Metastasis
Benefit of adjuvant interferon alfa-2b (IFN-?) therapy in melanoma patients with high serum MMP-8 levels.
Neoplasm Metastasis
Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.
Neoplasm Metastasis
Bone marrow-derived cells and epithelial tumours: more than just an inflammatory relationship.
Neoplasm Metastasis
Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
Neoplasm Metastasis
Capsaicin and sorafenib combination treatment exerts synergistic anti?hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling.
Neoplasm Metastasis
Carbamoylphosphonate matrix metalloproteinase inhibitors 3: in vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis.
Neoplasm Metastasis
Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Neoplasm Metastasis
Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Neoplasm Metastasis
Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize.
Neoplasm Metastasis
Caveolin-1 regulating the invasion and expression of matrix metalloproteinase (MMPs) in pancreatic carcinoma cells.
Neoplasm Metastasis
CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis.
Neoplasm Metastasis
CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.
Neoplasm Metastasis
CD97 Promotes Tumor Aggressiveness Through the Traditional G Protein-Coupled Receptor-Mediated Signaling in Hepatocellular Carcinoma.
Neoplasm Metastasis
Cell Specific Matrix Metalloproteinase-1 Regulates Lung Metastasis Synergistically with Smoke Exposure.
Neoplasm Metastasis
Cell surface association of matrix metalloproteinase-9 (gelatinase B).
Neoplasm Metastasis
Cell-based identification of natural substrates and cleavage sites for extracellular proteases by SILAC proteomics.
Neoplasm Metastasis
Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Neoplasm Metastasis
Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories.
Neoplasm Metastasis
Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Neoplasm Metastasis
Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis.
Neoplasm Metastasis
Combined evaluation of matrix metalloproteinases and their inhibitors has better clinical utility in oral cancer.
Neoplasm Metastasis
Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer.
Neoplasm Metastasis
Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Neoplasm Metastasis
Computational insights into the identification of a potent matrix metalloproteinase inhibitor from Indigofera aspalathoides to control cancer metastasis.
Neoplasm Metastasis
Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials.
Neoplasm Metastasis
Contributions of Thyroid Hormone to Cancer Metastasis.
Neoplasm Metastasis
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
Neoplasm Metastasis
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Neoplasm Metastasis
Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma.
Neoplasm Metastasis
Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
Neoplasm Metastasis
Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Neoplasm Metastasis
Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Neoplasm Metastasis
Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.
Neoplasm Metastasis
Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases.
Neoplasm Metastasis
Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.
Neoplasm Metastasis
Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene.
Neoplasm Metastasis
Crosstalk between TGF-? signaling and miRNAs in breast cancer metastasis.
Neoplasm Metastasis
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Neoplasm Metastasis
Current status and future prospects of transforming growth factor-? as a potential prognostic and therapeutic target in the treatment of breast cancer.
Neoplasm Metastasis
Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Neoplasm Metastasis
Des-?-carboxy prothrombin (DCP) as a potential autologous growth factor for the development of hepatocellular carcinoma.
Neoplasm Metastasis
Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Neoplasm Metastasis
Detection of Cancer-Specific Proteases Using Magnetic Relaxation of Peptide-Conjugated Nanoparticles in Biological Environment.
Neoplasm Metastasis
Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging.
Neoplasm Metastasis
Development of putrescine anchored nano-crystalsomes bearing doxorubicin and oleanolic acid: deciphering their role in inhibiting metastatic breast cancer.
Neoplasm Metastasis
Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer Cell Line.
Neoplasm Metastasis
DHA blocks TPA-induced cell invasion by inhibiting MMP-9 expression via suppression of the PPAR-?/NF-?B pathway in MCF-7 cells.
Neoplasm Metastasis
Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-?B Pathway.
Neoplasm Metastasis
Different expression patterns of MMP-2 and MMP-9 in breast cancer.
Neoplasm Metastasis
Different Role of Caveolin-1 Gene in the Progression of Gynecological Tumors.
Neoplasm Metastasis
Differential regulation of matrix metalloproteinases in human cancer cells by exogenous factors.
Neoplasm Metastasis
Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis.
Neoplasm Metastasis
Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP?2 and MMP?9.
Neoplasm Metastasis
Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.
Neoplasm Metastasis
DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A.
Neoplasm Metastasis
Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.
Neoplasm Metastasis
Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
Neoplasm Metastasis
Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18.
Neoplasm Metastasis
Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma.
Neoplasm Metastasis
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Neoplasm Metastasis
Downregulation of the Novel Tumor Suppressor DIRAS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Neoplasm Metastasis
Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.
Neoplasm Metastasis
Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma.
Neoplasm Metastasis
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Neoplasm Metastasis
Effect of CO2 pneumoperitoneum on the proliferation of human ovarian cancer cell line SKOV-3 and the expression of NM23-H1 and MMP-2.
Neoplasm Metastasis
Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.
Neoplasm Metastasis
Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control.
Neoplasm Metastasis
Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
Neoplasm Metastasis
Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis.
Neoplasm Metastasis
Effects of HAb18G/CD147 Knockout on Hepatocellular Carcinoma Cells In Vitro Using a Novel Zinc-Finger Nuclease-Targeted Gene Knockout Approach.
Neoplasm Metastasis
Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20.
Neoplasm Metastasis
Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer.
Neoplasm Metastasis
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Neoplasm Metastasis
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Neoplasm Metastasis
Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis.
Neoplasm Metastasis
EMMPRIN (basigin/CD147) expression is not correlated with MMP activity during adult mouse mammary gland development.
Neoplasm Metastasis
EMMPRIN (CD147) expression and differentiation of papillary thyroid carcinoma: implications for immunocytochemistry in FNA cytology.
Neoplasm Metastasis
EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Neoplasm Metastasis
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Neoplasm Metastasis
EMMPRIN reduction via scFv-M6-1B9 intrabody affects ?3?1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2.
Neoplasm Metastasis
Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors.
Neoplasm Metastasis
Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Neoplasm Metastasis
Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.
Neoplasm Metastasis
Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters.
Neoplasm Metastasis
ETV5 as a regulator of matrix metalloproteinase 2 in human chondrosarcoma.
Neoplasm Metastasis
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction.
Neoplasm Metastasis
Evidence for a role of GPRC6A in prostate cancer metastasis based on case-control and in vitro analyses.
Neoplasm Metastasis
Expression and Clinical Significance of CD147 in Genitourinary Carcinomas.
Neoplasm Metastasis
Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.
Neoplasm Metastasis
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Neoplasm Metastasis
Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.
Neoplasm Metastasis
Expression of CD147 is associated with prostate cancer progression.
Neoplasm Metastasis
Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: Correlation with clinicopathological characteristics.
Neoplasm Metastasis
Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
Neoplasm Metastasis
Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model.
Neoplasm Metastasis
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Neoplasm Metastasis
Expression of matrix metalloproteinase, tissue inhibitors of metalloproteinase and adhesion molecules in silicotic mice with lung tumor metastasis.
Neoplasm Metastasis
Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
Neoplasm Metastasis
Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma.
Neoplasm Metastasis
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Neoplasm Metastasis
Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis.
Neoplasm Metastasis
Expressions of CD147, MMP-2 and MMP-9 in Laryngeal Carcinoma and its Correlation with Poor Prognosis.
Neoplasm Metastasis
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
Neoplasm Metastasis
Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
Neoplasm Metastasis
Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats.
Neoplasm Metastasis
Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer.
Neoplasm Metastasis
Failure of matrix metalloproteinase-9 dimer induction by phorbol 12-myristate 13-acetate in normal human cell lines.
Neoplasm Metastasis
Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells.
Neoplasm Metastasis
Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor-initiating cells.
Neoplasm Metastasis
Full-length L1CAM and not its ?2?27 splice variant promotes metastasis through induction of gelatinase expression.
Neoplasm Metastasis
Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1.
Neoplasm Metastasis
Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Neoplasm Metastasis
Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells.
Neoplasm Metastasis
Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
Neoplasm Metastasis
Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism.
Neoplasm Metastasis
Gefitinib decreases the synthesis of matrix metalloproteinase and the adhesion to extracellular matrix proteins of colon cancer cells.
Neoplasm Metastasis
Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications.
Neoplasm Metastasis
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.
Neoplasm Metastasis
Giant cell tumor of bone: an immunohistochemical comparative study.
Neoplasm Metastasis
Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway.
Neoplasm Metastasis
Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling.
Neoplasm Metastasis
Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
Neoplasm Metastasis
Hepatitis C virus core protein promotes the migration and invasion of hepatocyte via activating transcription of extracellular matrix metalloproteinase inducer.
Neoplasm Metastasis
Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer.
Neoplasm Metastasis
HER-2/neu Represses the Metastasis Suppressor RECK via ERK and Sp Transcription Factors to Promote Cell Invasion.
Neoplasm Metastasis
Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-? Pathway.
Neoplasm Metastasis
High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Neoplasm Metastasis
High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
Neoplasm Metastasis
High incidence of EMMPRIN expression in human tumors.
Neoplasm Metastasis
High Mobility Group Box-1 promotes hepatocellular carcinoma progression through miR-21-mediated matrix metalloproteinase activity.
Neoplasm Metastasis
High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.
Neoplasm Metastasis
High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
Neoplasm Metastasis
Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.
Neoplasm Metastasis
Histone Deacetylase (HDAC) 10 Suppresses Cervical Cancer Metastasis through Inhibition of Matrix Metalloproteinase (MMP) 2 and 9 Expression.
Neoplasm Metastasis
Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE?-mediated activation of ?-catenin signaling.
Neoplasm Metastasis
Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts.
Neoplasm Metastasis
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
Neoplasm Metastasis
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.
Neoplasm Metastasis
Hypermethylation of miR-338-3p and Impact of its Suppression on Cell Metastasis Through N-Cadherin Accumulation at the Cell -Cell Junction and Degradation of MMP in Gastric Cancer.
Neoplasm Metastasis
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues.
Neoplasm Metastasis
Identification of highly selective MMP-14 inhibitory Fabs by deep sequencing.
Neoplasm Metastasis
Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
Neoplasm Metastasis
Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
Neoplasm Metastasis
Immunohistochemical expression of matrix metalloproteinase-2 and -9 in melanocytic nevi is altered by ultraviolet B.
Neoplasm Metastasis
Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Neoplasm Metastasis
Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis.
Neoplasm Metastasis
Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells.
Neoplasm Metastasis
Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Neoplasm Metastasis
Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Neoplasm Metastasis
In Situ Protease Secretion Visualization and Metastatic Lymph Nodes Imaging via a Cell Membrane-Anchored Upconversion Nanoprobe.
Neoplasm Metastasis
In vitro inhibition of matrix metalloproteinases, invasion and growth of Fanconi anemia human FANCA and FANCC lymphoblasts by nutrient mixture.
Neoplasm Metastasis
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Neoplasm Metastasis
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Neoplasm Metastasis
Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies.
Neoplasm Metastasis
Inclusion complex from cyclodextrin-grafted hyaluronic acid and pseudo protein as biodegradable nano-delivery vehicle for gambogic acid.
Neoplasm Metastasis
Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer.
Neoplasm Metastasis
Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
Neoplasm Metastasis
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.
Neoplasm Metastasis
Influence of HPV16 E2 and its localisation on the expression of matrix metalloproteinase-9.
Neoplasm Metastasis
Inhibition of AGS human gastric cancer cell invasion and proliferation by Capsosiphon fulvescens glycoprotein.
Neoplasm Metastasis
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
Neoplasm Metastasis
Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines.
Neoplasm Metastasis
Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study.
Neoplasm Metastasis
Inhibition of CD147 Expression Reduces Tumor Cell Invasion in Human Prostate Cancer Cell Line via RNA Interference.
Neoplasm Metastasis
Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells.
Neoplasm Metastasis
Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells.
Neoplasm Metastasis
Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
Neoplasm Metastasis
Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor.
Neoplasm Metastasis
Inhibition of invasion and lymph node metastasis of gastrointestinal cancer cells by R-94138, a matrix metalloproteinase inhibitor.
Neoplasm Metastasis
Inhibition of invasion and MMPs by a nutrient mixture in human cancer cell lines: a correlation study.
Neoplasm Metastasis
Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270.
Neoplasm Metastasis
Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue.
Neoplasm Metastasis
Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate.
Neoplasm Metastasis
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
Neoplasm Metastasis
Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
Neoplasm Metastasis
Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxyamino)-2R-isobutylsuccinyl]amino-1-methoxy-3,4-dihydroc arbostyril, a novel matrix metalloproteinase inhibitor.
Neoplasm Metastasis
Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.
Neoplasm Metastasis
Inhibitory effect of methanol extract of Euonymus alatus on matrix metalloproteinase-9.
Neoplasm Metastasis
Inhibitory effect of shRNA targeting GPR48 on invasion and metastasis of human cervical carcinoma cell line HeLa.
Neoplasm Metastasis
Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Neoplasm Metastasis
Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Neoplasm Metastasis
Inhibitory effects of low intensity pulsed ultrasound on osteoclastogenesis induced in vitro by breast cancer cells.
Neoplasm Metastasis
Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells.
Neoplasm Metastasis
Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Neoplasm Metastasis
Intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles.
Neoplasm Metastasis
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
Neoplasm Metastasis
Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer.
Neoplasm Metastasis
Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression.
Neoplasm Metastasis
Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody.
Neoplasm Metastasis
Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin.
Neoplasm Metastasis
Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK.
Neoplasm Metastasis
Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
Neoplasm Metastasis
Isoliquiritin Apioside Suppresses in vitro Invasiveness and Angiogenesis of Cancer Cells and Endothelial Cells.
Neoplasm Metastasis
JNP3, a new compound, suppresses PMA-induced tumor cell invasion via NF-?B down regulation in MCF-7 breast cancer cells.
Neoplasm Metastasis
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Neoplasm Metastasis
Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model.
Neoplasm Metastasis
Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo.
Neoplasm Metastasis
Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Neoplasm Metastasis
Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
Neoplasm Metastasis
Long non-coding RNA GASL1 restrains gastric carcinoma cell proliferation and metastasis by sponging microRNA-106a.
Neoplasm Metastasis
Long non-coding RNA SNHG5 affects the invasion and apoptosis of renal cell carcinoma by regulating the miR-363-3p-Twist1 interaction.
Neoplasm Metastasis
Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Neoplasm Metastasis
Luteolin-7-O-Glucoside Inhibits Oral Cancer Cell Migration and Invasion by Regulating Matrix Metalloproteinase-2 Expression and Extracellular Signal-Regulated Kinase Pathway.
Neoplasm Metastasis
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
Neoplasm Metastasis
Macrophage ABHD5 suppresses NF-?B-dependent matrix metalloproteinase expression and cancer metastasis.
Neoplasm Metastasis
Matrilysin in early stage intestinal tumorigenesis.
Neoplasm Metastasis
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Neoplasm Metastasis
Matrilysins may not predict the metastatic potential in squamous cell carcinoma of the tongue.
Neoplasm Metastasis
Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo.
Neoplasm Metastasis
Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma.
Neoplasm Metastasis
Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis.
Neoplasm Metastasis
Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
Neoplasm Metastasis
Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.
Neoplasm Metastasis
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
Neoplasm Metastasis
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Neoplasm Metastasis
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
Neoplasm Metastasis
Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
Neoplasm Metastasis
Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer.
Neoplasm Metastasis
Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Neoplasm Metastasis
Matrix metalloproteinase inhibitor, MMI270 (CGS27023A) inhibited hematogenic metastasis of B16 melanoma cells in both experimental and spontaneous metastasis models.
Neoplasm Metastasis
Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.
Neoplasm Metastasis
Matrix metalloproteinase-13 is a target gene of high-mobility group box-containing protein 1 in modulating oral cancer cell invasion.
Neoplasm Metastasis
Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
Neoplasm Metastasis
Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
Neoplasm Metastasis
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
Neoplasm Metastasis
Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer.
Neoplasm Metastasis
Matrix metalloproteinases and metastatic cancer.
Neoplasm Metastasis
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Neoplasm Metastasis
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
Neoplasm Metastasis
Mechanistic investigations of matrix metalloproteinase-8 inhibition by metal abstraction peptide.
Neoplasm Metastasis
Membrane type (MT) 1-matrix metalloproteinase (MMP) and MMP-2 expression in ligature-induced periodontitis in the rat.
Neoplasm Metastasis
Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumor vascular architecture.
Neoplasm Metastasis
Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.
Neoplasm Metastasis
Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis.
Neoplasm Metastasis
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model.
Neoplasm Metastasis
Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.
Neoplasm Metastasis
Methicillin-Resistant Staphylococcus Aureus infection exacerbates NSCLC cell metastasis by up-regulating TLR4/MyD88 pathway.
Neoplasm Metastasis
Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.
Neoplasm Metastasis
Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: the role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.
Neoplasm Metastasis
Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer.
Neoplasm Metastasis
MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
Neoplasm Metastasis
microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells.
Neoplasm Metastasis
MicroRNA?299?5p inhibits cell metastasis in breast cancer by directly targeting serine/threonine kinase 39.
Neoplasm Metastasis
Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases.
Neoplasm Metastasis
miR?133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP?14.
Neoplasm Metastasis
Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.
Neoplasm Metastasis
MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.
Neoplasm Metastasis
MMP-2 as a putative biomarker for carcinomatosis in gastric cancer.
Neoplasm Metastasis
Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin.
Neoplasm Metastasis
Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog.
Neoplasm Metastasis
MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma.
Neoplasm Metastasis
MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells.
Neoplasm Metastasis
Myricetin suppresses breast cancer metastasis through down-regulating the activity of matrix metalloproteinase (MMP)-2/9.
Neoplasm Metastasis
New biochemical insight of conserved water molecules at catalytic and structural Zn(2+) ions in human matrix metalloproteinase-I: a study by MD-simulation.
Neoplasm Metastasis
New directions for radiation biology research in cancer of the uterine cervix.
Neoplasm Metastasis
New oral chemotherapeutic agents for lung cancer.
Neoplasm Metastasis
Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma.
Neoplasm Metastasis
Notch1-MAPK Signaling Axis Regulates CD133(+) Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis.
Neoplasm Metastasis
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism.
Neoplasm Metastasis
Novel strategy in breast cancer therapy: Revealing the bright side of ginsenosides.
Neoplasm Metastasis
Oleuropein induces anti-metastatic effects in breast cancer.
Neoplasm Metastasis
Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
Neoplasm Metastasis
Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
Neoplasm Metastasis
Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin.
Neoplasm Metastasis
Osteoactivin Regulates Head and Neck Squamous Cell Carcinoma Invasion by Modulating Matrix Metalloproteases.
Neoplasm Metastasis
Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.
Neoplasm Metastasis
Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.
Neoplasm Metastasis
Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)?2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
Neoplasm Metastasis
Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.
Neoplasm Metastasis
Overexpression of EMMPRIN Isoform 2 Is Associated with Head and Neck Cancer Metastasis.
Neoplasm Metastasis
Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.
Neoplasm Metastasis
Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1? in pancreatic cancer: Implications for tumor progression and prognosis.
Neoplasm Metastasis
Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis.
Neoplasm Metastasis
Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.
Neoplasm Metastasis
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Neoplasm Metastasis
Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Neoplasm Metastasis
pH-sensitive tangeretin-ZnO quantum dots exert apoptotic and anti-metastatic effects in metastatic lung cancer cell line.
Neoplasm Metastasis
Pharmacological inhibition of gelatinase B induction and tumor cell invasion.
Neoplasm Metastasis
Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites.
Neoplasm Metastasis
Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity.
Neoplasm Metastasis
Piceatannol-3-O-?-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells.
Neoplasm Metastasis
Plastin 1 drives metastasis of colorectal cancer through the IQGAP1/Rac1/ERK pathway.
Neoplasm Metastasis
Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
Neoplasm Metastasis
Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
Neoplasm Metastasis
Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166.
Neoplasm Metastasis
Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma.
Neoplasm Metastasis
Prognostic significance of expression of matrix metalloproteinase in colorectal adenocarcinomas and their metastases.
Neoplasm Metastasis
Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma.
Neoplasm Metastasis
Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator twist1.
Neoplasm Metastasis
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression.
Neoplasm Metastasis
PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines.
Neoplasm Metastasis
Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier.
Neoplasm Metastasis
Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effects.
Neoplasm Metastasis
Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
Neoplasm Metastasis
Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.
Neoplasm Metastasis
Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer.
Neoplasm Metastasis
Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
Neoplasm Metastasis
Reciprocal activation between MMP-8 and TGF-?1 stimulates EMT and malignant progression of hepatocellular carcinoma.
Neoplasm Metastasis
Recklessness as a hallmark of aggressive cancer.
Neoplasm Metastasis
Recombinant human prothrombin kringle-2 inhibits B16F10 melanoma metastasis through inhibition of neovascularization and reduction of matrix metalloproteinase expression.
Neoplasm Metastasis
Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities.
Neoplasm Metastasis
Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.
Neoplasm Metastasis
Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting ?5?1 integrin to downregulate Akt and MMP-2.
Neoplasm Metastasis
Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Neoplasm Metastasis
Redox state of adipose tissue for patients with gastric cancer and its connection with the body mass index and distance from the tumor.
Neoplasm Metastasis
Reduced angiogenesis in peritoneal dissemination of gastric cancer through gelatinase inhibition.
Neoplasm Metastasis
Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
Neoplasm Metastasis
Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.
Neoplasm Metastasis
Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells.
Neoplasm Metastasis
Replication study for reported SNP associations with breast cancer survival.
Neoplasm Metastasis
Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
Neoplasm Metastasis
Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
Neoplasm Metastasis
RhoGDI? promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation.
Neoplasm Metastasis
RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer in vitro by modulating cathepsin B and MMP9 expression.
Neoplasm Metastasis
RNA interference screening identifies clathrin-B and cofilin-1 as mediators of MT1-MMP in endometrial cancer.
Neoplasm Metastasis
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion.
Neoplasm Metastasis
Role of matrix metalloproteinase-9 in transforming growth factor-?1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Neoplasm Metastasis
Roles of Rap1 signaling in tumor cell migration and invasion.
Neoplasm Metastasis
S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer.
Neoplasm Metastasis
Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Neoplasm Metastasis
Selection of peptide inhibitor to matrix metalloproteinase-2 using phage display and its effects on pancreatic cancer cell lines PANC-1 and CFPAC-1.
Neoplasm Metastasis
Sensitive detection of CD147/EMMPRIN and its expression on cancer cells with electrochemical technique.
Neoplasm Metastasis
Sensitivity of human cord blood cells to tetrachloroethylene: cellular and molecular endpoints.
Neoplasm Metastasis
Short-hairpin RNA-mediated MTA2 silencing inhibits human breast cancer cell line MDA-MB231 proliferation and metastasis.
Neoplasm Metastasis
Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer.
Neoplasm Metastasis
Silencing of the Metastasis Suppressor RECK by RAS Oncogene Is Mediated by DNA Methyltransferase 3b-Induced Promoter Methylation.
Neoplasm Metastasis
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
Neoplasm Metastasis
Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.
Neoplasm Metastasis
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Neoplasm Metastasis
Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.
Neoplasm Metastasis
Starfish polysaccharides downregulate metastatic activity through the MAPK signaling pathway in MCF-7 human breast cancer cells.
Neoplasm Metastasis
Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer.
Neoplasm Metastasis
Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Neoplasm Metastasis
Structural insights into the binding of MMP9 inhibitors.
Neoplasm Metastasis
Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique.
Neoplasm Metastasis
Sublethal irradiation promotes the metastatic potential of hepatocellular carcinoma cells.
Neoplasm Metastasis
Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Neoplasm Metastasis
Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Neoplasm Metastasis
Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line.
Neoplasm Metastasis
Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.
Neoplasm Metastasis
Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(?)anthracene-induced rat mammary carcinoma.
Neoplasm Metastasis
Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
Neoplasm Metastasis
Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.
Neoplasm Metastasis
Targeting of an antecedent proteinase by an activatable probe with deep tissue penetration facilitates early visualization and dynamic malignancy evaluation of orthotopic pancreatic ductal adenocarcinoma (PDAC).
Neoplasm Metastasis
Tauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13.
Neoplasm Metastasis
Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9.
Neoplasm Metastasis
The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.
Neoplasm Metastasis
The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.
Neoplasm Metastasis
The effect of tomatine on metastasis related matrix metalloproteinase (MMP) activities in breast cancer cell model.
Neoplasm Metastasis
The fibrinolytic factor tPA drives LRP1-mediated melanoma growth and metastasis.
Neoplasm Metastasis
The glycocalyx and its significance in human medicine.
Neoplasm Metastasis
The Goal of Cancer Treatment.
Neoplasm Metastasis
The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma.
Neoplasm Metastasis
The interplay of matrix metalloproteinase-8, transforming growth factor-?1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Neoplasm Metastasis
The intranuclear PEX domain of MMP involves proliferation, migration, and metastasis of aggressive adenocarcinoma cells.
Neoplasm Metastasis
The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo.
Neoplasm Metastasis
The many faces of EMMPRIN-Roles in neuroinflammation.
Neoplasm Metastasis
The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
Neoplasm Metastasis
The matrix metalloproteinase inhibitor batimastat inhibits the lung colonisation of orthotopically implanted malignant pancreatic tumor cells in SCID mice.
Neoplasm Metastasis
The matrix metalloproteinase system in oral squamous cell carcinoma.
Neoplasm Metastasis
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.
Neoplasm Metastasis
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
Neoplasm Metastasis
The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions.
Neoplasm Metastasis
The other side of MMPs: protective roles in tumor progression.
Neoplasm Metastasis
The overexpression and predictive significance of MMP-12 in esophageal squamous cell carcinoma.
Neoplasm Metastasis
The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis.
Neoplasm Metastasis
The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma.
Neoplasm Metastasis
The role of EMMPRIN expression in ovarian epithelial carcinomas.
Neoplasm Metastasis
The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction.
Neoplasm Metastasis
The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma.
Neoplasm Metastasis
The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors.
Neoplasm Metastasis
The Trinity of Matrix Metalloproteinases, Inflammation, and Cancer: A Literature Review of Recent Updates.
Neoplasm Metastasis
The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling.
Neoplasm Metastasis
Thrombin generation and the pathogenesis of cancer.
Neoplasm Metastasis
Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential.
Neoplasm Metastasis
TIMP-1 Overexpression in Lung Carcinoma Enhances Tumor Kinetics and Angiogenesis in Brain Metastasis.
Neoplasm Metastasis
TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Neoplasm Metastasis
TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
Neoplasm Metastasis
Tissue inhibitor of matrix metalloproteinase-2 in nasopharyngeal carcinoma.
Neoplasm Metastasis
Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas.
Neoplasm Metastasis
Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Neoplasm Metastasis
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.
Neoplasm Metastasis
Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis.
Neoplasm Metastasis
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.
Neoplasm Metastasis
Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression.
Neoplasm Metastasis
Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells - A critical role of Cdk1 in mitotic entry.
Neoplasm Metastasis
Tumor targeting with a selective gelatinase inhibitor.
Neoplasm Metastasis
Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.
Neoplasm Metastasis
Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein.
Neoplasm Metastasis
Tumour necrosis factor-alpha provokes upregulation of alpha2beta1 and alpha5beta1 integrins, and cell migration in OST osteosarcoma cells.
Neoplasm Metastasis
Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.
Neoplasm Metastasis
Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.
Neoplasm Metastasis
Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Neoplasm Metastasis
Upregulated Expression of ADAM17 Is a Prognostic Marker for Patients With Gastric Cancer.
Neoplasm Metastasis
Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer.
Neoplasm Metastasis
Upregulation of extracellular matrix metalloproteinase inducer promotes hypoxia-induced epithelial-mesenchymal transition in esophageal cancer.
Neoplasm Metastasis
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas.
Neoplasm Metastasis
Upregulation of serum vascular endothelial growth factor and matrix metalloproteinase-3 in patients with oral squamous cell carcinoma.
Neoplasm Metastasis
Ursolic acid and its esters: occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells.
Neoplasm Metastasis
Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.
Neoplasm Metastasis
Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis.
Neoplasm Metastasis
Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential anti-tumor effect in cancer invasion and metastasis.
Neoplasm Metastasis
Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells.
Neoplasm Metastasis
Wortmannin Reduces Metastasis and Angiogenesis of Human Breast Cancer Cells via Nuclear Factor- B-dependent Matrix Metalloproteinase-9 and Interleukin-8 Pathways.
Neoplasm Metastasis
[An experimental study of matrix metalloproteinase inhibitor BB-94 inhibits the invasion and metastasis of the human salivary adenoid cystic carcinoma in vitro and in vivo]
Neoplasm Metastasis
[Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization]
Neoplasm Metastasis
[Effect of Src tyrosine kinase inhibition on secretion of MMP-2 and MMP-9 by non-small cell lung cancer cells].
Neoplasm Metastasis
[Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colorectal cancer cell line HT-29]
Neoplasm Metastasis
[Expression and clinical significance of CD147 and MMP-2 ?in squamous cell carcinoma and adenocarcinoma of the lungs].
Neoplasm Metastasis
[Expression of extracellular matrix metalloproteinase inducer in human bladder transitional cell carcinoma]
Neoplasm Metastasis
[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma]
Neoplasm Metastasis
[Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia]
Neoplasm Metastasis
[Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance]
Neoplasm Metastasis
[How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
Neoplasm Metastasis
[Increased expression of extracellular matrix metalloproteinase inducer through interaction between fibroblasts and colonic cancer cells]
Neoplasm Metastasis
[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]
Neoplasm Metastasis
[Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma]
Neoplasm Metastasis
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]
Neoplasm Metastasis
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Neoplasm Metastasis
[Significance of caveolin-1 protein detected by quantum dots technique in human lung cancer invasiveness and metastasis.]
Neoplasm Metastasis
[Study of the relation between MMP2, MMP9 and nasopharyngeal carcinoma]
Neoplasm Metastasis
[Therapeutic effect of matrix metalloproteinase inhibitor (R-94138) for peritoneal metastasis of stomach neoplasm models]
Neoplasm Metastasis
[Tumor metastasis and MMP inhibitor.]
Neoplasm Metastasis
ß-1,3-galactosyl-O-glycosyl-glycoprotein ß-1,6-N-acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility.
Neoplasm Micrometastasis
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice.
Neoplasm Micrometastasis
Intrahepatic micrometastases around liver metastases from gastric cancer.
Neoplasm Micrometastasis
Prognostic significance of matrix metalloproteinases type I expression and tumor front parameters in the presence of lymph node micrometastases in carcinoma of the larynx.
Neoplasm Micrometastasis
[Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma]
Neoplasm, Residual
Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
Neoplasm, Residual
Targeting lethal minimal residual disease in small cell lung cancer.
Neoplasms
"Locked" cancer cells are more sensitive to chemotherapy.
Neoplasms
'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
Neoplasms
1,25-dihydroxyvitamin D deficiency accelerates alveolar bone loss independent of aging and extracellular calcium and phosphorus.
Neoplasms
1?Palmitoyl?2?linoleoyl?3?acetyl?rac?glycerol ameliorates EGF?induced MMP?9 expression by promoting receptor desensitization in MDA?MB?231 cells.
Neoplasms
2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9.
Neoplasms
3, 4-dihydroxybenzalacetone attenuates lipopolysaccharide-induced inflammation in acute lung injury via down-regulation of MMP-2 and MMP-9 activities through suppressing ROS-mediated MAPK and PI3K/AKT signaling pathways.
Neoplasms
4-Hydroxy-7-oxo-5-heptenoic acid lactone is a potent inducer of brain cancer cell invasiveness that may contribute to the failure of anti-angiogenic therapies.
Neoplasms
7,8-Dihydroxyflavone activates Nrf2/HO-1 signaling pathways and protects against osteoarthritis.
Neoplasms
?-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer.
Neoplasms
?3GnT8 plays an important role in CD147 signal transduction as an upstream modulator of MMP production in tumor cells.
Neoplasms
A 24-h work shift in intensive care personnel: biological pathways between work stress and ill health.
Neoplasms
A Cancer Invasion Model Combined with Cancer-Associated Fibroblasts Aggregates Incorporating Gelatin Hydrogel Microspheres Containing a p53 Inhibitor.
Neoplasms
A cancer invasion model of cancer-associated fibroblasts aggregates combined with TGF-?1 release system.
Neoplasms
A carcinogenic trigger to study the function of tumor suppressor genes in Schmidtea mediterranea.
Neoplasms
A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.
Neoplasms
A comparative analysis and systematic review of the wound-healing milieu: implications for body contouring after massive weight loss.
Neoplasms
A Competitive ELISA for quantifying serum CD147: reduction of soluble CD147 levels in cancer patient sera.
Neoplasms
A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Neoplasms
A dietary polysaccharide from Eucheuma cottonii downregulates proinflammatory cytokines and ameliorates osteoarthritis-associated cartilage degradation in obese rats.
Neoplasms
A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid.
Neoplasms
A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹?F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Neoplasms
A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Neoplasms
A high throughput fluorogenic substrate for stromelysin (MMP-3).
Neoplasms
A hydroxamic acid-methacrylated collagen conjugate for the modulation of inflammation-related MMP upregulation.
Neoplasms
A matrix metalloproteinase activation probe for painting human tumours.
Neoplasms
A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Neoplasms
A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment.
Neoplasms
A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality.
Neoplasms
A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice.
Neoplasms
A Model for the Solution Structure of Human Fe(II)-Bound Acireductone Dioxygenase and Interactions with the Regulatory Domain of Matrix Metalloproteinase I (MMP-I).
Neoplasms
A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies.
Neoplasms
A new gallium complex inhibits tumor cell invasion and matrix metalloproteinase MMP-14 expression and activity.
Neoplasms
A new matrix metalloproteinase-9 inhibitor 3,4-dihydroxycinnamic acid (caffeic acid) from methanol extract of Euonymus alatus: isolation and structure determination.
Neoplasms
A new paradigm for mechanobiological mechanisms in tumor metastasis.
Neoplasms
A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes.
Neoplasms
A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma.
Neoplasms
A novel functional site of extracellular matrix metalloproteinase inducer (EMMPRIN) that limits the migration of human uterine cervical carcinoma cells.
Neoplasms
A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation.
Neoplasms
A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
Neoplasms
A Novel Nonviral Gene Delivery System: Multifunctional Envelope-Type Nano Device.
Neoplasms
A novel peptide blocking cancer cell invasion by structure-based drug design.
Neoplasms
A Peptide-Network Weaved Nanoplatform with Tumor Microenvironment Responsiveness and Deep Tissue Penetration Capability for Cancer Therapy.
Neoplasms
A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors.
Neoplasms
A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours.
Neoplasms
A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours.
Neoplasms
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors.
Neoplasms
A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancer.
Neoplasms
A phase II trial of marimastat in advanced pancreatic cancer.
Neoplasms
A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.
Neoplasms
A polysaccharide from mushroom Huaier retards human hepatocellular carcinoma growth, angiogenesis, and metastasis in nude mice.
Neoplasms
A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis.
Neoplasms
A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis.
Neoplasms
A role for endothelin-2 and its receptors in breast tumor cell invasion.
Neoplasms
A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells.
Neoplasms
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma.
Neoplasms
A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription.
Neoplasms
A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.
Neoplasms
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice.
Neoplasms
A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases.
Neoplasms
A tumor environment responsive Doxorubicin-loaded nanoparticle for targeted cancer therapy.
Neoplasms
A zinc chelator inhibiting gelatinases exerts potent in vitro anti-invasive effects.
Neoplasms
A20 suppresses inflammatory responses and bone destruction in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis.
Neoplasms
AAC-11 overexpression induces invasion and protects cervical cancer cells from apoptosis.
Neoplasms
Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas.
Neoplasms
Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.
Neoplasms
Absence of circulating aldosterone attenuates foreign body reaction around surgical sutures.
Neoplasms
Accelerated degradation of collagen membranes in type 1 diabetic rats is associated with increased expression and production of several inflammatory molecules.
Neoplasms
Accumulation of differentiating intestinal stem cell progenies drives tumorigenesis.
Neoplasms
Acrylamide exposure aggravates the development of ulcerative colitis in mice through activation of NF-?B, inflammatory cytokines, iNOS, and oxidative stress.
Neoplasms
Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A.
Neoplasms
Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis.
Neoplasms
Activation of cultured rat hepatic stellate cells by tumoral hepatocytes.
Neoplasms
Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis.
Neoplasms
Activation of protein kinase CK2 is an early step in the ultraviolet B-mediated increase in interstitial collagenase (matrix metalloproteinase-1; MMP-1) and stromelysin-1 (MMP-3) protein levels in human dermal fibroblasts.
Neoplasms
Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2.
Neoplasms
ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Neoplasms
ADAM17 promotes the invasion of hepatocellular carcinoma via upregulation MMP21.
Neoplasms
ADAMTS-5 Decreases in Aortas and Plasma From Aortic Dissection Patients and Alleviates Angiotensin II-Induced Smooth Muscle-Cell Apoptosis.
Neoplasms
Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer.
Neoplasms
Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells.
Neoplasms
Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasion.
Neoplasms
Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis.
Neoplasms
Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.
Neoplasms
Adjuvant therapy for gastric carcinoma: closing out the century.
Neoplasms
Administration of a matrix metalloproteinase inhibitor after hemorrhage improves cardiovascular and hepatocellular function.
Neoplasms
Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice.
Neoplasms
Adrenomedullin protects rat dorsal root ganglion neurons against doxorubicin-induced toxicity by ameliorating oxidative stress.
Neoplasms
Age- and gender-dependent myocardial transcription patterns of cytokines and extracellular matrix remodelling enzymes in cats with non-cardiac diseases.
Neoplasms
Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines.
Neoplasms
ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.
Neoplasms
alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity.
Neoplasms
Alterations in gene expression of proprotein convertases in human lung cancer have a limited number of scenarios.
Neoplasms
Alterations of gene expression in human neutrophils induced by smoking cessation.
Neoplasms
Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas.
Neoplasms
Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression.
Neoplasms
Altered Protein Composition and Gene Expression in Strabismic Human Extraocular Muscles and Tendons.
Neoplasms
Alternative splicing and promoter usage generates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase.
Neoplasms
Alveolar bone protective and hypoglycemic effects of systemic propolis treatment in experimental periodontitis and diabetes mellitus.
Neoplasms
Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice.
Neoplasms
Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
Neoplasms
An assessment of MMP and TIMP gene expression in cell lines and stroma - tumour differences in microdissected breast cancer biopsies.
Neoplasms
An epitope-specific novel anti-EMMPRIN polyclonal antibody inhibits tumor progression.
Neoplasms
An in vivo model for screening peptidomimetic inhibitors of gelatinase A.
Neoplasms
An insight to conserved water molecular dynamics of catalytic and structural Zn(+2) ions in matrix metalloproteinase 13 of human.
Neoplasms
An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin.
Neoplasms
An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin.
Neoplasms
An Overview of Matrix Metalloproteinase 9 Polymorphism and Gastric Cancer Risk.
Neoplasms
An Unusually Stable G-Quadruplex within the 5'-UTR of the MT3 Matrix Metalloproteinase mRNA Represses Translation in Eukaryotic Cells.
Neoplasms
Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.
Neoplasms
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.
Neoplasms
Analysis of intra-uterine cytokine concentration and matrix-metalloproteinase activity in women with recurrent failed embryo transfer.
Neoplasms
Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.
Neoplasms
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
Neoplasms
Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response.
Neoplasms
Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
Neoplasms
Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases.
Neoplasms
Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice.
Neoplasms
Anserine and glucosamine supplementation attenuates the levels of inflammatory markers in rats with rheumatoid arthritis.
Neoplasms
Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts.
Neoplasms
Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
Neoplasms
Anti-Apoptotic and Anti-Inflammatory Activities of Edible Fresh Water Algae Prasiola japonica in UVB-Irradiated Skin Keratinocytes.
Neoplasms
Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model.
Neoplasms
Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma.
Neoplasms
Anti-inflammatory and Anti-apoptotic Effect of Valproic Acid and Doxycycline Independent from MMP Inhibition in Early Radiation Damage.
Neoplasms
Anti-inflammatory and anti-nociceptive effect of Betula platyphylla var. japonica in human interleukin-1?-stimulated fibroblast-like synoviocytes and in experimental animal models.
Neoplasms
Anti-invasive activity of anthocyanins isolated from Vitis coignetiae in human hepatocarcinoma cells.
Neoplasms
Anti-Osteoarthritic Effects of a Mixture of Dried Pomegranate Concentrate Powder, Eucommiae Cortex, and Achyranthis Radix 5:4:1 (g/g) in a Surgically Induced Osteoarthritic Rabbit Model.
Neoplasms
Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Ameliorates Cartilage Degradation in a Rat Model of Chronic Sports Arthritic Injury.
Neoplasms
Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis.
Neoplasms
Antihypertensive and Antifibrosis Effects of Acupuncture at PC6 Acupoints in Spontaneously Hypertensive Rats and the Underlying Mechanisms.
Neoplasms
Antimetastatic activity of polyphenol-rich extract of Ecklonia cava through the inhibition of the Akt pathway in A549 human lung cancer cells.
Neoplasms
Antineoplastic effects of nutrient mixture on raji and jurkat t cells: the two highly aggressive non hodgkin's lymphoma cell lines.
Neoplasms
Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.
Neoplasms
Antitumor activity of targeting SRC kinases in endothelial and myeloid cell compartments of the tumor microenvironment.
Neoplasms
Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24.
Neoplasms
Antitumor effects of recombinant human adenovirus-p53 against human cutaneous squamous cell carcinoma in mice.
Neoplasms
Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
Neoplasms
Arsenic enhances matrix metalloproteinase-14 expression in fibroblasts.
Neoplasms
Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview.
Neoplasms
Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.
Neoplasms
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
Neoplasms
Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markers.
Neoplasms
ASSESSMENT OF GELATINASE AND TUMOR NECROSIS FACTOR-? LEVEL IN THE VITREOUS AND SERUM OF PATIENTS WITH EALES DISEASE: Role of Inflammation-Mediated Angiogenesis in the Pathogenesis of Eales Disease.
Neoplasms
Assessment of MicroRNA (miR)-365 Effects on Oral Squamous Carcinoma Cell Line Phenotypes.
Neoplasms
Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase.
Neoplasms
Association between Inflammatory Biomarkers and Progression of Intracranial Large Artery Stenosis after Ischemic Stroke.
Neoplasms
Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Neoplasms
Association of BCSC-1 and MMP-14 with human breast cancer.
Neoplasms
Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Neoplasms
Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Neoplasms
Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer.
Neoplasms
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Neoplasms
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Neoplasms
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Neoplasms
Association of matrix metalloproteinase (MMP)-2 and -9 expression with extra-gastrointestinal stromal tumor metastasis.
Neoplasms
Association of matrix metalloproteinases 3 and 9 single nucleotide polymorphisms with breast cancer risk: A case-control study.
Neoplasms
Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice.
Neoplasms
Atorvastatin May Delay Cardiac Aging by Upregulating Peroxisome Proliferator-Activated Receptors in Rats.
Neoplasms
Attenuated expression and function of the RECK tumor suppressor under hypoxic conditions is mediated by the MAPK signaling pathways.
Neoplasms
Auraptene Inhibits Migration and Invasion of Cervical and Ovarian Cancer Cells by Repression of Matrix Metalloproteinasas 2 and 9 Activity.
Neoplasms
Autoantigen-pulsed dendritic cells constitute a beneficial cytokine and growth factor network in ameliorating experimental allergic encephalomyelitis.
Neoplasms
Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion.
Neoplasms
Autofluorescent gelatin nanoparticles as imaging probes to monitor matrix metalloproteinase metabolism of cancer cells.
Neoplasms
Autologous Adipose-Derived Mesenchymal Stem Cells Combined with Shockwave Therapy Synergistically Ameliorates the Osteoarthritic Pathological Factors in Knee Joint.
Neoplasms
Autotaxin levels in serum and bronchoalveolar lavage fluid are associated with inflammatory and fibrotic biomarkers and the clinical outcome in patients with acute respiratory distress syndrome.
Neoplasms
Basement membrane remodeling is essential for Drosophila disc eversion and tumor invasion.
Neoplasms
Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts.
Neoplasms
Basigin-2 is a cell surface receptor for soluble basigin ligand.
Neoplasms
Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.
Neoplasms
Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
Neoplasms
Beneficial effects of treatment with transglutaminase inhibitor cystamine on macrophage response in NZB/W F1 mice.
Neoplasms
Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells.
Neoplasms
Bio-inspired polymer envelopes around adenoviral vectors to reduce immunogenicity and improve in vivo kinetics.
Neoplasms
Biochemical and spectroscopic characterization of the catalytic domain of MMP16 (cdMMP16).
Neoplasms
Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion.
Neoplasms
Biological activity and clinical implications of the matrix metalloproteinases.
Neoplasms
Biological Characteristics of Cluster of Differentiation 147 and Its Relationship with Tumour.
Neoplasms
Biological strategies for osteoarthritis: from early diagnosis to treatment.
Neoplasms
Biomarkers in dysplasia of the oral cavity: A systematic review.
Neoplasms
Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing.
Neoplasms
Bismaleimide cross-linked anthrax toxin forms functional octamers with high specificity in tumor targeting.
Neoplasms
Bisphosphonates and cancer.
Neoplasms
Black tea theaflavins attenuate Porphyromonas gingivalis virulence properties, modulate gingival keratinocyte tight junction integrity and exert anti-inflammatory activity.
Neoplasms
Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.
Neoplasms
Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy.
Neoplasms
Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner.
Neoplasms
Blocking HOTAIR protects human chondrocytes against IL-1?-induced cell apoptosis, ECM degradation, inflammatory response and oxidative stress via regulating miR-222-3p/ADAM10 axis.
Neoplasms
Blood Droplet-Based Cancer Diagnosis via Proteolytic Activity Measurement in Cancer Progression.
Neoplasms
Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam.
Neoplasms
BMS-275291. Bristol-Myers Squibb.
Neoplasms
Bone marrow-derived cells and epithelial tumours: more than just an inflammatory relationship.
Neoplasms
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy.
Neoplasms
Bortezomib attenuates murine collagen-induced arthritis.
Neoplasms
Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B.
Neoplasms
Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
Neoplasms
Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?
Neoplasms
Cancer biology: extracellular proteinases in malignancy.
Neoplasms
Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors.
Neoplasms
Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity.
Neoplasms
Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance.
Neoplasms
Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular level.
Neoplasms
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Neoplasms
Carnosine Prevents Type 2 Diabetes-Induced Osteoarthritis Through the ROS/NF-?B Pathway.
Neoplasms
Carvacrol Ameliorates Ligation-Induced Periodontitis in Rats.
Neoplasms
Case of primary malignant hemangiopericytoma of the heart expressing basement membrane-degradable enzymes.
Neoplasms
Cathepsin B-degradable, NIR-responsive nanoparticulate platform for target-specific cancer therapy.
Neoplasms
Caveolin-1 regulating the invasion and expression of matrix metalloproteinase (MMPs) in pancreatic carcinoma cells.
Neoplasms
Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines.
Neoplasms
CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway.
Neoplasms
CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.
Neoplasms
CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis.
Neoplasms
CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.
Neoplasms
CD147 expression correlates with lymph node metastasis in T1-T2 squamous cell carcinoma of the tongue.
Neoplasms
CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer.
Neoplasms
CD147 induces up-regulation of vascular endothelial growth factor in U937-derived foam cells through PI3K/AKT pathway.
Neoplasms
CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
Neoplasms
CD147 regulates vascular endothelial growth factor-A expression, tumorigenicity, and chemosensitivity to curcumin in hepatocellular carcinoma.
Neoplasms
CD147/basigin promotes progression of malignant melanoma and other cancers.
Neoplasms
CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer.
Neoplasms
CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.
Neoplasms
CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells.
Neoplasms
CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury.
Neoplasms
CD44(+) gastric cancer cells with stemness properties are chemoradioresistant and highly invasive.
Neoplasms
CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
Neoplasms
CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling.
Neoplasms
CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts.
Neoplasms
Celastrol Inhibits Breast Cancer Cell Invasion via Suppression of NF-?B-mediated Matrix Metalloproteinase-9 Expression.
Neoplasms
Cell Specific Matrix Metalloproteinase-1 Regulates Lung Metastasis Synergistically with Smoke Exposure.
Neoplasms
Cell surface association of matrix metalloproteinase-9 (gelatinase B).
Neoplasms
Cell surface remodeling by plasmin: a new function for an old enzyme.
Neoplasms
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
Neoplasms
Cell-based identification of natural substrates and cleavage sites for extracellular proteases by SILAC proteomics.
Neoplasms
Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology.
Neoplasms
Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Neoplasms
Changes in biochemical parameters after anterior cruciate ligament injury.
Neoplasms
Changes in Inflammatory Cytokines in Saliva after Non-Surgical Periodontal Therapy: A Systematic Review and Meta-Analysis.
Neoplasms
Changes of gene expression after bone marrow cell transfusion in rats with monocrotaline-induced pulmonary hypertension.
Neoplasms
Changes of synovial fluid biomarker levels after opening wedge high tibial osteotomy in patients with knee osteoarthritis.
Neoplasms
Characterisation of tumour-derived microvesicles in cancer patients' blood and correlation with clinical outcome.
Neoplasms
Characterization of matrix metalloproteinase inhibitors: angiogenesis and tumor models.
Neoplasms
Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases.
Neoplasms
Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases.
Neoplasms
Chemical biology for understanding matrix metalloproteinase function.
Neoplasms
Chemotherapy based on "Domino-effect" combined with immunotherapy amplifying the efficacy of an anti-metastatic treatment.
Neoplasms
Chemotherapy-Enriched THBS2-Deficient Cancer Stem Cells Drive Hepatocarcinogenesis through Matrix Softness Induced Histone H3 Modifications.
Neoplasms
Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
Neoplasms
Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism.
Neoplasms
Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression.
Neoplasms
Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
Neoplasms
Chronic Exposure of Renal Stem Cells to Inorganic Arsenic Induces a Cancer Phenotype.
Neoplasms
Chymase inhibition attenuates lipopolysaccharide/ d-galactosamine-induced acute liver failure in hamsters.
Neoplasms
Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories.
Neoplasms
Citrus auraptene targets translation of MMP-7 (matrilysin) via ERK1/2-dependent and mTOR-independent mechanism.
Neoplasms
Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancer.
Neoplasms
Clinical and immunological peri-implant parameters among cigarette and electronic smoking patients treated with photochemotherapy: A randomized controlled clinical trial.
Neoplasms
Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas.
Neoplasms
Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma.
Neoplasms
Clinical study of systemic chemotherapy combined with bronchoscopic interventional cryotherapy in the treatment of lung cancer.
Neoplasms
Clinical trials of a low molecular weight matrix metalloproteinase inhibitor in cancer.
Neoplasms
Clinicopathological significance of human macrophage metalloelastase expression in esophageal squamous cell carcinoma.
Neoplasms
Clonal variation in phenotype and life span of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT).
Neoplasms
COBRA: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors.
Neoplasms
Codelivery of Anti-PD-1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual-Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy.
Neoplasms
Cold-inducible RNA-binding protein plays a central role in the pathogenesis of abdominal aortic aneurysm in a murine experimental model.
Neoplasms
Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor.
Neoplasms
Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas.
Neoplasms
Collagenases (MMP-1, -8 and -13) and trypsinogen-2 in fluid from benign and malignant ovarian cysts.
Neoplasms
Colorectal Cancer and Mitochondrial Dysfunctions of the Adjunct Adipose Tissues: A Case Study.
Neoplasms
Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Neoplasms
Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
Neoplasms
Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.
Neoplasms
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
Neoplasms
Combined effects of tumor necrosis factor-? and interleukin-1? on lysyl oxidase and matrix metalloproteinase expression in human knee synovial fibroblasts
Neoplasms
Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
Neoplasms
Comparative expression of matrix metalloproteinases in internal malignancies and paired cutaneous metastatic lesions.
Neoplasms
Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer.
Neoplasms
Comparative Role of Matrixins in Diagnostics of Parotid Gland Tumors.
Neoplasms
Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.
Neoplasms
Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Neoplasms
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
Neoplasms
Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma.
Neoplasms
Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Neoplasms
Comparison of p38MAPK (mitogene activated protein kinase), p65 NFkappaB (nuclear factor kappa b) and EMMPRIN (extracellular matrix metalloproteinase inducer) expressions with tumor grade and stage of superficial and invasive bladder tumors.
Neoplasms
Comparison of Serum and Cervical Cytokine Levels throughout Pregnancy between Preterm and Term Births.
Neoplasms
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-? Release from Activated Microglia and TNF-? Converting Enzyme Activity.
Neoplasms
Complex regulation of pulmonary inflammation and fibrosis by CCL18.
Neoplasms
Complex Regulation of the Pericellular Proteolytic Microenvironment during Tumor Progression and Wound Repair: Functional Interactions between the Serine Protease and Matrix Metalloproteinase Cascades.
Neoplasms
Computational insights into the identification of a potent matrix metalloproteinase inhibitor from Indigofera aspalathoides to control cancer metastasis.
Neoplasms
Contributions of Thyroid Hormone to Cancer Metastasis.
Neoplasms
Control of matrix metalloproteinase activity in cancer.
Neoplasms
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Neoplasms
Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-?, NF-?B, TGF-?, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1?] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma.
Neoplasms
Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma.
Neoplasms
Correlation between plasma angiopoietin-1, angiopoietin-2 and matrix metalloproteinase-2 in coronary heart disease.
Neoplasms
Correlation of Synovial Fluid Biomarkers With Cartilage Pathology and Associated Outcomes in Knee Arthroscopy.
Neoplasms
Correlation of Vascular Endothelial Growth Factor Expression With Tumor Recurrence and Poor Prognosis in Patients With pN0 Gastric Cancer.
Neoplasms
COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
Neoplasms
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Neoplasms
Critical role and its underlying molecular events of the plasminogen receptor, S100A10 in malignant tumor and non-tumor diseases.
Neoplasms
CRN2 binds to TIMP4 and MMP14 and promotes perivascular invasion of glioblastoma cells.
Neoplasms
Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene.
Neoplasms
Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.
Neoplasms
Crosstalk between TGF-? signaling and miRNAs in breast cancer metastasis.
Neoplasms
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Neoplasms
Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.
Neoplasms
CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
Neoplasms
Culture of human fibrosarcoma HT-1080 cells in presence of fibronectin activates MMP-2.
Neoplasms
Curcumin ameliorates left ventricular function in rabbits with pressure overload: inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinase-2 expression.
Neoplasms
Curcumin and tetrahydrocurcumin both prevent osteoarthritis symptoms and decrease the expressions of pro-inflammatory cytokines in estrogen-deficient rats.
Neoplasms
Curcumin inhibits adverse psychological stress-induced proliferation and invasion of glioma cells via down-regulating the ERK/MAPK pathway.
Neoplasms
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
Neoplasms
Curcumin suppresses tumor necrosis factor-?-induced matrix metalloproteinase-2 expression and activity in rat vascular smooth muscle cells via the NF-?B pathway.
Neoplasms
Curcumin: a potential candidate for matrix metalloproteinase inhibitors.
Neoplasms
Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae.
Neoplasms
Current status and future prospects of transforming growth factor-? as a potential prognostic and therapeutic target in the treatment of breast cancer.
Neoplasms
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Neoplasms
Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
Neoplasms
Cyclooxygenase Inhibition Limits Blood-Brain Barrier Disruption following Intracerebral Injection of Tumor Necrosis Factor-{alpha} in the Rat.
Neoplasms
Cypermethrin Induces the Activation of Rat Primary Microglia and Expression of Inflammatory Proteins.
Neoplasms
Cytokine profile in the gingival crevicular fluid of rheumatoid arthritis patients with chronic periodontitis.
Neoplasms
Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
Neoplasms
Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging.
Neoplasms
Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer.
Neoplasms
Cytokines, Angiogenesis, and Extracellular Matrix Degradation are Augmented by Oxidative Stress in Endometriosis.
Neoplasms
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.
Neoplasms
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.
Neoplasms
Cytoskeletal Alteration Is an Early Cellular Response in Pulmonary Epithelium Infected with Aspergillus fumigatus Rather than Scedosporium apiospermum.
Neoplasms
DAPT suppresses proliferation and migration of hepatocellular carcinoma by regulating the extracellular matrix and inhibiting the Hes1/PTEN/AKT/mTOR signaling pathway.
Neoplasms
DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-?B pathway.
Neoplasms
Decreased expression of carbonyl reductase 1 promotes ovarian cancer growth and proliferation.
Neoplasms
Decursinol angelate blocks transmigration and inflammatory activation of cancer cells through inhibition of PI3K, ERK and NF-kappaB activation.
Neoplasms
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
Neoplasms
Degradation and Remodeling of Epitaxially Grown Collagen Fibrils.
Neoplasms
Deguelin targets multiple oncogenic signaling pathways to combat human malignancies.
Neoplasms
Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Neoplasms
Des-?-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
Neoplasms
Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Neoplasms
Detection of Cancer-Specific Proteases Using Magnetic Relaxation of Peptide-Conjugated Nanoparticles in Biological Environment.
Neoplasms
Determination of PNU-248686A, a novel matrix metalloproteinase inhibitor, in human plasma by liquid chromatography-tandem mass spectrometry, following protein precipitation in the 96-well plate format.
Neoplasms
Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging.
Neoplasms
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
Neoplasms
Development of matrix metalloproteinase inhibitors in cancer therapy.
Neoplasms
Development of putrescine anchored nano-crystalsomes bearing doxorubicin and oleanolic acid: deciphering their role in inhibiting metastatic breast cancer.
Neoplasms
Dexamethasone prevents alteration of tight junction-associated proteins and barrier function in porcine choroid plexus epithelial cells after infection with Streptococcus suis in vitro.
Neoplasms
Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer Cell Line.
Neoplasms
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Neoplasms
Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-?B Pathway.
Neoplasms
Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
Neoplasms
Different expression patterns of MMP-2 and MMP-9 in breast cancer.
Neoplasms
Differential effect of the expression of TGF-? pathway inhibitors, Smad-7 and Ski, on invasive breast carcinomas: relation to biologic behavior.
Neoplasms
Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.
Neoplasms
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
Neoplasms
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Neoplasms
Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma.
Neoplasms
Differential inductions of matrix metalloproteinase-2 and -9 in host tissues during the growth of ascitic sarcoma 180 cells in mice.
Neoplasms
Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
Neoplasms
Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Neoplasms
Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
Neoplasms
Differential regulation of matrix metalloproteinases in human cancer cells by exogenous factors.
Neoplasms
Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis.
Neoplasms
Direct Activation of Emmprin and Associated Pathogenesis by an Oncogenic Herpesvirus.
Neoplasms
Direct and indirect markers of cartilage metabolism in synovial fluid obtained from dogs with hip dysplasia and correlation with clinical and radiographic variables.
Neoplasms
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours.
Neoplasms
Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.
Neoplasms
Direct production of functional matrix metalloproteinase--14 without refolding or activation and its application for in vitro inhibition assays.
Neoplasms
Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-alpha converting enzyme.
Neoplasms
Distribution and clinical significance of circulating tumor cells in nasopharyngeal carcinoma.
Neoplasms
Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas.
Neoplasms
Diverse Functions of Plasma PAF-AH in Tumorigenesis.
Neoplasms
Diverse matrix metalloproteinase functions regulate cancer amoeboid migration.
Neoplasms
Do the levels of tumor makers or proinflammatory cytokines in mid-trimester cervical fluid predict early-stage cervical shortening?
Neoplasms
Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independent.
Neoplasms
Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
Neoplasms
Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Neoplasms
Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma.
Neoplasms
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Neoplasms
Doxorubicin conjugates for selective delivery to tumors.
Neoplasms
Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer.
Neoplasms
Drosophila matrix metalloproteinases are required for tissue remodeling, but not embryonic development.
Neoplasms
Drug-induced apoptosis by a matrix metalloproteinase inhibitor, SI-27 on human malignant glioma cell lines; in vitro study.
Neoplasms
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.
Neoplasms
Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Neoplasms
Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.
Neoplasms
Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes.
Neoplasms
Dual targeting of integrin ?v?3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.
Neoplasms
Dysregulation of adenosine kinase isoforms in breast cancer.
Neoplasms
Dysregulation of FURIN by prostaglandin-endoperoxide synthase 2 in lung epithelial NCI-H292 cells.
Neoplasms
Dystroglycan complex in cancer.
Neoplasms
E1AF, an ets-oncogene family transcription factor.
Neoplasms
Early short-term vagal nerve stimulation attenuates cardiac remodeling after reperfused myocardial infarction.
Neoplasms
Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis.
Neoplasms
Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells.
Neoplasms
Effect of ?-anhydroicaritin on the expression levels of tumor necrosis factor-? and matrix metalloproteinase-3 in periodontal tissue of diabetic rats.
Neoplasms
Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma.
Neoplasms
Effect of a matrix metalloproteinase inhibitor on host resistance against Listeria monocytogenes infection.
Neoplasms
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Neoplasms
Effect of CO2 pneumoperitoneum on the proliferation of human ovarian cancer cell line SKOV-3 and the expression of NM23-H1 and MMP-2.
Neoplasms
Effect of cold plasma on periodontal wound healing-an in vitro study.
Neoplasms
Effect of cyclosporin A intervention on the immunological mechanisms of coronary heart disease and restenosis.
Neoplasms
Effect of Environmental Conditions on the Concentration of Tear Inflammatory Mediators During Contact Lens Wear.
Neoplasms
Effect of Gastrodia elata on tumor necrosis factor-alpha-induced matrix metalloproteinase activity in endothelial cells.
Neoplasms
Effect of GCSB-5, a Herbal Formulation, on Monosodium Iodoacetate-Induced Osteoarthritis in Rats.
Neoplasms
Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control.
Neoplasms
Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis.
Neoplasms
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Neoplasms
Effect of photodynamic therapy and laser alone as adjunct to scaling and root planing on gingival crevicular fluid inflammatory proteins in periodontal disease: A systematic review.
Neoplasms
Effect of Repeated Freezing and Thawing on Biomarker Stability in Plasma and Serum Samples.
Neoplasms
Effect of specific silencing of EMMPRIN on the growth and cell cycle distribution of MCF-7 breast cancer cells.
Neoplasms
Effect of traditional Chinese medicine Shu-Mai-Tang on attenuating TNFalpha-induced myocardial fibrosis in myocardial ischemia rats.
Neoplasms
Effect of tranexamic acid in improving the lifespan of naturally aging mice.
Neoplasms
Effect of Ulinastatin Combined With Dexmedetomidine on Postoperative Cognitive Dysfunction in Patients Who Underwent Cardiac Surgery.
Neoplasms
Effects and Mechanism of Noninvasive Positive-Pressure Ventilation in a Rat Model of Heart Failure Due to Myocardial Infarction.
Neoplasms
Effects of a High-Fat or High-Sucrose Diet on Ultraviolet B Irradiation-Induced Carcinogenesis and Tumor Growth in Melanin-Possessing Hairless Mice.
Neoplasms
Effects of a nutrient mixture on immunohistochemical localization of cancer markers in human cervical cancer HeLa cell tumor xenografts in female nude mice.
Neoplasms
Effects of a selective cyclooxygenase-2 inhibitor on cancer cells in vitro.
Neoplasms
Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells.
Neoplasms
Effects of bromopride on expression of metalloproteinases and interleukins in left colonic anastomoses: an experimental study.
Neoplasms
Effects of Calendula officinalis on human gingival fibroblasts.
Neoplasms
Effects of chitin and sepia ink hybrid sponge on the healing of burning wound rats and its impact on macrophages in vitro.
Neoplasms
Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
Neoplasms
Effects of Edaravone, a Free Radical Scavenger, on Serum Levels of Inflammatory Biomarkers in Acute Brain Infarction.
Neoplasms
Effects of Enzymatic Activation on the Distribution of Fluorescently Tagged MMP-2 Cleavable Peptides in Cancer Cells and Spheroids.
Neoplasms
Effects of GGCX overexpression on anterior cruciate ligament transection-induced osteoarthritis in rabbits.
Neoplasms
Effects of HAb18G/CD147 Knockout on Hepatocellular Carcinoma Cells In Vitro Using a Novel Zinc-Finger Nuclease-Targeted Gene Knockout Approach.
Neoplasms
Effects of Hesperidin on H?O?-Treated Chondrocytes and Cartilage in a Rat Osteoarthritis Model.
Neoplasms
Effects of inhaled air pollution on markers of integrity, inflammation, and microbiota profiles of the intestines in Apolipoprotein E knockout mice.
Neoplasms
Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Neoplasms
Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice.
Neoplasms
Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis.
Neoplasms
Effects of Photodynamic Therapy on the Clinical and Gingival Crevicular Fluid Inflammatory Biomarkers in Chronic Periodontitis: A Split-Mouth Randomized Clinical Trial.
Neoplasms
Effects of resveratrol and genistein on nuclear factor??B, tumor necrosis factor?? and matrix metalloproteinase?9 in patients with chronic obstructive pulmonary disease.
Neoplasms
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-?B and MMP-9.
Neoplasms
Elastin-elastases and inflamm-aging.
Neoplasms
Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
Neoplasms
Elevated expression levels of androgen receptors and matrix metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and staging.
Neoplasms
Elevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancer.
Neoplasms
Elevated expression of hypoxia-inducible factor-2alpha regulated catabolic factors during intervertebral disc degeneration.
Neoplasms
Elevated interleukin-12 in pseudosynovial fluid in patients with aseptic loosening of hip prosthesis.
Neoplasms
Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer.
Neoplasms
Elevated levels of circulating matrix metalloproteinase-9 in non-small cell lung cancer patients.
Neoplasms
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Neoplasms
Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo.
Neoplasms
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Neoplasms
Elevated plasma and synovial fluid interleukin-8 and interleukin-18 may be associated with the pathogenesis of knee osteoarthritis.
Neoplasms
Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma.
Neoplasms
EMMPRIN (basigin/CD147) expression is not correlated with MMP activity during adult mouse mammary gland development.
Neoplasms
Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression.
Neoplasms
EMMPRIN (CD147) expression and differentiation of papillary thyroid carcinoma: implications for immunocytochemistry in FNA cytology.
Neoplasms
EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface.
Neoplasms
EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
Neoplasms
EMMPRIN contributes to the in vitro invasion of human salivary adenoid cystic carcinoma cells.
Neoplasms
EMMPRIN Down-regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1?.
Neoplasms
EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Neoplasms
EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.
Neoplasms
EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.
Neoplasms
EMMPRIN Is an Independent Negative Prognostic Factor for Patients with Astrocytic Glioma.
Neoplasms
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Neoplasms
EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma.
Neoplasms
Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production.
Neoplasms
EMMPRIN reduction via scFv-M6-1B9 intrabody affects ?3?1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2.
Neoplasms
EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo.
Neoplasms
EMMPRIN/CD147 deficiency disturbs ameloblast-odontoblast cross-talk and delays enamel mineralization.
Neoplasms
EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis.
Neoplasms
Emodin inhibits tumor necrosis factor-?-induced migration and inflammatory responses in rat aortic smooth muscle cells.
Neoplasms
Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.
Neoplasms
Endogenous modulators for drug dependence.
Neoplasms
Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
Neoplasms
Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy.
Neoplasms
Endostatin binds to the catalytic domain of matrix metalloproteinase-2.
Neoplasms
Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.
Neoplasms
Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats.
Neoplasms
Endurance Training Depletes Antioxidant System but Does Not Affect Endothelial Functions in Women with Abdominal Obesity: A Randomized Trial with a Comparison to Endurance-Strength Training.
Neoplasms
Engineering Cellular Microenvironments with Photo- and Enzymatically Responsive Hydrogels: Toward Biomimetic 3D Cell Culture Models.
Neoplasms
Enhanced expression of mRNA for nuclear factor kappaB1 (p50) in CD34+ cells of the bone marrow in rheumatoid arthritis.
Neoplasms
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model.
Neoplasms
Enhanced matrix metalloproteinase activity in skeletal muscles of rats with congestive heart failure.
Neoplasms
Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.
Neoplasms
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Neoplasms
Environmental arsenic exposure and serum matrix metalloproteinase-9.
Neoplasms
Enzymatic activatable self-assembled peptide nanowire for targeted therapy and fluorescence imaging of tumors.
Neoplasms
Enzyme-directed assembly of nanoparticles in tumors monitored by in vivo whole animal imaging and ex vivo super-resolution fluorescence imaging.
Neoplasms
Enzyme-Induced Matrix Softening Regulates Hepatocarcinoma Cancer Cell Phenotypes.
Neoplasms
EphA2 overexpression is associated with angiogenesis in ovarian cancer.
Neoplasms
Epidermal growth factor promotes invasiveness of pancreatic cancer cells through NF-kappaB-mediated proteinase productions.
Neoplasms
Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?
Neoplasms
Epigallocatechin-3-gallate Increases RXR?-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines.
Neoplasms
Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors.
Neoplasms
Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Neoplasms
Epithelial expression of extracellular matrix metalloproteinase inducer/CD147 and matrix metalloproteinase-2 in neoplasms and precursor lesions derived from cutaneous squamous cells: An immunohistochemical study.
Neoplasms
Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.
Neoplasms
ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: A comparison between mesothelioma and mesothelial cells.
Neoplasms
ERK1/2 regulate exocytosis through direct phosphorylation of the exocyst component Exo70.
Neoplasms
Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression.
Neoplasms
Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis.
Neoplasms
Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
Neoplasms
Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters.
Neoplasms
Eupatilin with PPAR? agonistic effects inhibits TNF?-induced MMP signaling in HaCaT cells.
Neoplasms
Euphorbia humifusa Willd exerts inhibition of breast cancer cell invasion and metastasis through inhibition of TNF?-induced MMP-9 expression.
Neoplasms
Euterpe oleracea extract inhibits tumorigenesis effect of the chemical carcinogen DMBA in breast experimental cancer.
Neoplasms
Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma.
Neoplasms
Evaluation of Local Injection of Bevacizumab against Triple-Negative Breast Cancer Xenograft Tumors.
Neoplasms
Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system.
Neoplasms
Evaluation of matrix metalloproteinase-2 and -9 in the cerebrospinal fluid of dogs with intracranial tumors.
Neoplasms
Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
Neoplasms
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction.
Neoplasms
Exenatide ameliorates inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes.
Neoplasms
Exosomal Tumor MicroRNA Modulates Premetastatic Organ Cells.
Neoplasms
Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3.
Neoplasms
Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer.
Neoplasms
Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection.
Neoplasms
Expression and Clinical Significance of CD147 in Genitourinary Carcinomas.
Neoplasms
Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.
Neoplasms
Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Neoplasms
Expression and correlation of Twist and gelatinases in breast cancer.
Neoplasms
Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.
Neoplasms
Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions.
Neoplasms
Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.
Neoplasms
Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Neoplasms
Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas.
Neoplasms
Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.
Neoplasms
Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors.
Neoplasms
Expression of CD147 is associated with prostate cancer progression.
Neoplasms
Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
Neoplasms
Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
Neoplasms
Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters.
Neoplasms
Expression of emmprin by oral squamous cell carcinoma.
Neoplasms
Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Neoplasms
Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Neoplasms
Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Neoplasms
Expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in pancreatic neoplasm and pancreatic stellate cells.
Neoplasms
Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
Neoplasms
Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: Correlation with clinicopathological characteristics.
Neoplasms
Expression of extracellular matrix metalloproteinase inducer in human placenta and fetal membranes at term labor.
Neoplasms
Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
Neoplasms
Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance.
Neoplasms
Expression of inducible nitric oxide synthase in mast cells contributes to the regulation of inflammatory cytokines in irritable bowel syndrome with diarrhea.
Neoplasms
Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma.
Neoplasms
Expression of LOXs and MMP-1, 2, 3 by ACL Fibroblasts and Synoviocytes Impact of Coculture and TNF-?.
Neoplasms
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Neoplasms
Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.
Neoplasms
Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Neoplasms
Expression of Matrix Metalloproteinase 2 and Extracellular Matrix Metalloproteinase Inducer are Unfavorable Postoperative Prognostic Factors in Intrahepatic Cholangiocarcinoma.
Neoplasms
Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.
Neoplasms
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Neoplasms
Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
Neoplasms
Expression of matrix metalloproteinase, tissue inhibitors of metalloproteinase and adhesion molecules in silicotic mice with lung tumor metastasis.
Neoplasms
Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Neoplasms
Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Neoplasms
Expression of Matrix Metalloproteinase-13 and Ki-67 in Nonmelanoma Skin Cancer in Xeroderma Pigmentosum and Non-xeroderma Pigmentosum.
Neoplasms
Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Neoplasms
Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma.
Neoplasms
Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-? and interleukin-1?.
Neoplasms
Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formation.
Neoplasms
Expression of matrix metalloproteinase-9 in high-grade salivary gland carcinomas is associated with their metastatic potential.
Neoplasms
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.
Neoplasms
Expression of matrix metalloproteinases in feline vaccine site-associated sarcomas.
Neoplasms
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Neoplasms
Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
Neoplasms
Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) mRNA in trophoblast and endometrial epithelial cell populations of the synepitheliochorial placenta of goats (Capra hircus).
Neoplasms
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
Neoplasms
Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas.
Neoplasms
Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma.
Neoplasms
Expression of MMP-10 in lung cancer.
Neoplasms
Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma.
Neoplasms
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Neoplasms
Expression of MMP-9, MMP-10 and TNF-alpha and lack of epithelial MMP-1 and MMP-26 characterize pyoderma gangrenosum.
Neoplasms
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Neoplasms
Expression of MTAP inhibits tumor-related phenotypes in HT1080 cells via a mechanism unrelated to its enzymatic function.
Neoplasms
Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling.
Neoplasms
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2.
Neoplasms
Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis.
Neoplasms
Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts.
Neoplasms
Expression of type IV collagenase correlates with the expression of vascular endothelial growth factor in primary non-small cell lung cancer.
Neoplasms
Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Neoplasms
Expression patterns of emmprin and monocarboxylate transporter-1 in ovarian epithelial tumors.
Neoplasms
Expression profile of lipoxygenases in gingival tissues of human periodontitis.
Neoplasms
Expression profiles associated with aggressive behavior in Merkel cell carcinoma.
Neoplasms
Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes.
Neoplasms
Expressions of CD147, MMP-2 and MMP-9 in Laryngeal Carcinoma and its Correlation with Poor Prognosis.
Neoplasms
Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication.
Neoplasms
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
Neoplasms
Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Neoplasms
Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
Neoplasms
Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma.
Neoplasms
Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.
Neoplasms
Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer.
Neoplasms
Extracellular matrix metalloproteinase inducer expression in histological grades of oral squamous cell carcinoma - An immunohistochemical study.
Neoplasms
Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Neoplasms
Extracellular Matrix Metalloproteinase Inducer is a Negative Prognostic Factor of Pediatric Medulloblastoma.
Neoplasms
Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Neoplasms
Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Neoplasms
Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling.
Neoplasms
Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
Neoplasms
Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis.
Neoplasms
Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studies.
Neoplasms
Failure of matrix metalloproteinase-9 dimer induction by phorbol 12-myristate 13-acetate in normal human cell lines.
Neoplasms
Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells.
Neoplasms
Features of bilirubin-induced reactive microglia: from phagocytosis to inflammation.
Neoplasms
Fenofibrate inhibits tumor necrosis factor-alpha-induced expression of CD40 and matrix metalloproteinase in human vascular endothelial cells.
Neoplasms
Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells.
Neoplasms
Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis.
Neoplasms
Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.
Neoplasms
Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways.
Neoplasms
Flavonoid components in Scutellaria baicalensis inhibit nicotine-induced proliferation, metastasis and lung cancer-associated inflammation in vitro.
Neoplasms
FlexPro MD®, a Combination of Krill Oil, Astaxanthin and Hyaluronic Acid, Reduces Pain Behavior and Inhibits Inflammatory Response in Monosodium Iodoacetate-Induced Osteoarthritis in Rats.
Neoplasms
Fourteenth Annual Pezcoller Symposium: the novel dichotomy of immune interactions with tumors.
Neoplasms
Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells-a potential novel treatment for intervertebral disc degeneration.
Neoplasms
Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2).
Neoplasms
Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1.
Neoplasms
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
Neoplasms
Furin-dependent intracellular activation of the human stromelysin-3 zymogen.
Neoplasms
Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells.
Neoplasms
Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
Neoplasms
Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.
Neoplasms
Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
Neoplasms
Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism.
Neoplasms
Gastroesophageal cancer, palmar fasciitis and a matrix metalloproteinase inhibitor.
Neoplasms
Gefitinib decreases the synthesis of matrix metalloproteinase and the adhesion to extracellular matrix proteins of colon cancer cells.
Neoplasms
Gelatin-Encapsulated Magnetic Nanoparticles for pH, Redox, and Enzyme Multiple Stimuli-Responsive Drug Delivery and Magnetic Resonance Imaging.
Neoplasms
Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton.
Neoplasms
Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications.
Neoplasms
Gelatinolytic activity of matrix metalloproteinase in lung cancer studied using film in situ zymography stamp method.
Neoplasms
Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer.
Neoplasms
Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
Neoplasms
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Neoplasms
Generation of antitumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an endostatin fragment.
Neoplasms
Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Neoplasms
Genetic polymorphisms in chronic obstructive pulmonary disease.
Neoplasms
Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
Neoplasms
Genipin inhibits MMP-1 and MMP-3 release from TNF-a-stimulated human periodontal ligament cells.
Neoplasms
Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer.
Neoplasms
Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility.
Neoplasms
Gingival Fluid Inflammatory Biomarkers and Hypertension in African Americans.
Neoplasms
Ginkgolide B attenuates collagen-induced rheumatoid arthritis and regulates fibroblast-like synoviocytes-mediated apoptosis and inflammation.
Neoplasms
Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.
Neoplasms
Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin.
Neoplasms
GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune-compromised mice.
Neoplasms
GM6001 Increases Anastomotic Leakage following Colonic Obstruction Possibly by Impeding Epithelialization.
Neoplasms
Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells.
Neoplasms
GPDPLQ1237-A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in vitro.
Neoplasms
Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway.
Neoplasms
Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.
Neoplasms
Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling.
Neoplasms
Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa.
Neoplasms
Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1? in osteoarthritic osteoblasts.
Neoplasms
Heparinoids Activate a Protease, Secreted by Mucosa and Tumors, via Tethering Supplemented by Allostery.
Neoplasms
Hepatic integrity dependent on matrix metalloproteinase inhibition, not tumor necrosis factor alpha or different bleeding rates.
Neoplasms
Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer.
Neoplasms
Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Neoplasms
HER-2/neu Represses the Metastasis Suppressor RECK via ERK and Sp Transcription Factors to Promote Cell Invasion.
Neoplasms
Herniated and spondylotic intervertebral discs of the human cervical spine: histological and immunohistological findings in 500 en bloc surgical samples. Laboratory investigation.
Neoplasms
Heterogeneous activation of MMP-9 due to prostate cancer-bone interaction.
Neoplasms
High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
Neoplasms
High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Neoplasms
High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
Neoplasms
High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
Neoplasms
High incidence of EMMPRIN expression in human tumors.
Neoplasms
High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
Neoplasms
High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.
Neoplasms
High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
Neoplasms
High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.
Neoplasms
High MMP-26 expression in glioma is correlated with poor clinical outcome of patients.
Neoplasms
High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
Neoplasms
High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.
Neoplasms
High-Level Expression and Prognostic Significance of Matrix Metalloprotease-19 and Matrix Metalloprotease-20 in Human Pancreatic Ductal Adenocarcinoma.
Neoplasms
High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
Neoplasms
Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Neoplasms
Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Neoplasms
High Glucose and Hypoxia-Mediated Damage to Human Brain Microvessel Endothelial Cells Induces an Altered, Pro-Inflammatory Phenotype in BV-2 Microglia In Vitro.
Neoplasms
Hijacking a Morphogenesis Proteinase for Cancer Cell Invasion.
Neoplasms
Hinokitiol Exerts Anticancer Activity through Downregulation of MMPs 9/2 and Enhancement of Catalase and SOD Enzymes: In Vivo Augmentation of Lung Histoarchitecture.
Neoplasms
Histone Deacetylase (HDAC) 10 Suppresses Cervical Cancer Metastasis through Inhibition of Matrix Metalloproteinase (MMP) 2 and 9 Expression.
Neoplasms
Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells.
Neoplasms
HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Neoplasms
Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE?-mediated activation of ?-catenin signaling.
Neoplasms
Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts.
Neoplasms
How molecular imaging is speeding up antiangiogenic drug development.
Neoplasms
How the matrix metalloproteinase MMP14 contributes to the progression of colorectal cancer.
Neoplasms
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema.
Neoplasms
Human cervical tumor cell (SiHa) surface alphavbeta3 integrin receptor has associated matrix metalloproteinase (MMP-2) activity.
Neoplasms
Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer.
Neoplasms
Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
Neoplasms
Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90.
Neoplasms
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
Neoplasms
Hydroquinone-induced malignant transformation of TK6 cells by facilitating SIRT1-mediated p53 degradation and up-regulating KRAS.
Neoplasms
Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.
Neoplasms
Identification and role of the homodimerization interface of the glycosylphosphatidylinositol-anchored membrane type 6 matrix metalloproteinase (MMP25).
Neoplasms
Identification of ADAM12 as a Novel Basigin Sheddase.
Neoplasms
Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts.
Neoplasms
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues.
Neoplasms
Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Neoplasms
Identification of highly selective MMP-14 inhibitory Fabs by deep sequencing.
Neoplasms
Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
Neoplasms
Identification of Proteolytic Cleavage Sites of EphA2 by Membrane Type 1 Matrix Metalloproteinase on the Surface of Cancer Cells.
Neoplasms
Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
Neoplasms
IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
Neoplasms
Imaging matrix metalloproteinase expression in tumors.
Neoplasms
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Neoplasms
Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor.
Neoplasms
Immunohistochemical analysis of matrix metalloproteinase-1, -3, and -13 in naturally occurring cartilaginous tumors of dogs.
Neoplasms
Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
Neoplasms
Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths.
Neoplasms
Immunohistochemical expression of matrix metalloproteinase-2 and -9 in melanocytic nevi is altered by ultraviolet B.
Neoplasms
Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Neoplasms
Immunohistochemical Study of Laminin-332 ?2 Chain and MMP-9 in High Risk of Malignant Transformation Oral Lesions and OSCC.
Neoplasms
Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis.
Neoplasms
Immunohistochemical study of tumor necrosis factor-alpha, matrix metalloproteinase-12, and tissue inhibitor of metalloproteinase-2 on alveolar macrophages of BALB/c mice exposed to short-term cigarette smoke.
Neoplasms
Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium.
Neoplasms
Immunological and microbiological periodontal profiles in isolated growth hormone deficiency.
Neoplasms
Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Neoplasms
Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model.
Neoplasms
Immunomodulatory glc/man-directed Dolichos lablab lectin (DLL) evokes anti-tumour response in vivo by counteracting angiogenic gene expressions.
Neoplasms
Immunopathologic characteristics of nasal polyps in adult Koreans: A single-center study.
Neoplasms
Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins.
Neoplasms
Impact of a chronic smoking habit on the osteo-immunoinflammatory mediators in the peri-implant fluid of clinically healthy dental implants.
Neoplasms
Impact of Bevacizumab on Liver Damage After Massive Hepatectomy in Rats.
Neoplasms
Impact of calorie restriction and intermittent fasting on periodontal health.
Neoplasms
Impact of Flavonoids on Matrix Metalloproteinase Secretion and Invadopodia Formation in Highly Invasive A431-III Cancer Cells.
Neoplasms
Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Neoplasms
Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis.
Neoplasms
Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
Neoplasms
In Situ Protease Secretion Visualization and Metastatic Lymph Nodes Imaging via a Cell Membrane-Anchored Upconversion Nanoprobe.
Neoplasms
In vitro analysis of the anticancer properties of scorpion venom in colorectal and breast cancer cell lines.
Neoplasms
In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models.
Neoplasms
In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis.
Neoplasms
In vitro effects of Apixaban on 5 different cancer cell lines.
Neoplasms
In vitro inhibition of matrix metalloproteinases, invasion and growth of Fanconi anemia human FANCA and FANCC lymphoblasts by nutrient mixture.
Neoplasms
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Neoplasms
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Neoplasms
In vivo evaluation of matrix metalloproteinase responsive silk-elastinlike protein polymers for cancer gene therapy.
Neoplasms
In vivo optical molecular imaging of matrix metalloproteinase activity following celecoxib therapy for colorectal cancer.
Neoplasms
In vivo relationship between collagenase-2 and interleukin-8 but not tumour necrosis factor-alpha in chronic rhinosinusitis with nasal polyposis.
Neoplasms
In-Silico Characterization and in-Vivo Validation of Albiziasaponin-A, Iso-Orientin, and Salvadorin Using a Rat Model of Alzheimer's Disease.
Neoplasms
Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies.
Neoplasms
Inclusion complex from cyclodextrin-grafted hyaluronic acid and pseudo protein as biodegradable nano-delivery vehicle for gambogic acid.
Neoplasms
Increase of anti-metastatic efficacy by selectivity- but not affinity-optimization of synthetic serine protease inhibitors.
Neoplasms
Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
Neoplasms
Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
Neoplasms
Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
Neoplasms
Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
Neoplasms
Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma.
Neoplasms
Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis.
Neoplasms
Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes.
Neoplasms
Increased serum TWEAK levels in Psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels.
Neoplasms
Increasing production of matrix metalloproteinases, tumor necrosis factor-?, vascular endothelial growth factor and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts by different adiponectin isoforms in a concentration-dependent manner.
Neoplasms
Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1.
Neoplasms
Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells.
Neoplasms
Induction of MMP-13 expression by soluble human glucocorticoid-induced tumor necrosis factor receptor in fibroblast-like synovial cells.
Neoplasms
Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway.
Neoplasms
Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
Neoplasms
Inflammation and diabetic retinopathy.
Neoplasms
Inflammation and oxidative stress in corneal tissue in experimental keratitis due to Fusarium solani: Amelioration following topical therapy with voriconazole and epigallocatechin gallate.
Neoplasms
Inflammatory response to contact lenses in patients with keratoconus compared with myopic subjects.
Neoplasms
Inhibiting effects of common trivalent metal ions on transmembrane-type 2 matrix metalloproteinase.
Neoplasms
Inhibition activity of sulfated polysaccharide of Sepiella maindroni ink on matrix metalloproteinase (MMP)-2.
Neoplasms
Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness.
Neoplasms
Inhibition of AGS human gastric cancer cell invasion and proliferation by Capsosiphon fulvescens glycoprotein.
Neoplasms
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
Neoplasms
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
Neoplasms
Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression.
Neoplasms
Inhibition of Basigin Expression in Glioblastoma Cell Line via Antisense RNA Reduces Tumor Cell Invasion and Angiogenesis.
Neoplasms
Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines.
Neoplasms
Inhibition of CD147 Expression Reduces Tumor Cell Invasion in Human Prostate Cancer Cell Line via RNA Interference.
Neoplasms
Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells.
Neoplasms
Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells.
Neoplasms
Inhibition of CD44 induces apoptosis, inflammation, and matrix metalloproteinase expression in tendinopathy.
Neoplasms
Inhibition of cyclo-oxygenase 2 reduces tumor metastasis and inflammatory signaling during blockade of vascular endothelial growth factor.
Neoplasms
Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
Neoplasms
Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
Neoplasms
Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg.
Neoplasms
Inhibition of integrin ?1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
Neoplasms
Inhibition of invasion and MMPs by a nutrient mixture in human cancer cell lines: a correlation study.
Neoplasms
Inhibition of lethal endotoxin shock with an L-pyridylalanine containing metalloproteinase inhibitor selected by high-throughput screening of a new peptide library.
Neoplasms
Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270.
Neoplasms
Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody.
Neoplasms
Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha.
Neoplasms
Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue.
Neoplasms
Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate.
Neoplasms
Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract.
Neoplasms
Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease.
Neoplasms
Inhibition of matrix metalloproteinases expression in human dental pulp cells by all-trans retinoic acid.
Neoplasms
Inhibition of matrix metalloproteinases-2/-9 transiently reduces pre-oligodendrocyte loss during lipopolysaccharide- but not tumour necrosis factor-alpha-induced inflammation in fetal ovine glial culture.
Neoplasms
Inhibition of metalloproteinase and proteasome activities in colon cancer cells by citrus peel extracts.
Neoplasms
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
Neoplasms
Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
Neoplasms
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
Neoplasms
Inhibition of SOX9 Promotes Inflammatory and Immune Responses of Dental Pulp.
Neoplasms
Inhibition of Stat3 Signaling Pathway by Natural Product Pectolinarigenin Attenuates Breast Cancer Metastasis.
Neoplasms
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.
Neoplasms
Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment.
Neoplasms
Inhibition of vacuolar ATPase subunit in tumor cells delays tumor growth by decreasing the essential macrophage population in the tumor microenvironment.
Neoplasms
Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.
Neoplasms
Inhibitory effect of ?-solanine on esophageal carcinoma in vitro.
Neoplasms
Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model.
Neoplasms
Inhibitory effect of caffeic acid phenethyl ester on mice bearing tumor involving angiostatic and apoptotic activities.
Neoplasms
Inhibitory effect of Ginkgol C17:1 on the biological behavior of tumor cells.
Neoplasms
Inhibitory effect of methanol extract of Euonymus alatus on matrix metalloproteinase-9.
Neoplasms
Inhibitory effect of shRNA targeting GPR48 on invasion and metastasis of human cervical carcinoma cell line HeLa.
Neoplasms
Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Neoplasms
Inhibitory effects of brusatol delivered using glycosaminoglycan?placental chondroitin sulfate A?modified nanoparticles on the proliferation, migration and invasion of cancer cells.
Neoplasms
Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Neoplasms
Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.
Neoplasms
Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction.
Neoplasms
Inotilone from Inonotus linteus suppresses lung cancer metastasis in vitro and in vivo through ROS-mediated PI3K/AKT/MAPK signaling pathways.
Neoplasms
Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
Neoplasms
Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Neoplasms
Intake of grape-derived polyphenols reduces C26 tumor growth by inhibiting angiogenesis and inducing apoptosis.
Neoplasms
Intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles.
Neoplasms
Interaction between CD147 and P-glycoprotein and their regulation by ubiquitination in breast cancer cells.
Neoplasms
Interaction between stromal cells and tumor cells induces chemoresistance and matrix metalloproteinase secretion.
Neoplasms
Interactions of tachykinin receptor antagonists with lipopolysaccharide-induced airway inflammation in mice.
Neoplasms
Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice.
Neoplasms
Interferon-? and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment.
Neoplasms
Interferon-beta induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1.
Neoplasms
Interleukin 1beta enhances invasive ability of gastric carcinoma through nuclear factor-kappaB activation.
Neoplasms
Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer.
Neoplasms
Interleukin-11 induces the expression of matrix metalloproteinase 13 in gastric cancer SCH cells partly via the PI3K-AKT and JAK-STAT3 pathways.
Neoplasms
Interleukin-17 potently increases non-small cell lung cancer growth.
Neoplasms
Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease.
Neoplasms
Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.
Neoplasms
Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts.
Neoplasms
Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
Neoplasms
Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression.
Neoplasms
Interleukin-8 synthesis and the onset of labor.
Neoplasms
Interplay between epidermal growth factor receptor and Janus kinase 3 regulates polychlorinated biphenyl-induced matrix metalloproteinase-3 expression and transendothelial migration of tumor cells.
Neoplasms
Interstitial Score and Concentrations of IL-4R?, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias.
Neoplasms
Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Neoplasms
Intra-articular lentivirus-mediated insertion of the fat-1 gene ameliorates osteoarthritis.
Neoplasms
Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody.
Neoplasms
Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin.
Neoplasms
Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK.
Neoplasms
Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
Neoplasms
Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression.
Neoplasms
Involvement of plasmin-mediated extracellular activation of progalanin in angiogenesis.
Neoplasms
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
Neoplasms
Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A.
Neoplasms
Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress.
Neoplasms
Irradiation of normal mouse tissue increases the invasiveness of mammary cancer cells.
Neoplasms
Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression.
Neoplasms
Isolation and characterization of novel RECK tumor suppressor gene splice variants.
Neoplasms
Isolation, characterization, and expression of feline stromelysin-1 in naturally developing tumors in cats.
Neoplasms
Isoliquiritin Apioside Suppresses in vitro Invasiveness and Angiogenesis of Cancer Cells and Endothelial Cells.
Neoplasms
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells.
Neoplasms
Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
Neoplasms
JNP3, a new compound, suppresses PMA-induced tumor cell invasion via NF-?B down regulation in MCF-7 breast cancer cells.
Neoplasms
Kaempferitrin inhibits proliferation, induces apoptosis, and ameliorates inflammation in human rheumatoid arthritis fibroblast-like synoviocytes.
Neoplasms
Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKC{delta}-mediated signaling in MCF-7 human breast cancer cells.
Neoplasms
KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production.
Neoplasms
Keratoconus: an inflammatory disorder?
Neoplasms
Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth.
Neoplasms
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Neoplasms
Knockdown of EMMPRIN (OX47) in MRMT-1 Carcinoma Cells Inhibits Tumor Growth and Decreases Cancer-induced Bone Destruction and Pain.
Neoplasms
Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model.
Neoplasms
Knockout of MMP3 Weakens Solid Tumor Organoids and Cancer Extracellular Vesicles.
Neoplasms
KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction.
Neoplasms
LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.
Neoplasms
Latanoprost-induced changes in rat intraocular pressure: direct or indirect?
Neoplasms
Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
Neoplasms
Lentivirus-induced knockdown of LRP1 induces osteoarthritic-like effects and increases susceptibility to apoptosis in chondrocytes via the nuclear factor-?B pathway.
Neoplasms
Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells.
Neoplasms
Likelihood ratios for the prediction of preterm delivery with biomarkers.
Neoplasms
LncRNA DANCR promotes the proliferation, migration, and invasion of tongue squamous cell carcinoma cells through miR-135a-5p/KLF8 axis.
Neoplasms
LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis.
Neoplasms
Local activity of matrix metalloproteinases in a case of botryoid sarcoma.
Neoplasms
Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
Neoplasms
Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds.
Neoplasms
Localized Affinity-Based Delivery of Prinomastat for Cancer Treatment.
Neoplasms
Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
Neoplasms
Long non-coding RNA SNHG5 affects the invasion and apoptosis of renal cell carcinoma by regulating the miR-363-3p-Twist1 interaction.
Neoplasms
Long-term effects of silver nanoparticles in caco-2 cells.
Neoplasms
Lonidamine causes inhibition of angiogenesis-related endothelial cell functions.
Neoplasms
Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.
Neoplasms
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice.
Neoplasms
Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Neoplasms
Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism.
Neoplasms
Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Neoplasms
Low molecular weight fucoidan attenuates experimental abdominal aortic aneurysm through interfering the leukocyte-endothelial cells interaction.
Neoplasms
Luteolin inhibits IL-1?-induced in?ammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model.
Neoplasms
Luteolin-7-O-Glucoside Inhibits Oral Cancer Cell Migration and Invasion by Regulating Matrix Metalloproteinase-2 Expression and Extracellular Signal-Regulated Kinase Pathway.
Neoplasms
Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice.
Neoplasms
Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
Neoplasms
Macrophage ABHD5 suppresses NF-?B-dependent matrix metalloproteinase expression and cancer metastasis.
Neoplasms
Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy.
Neoplasms
Macrophages Polarized by Expression of ToxoGRA15II Inhibit Growth of Hepatic Carcinoma.
Neoplasms
Macrophages regulate tumor necrosis factor-alpha expression in adipocytes through the secretion of matrix metalloproteinase-3.
Neoplasms
Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
Neoplasms
Macroscopic portal vein tumor thrombi of liver metastasis from colorectal cancer.
Neoplasms
Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1beta, interleukin-6 and matrix metalloproteinase 9 by primary human peripheral blood monocytes.
Neoplasms
MALDI-TOF MS characterization of proanthocyanidins from cranberry fruit (Vaccinium macrocarpon) that inhibit tumor cell growth and matrix metalloproteinase expression in vitro
Neoplasms
Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs).
Neoplasms
Mangiferin: a natural miracle bioactive compound against lifestyle related disorders.
Neoplasms
Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21-->q22.
Neoplasms
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial.
Neoplasms
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
Neoplasms
Markers of squamocolumnar junction cells in normal tonsils and oropharyngeal cancer with and without HPV infection.
Neoplasms
Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Neoplasms
Mast cell infiltration in acute coronary syndromes: implications for plaque rupture.
Neoplasms
Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo.
Neoplasms
Matrilysin in early stage intestinal tumorigenesis.
Neoplasms
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis.
Neoplasms
Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
Neoplasms
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Neoplasms
Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures.
Neoplasms
Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.
Neoplasms
Matrix metalloproteinase (MMP)-2 and MMP-9 Expression in Tumor Infiltrating CD3 Lymphocytes From Women With Endometrial Cancer.
Neoplasms
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Neoplasms
Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo.
Neoplasms
Matrix metalloproteinase (MMP-2 and MMP-9) and steroid receptor expressions in feline mammary tumors.
Neoplasms
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
Neoplasms
Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas.
Neoplasms
Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.
Neoplasms
Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Neoplasms
Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
Neoplasms
Matrix metalloproteinase 9 inhibits the motility of highly aggressive HSC-3 oral squamous cell carcinoma cells.
Neoplasms
Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.
Neoplasms
Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor ?: a contributor to endothelial cell glycocalyx dysfunction.
Neoplasms
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
Neoplasms
Matrix Metalloproteinase Activity in the Stromal Cell of Giant Cell Tumor of Bone.
Neoplasms
Matrix metalloproteinase activity in tumor, stromal tissue, and serum from cats with malignancies.
Neoplasms
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.
Neoplasms
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Neoplasms
Matrix metalloproteinase and G protein coupled receptors: Co-conspirators in the pathogenesis of autoimmune disease and cancer.
Neoplasms
Matrix Metalloproteinase Cleavable Nanoparticles for Tumor Microenvironment and Tumor Cell Dual-Targeting Drug Delivery.
Neoplasms
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
Neoplasms
Matrix metalloproteinase digestion of aggrecan in human cartilage tumours.
Neoplasms
Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.
Neoplasms
Matrix metalloproteinase expression in high grade soft tissue sarcomas.
Neoplasms
Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients.
Neoplasms
Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities.
Neoplasms
Matrix metalloproteinase gene polymorphisms and oral cancer.
Neoplasms
Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.
Neoplasms
Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
Neoplasms
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
Neoplasms
Matrix metalloproteinase inhibitor RECK expression in canine tumors.
Neoplasms
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.
Neoplasms
Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Neoplasms
Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.
Neoplasms
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.
Neoplasms
Matrix metalloproteinase inhibitors in cancer: an update.
Neoplasms
Matrix metalloproteinase inhibitors in the treatment of cancer.
Neoplasms
Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignancies.
Neoplasms
Matrix metalloproteinase inhibitors: a novel class of anticancer agents.
Neoplasms
Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses.
Neoplasms
Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer.
Neoplasms
Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha.
Neoplasms
Matrix Metalloproteinase Sensitive Gold Nanorod for Simultaneous Bioimaging and Photothermal Therapy of Cancer.
Neoplasms
Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
Neoplasms
Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas.
Neoplasms
Matrix metalloproteinase-1 and cytokines in patients with acute pancreatitis.
Neoplasms
Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
Neoplasms
Matrix metalloproteinase-13 is a target gene of high-mobility group box-containing protein 1 in modulating oral cancer cell invasion.
Neoplasms
Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma.
Neoplasms
Matrix metalloproteinase-2 and -9 expression in astrocytic tumors.
Neoplasms
Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
Neoplasms
Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.
Neoplasms
Matrix metalloproteinase-2-targeted superparamagnetic Fe3O4-PEG-G5-MMP2@Ce6 nanoprobes for dual-mode imaging and photodynamic therapy.
Neoplasms
Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17.
Neoplasms
Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinoma.
Neoplasms
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.
Neoplasms
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline.
Neoplasms
Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer.
Neoplasms
Matrix metalloproteinase-8: cleavage can be decisive.
Neoplasms
Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
Neoplasms
Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer.
Neoplasms
Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and tumour necrosis factor alpha release during cardiopulmonary bypass.
Neoplasms
Matrix metalloproteinase-dependent microsomal prostaglandin E synthase-1 expression in macrophages: role of TNF-? and the EP4 prostanoid receptor.
Neoplasms
Matrix metalloproteinase-mediation of tumor targeting human recombinant tumor necrosis factor-? fusion protein.
Neoplasms
Matrix metalloproteinases 21 and 26 are differentially expressed in esophageal squamous cell cancer.
Neoplasms
Matrix metalloproteinases and inhibitors in dentistry.
Neoplasms
Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.
Neoplasms
Matrix metalloproteinases and metastatic cancer.
Neoplasms
Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases Are Essential for the Inflammatory Response in Cancer Cells.
Neoplasms
Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic.
Neoplasms
Matrix metalloproteinases as breast cancer drivers and therapeutic targets.
Neoplasms
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Neoplasms
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.
Neoplasms
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Neoplasms
Matrix metalloproteinases in human melanoma.
Neoplasms
Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery.
Neoplasms
Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.
Neoplasms
Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
Neoplasms
Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus.
Neoplasms
Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation.
Neoplasms
Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma.
Neoplasms
Matrix metalloproteinases: new directions toward inhibition in the fight against cancers.
Neoplasms
Matrix metalloproteinases: roles in cancer and metastasis.
Neoplasms
Matrix-directed regulation of pericellular proteolysis and tumor progression.
Neoplasms
MBP-1 inhibits breast cancer growth and metastasis in immunocompetent mice.
Neoplasms
Mechanical impact induces cartilage degradation via mitogen activated protein kinases.
Neoplasms
Mechanisms of KE298, 2-acetylthiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis.
Neoplasms
Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection.
Neoplasms
Mechanistic Insights into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol.
Neoplasms
Mechanistic investigations of matrix metalloproteinase-8 inhibition by metal abstraction peptide.
Neoplasms
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Neoplasms
Medical treatment of endometriosis.
Neoplasms
Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.
Neoplasms
Melatonin improves periodontitis-induced kidney damages by decreasing inflammatory stress and apoptosis in rats.
Neoplasms
Membrane type (MT) 1-matrix metalloproteinase (MMP) and MMP-2 expression in ligature-induced periodontitis in the rat.
Neoplasms
Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.
Neoplasms
Membrane type 1 matrix metalloproteinase regulates cellular invasiveness and survival in cutaneous epidermal cells.
Neoplasms
Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.
Neoplasms
Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.
Neoplasms
Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.
Neoplasms
Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.
Neoplasms
Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
Neoplasms
Met inactivation by S-allylcysteine suppresses the migration and invasion of nasopharyngeal cancer cells induced by hepatocyte growth factor.
Neoplasms
Metalloproteinases and their roles in human cancer.
Neoplasms
Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
Neoplasms
Metalloproteinases in Ovarian Cancer.
Neoplasms
Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A.
Neoplasms
Methylarsonous acid causes oxidative DNA damage in cells independent of the ability to biomethylate inorganic arsenic.
Neoplasms
Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.
Neoplasms
Methylsulfonylmethane is effective against gastric mucosal injury.
Neoplasms
Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens and related genes in cancer.
Neoplasms
Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer.
Neoplasms
MicroRNA let-7i-3p affects osteoblast differentiation in ankylosing spondylitis via targeting PDK1.
Neoplasms
MicroRNA-155-5p inhibits the invasion and migration of prostate cancer cells by targeting SPOCK1.
Neoplasms
microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells.
Neoplasms
MicroRNA?15a?5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP?2 signaling pathway.
Neoplasms
Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study.
Neoplasms
Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases.
Neoplasms
Minocycline impedes African trypanosome invasion of the brain in a murine model.
Neoplasms
miR-1307-5p regulates proliferation and apoptosis of chondrocytes in osteoarthritis by specifically inhibiting transforming growth factor beta-induced gene.
Neoplasms
miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.
Neoplasms
miR-195 suppresses abdominal aortic aneurysm through the TNF-?/NF-?B and VEGF/PI3K/Akt pathway.
Neoplasms
MiR-26b Mimic Inhibits Glioma Proliferation In Vitro and In Vivo Suppressing COX-2 Expression.
Neoplasms
miR-410-3p Suppresses Cytokine Release from Fibroblast-Like Synoviocytes by Regulating NF-?B Signaling in Rheumatoid Arthritis.
Neoplasms
Missing the target: matrix metalloproteinase antitargets in inflammation and cancer.
Neoplasms
Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes.
Neoplasms
Mitochondrial-Targeting Antioxidant SS-31 Suppresses Airway Inflammation and Oxidative Stress Induced by Cigarette Smoke.
Neoplasms
Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.
Neoplasms
MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.
Neoplasms
MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas.
Neoplasms
MMP-11 as a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry.
Neoplasms
MMP-2 activation and stepwise progression of pulmonary adenocarcinoma: analysis of MMP-2 and MMP-9 with gelatin zymography.
Neoplasms
MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts.
Neoplasms
MMP-2, TNF-? and NLRP1 polymorphisms in Chinese patients with ankylosing spondylitis and rheumatoid arthritis.
Neoplasms
MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure.
Neoplasms
MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors.
Neoplasms
MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer.
Neoplasms
MMP-8 C-799?T, Lys460Thr, and Lys87Glu variants are not related to risk of cancer.
Neoplasms
MMP-9 mRNA as a therapeutic marker in acute and chronic stages of arthritis induced by type II collagen antibody.
Neoplasms
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.
Neoplasms
MMP13 is a potential prognostic marker for colorectal cancer.
Neoplasms
MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Neoplasms
MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
Neoplasms
Modulation of matrix metalloproteinase-9 secretion from tumor-associated macrophage-like cells by proteolytically processed laminin-332 (laminin-5).
Neoplasms
Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.
Neoplasms
Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells.
Neoplasms
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Neoplasms
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines.
Neoplasms
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
Neoplasms
Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines.
Neoplasms
Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Neoplasms
Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog.
Neoplasms
Molecular Link Mechanisms between Inflammation and Cancer.
Neoplasms
Molecular mechanism of force induced stabilization of collagen against enzymatic breakdown.
Neoplasms
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.
Neoplasms
Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells.
Neoplasms
Molecular mechanisms of therapeutic hypothermia on neurological function in a swine model of cardiopulmonary resuscitation.
Neoplasms
Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects.
Neoplasms
Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study.
Neoplasms
Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration.
Neoplasms
Monascus purpureus-fermented rice inhibits tumor necrosis factor-?-induced upregulation of matrix metalloproteinase 2 and 9 in human aortic smooth muscle cells.
Neoplasms
Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231.
Neoplasms
Monoclonal anti?MUC1 antibody with novel octahydropyrazino[2,1?a:5,4?a']diisoquinoline derivative as a potential multi?targeted strategy in MCF?7 breast cancer cells.
Neoplasms
Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B.
Neoplasms
MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion.
Neoplasms
MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
Neoplasms
MT1-mmp: a collagenase essential for tumor cell invasive growth.
Neoplasms
MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma.
Neoplasms
MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-?B p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
Neoplasms
Multi-analyte profiling in human carotid atherosclerosis uncovers pro-inflammatory macrophage programming in plaques.
Neoplasms
Multidrug-Resistant Pseudomonas aeruginosa Evokes Differential Inflammatory Responses in Human Microglial and Retinal Pigment Epithelial Cells.
Neoplasms
Multifunctional Mesoporous Silica Nanoparticles with Thermal-Responsive Gatekeeper for NIR Light-Triggered Chemo/Photothermal-Therapy.
Neoplasms
Multiplex Cytokine Profiling Identifies Interleukin-27 as a Novel Biomarker for Neonatal Early Onset Sepsis.
Neoplasms
Mutational analysis of the GNA11, MMP27, FGD1, TRRAP and GRM3 genes in thyroid cancer.
Neoplasms
Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice.
Neoplasms
Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKC? signalling: a potential candidate in melanoma cancer therapy.
Neoplasms
Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice.
Neoplasms
N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer.
Neoplasms
Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells.
Neoplasms
NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma.
Neoplasms
Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.
Neoplasms
Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity.
Neoplasms
NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis.
Neoplasms
Neoadjuvant radiochemotherapy increases matrix metalloproteinase activity in healthy tissue in esophageal cancer patients.
Neoplasms
Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer.
Neoplasms
Neuroinflammation Induces Neurodegeneration.
Neoplasms
Neurotransmitter Substance P Mediates Pancreatic Cancer Perineural Invasion via NK-1R in Cancer Cells.
Neoplasms
Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.
Neoplasms
New approaches to selectively target cancer-associated matrix metalloproteinase activity.
Neoplasms
New HIV-drug inhibits in vitro bladder cancer migration and invasion.
Neoplasms
New hope for matrix metalloproteinase inhibitors in cancer therapy.
Neoplasms
New medical treatments for endometriosis.
Neoplasms
New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.
Neoplasms
Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model.
Neoplasms
Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
Neoplasms
Non-small cell lung cancer invasion and metastasis promoted by MMP-26.
Neoplasms
Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation.
Neoplasms
Nonselective matrix metalloproteinase but not tumor necrosis factor-? inhibition effectively preserves the early critical colon anastomotic integrity.
Neoplasms
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
Neoplasms
Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
Neoplasms
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism.
Neoplasms
Novel approach to analysis of in vitro tumor angiogenesis with a variable-pressure scanning electron microscope: suppression by matrix metalloproteinase inhibitor SI-27.
Neoplasms
Novel approaches to target pancreatic cancer.
Neoplasms
Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines.
Neoplasms
Novel matrix metalloproteinase inhibitor [18F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer.
Neoplasms
Novel matrix metalloproteinase inhibitors: an updated patent review (2014 - 2020).
Neoplasms
Novel Potent Proline-Based Metalloproteinase Inhibitors: Design, (Radio)Synthesis, and First in Vivo Evaluation as Radiotracers for Positron Emission Tomography.
Neoplasms
Novel retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cells.
Neoplasms
Nrf2-peroxiredoxin I axis in polymorphous adenocarcinoma is associated with low matrix metalloproteinase 2 level.
Neoplasms
O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme.
Neoplasms
Obesity-associated Adipose Stromal Cells Promote Breast Cancer Invasion Through Direct Cell Contact and ECM Remodeling.
Neoplasms
Oleuropein induces anti-metastatic effects in breast cancer.
Neoplasms
Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes.
Neoplasms
Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
Neoplasms
Optical imaging of cancer-related proteases using near-infrared fluorescence matrix metalloproteinase-sensitive and cathepsin B-sensitive probes.
Neoplasms
Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity.
Neoplasms
Oral and ocular administration of crocetin prevents retinal edema in a murine retinal vein occlusion model.
Neoplasms
Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
Neoplasms
Orally active MMP-1 sparing ?-tetrahydropyranyl and ?-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.
Neoplasms
Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis.
Neoplasms
Osteoactivin Regulates Head and Neck Squamous Cell Carcinoma Invasion by Modulating Matrix Metalloproteases.
Neoplasms
Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-?B-mediated matrix metalloproteinase-9 expression.
Neoplasms
Ovariectomy Exacerbates Apical Periodontitis in Rats with an Increase in Expression of Proinflammatory Cytokines and Matrix Metalloproteinases.
Neoplasms
Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8.
Neoplasms
Overexpression of CD147 in ovarian cancer is initiated by the hypoxic microenvironment.
Neoplasms
Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.
Neoplasms
Overexpression of EMMPRIN Isoform 2 Is Associated with Head and Neck Cancer Metastasis.
Neoplasms
Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.
Neoplasms
Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells.
Neoplasms
Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1? in pancreatic cancer: Implications for tumor progression and prognosis.
Neoplasms
Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis.
Neoplasms
Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.
Neoplasms
Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Neoplasms
Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-kappaB activity in melanoma cells.
Neoplasms
Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Neoplasms
Overweight, hypertension and renal dysfunction in adulthood of neonatally overfed rats.
Neoplasms
Oxidized LDL inhibit hepatocyte growth factor synthesis in coronary smooth muscle cells.
Neoplasms
Palmatine inhibits TRIF-dependent NF-?B pathway against inflammation induced by LPS in goat endometrial epithelial cells.
Neoplasms
Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.
Neoplasms
Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay.
Neoplasms
Pancreatic stellate cells-role in pancreas cancer.
Neoplasms
Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides.
Neoplasms
Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model.
Neoplasms
Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage.
Neoplasms
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Neoplasms
PD-1 Blockade for Improving the Antitumor Efficiency of Polymer-Doxorubicin Nanoprodrug.
Neoplasms
PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
Neoplasms
Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens Results from the Italian Pediatric Rare Tumor (TREP) Study project.
Neoplasms
Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects.
Neoplasms
Peptidomic analysis of pilose antler and its inhibitory effect on triple-negative breast cancer at multiple sites.
Neoplasms
Perinatal Ureaplasma Exposure Is Associated With Increased Risk of Late Onset Sepsis and Imbalanced Inflammation in Preterm Infants and May Add to Lung Injury.
Neoplasms
Periodontal treatment down-regulates protease-activated receptor-2 in human gingival crevicular fluid cells.
Neoplasms
Periodontitis and Endothelial Dysfunction: Periodontal Clinical Parameters and Levels of Salivary Markers Interleukin-1?, Tumor Necrosis Factor-?, Matrix Metalloproteinase-2, Tissue Inhibitor of Metalloproteinases-2 Complex, and Nitric Oxide.
Neoplasms
Periodontitis exacerbates the renal degenerative effects of obesity in rats.
Neoplasms
Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.
Neoplasms
Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
Neoplasms
Pharmacologic therapies in endometriosis: a systematic review.
Neoplasms
Pharmacological inhibition of gelatinase B induction and tumor cell invasion.
Neoplasms
Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.
Neoplasms
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies.
Neoplasms
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
Neoplasms
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer.
Neoplasms
Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
Neoplasms
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors.
Neoplasms
Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites.
Neoplasms
Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group.
Neoplasms
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status.
Neoplasms
Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen.
Neoplasms
Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastase.
Neoplasms
Phyllanthus spp. Exerts Anti-Angiogenic and Anti-Metastatic Effects Through Inhibition on Matrix Metalloproteinase Enzymes.
Neoplasms
Piceatannol-3-O-?-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells.
Neoplasms
Pigment epithelium-derived factor as a natural matrix metalloproteinase inhibitor: a comparison with classical matrix metalloproteinase inhibitors used for cancer treatment.
Neoplasms
Piperine inhibit inflammation, alveolar bone loss and collagen fibers breakdown in a rat periodontitis model.
Neoplasms
PKM2 enhances cancer invasion via ETS-1-dependent induction of matrix metalloproteinase in oral squamous cell carcinoma cells.
Neoplasms
Placental growth factor promotes metastases of ovarian cancer through MiR-543-regulated MMP7.
Neoplasms
Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.
Neoplasms
Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
Neoplasms
Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-? in Chronic Hepatitis C Virus Patients.
Neoplasms
Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells.
Neoplasms
Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke.
Neoplasms
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
Neoplasms
Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
Neoplasms
Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients.
Neoplasms
Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
Neoplasms
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review.
Neoplasms
Pleural fluid tests to identify complicated parapneumonic effusions.
Neoplasms
Pneumoperitoneum augmented tumor invasiveness is abolished by matrix metalloproteinase blockade.
Neoplasms
Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
Neoplasms
Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
Neoplasms
Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
Neoplasms
Polymorphisms of the matrix metalloproteinases associated with prostate cancer.
Neoplasms
Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitro.
Neoplasms
Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget's disease by receptor activator of nuclear factor kappa-B ligand (RANKL)/ RANK pathways.
Neoplasms
Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas.
Neoplasms
Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin.
Neoplasms
Preclinical and clinical studies of MMP inhibitors in cancer.
Neoplasms
Preconditioning of Adipose-Derived Mesenchymal Stem-Like Cells with Eugenol Potentiates Their Migration and Proliferation In Vitro and Therapeutic Abilities in Rat Hepatic Fibrosis.
Neoplasms
Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors.
Neoplasms
Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Neoplasms
Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
Neoplasms
Preventive and therapeutic effect of anti-IL-17 in an experimental model of elastase-induced lung injury in C57Bl6 mice.
Neoplasms
Primary ductal adenocarcinoma of the lacrimal gland: case report.
Neoplasms
Pro-addictive and anti-addictive factors for drug dependence.
Neoplasms
Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.
Neoplasms
Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance.
Neoplasms
Profiling the evolution of human metastatic bladder cancer.
Neoplasms
Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity.
Neoplasms
Prognostic Markers for Chorioamnionitis: IL-6, TNF-?, and MMP-8 in Vaginally Obtained Amniotic Fluid.
Neoplasms
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Neoplasms
Prognostic significance of abnormal matrix collagen remodeling in colorectal cancer based on histologic and bioinformatics analysis.
Neoplasms
Prognostic significance of matrix metalloproteinases type I expression and tumor front parameters in the presence of lymph node micrometastases in carcinoma of the larynx.
Neoplasms
Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
Neoplasms
Proinflammatory cytokines and lipopolysaccharides up regulate MMP-3 and MMP-13 production in Asian elephant (Elephas maximus) chondrocytes: attenuation by anti-arthritic agents.
Neoplasms
Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.
Neoplasms
Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells.
Neoplasms
Protease Nexin-1 affects the migration and invasion of C6 glioma cells through the regulation of urokinase Plasminogen Activator and Matrix Metalloproteinase-9/2.
Neoplasms
Protease Responsive Nanogels for Transcytosis across the Blood-Brain Barrier and Intracellular Delivery of Radiopharmaceuticals to Brain Tumor Cells.
Neoplasms
Proteases as drug targets.
Neoplasms
Proteases in invasion: matrix metalloproteinases.
Neoplasms
Protective effect of MAAs extracted from Porphyra tenera against UV irradiation-induced photoaging in mouse skin.
Neoplasms
Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury.
Neoplasms
Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients.
Neoplasms
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression.
Neoplasms
Proteolytic mechanisms in the ovulatory folliculo-luteal transformation.
Neoplasms
Proto-oncogene ACTR/AIB1 promotes cancer cell invasion by up-regulating specific matrix metalloproteinase expression.
Neoplasms
Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats.
Neoplasms
Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis.
Neoplasms
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors.
Neoplasms
PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines.
Neoplasms
Quantitative analysis of glioma cell invasion by confocal laser scanning microscopy in a novel brain slice model.
Neoplasms
Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats.
Neoplasms
Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier.
Neoplasms
Raf kinase inhibitor protein suppresses nuclear factor-?B-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
Neoplasms
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.
Neoplasms
Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
Neoplasms
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18.
Neoplasms
Rap2a is a novel target gene of p53 and regulates cancer cell migration and invasion.
Neoplasms
Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
Neoplasms
Real-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment.
Neoplasms
Recanalization of arterial thrombus, and inhibition with beta-radiation in a new murine carotid occlusion model: MRNA expression of angiopoietins, metalloproteinases, and their inhibitors.
Neoplasms
Recent insights into natural product inhibitors of matrix metalloproteinases.
Neoplasms
Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer.
Neoplasms
RECK impedes DNA repair by inhibiting the erbB/JAB1/Rad51 signaling axis and enhances chemosensitivity of breast cancer cells.
Neoplasms
Recklessness as a hallmark of aggressive cancer.
Neoplasms
Recombinant fimbriae protein of Porphyromonas gingivalis induces an inflammatory response via the TLR4/NF??B signaling pathway in human peripheral blood mononuclear cells.
Neoplasms
Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.
Neoplasms
Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting ?5?1 integrin to downregulate Akt and MMP-2.
Neoplasms
Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors.
Neoplasms
Redox state of adipose tissue for patients with gastric cancer and its connection with the body mass index and distance from the tumor.
Neoplasms
Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia.
Neoplasms
Reducing bleeding complications after thrombolytic therapy for stroke: clinical potential of metalloproteinase inhibitors and spin trap agents.
Neoplasms
Reduction by dietary matrix metalloproteinase inhibitor BAY 12-9566N of neoplastic development induced by diethylnitrosamine, N-nitrosodimethylamine, or 7,12-dimethylbenz(a)anthracene in rats.
Neoplasms
Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis.
Neoplasms
Reduction of alachlor-induced olfactory mucosal neoplasms by the matrix metalloproteinase inhibitor Ro 28-2653.
Neoplasms
Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.
Neoplasms
Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.
Neoplasms
Reduction of Membrane Protein CRIM1 Decreases E-Cadherin and Increases Claudin-1 and MMPs, Enhancing the Migration and Invasion of Renal Carcinoma Cells.
Neoplasms
Regorafenib diminishes the expression and secretion of angiogenesis and metastasis associated proteins and inhibits cell invasion via NF-?B inactivation in SK-Hep1 cells.
Neoplasms
Regulation of apoptosis and inflammatory responses by IGFBP-3 in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis.
Neoplasms
Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization.
Neoplasms
Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.
Neoplasms
Regulation of matrix metalloproteinase expression in tumor invasion.
Neoplasms
Regulation of matrix metalloproteinase production and tumor cell invasion by four monoclonal antibodies against different epitopes of HAb18G/CD147 extracellular domain.
Neoplasms
Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.
Neoplasms
Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.
Neoplasms
Regulation of metastasis-related gene expression by p53: a potential clinical implication.
Neoplasms
Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells.
Neoplasms
Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells.
Neoplasms
Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Neoplasms
Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.
Neoplasms
Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.
Neoplasms
Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis.
Neoplasms
Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
Neoplasms
Remitted depression and cognition in HIV: The role of cortisol and inflammation.
Neoplasms
Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
Neoplasms
Remodeling of the extracellular matrix by endothelial cell-targeting siRNA improves the EPR-based delivery of 100 nm particles.
Neoplasms
Remodeling of the Tumor Microenvironment Predicts Increased Risk of Cancer in Postmenopausal Women: The Prospective Epidemiologic Risk Factor (PERF I) Study.
Neoplasms
Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis.
Neoplasms
Reoxygenation using a novel CO2 therapy decreases the metastatic potential of osteosarcoma cells.
Neoplasms
Replication study for reported SNP associations with breast cancer survival.
Neoplasms
Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
Neoplasms
Repression of matrix metalloproteinases and inhibition of cell invasion by a nutrient mixture, containing ascorbic acid, lysine, proline, and green tea extract on human fanconi anemia fibroblast cell lines.
Neoplasms
Requirement of arsenic biomethylation for oxidative DNA damage.
Neoplasms
Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles.
Neoplasms
Retinoid-mediated suppression of tumor invasion and matrix metalloproteinase synthesis.
Neoplasms
Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
Neoplasms
RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-?1.
Neoplasms
Rheumatoid arthritis and salivary biomarkers of periodontal disease.
Neoplasms
RNA interference targeting carbohydrate sulfotransferase 3 diminishes macrophage accumulation, inhibits MMP-9 expression and promotes lung recovery in murine pulmonary emphysema.
Neoplasms
RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.
Neoplasms
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion.
Neoplasms
Role of cancer cell-stroma interaction in invasive growth of cancer cells.
Neoplasms
Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
Neoplasms
Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.
Neoplasms
Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis.
Neoplasms
Role of matrix metalloproteinase-9 in transforming growth factor-?1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Neoplasms
Role of matrix metalloproteinases and their inhibitors in pancreatic cancer.
Neoplasms
Role of membrane type 1-matrix metalloproteinase and gelatinase A in head and neck squamous cell carcinoma invasion in vitro.
Neoplasms
Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.
Neoplasms
Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases.
Neoplasms
Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Neoplasms
Role of the V1G1 subunit of V-ATPase in breast cancer cell migration.
Neoplasms
Role of thymosin beta4 in tumor metastasis and angiogenesis.
Neoplasms
Roles of low-density lipoprotein receptor-related protein 1 in tumors.
Neoplasms
Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression.
Neoplasms
Roles of the ovarian surface epithelium in ovulation and carcinogenesis.
Neoplasms
Rotational stress-induced increase in epinephrine levels delays cutaneous wound healing in mice.
Neoplasms
RSPO1-mutated fibroblasts from non-tumoural areas of palmoplantar keratoderma display a cancer-associated phenotype.
Neoplasms
S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer.
Neoplasms
Salvianolic Acid B Slows the Progression of Breast Cancer Cell Growth via Enhancement of Apoptosis and Reduction of Oxidative Stress, Inflammation, and Angiogenesis.
Neoplasms
Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Neoplasms
Secretions of MMP-9 by soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) mediated by protein kinase C (PKC)delta and phospholipase D (PLD) in murine macrophage.
Neoplasms
Secretory Leukoprotease Inhibitor: A Native Antimicrobial Protein in the Innate Immune Response in a Rat Model of S. aureus Keratitis.
Neoplasms
Selection of peptide inhibitor to matrix metalloproteinase-2 using phage display and its effects on pancreatic cancer cell lines PANC-1 and CFPAC-1.
Neoplasms
Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
Neoplasms
Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time?
Neoplasms
Selective Matrix Metalloproteinase Inhibitors for Cancer.
Neoplasms
Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.
Neoplasms
Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion.
Neoplasms
Sensitive detection of CD147/EMMPRIN and its expression on cancer cells with electrochemical technique.
Neoplasms
Sensitivity of human cord blood cells to tetrachloroethylene: cellular and molecular endpoints.
Neoplasms
Sequential activation of anticancer therapy triggered by tumor microenvironment-selective imaging.
Neoplasms
Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation.
Neoplasms
Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study.
Neoplasms
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
Neoplasms
Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors.
Neoplasms
Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy.
Neoplasms
Shape-Defined microPlates for the Sustained Intra-articular Release of Dexamethasone in the Management of Overload-Induced Osteoarthritis.
Neoplasms
Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor alpha protease inhibitor-2.
Neoplasms
Shifts in biochemical markers associated with wound healing in laryngeal secretions following phonotrauma: a preliminary study.
Neoplasms
Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells.
Neoplasms
Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.
Neoplasms
Significance of lymphatic invasion and cancer invasion-related proteins on lymph node metastasis in gastric cancer.
Neoplasms
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
Neoplasms
Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer.
Neoplasms
Significant correlation between matrix metalloproteinase activity and tumor necrosis factor-alpha in salivary extravasation mucoceles.
Neoplasms
Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer.
Neoplasms
Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
Neoplasms
Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells.
Neoplasms
Silencing of TGF-?1 in tumor cells impacts MMP-9 in tumor microenvironment.
Neoplasms
Silencing of the Metastasis Suppressor RECK by RAS Oncogene Is Mediated by DNA Methyltransferase 3b-Induced Promoter Methylation.
Neoplasms
Simultaneous Inhibition of Tumor Necrosis Factor Receptor 1 and Matrix Metalloproteinase 8 Completely Protects Against Acute Inflammation and Sepsis.
Neoplasms
Single Nucleotide Polymorphisms and Haplotypes of MMP-14 are Associated with the Risk and Pathological Development of Oral Cancer.
Neoplasms
Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
Neoplasms
Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.
Neoplasms
Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues.
Neoplasms
Smoking-induced changes in cancer-related factors in patients with upper tract urothelial cancer.
Neoplasms
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
Neoplasms
Snail levels control the migration mechanism of mesenchymal tumor cells.
Neoplasms
Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
Neoplasms
Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.
Neoplasms
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Neoplasms
SPA0355, a thiourea analog, suppresses inflammatory responses and joint destruction in cultured fibroblast-like synoviocytes and collagen-induced arthritic mice.
Neoplasms
Specific Inhibitor of Matrix Metalloproteinase Decreases Tumor Invasiveness After Radiofrequency Ablation in Liver Tumor Animal Model.
Neoplasms
Sphingosine-1-phosphate reduces adhesion of malignant mammary tumor cells MDA-MB-231 to microvessel walls by protecting endothelial surface glycocalyx.
Neoplasms
SPIONs embedded in polyamino acid nanogels to synergistically treat tumor microenvironment and breast cancer cells.
Neoplasms
Sputum and salivary protein biomarkers and point-of-care biosensors for the management of COPD.
Neoplasms
Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression.
Neoplasms
Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration.
Neoplasms
Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.
Neoplasms
Status of research on matrix metalloproteinases (MMPs) in India.
Neoplasms
Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells.
Neoplasms
Stimulatory effects of EGF and TGF-alpha on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in uterine cervical-carcinoma SKG-IIIb cells.
Neoplasms
Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer.
Neoplasms
Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.
Neoplasms
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Neoplasms
Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Neoplasms
Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors.
Neoplasms
Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
Neoplasms
Stromelysin-3 expression promotes tumor take in nude mice.
Neoplasms
Structural characterization of the catalytic active site in the latent and active natural gelatinase B from human neutrophils.
Neoplasms
Structural insights into the binding of MMP9 inhibitors.
Neoplasms
Studies of a cobalt(III) complex of the MMP inhibitor marimastat: a potential hypoxia-activated prodrug.
Neoplasms
Study of cardioprotective activity of the methanolic extract of the aerial parts of Bauhinia madagascariensis compared to Bauhinia purpurea against adrenaline-induced myocardial toxicity in rats.
Neoplasms
Sublethal irradiation promotes the metastatic potential of hepatocellular carcinoma cells.
Neoplasms
Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth.
Neoplasms
Sudachitin Inhibits Matrix Metalloproteinase-1 and -3 Production in Tumor Necrosis Factor-?-Stimulated Human Periodontal Ligament Cells.
Neoplasms
Sulphonamides: Deserving class as MMP inhibitors?
Neoplasms
Superoxide- and NO-dependent mechanisms of antitumor and antimetastatic effect of L-arginine hydrochloride and coenzyme Q10.
Neoplasms
Supervillin promotes tumor angiogenesis in liver cancer.
Neoplasms
Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
Neoplasms
Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Neoplasms
Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Neoplasms
Suppressions of Migration and Invasion by Cantharidin in TSGH-8301 Human Bladder Carcinoma Cells through the Inhibitions of Matrix Metalloproteinase-2/-9 Signaling.
Neoplasms
Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line.
Neoplasms
Supramolecular gelatin nanoparticles as matrix metalloproteinase responsive cancer cell imaging probes.
Neoplasms
Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells.
Neoplasms
Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
Neoplasms
Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.
Neoplasms
Synovial fluid levels of tumor necrosis factor-alpha in the inflamed rat knee: modulation by dexamethasone and inhibitors of matrix metalloproteinase and phosphodiesterase.
Neoplasms
Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX.
Neoplasms
Synthesis and Evaluation of a Novel Hydroxamate Based Fluorescent Photoprobe for Imaging of Matrix Metalloproteinases.
Neoplasms
Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.
Neoplasms
Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.
Neoplasms
Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.
Neoplasms
Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.
Neoplasms
Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
Neoplasms
Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents.
Neoplasms
Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
Neoplasms
Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K.
Neoplasms
Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029.
Neoplasms
Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis.
Neoplasms
Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes.
Neoplasms
TAK1-TAB2 Signaling Contributes to Bone Destruction by Breast Carcinoma Cells.
Neoplasms
Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(?)anthracene-induced rat mammary carcinoma.
Neoplasms
Targeted blockade of JAK/STAT3 signaling inhibits ovarian carcinoma growth.
Neoplasms
Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma-Associated Bone Loss.
Neoplasms
Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
Neoplasms
Targeting CD147 is a novel strategy for antitumor therapy.
Neoplasms
Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.
Neoplasms
Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth.
Neoplasms
Targeting matrix metalloproteinase MMP3 greatly enhances oncolytic virus mediated tumor therapy.
Neoplasms
Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock.
Neoplasms
Targeting of an antecedent proteinase by an activatable probe with deep tissue penetration facilitates early visualization and dynamic malignancy evaluation of orthotopic pancreatic ductal adenocarcinoma (PDAC).
Neoplasms
Tenocyte activation and regulation of complement factors in response to in vitro cell injury.
Neoplasms
Terminalia Chebulanin Attenuates Psoriatic Skin Lesion via Regulation of Heme Oxygenase-1.
Neoplasms
Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9.
Neoplasms
TGF-?1 facilitates MT1-MMP-mediated proMMP-9 activation and invasion in oral squamous cell carcinoma cells.
Neoplasms
The 2G allele of promoter region of Matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma.
Neoplasms
The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.
Neoplasms
The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion.
Neoplasms
The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.
Neoplasms
The association between individual SNPs or haplotypes of matrix metalloproteinase 1 and gastric cancer susceptibility, progression and prognosis.
Neoplasms
The association of genotype polymorphisms with vascular access patency in hemodialysis patients.
Neoplasms
The beneficial effect of cold atmospheric plasma on parameters of molecules and cell function involved in wound healing in human osteoblast-like cells in vitro.
Neoplasms
The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation.
Neoplasms
The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells.
Neoplasms
The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression.
Neoplasms
The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies.
Neoplasms
The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice.
Neoplasms
The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan.
Neoplasms
The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma.
Neoplasms
The Contribution of MMP-8 Promoter Genotypes to Childhood Leukemia.
Neoplasms
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
Neoplasms
The Dynamics of CD147 in Alzheimer's Disease Development and Pathology.
Neoplasms
The effect of a single episode of antimicrobial photodynamic therapy in the treatment of experimental periodontitis. Microbiological profile and cytokine pattern in the dog mandible.
Neoplasms
The effect of diabetes on vitreous levels of adiponectin and inflammatory cytokines in experimental rat model.
Neoplasms
The effect of dietary supplementation with limonene or myo-inositol on the induction of neoplasia and matrix metalloproteinase and plasminogen activator activities in accessory sex organs of male Lobund-Wistar rats.
Neoplasms
The effect of tomatine on metastasis related matrix metalloproteinase (MMP) activities in breast cancer cell model.
Neoplasms
The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances.
Neoplasms
The Elastin Receptor Complex: A Unique Matricellular Receptor with High Anti-tumoral Potential.
Neoplasms
The expression of apoptotic proteins and matrix metalloproteinases in odontogenic myxomas.
Neoplasms
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Neoplasms
The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane.
Neoplasms
The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Neoplasms
The glycocalyx and its significance in human medicine.
Neoplasms
The Goal of Cancer Treatment.
Neoplasms
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.
Neoplasms
The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells.
Neoplasms
The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily.
Neoplasms
The IGF-I Receptor Can Alter the Matrix Metalloproteinase Repertoire of Tumor Cells through Transcriptional Regulation of PKC-{alpha}
Neoplasms
The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process.
Neoplasms
The indirect antiangiogenic effect of IL-37 in the tumor microenvironment.
Neoplasms
The influence of repeated arthrocentesis and exercise on matrix metalloproteinase and tumour necrosis factor alpha activities in normal equine joints.
Neoplasms
The influence of transforming growth factor-?, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Neoplasms
The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy.
Neoplasms
The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9.
Neoplasms
The interplay of matrix metalloproteinase-8, transforming growth factor-?1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Neoplasms
The intranuclear PEX domain of MMP involves proliferation, migration, and metastasis of aggressive adenocarcinoma cells.
Neoplasms
The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo.
Neoplasms
The many faces of EMMPRIN-Roles in neuroinflammation.
Neoplasms
The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
Neoplasms
The matrix metalloproteinase inhibitor batimastat inhibits the lung colonisation of orthotopically implanted malignant pancreatic tumor cells in SCID mice.
Neoplasms
The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.
Neoplasms
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Neoplasms
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.
Neoplasms
The matrix metalloproteinase system in oral squamous cell carcinoma.
Neoplasms
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.
Neoplasms
The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts.
Neoplasms
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
Neoplasms
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
Neoplasms
The microtubule stabilizer patupilone counteracts ionizing radiation-induced matrix metalloproteinase activity and tumor cell invasion.
Neoplasms
The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions.
Neoplasms
The MMP-8 rs11225395 Promoter Polymorphism Increases Cancer Risk of Non-Asian Populations: Evidence from a Meta-Analysis.
Neoplasms
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.
Neoplasms
The novel non-immunological role and underlying mechanisms of B7-H3 in tumorigenesis.
Neoplasms
The novel relationship between polycystic ovary syndrome and temporomandibular joint disorders.
Neoplasms
The other side of MMPs: protective roles in tumor progression.
Neoplasms
The overexpression and predictive significance of MMP-12 in esophageal squamous cell carcinoma.
Neoplasms
The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.
Neoplasms
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Neoplasms
The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis.
Neoplasms
The planar cell polarity protein Van Gogh-Like 2 regulates tumor cell migration and matrix metalloproteinase-dependent invasion.
Neoplasms
The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology.
Neoplasms
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Neoplasms
The preventive and curative effects of melatonin against abdominal aortic aneurysm in rats.
Neoplasms
The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer.
Neoplasms
The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 gene promoter region in invasion and prognosis of meningiomas.
Neoplasms
The role of EMMPRIN expression in ovarian epithelial carcinomas.
Neoplasms
The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease.
Neoplasms
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
Neoplasms
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.
Neoplasms
The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.
Neoplasms
The role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcription.
Neoplasms
The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma.
Neoplasms
The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes.
Neoplasms
The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
Neoplasms
The Role of the exocyst in matrix metalloproteinase secretion and actin dynamics during tumor cell invadopodia formation.
Neoplasms
The Role of the Mediators of Inflammation in Cancer Development.
Neoplasms
The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis.
Neoplasms
The silencing of ApoC3 suppresses oxidative stress and inflammatory responses in placenta cells from mice with preeclampsia via inhibition of the NF-?B signaling pathway.
Neoplasms
The SOX2OT/miR-194-5p axis regulates cell proliferation and mobility of gastric cancer through suppressing epithelial-mesenchymal transition.
Neoplasms
The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors.
Neoplasms
The synthesis and preliminary activity assay in vitro of peptide-like derivatives as APN inhibitors.
Neoplasms
The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates.
Neoplasms
The tumor microenvironment promotes cancer progression and cell migration.
Neoplasms
The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling.
Neoplasms
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment.
Neoplasms
The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitors.
Neoplasms
Therapeutic Angiogenesis of Human Early Endothelial Progenitor Cells Is Enhanced by Thrombomodulin.
Neoplasms
Therapeutic effects of blocking ?-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion.
Neoplasms
Therapeutic Effects of Three Human-derived Materials in a Mouse Corneal Alkali Burn Model.
Neoplasms
Therapeutic Hypothermia Reduces the Inflammatory Response Following Ischemia/Reperfusion Injury in Rat Hearts.
Neoplasms
Therapeutic Potential of Luteolin on Impaired Wound Healing in Streptozotocin-Induced Rats.
Neoplasms
Thermoresponsive and Protease-Cleavable Interferon-Polypeptide Conjugates with Spatiotemporally Programmed Two-Step Release Kinetics for Tumor Therapy.
Neoplasms
Thioredoxin fusion construct enables high-yield production of soluble, active matrix metalloproteinase-8 (MMP-8) in Escherichia coli.
Neoplasms
Three Tiaobu Feishen formulae reduces cigarette smoke-induced inflammation in human airway epithelial cells.
Neoplasms
Three-dimensional printing of Hela cells for cervical tumor model in vitro.
Neoplasms
Thrombin generation and the pathogenesis of cancer.
Neoplasms
Thrombin-thrombomodulin activation of protein C facilitates the activation of progelatinase A.
Neoplasms
Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract.
Neoplasms
Thrombospondin-2 inhibits tumor cell invasion through the modulation of MMP-9 and uPA in pancreatic cancer cells.
Neoplasms
Thrombospondin-4 promotes bladder cancer cell migration and invasion via MMP2 production.
Neoplasms
Thuja orientalis reduces airway inflammation in ovalbumin-induced allergic asthma.
Neoplasms
Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma.
Neoplasms
Thymoquinone inhibits IL-7-induced tumor progression and metastatic invasion in prostate cancer cells by attenuating matrix metalloproteinase activity and Akt/NF-?B signaling.
Neoplasms
Time Course of the Phenotype of Blood and Bone Marrow Monocytes and Macrophages in the Lung after Cigarette Smoke Exposure In Vivo.
Neoplasms
TIMP-1 Overexpression in Lung Carcinoma Enhances Tumor Kinetics and Angiogenesis in Brain Metastasis.
Neoplasms
TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Neoplasms
TIMP1 and adverse prognosis in non-small cell lung cancer.
Neoplasms
TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
Neoplasms
Tissue inhibitor of matrix metalloproteinase-2 in nasopharyngeal carcinoma.
Neoplasms
Tissue inhibitor of matrix metalloproteinase-3 levels in the extracellular matrix of lung, kidney, and eye increase with age.
Neoplasms
Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.
Neoplasms
Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model.
Neoplasms
Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Neoplasms
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.
Neoplasms
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
Neoplasms
TLR4-mediated hippocampal MMP/TIMP imbalance contributes to the aggravation of perioperative neurocognitive disorder in db/db mice.
Neoplasms
TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease.
Neoplasms
Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
Neoplasms
Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
Neoplasms
Towards third generation matrix metalloproteinase inhibitors for cancer therapy.
Neoplasms
Toxicodendron vernicifluum Stokes extract inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
Neoplasms
Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.
Neoplasms
Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
Neoplasms
Transcriptional regulation of stromelysin-1 gene expression is altered during progression of mouse mammary epithelial cells from functionally normal to malignant.
Neoplasms
Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Neoplasms
Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis.
Neoplasms
Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Neoplasms
Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.
Neoplasms
Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis.
Neoplasms
Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells.
Neoplasms
Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin ?1.
Neoplasms
Transplantation of fibroblasts that overexpress matrix metalloproteinase-3 into the site of spinal cord injury in rats.
Neoplasms
Treatment of periodontitis reduces systemic inflammation in type 2 diabetes.
Neoplasms
Treatment of Sorsby fundus dystrophy with anti-tumor necrosis factor-alpha medication.
Neoplasms
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.
Neoplasms
Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents.
Neoplasms
Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.
Neoplasms
Tumor associated proteases -- prognostic markers of colorectal cancer.
Neoplasms
Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase.
Neoplasms
Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer.
Neoplasms
Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.
Neoplasms
Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis.
Neoplasms
Tumor necrosis factor receptor-associated factor 6 (TRAF6) inhibition modulates bone loss and matrix metalloproteinase expression levels in collagen-induced rheumatoid arthritis rat.
Neoplasms
Tumor necrosis factor-?-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo.
Neoplasms
Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis.
Neoplasms
Tumor necrosis factor-alpha G(-308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C(-1562)T promoter polymorphism and risk and extent of ischemic heart disease.
Neoplasms
Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Neoplasms
Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk.
Neoplasms
Tumor progression: defining the soil round the tumor seed.
Neoplasms
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
Neoplasms
Tumor suppression by control of matrix metalloproteinase recycling.
Neoplasms
Tumor targeting with a selective gelatinase inhibitor.
Neoplasms
Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.
Neoplasms
Tumor-derived death receptor 6 modulates dendritic cell development.
Neoplasms
Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38.
Neoplasms
Tumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells.
Neoplasms
Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein.
Neoplasms
Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Neoplasms
Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models.
Neoplasms
Tumorigenic potential of extracellular matrix metalloproteinase inducer.
Neoplasms
Tumour metastasis to the liver, and the roles of proteinases and adhesion molecules: new concepts from in vivo videomicroscopy.
Neoplasms
Tumour necrosis factor-alpha provokes upregulation of alpha2beta1 and alpha5beta1 integrins, and cell migration in OST osteosarcoma cells.
Neoplasms
Tuning Liposome Membrane Permeability by Competitive Peptide Dimerization and Partitioning-Folding Interactions Regulated by Proteolytic Activity.
Neoplasms
Two-photon laser-generated microtracks in 3D collagen lattices: principles of MMP-dependent and -independent collective cancer cell invasion.
Neoplasms
Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma.
Neoplasms
Type IV collagenases in tumor invasion and metastasis.
Neoplasms
Ultrasound-guided intratumoral administration of collagenase-2 improved liposome drug accumulation in solid tumor xenografts.
Neoplasms
Ultrastructural and cytobiological studies on possible interactions between PTHrP-secreting tumor cells, stromal cells, and bone cells.
Neoplasms
Unique proliferation response in odontoblastic cells derived from human skeletal muscle stem cells by cytokine-induced matrix metalloproteinase-3.
Neoplasms
Up-regulated DERL3 in fibroblast-like synoviocytes exacerbates inflammation of rheumatoid arthritis.
Neoplasms
Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.
Neoplasms
Up-regulated gene expression of angiogenesis factors in post-chemotherapeutic lung cancer tissues determined by cDNA macroarray.
Neoplasms
Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
Neoplasms
Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
Neoplasms
Up-regulation of matrix metalloproteinase family gene involvement in ursolic acid-induced human lung non-small carcinoma cell apoptosis.
Neoplasms
Up-regulation of matrix metalloproteinase-8 by betel quid extract and arecoline and its role in 2D motility.
Neoplasms
Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Neoplasms
Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.
Neoplasms
Update meta-analysis on MMP-7 -181A>G polymorphism and cancer risk: evidence from 25 studies.
Neoplasms
Upregulated Expression of ADAM17 Is a Prognostic Marker for Patients With Gastric Cancer.
Neoplasms
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma.
Neoplasms
Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer.
Neoplasms
Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma.
Neoplasms
Upregulation of extracellular matrix metalloproteinase inducer promotes hypoxia-induced epithelial-mesenchymal transition in esophageal cancer.
Neoplasms
Upregulation of human heme oxygenase gene expression by Ets-family proteins.
Neoplasms
Upregulation of RECK gene expression by small double-stranded RNA targeting the promoter region.
Neoplasms
Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy.
Neoplasms
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.
Neoplasms
Ursolic acid alleviates early brain injury after experimental subarachnoid hemorrhage by suppressing TLR4-mediated inflammatory pathway.
Neoplasms
Ursolic acid and its esters: occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells
Neoplasms
Ursolic acid and its esters: occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells.
Neoplasms
Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.
Neoplasms
Use of IL-1 ?, IL-6, TNF-?, and MMP-8 biomarkers to distinguish peri-implant diseases: A systematic review and meta-analysis.
Neoplasms
Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
Neoplasms
Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
Neoplasms
Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents.
Neoplasms
Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study.
Neoplasms
Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
Neoplasms
Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.
Neoplasms
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Neoplasms
Vascular endothelial growth factor expression in the basal subtype of breast carcinoma.
Neoplasms
Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas.
Neoplasms
Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor.
Neoplasms
Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma.
Neoplasms
Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential anti-tumor effect in cancer invasion and metastasis.
Neoplasms
Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells.
Neoplasms
Within-subject variability in repeated measures of salivary analytes in healthy adults.
Neoplasms
Zebrafish Xenograft: An Evolutionary Experiment in Tumour Biology.
Neoplasms
Zingiber mioga (Thunb.) Roscoe attenuates allergic asthma induced by ovalbumin challenge.
Neoplasms
ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
Neoplasms
Zn(II)-Chlorido complexes of phytohormone kinetin and its derivatives modulate expression of inflammatory mediators in THP-1 cells.
Neoplasms
[A Simple Medical Research Microdevice for Analyzing Three-dimensional Migration of Tumor Cells in Vitro].
Neoplasms
[Antiangiogenic and antitumor effect of BPHA, an orally-active matrix metalloproteinase inhibitor, in in vivo murine and human tumor model]
Neoplasms
[Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma]
Neoplasms
[Collagenase-3 (MMP-13) expression in epithelial cancers of the eyelids]
Neoplasms
[Construction and Anti-tumor Effect Evaluation of a Dual-Responsive Hyaluronic Acid Carbon Quantum Dot-Gelatin Nano-Drug Delivery System].
Neoplasms
[Correlation between expressions of matrix metalloproteinase-2 & 9 and vasculogenic mimicry in gastrointestinal stromal tumors]
Neoplasms
[Correlation of membrane type I matrix metalloproteinase (MT1-MMP) expression with clinicomorphological features of tumor front in squamous cell carcinoma of the larynx]
Neoplasms
[Current data on metalloproteinases, obligatory partners of tumor progression]
Neoplasms
[Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization]
Neoplasms
[Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid]
Neoplasms
[Effect of Gancao Fuzi Decoction on osteoarthritis and proteomics of articular cartilage in rats].
Neoplasms
[Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells]
Neoplasms
[Effects of alprostadil and ulinastatin on inflammatory response and lung injury after cardiopulmonary bypass in pediatric patients with congenital heart diseases]
Neoplasms
[Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colorectal cancer cell line HT-29]
Neoplasms
[EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer].
Neoplasms
[Expression and clinical significance of CD147 and MMP-2 ?in squamous cell carcinoma and adenocarcinoma of the lungs].
Neoplasms
[Expression and clinical significance of matrix metalloproteinase in gastric stromal tumor]
Neoplasms
[Expression and clinicopathologic significance of OPN, CD44v6 and MMP-2 in squamous cell carcinoma and adenocarcinoma of the lung].
Neoplasms
[Expression of dishevelled-2 in cartilage of rheumatoid arthritis and its effect on cartilage destruction].
Neoplasms
[Expression of extracellular matrix metalloproteinase inducer in human bladder transitional cell carcinoma]
Neoplasms
[Expression of matrix metalloproteinases in patients with malignant tumors]
Neoplasms
[Expression of miR-146b in peripheral blood serum and aortic tissues in patients with acute type Stanford A aortic dissection and its clinical significance].
Neoplasms
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
Neoplasms
[Intervention of Qingshen Granule for Immune Inflammation of Chronic Renal Failure Patients with Damp-heat Syndrome].
Neoplasms
[Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis]
Neoplasms
[Matrix metalloproteinase inhibitors for therapy of cancer]
Neoplasms
[Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma]
Neoplasms
[Non-specific immunotherapy inhibits angiogenesis - results of the monitoring of serum levels of vascular endothelial growth factor and matrix metalloproteinase 8 in patients with malignant melanoma receiving adjuvant high-dose interferon therapy].
Neoplasms
[Pathological features of lymph node metastasis. 2) From morphological aspects]
Neoplasms
[Phenotypic and functional characteristics of endothelial cells derived from human liver cancer]
Neoplasms
[Recent progress of matrix metalloproteinase (MMP) research and its clinical application for cancer therapy]
Neoplasms
[Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloroliferative neoplasms cells].
Neoplasms
[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]
Neoplasms
[Role of a latent soluble TNF receptor type I (hsTNFRI) fusion protein in targeted treatment of endometriosis]
Neoplasms
[Role of cytokine-matrix metalloproteinase axis on promoting vascular neointima hyperplasia in mice].
Neoplasms
[Study on expression of matrix metalloproteinases and their inhibitors in parotid gland tumors]
Neoplasms
[The basement membrane and metastasis]
Neoplasms
[The expressions of TNF-alpha and MMP-9 in serum and MMP-1 mRNA in the bone tissue in chronic obstructive pulmonary disease patients of cold dryness syndrome in northwest China].
Neoplasms
[The matrix metalloproteinase in oral and oropharyngeol cancer - literature review].
Neoplasms
[The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
Neoplasms
[The role of stromal mast cells in the modification of CD4+CD25+Foxp³ regulatory T cells, Th17 lymphocytes and cytotoxic lymphocytes Tc1 in the development and progression of tumor].
Neoplasms
[Tumor metastasis and MMP inhibitor.]
Neoplasms
[Urothelial tumors and the extracellular matrix]
Neoplasms
ß-1,3-galactosyl-O-glycosyl-glycoprotein ß-1,6-N-acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility.
Neoplasms, Squamous Cell
Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
Neoplastic Cells, Circulating
NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma.
Neoplastic Cells, Circulating
Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis.
Nephritis
A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.
Nephritis
Decrease in cell proliferation by an matrix metalloproteinase inhibitor, doxycycline, in a model of immune-complex nephritis.
Nephritis
Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis.
Nephritis
Renoprotective action of a matrix metalloproteinase inhibitor in progressive mesangioproliferative nephritis.
Nephritis
The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura.
Nephritis, Hereditary
Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.
Nephritis, Hereditary
Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: implications for capillary basement membrane pathology.
Nervous System Diseases
Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation.
Nervous System Diseases
Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis.
Neuralgia
Biomarker Analysis of Orally Dosed, Dual Active, Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitor, AQU-118, in the Spinal Nerve Ligation (SNL) Rat Model of Neuropathic Pain.
Neuralgia
N-acetyl-cysteine attenuates neuropathic pain by suppressing matrix metalloproteinases.
Neuralgia
Paeoniflorin attenuates postoperative pain by suppressing Matrix Metalloproteinase-9/2 in mice.
Neuralgia
Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2.
Neuralgia
Spatial and temporal analysis of nociception-related spinal cord matrix metalloproteinase expression in a murine neuropathic pain model.
Neuritis
A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.
Neuritis
Matrix metalloproteinase expression during experimental autoimmune neuritis.
Neuritis
MMP-mediated cleavage of beta-dystroglycan in myelin sheath is involved in autoimmune neuritis.
Neuritis, Autoimmune, Experimental
A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.
Neuritis, Autoimmune, Experimental
Matrix metalloproteinase expression during experimental autoimmune neuritis.
Neuroblastoma
All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
Neuroblastoma
Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk.
Neuroblastoma
Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation.
Neuroblastoma
Rapid Unperturbed-Tissue Analysis for Intraoperative Cancer Diagnosis Using an Enzyme-Activated NIR-II Nanoprobe.
Neuroblastoma
Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression is regulated by multiple neural differentiation signals.
Neurocysticercosis
Doxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity.
Neurodegenerative Diseases
Chemical biology for understanding matrix metalloproteinase function.
Neurodegenerative Diseases
Exploring the Association Between Rosacea and Parkinson Disease: A Danish Nationwide Cohort Study.
Neurodegenerative Diseases
Mechanistic Insights into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol.
Neurodegenerative Diseases
Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.
Neurodegenerative Diseases
Recent insights into natural product inhibitors of matrix metalloproteinases.
Neuroectodermal Tumors
Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.
Neuroectodermal Tumors
Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
Neuroinflammatory Diseases
Anti-inflammatory and anti-oxidant mechanisms of an MMP-8 inhibitor in lipoteichoic acid-stimulated rat primary astrocytes: involvement of NF-?B, Nrf2, and PPAR-? signaling pathways.
Neuroinflammatory Diseases
Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro.
Neuroinflammatory Diseases
Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing-remitting multiple sclerosis patients and their first-degree family.
Neuroinflammatory Diseases
Flavonoids targeting of I?B phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells.
Neuroinflammatory Diseases
Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke.
Neuroinflammatory Diseases
Galangin Inhibits Thrombin-Induced MMP-9 Expression in SK-N-SH Cells via Protein Kinase-Dependent NF-?B Phosphorylation.
Neuroinflammatory Diseases
High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.
Neuroinflammatory Diseases
Intercellular Adhesion Molecule-1-Induced Posttraumatic Brain Injury Neuropathology in the Prefrontal Cortex and Hippocampus Leads to Sensorimotor Function Deficits and Psychological Stress.
Neuroinflammatory Diseases
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
Neuroinflammatory Diseases
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice.
Neuroinflammatory Diseases
Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.
Neuroinflammatory Diseases
Matrix metalloproteinase-8 plays a pivotal role in neuroinflammation by modulating TNF-? activation.
Neuroinflammatory Diseases
Multimodal Molecular Imaging Demonstrates Myeloperoxidase Regulation of Matrix Metalloproteinase Activity in Neuroinflammation.
Neuroinflammatory Diseases
Paeoniflorin attenuates postoperative pain by suppressing Matrix Metalloproteinase-9/2 in mice.
Neuroinflammatory Diseases
Regulation of neuroinflammation by matrix metalloproteinase-8 inhibitor derivatives in activated microglia and astrocytes.
Neuroinflammatory Diseases
Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and LRRK2 G2019S Parkinson's disease model mice challenged with lipopolysaccharide.
Neurologic Manifestations
Simvastatin in traumatic brain injury: Effect on brain edema mechanisms.
Neuroma, Acoustic
Cystic vestibular schwannomas: a possible role of matrix metalloproteinase-2 in cyst development and unfavorable surgical outcome.
Neuromyelitis Optica
MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?
neutrophil collagenase deficiency
Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice.
neutrophil collagenase deficiency
Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression.
neutrophil collagenase deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
neutrophil collagenase deficiency
Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity.
neutrophil collagenase deficiency
Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.
neutrophil collagenase deficiency
Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation.
neutrophil collagenase deficiency
MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia.
Nevus
TGF-? signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.
Nevus, Pigmented
Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Newcastle Disease
Assay of extracellular matrix degradation and transmigration of chicken peripheral blood mononuclear cells after infection with genotype VII Newcastle disease virus in vitro.
Newcastle Disease
Matrix metalloproteinase-14 regulates collagen degradation and migration of mononuclear cells during infection with genotype VII Newcastle disease virus.
Non-alcoholic Fatty Liver Disease
Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study.
Obesity
A case of 14q11.2 microdeletion with autistic features, severe obesity and facial dysmorphisms suggestive of Wolf-Hirschhorn syndrome.
Obesity
Association of MMP-8 with obesity, smoking and insulin resistance.
Obesity
Diet-induced Obesity and Matrix Metalloproteinase Gene Expression at the Onset of Skeletal Muscle Regeneration: 2078 Board #230 June 2, 2: 00 PM - 3: 30 PM.
Obesity
Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice.
Obesity
Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women.
Obesity
Effect of gelatinase inhibition on adipogenesis and adipose tissue development.
Obesity
Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women.
Obesity
Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity.
Obesity
Hydrogen Sulfide Depletion Contributes to Microvascular Remodeling in Obesity.
Obesity
Kidney osteoclast factors and matrix metalloproteinase expression in a mice model of diet-induced obesity and diabetes.
Obesity
Korean red ginseng (Panax ginseng) prevents obesity by inhibiting angiogenesis in high fat diet-induced obese C57BL/6J mice.
Obesity
Leptin-induced matrix metalloproteinase-2 secretion is suppressed by trans-10,cis-12 conjugated linoleic acid.
Obesity
Matrix metalloproteinase-1 promoter is associated with body mass index in Korean population with aged greater or equal to 50 years.
Obesity
Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1.
Obesity
Obesity and vascular risk.
Obesity
Pam3CSK4 Induces MMP-9 Expression in Human Monocytic THP-1 Cells.
Obesity
Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity.
Obesity, Abdominal
Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study.
Obesity, Maternal
Cellular inhibitors of apoptosis (cIAP) 1 and 2 are increased in placenta from obese pregnant women.
Obstetric Labor, Premature
Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes.
Obstetric Labor, Premature
Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection.
Obstetric Labor, Premature
An elevated amniotic fluid prostaglandin F2? concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes.
Obstetric Labor, Premature
Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor.
Obstetric Labor, Premature
Clinical significance of oligohydramnios in patients with preterm labor and intact membranes*,**.
Obstetric Labor, Premature
Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes().
Obstetric Labor, Premature
Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection.
Obstetric Labor, Premature
Hyaluronidase Impairs Neutrophil Function and Promotes Group B Streptococcus Invasion and Preterm Labor in Nonhuman Primates.
Obstetric Labor, Premature
Low maternal serum matrix metalloproteinase (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response.
Obstetric Labor, Premature
Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor.
Obstetric Labor, Premature
Performance characteristics of putative tests for subclinical chorioamnionitis.
Obstetric Labor, Premature
Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Obstetric Labor, Premature
Recombinant human lactoferrin inhibits matrix metalloproteinase (MMP-2, MMP-3, and MMP-9) activity in a rabbit preterm delivery model.
Obstetric Labor, Premature
The frequency and clinical significance of intra-amniotic inflammation defined as an elevated amniotic fluid matrix metalloproteinase-8 in patients with preterm labor and low amniotic fluid white blood cell counts.
Obstetric Labor, Premature
The frequency and clinical significance of intra-uterine infection and inflammation in patients with placenta previa and preterm labor and intact membranes.
Obstetric Labor, Premature
[Extracellular matrix metalloproteases profile identification in chorioamniotic membranes of term and preterm pregnancies through soluble microarrays]
Ocular Hypertension
Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.
Odontogenic Cysts
Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions.
Odontogenic Cysts
Expression of extracellular matrix metalloproteinase inducer in odontogenic cysts.
Odontogenic Cysts
Intracystic negative pressure may promote bone formation around jaw cysts.
Odontogenic Cysts
MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts.
Odontogenic Cysts
[Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma]
Odontogenic Tumors
Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors.
Odontogenic Tumors
Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
Odontogenic Tumors
Matrix metalloproteinase expression in keratocystic odontogenic tumors and primary cells.
Oligohydramnios
Clinical significance of oligohydramnios in patients with preterm labor and intact membranes*,**.
Oncogene Addiction
Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma.
Oral Submucous Fibrosis
Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
Osteoarthritis
A Mixture Containing Fermented Achyranthes japonica Nakai Ameliorates Osteoarthritis in Knee Joints of Monoiodoacetate-Injected Rats.
Osteoarthritis
A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies.
Osteoarthritis
A Systematic Review of Basic Science and Animal Studies on the Use of Doxycycline to Reduce the Risk of Posttraumatic Osteoarthritis After Anterior Cruciate Ligament Rupture/Transection.
Osteoarthritis
Aggravation of ADAMTS and Matrix Metalloproteinase Production and Role of ERK1/2 Pathway in the Interaction of Osteoarthritic Subchondral Bone Osteoblasts and Articular Cartilage Chondrocytes -- Possible Pathogenic Role in Osteoarthritis.
Osteoarthritis
An insight to conserved water molecular dynamics of catalytic and structural Zn(+2) ions in matrix metalloproteinase 13 of human.
Osteoarthritis
Analysis of the trajectory of osteoarthritis development in a mouse model by serial near-infrared fluorescence imaging of matrix metalloproteinase activities.
Osteoarthritis
Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses.
Osteoarthritis
Biologic basis of osteoarthritis: state of the evidence.
Osteoarthritis
cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis.
Osteoarthritis
Chemical biology for understanding matrix metalloproteinase function.
Osteoarthritis
Chicken collagen type II reduces articular cartilage destruction in a model of osteoarthritis in rats.
Osteoarthritis
Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
Osteoarthritis
CITED2 mediates the cross-talk between mechanical loading and IL-4 to promote chondroprotection.
Osteoarthritis
Clinical trials of a stromelysin inhibitor. Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications.
Osteoarthritis
Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine.
Osteoarthritis
Comparison of Northern blot hybridization and a reverse transcriptase-polymerase chain reaction technique for measurement of mRNA expression of metalloproteinases and matrix components in articular cartilage and synovial membrane from horses with osteoarthritis.
Osteoarthritis
Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.
Osteoarthritis
Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification.
Osteoarthritis
Curcumin and tetrahydrocurcumin both prevent osteoarthritis symptoms and decrease the expressions of pro-inflammatory cytokines in estrogen-deficient rats.
Osteoarthritis
Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model.
Osteoarthritis
Cystatin C in Cerebrospinal Fluid is Upregulated in Elderly Patients With Chronic Osteoarthritis Pain and Modulated Through Matrix Metalloproteinase 9-Specific Pathway.
Osteoarthritis
Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo.
Osteoarthritis
Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13 (dagger).
Osteoarthritis
DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes.
Osteoarthritis
Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs.
Osteoarthritis
Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes.
Osteoarthritis
Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Osteoarthritis
Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis.
Osteoarthritis
Effects of celecoxib on human chondrocytes--enhanced production of chemokines.
Osteoarthritis
Effects of estradiol on reduction of osteoarthritis in rabbits through effect on matrix metalloproteinase proteins.
Osteoarthritis
Evaluation of a magnetic resonance biomarker of osteoarthritis disease progression: doxycycline slows tibial cartilage loss in the Dunkin Hartley guinea pig.
Osteoarthritis
Evaluation of the effect of oral administration of collagen peptides on an experimental rat osteoarthritis model.
Osteoarthritis
Expression and correlation of matrix metalloproteinase-7 and interleukin-15 in human osteoarthritis.
Osteoarthritis
Expression of collagenases (matrix metalloproteinase-1, 8, 13) and tissue inhibitor of metalloproteinase-1 of retrodiscal tissue in temporomandibular joint disorder patients.
Osteoarthritis
Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Osteoarthritis
Expression of membrane type 1 matrix metalloproteinase in human articular cartilage.
Osteoarthritis
Expression of membrane-type matrix metalloproteinases in synovial tissue from patients with rheumatoid arthritis or osteoarthritis.
Osteoarthritis
Expression profiling of metalloproteinases and their inhibitors in cartilage.
Osteoarthritis
Ferulic acid suppresses interleukin-1?-induced degeneration of chondrocytes isolated from patients with osteoarthritis through the SIRT1/AMPK/PGC-1? signaling pathway.
Osteoarthritis
Heparan sulfate deficiency leads to hypertrophic chondrocytes by increasing bone morphogenetic protein signaling.
Osteoarthritis
Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Osteoarthritis
Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38.
Osteoarthritis
Hyaluronan Suppresses IL-1beta-induced Metalloproteinase Activity from Synovial Tissue.
Osteoarthritis
Hyaluronan suppresses IL-1beta-induced metalloproteinase activity from synovial tissue.
Osteoarthritis
Immobilization of matrix metalloproteinase 8 (MMP-8) for online drug screening.
Osteoarthritis
Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium.
Osteoarthritis
Induction of Matrix Metalloproteinase Expression by Synovial Wnt Signaling and Association With Disease Progression in Early Symptomatic Osteoarthritis.
Osteoarthritis
Induction of matrix metalloproteinase-8 in human fibroblasts by basic calcium phosphate and calcium pyrophosphate dihydrate crystals: effect of phosphocitrate.
Osteoarthritis
Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor.
Osteoarthritis
Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
Osteoarthritis
Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction.
Osteoarthritis
Intact pericellular matrix of articular cartilage is required for unactivated discoidin domain receptor 2 in the mouse model.
Osteoarthritis
Interferonregulatoryfactor-8(IRF-8) regulates the expression of matrix metalloproteinase-13 (MMP-13) in chondrocytes.
Osteoarthritis
Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
Osteoarthritis
Intra-articular lentivirus-mediated insertion of the fat-1 gene ameliorates osteoarthritis.
Osteoarthritis
Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients.
Osteoarthritis
Lipooxygenase inhibition in osteoarthritis: a potential symptomatic and disease modifying effect?
Osteoarthritis
Matrix metalloproteinase 28/epilysin expression in cartilage from patients with rheumatoid arthritis and osteoarthritis: comment on the article by Kevorkian et al.
Osteoarthritis
Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis.
Osteoarthritis
Matrix metalloproteinase and its inhibitor in temporomandibular joint osteoarthrosis after indirect trauma in young goats.
Osteoarthritis
Matrix Metalloproteinase Inhibition With Doxycycline Affects the Progression of Posttraumatic Osteoarthritis After Anterior Cruciate Ligament Rupture: Evaluation in a New Nonsurgical Murine ACL Rupture Model.
Osteoarthritis
Matrix metalloproteinase inhibitors in rheumatic diseases.
Osteoarthritis
Matrix metalloproteinases and inhibitors in cartilage tissue engineering.
Osteoarthritis
Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis.
Osteoarthritis
Mechanical strain attenuates cytokine-induced ADAMTS9 expression via transient receptor potential vanilloid type 1.
Osteoarthritis
MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1?-stimulated human articular chondrocyte C28/I2 cells.
Osteoarthritis
MMP-3 and -8 expression is found in the condylar surface of temporomandibular joints with internal derangement.
Osteoarthritis
Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors.
Osteoarthritis
Molecular changes in human osteoarthritic cartilage after 3 weeks of oral administration of BAY 12-9566, a matrix metalloproteinase inhibitor.
Osteoarthritis
NAD(P)H Oxidase Activity of Nox4 in Chondrocytes Is Both Inducible and Involved in Collagenase Expression.
Osteoarthritis
Optimization of matrix metalloproteinase fluorogenic probes for osteoarthritis imaging.
Osteoarthritis
Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits.
Osteoarthritis
Osteoarthritic lesions: involvement of three different collagenases.
Osteoarthritis
Osteoblasts Regulate the Expression of ADAMTS and MMPs in Chondrocytes through ERK Signaling Pathway.
Osteoarthritis
Overexpression of HMGB1 A-box reduced IL-1?-induced MMP expression and the production of inflammatory mediators in human chondrocytes.
Osteoarthritis
Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis.
Osteoarthritis
Platelets Contribute to the Accumulation of Matrix Metalloproteinase Type 2 in Synovial Fluid in Osteoarthritis.
Osteoarthritis
Polysaccharide from Angelica sinensis protects chondrocytes from H2O2-induced apoptosis through its antioxidant effects in vitro.
Osteoarthritis
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.
Osteoarthritis
Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity.
Osteoarthritis
Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes.
Osteoarthritis
Protective Effect of Withania somnifera and Cardiospermum halicacabum Extracts Against Collagenolytic Degradation of Collagen.
Osteoarthritis
Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.
Osteoarthritis
Quantitative pre-clinical screening of therapeutics for joint diseases using contrast enhanced micro-computed tomography.
Osteoarthritis
Rac1 is required for matrix metalloproteinase-13 production by chondrocytes in response to fibronectin fragments.
Osteoarthritis
Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.
Osteoarthritis
Relationship Between Magnetic Resonance T2-Mapping and Matrix Metalloproteinase 1,3 in Knee Osteoarthritis.
Osteoarthritis
Role of PPAR? in down-regulating AGE-induced TGF-? and MMP-9 expressions in chondrocytes.
Osteoarthritis
S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.
Osteoarthritis
Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
Osteoarthritis
Standardized butanol fraction of WIN-34B suppresses cartilage destruction via inhibited production of matrix metalloproteinase and inflammatory mediator in osteoarthritis human cartilage explants culture and chondrocytes.
Osteoarthritis
Synovial matrix metalloproteinase-2 in different stages of sheep temporomandibular joint osteoarthrosis.
Osteoarthritis
Synthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.
Osteoarthritis
Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.
Osteoarthritis
Targeted designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection.
Osteoarthritis
Tetracycline use in treating osteoarthritis: a systematic review.
Osteoarthritis
The effect of non-steroidal anti-inflammatory drugs on matrix metalloproteinases levels in patients with osteoarthritis.
Osteoarthritis
The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
Osteoarthritis
The NAD-Dependent Deacetylase Sirtuin-1 Regulates the Expression of Osteogenic Transcriptional Activator Runt-Related Transcription Factor 2 (Runx2) and Production of Matrix Metalloproteinase (MMP)-13 in Chondrocytes in Osteoarthritis.
Osteoarthritis
Thymoquinone inhibits matrix metalloproteinase expression in rabbit chondrocytes and cartilage in experimental osteoarthritis.
Osteoarthritis
TNF-? increases the expression of inflammatory factors in synovial fibroblasts by inhibiting the PI3K/AKT pathway in a rat model of monosodium iodoacetate-induced osteoarthritis.
Osteoarthritis
Transcriptional activation of human MMP-13 gene expression by c-Maf in osteoarthritic chondrocyte.
Osteoarthritis
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors.
Osteoarthritis
Up-regulated DERL3 in fibroblast-like synoviocytes exacerbates inflammation of rheumatoid arthritis.
Osteoarthritis
[Effect of acupotomy lysis on serum matrix metalloproteinase (MMP)-3 and MMP-13 contents in osteoarthritis rabbits]
Osteoarthritis
[Effects of intra-articular injection of p38 mitogen-activated protein kinase inhibitor on matrix metalloproteinase in articular cartilage of a rat model of osteoarthritis]
Osteoarthritis, Knee
Associations between knee structural measures, circulating inflammatory factors and MMP13 in patients with knee osteoarthritis.
Osteoarthritis, Knee
Development of musculoskeletal toxicity without clear benefit after administration of PG 116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12 month, double-blind, placebo-controlled study.
Osteoarthritis, Knee
Effects of Exercise Training Alone and in Combination With Kinesio Taping on Pain, Functionality, and Biomarkers Related to the Cartilage Metabolism in Knee Osteoarthritis.
Osteoarthritis, Knee
Effects of l-Carnitine Supplementation on Serum Inflammatory Factors and Matrix Metalloproteinase Enzymes in Females with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Osteoarthritis, Knee
Increased serum ADAMTS-4 in knee osteoarthritis: a potential indicator for the diagnosis of osteoarthritis in early stages.
Osteoarthritis, Knee
Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis.
Osteoarthritis, Knee
Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis.
Osteoarthritis, Knee
Relationship Between Magnetic Resonance T2-Mapping and Matrix Metalloproteinase 1,3 in Knee Osteoarthritis.
Osteoarthritis, Knee
Serum levels of matrix metalloproteinase-3 as a prognostic marker for progression of cartilage injury in patients with knee osteoarthritis.
Osteochondritis Dissecans
Microscopic localization of active gelatinases in equine osteochondritis dissecans (OCD) cartilage.
Osteochondrodysplasias
Differential expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in avian tibial dyschondroplasia.
Osteochondrodysplasias
Matrix metalloproteinase activities in avian tibial dyschondroplasia.
Osteochondrosis
Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis.
Osteolysis
Characterization of Normal Murine Carpal Bone Development Prompts Re-Evaluation of Pathologic Osteolysis as the Cause of Human Carpal-Tarsal Osteolysis Disorders.
Osteolysis
Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
Osteolysis
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints.
Osteolysis
Possible role of matrix metalloproteinase in osteolytic intracranial meningiomas.
Osteolysis
[Influence and role of expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 9 in aseptic loosening of prosthesis].
Osteonecrosis
Association of MMP-8 rs2012390 and rs11225394 polymorphisms with osteonecrosis of the femoral head risks: Evidence from a meta-analysis.
Osteonecrosis
MMP-3 and MMP-8 single-nucleotide polymorphisms are related to alcohol-induced osteonecrosis of the femoral head in Chinese males.
Osteophyte
Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development.
Osteoporosis
Dynamic expression of matrix metalloproteinases 2, 9 and 13 in ovariectomy-induced osteoporosis rats.
Osteoporosis
Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis.
Osteoporosis
EVALUATION OF BONE RESORPTIVE POTENTIAL IN THE TREATMENT OF GENERALIZED PERIODONTITIS.
Osteoporosis
Immunolocalization of MMP 2, 9 and 13 in prednisolone induced osteoporosis in mice.
Osteosarcoma
Actopaxin (?-Parvin) phosphorylation is required for matrix degradation and cancer cell invasion.
Osteosarcoma
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs.
Osteosarcoma
AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element.
Osteosarcoma
Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells.
Osteosarcoma
Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study.
Osteosarcoma
Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.
Osteosarcoma
Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.
Osteosarcoma
Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma.
Osteosarcoma
Glucosamine sulfate suppresses the expression of matrix metalloproteinase-3 in osteosarcoma cells in vitro.
Osteosarcoma
Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxyamino)-2R-isobutylsuccinyl]amino-1-methoxy-3,4-dihydroc arbostyril, a novel matrix metalloproteinase inhibitor.
Osteosarcoma
MicroRNA-2682-3p inhibits osteosarcoma cell proliferation by targeting CCND2, MMP8 and Myd88.
Osteosarcoma
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.
Osteosarcoma
Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma.
Osteosarcoma
Oridonin inhibits the proliferation, migration and invasion of human osteosarcoma cells via suppression of matrix metalloproteinase expression and STAT3 signalling pathway.
Osteosarcoma
Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats.
Osteosarcoma
Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells.
Osteosarcoma
Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma.
Osteosarcoma
Reoxygenation using a novel CO2 therapy decreases the metastatic potential of osteosarcoma cells.
Osteosarcoma
S100A7 promotes the migration and invasion of osteosarcoma cells via the receptor for advanced glycation end products.
Osteosarcoma
Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.
Osteosarcoma
STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation.
Osteosarcoma
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas.
Osteosarcoma
VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma.
Otitis Media
Expression of matrix metalloproteinase in cholesteatoma epithelium of patients with cholesteatoma otitis media.
Otitis Media
Matrix metalloproteinase-8/collagenase-2 in childhood otitis media with effusion.
Otitis Media
Selected cytokines in hypertrophic adenoids in children suffering from otitis media with effusion.
Otitis Media with Effusion
Matrix metalloproteinase-8/collagenase-2 in childhood otitis media with effusion.
Otitis Media with Effusion
Selected cytokines in hypertrophic adenoids in children suffering from otitis media with effusion.
Ovarian Cysts
Collagenases (MMP-1, -8 and -13) and trypsinogen-2 in fluid from benign and malignant ovarian cysts.
Ovarian Cysts
Study on matrix metalloproteinase 1 and 2 gene expression and NO in dairy cows with ovarian cysts.
Ovarian Neoplasms
CD147 in ovarian and other cancers.
Ovarian Neoplasms
Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
Ovarian Neoplasms
Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer.
Ovarian Neoplasms
Editor's Note: The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer.
Ovarian Neoplasms
Effect of CO2 pneumoperitoneum on the proliferation of human ovarian cancer cell line SKOV-3 and the expression of NM23-H1 and MMP-2.
Ovarian Neoplasms
EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.
Ovarian Neoplasms
Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
Ovarian Neoplasms
Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.
Ovarian Neoplasms
Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2).
Ovarian Neoplasms
Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.
Ovarian Neoplasms
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
Ovarian Neoplasms
Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.
Ovarian Neoplasms
Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Ovarian Neoplasms
Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1?/miR-210/VMP1 signaling pathway.
Ovarian Neoplasms
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Ovarian Neoplasms
Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration.
Ovarian Neoplasms
Inhibition of integrin ?1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
Ovarian Neoplasms
Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract.
Ovarian Neoplasms
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.
Ovarian Neoplasms
Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome.
Ovarian Neoplasms
Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer.
Ovarian Neoplasms
Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells.
Ovarian Neoplasms
Novel functions for 2-phenylbenzimidazole-5-sulphonic acid: Inhibition of ovarian cancer cell responses and tumour angiogenesis.
Ovarian Neoplasms
Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe.
Ovarian Neoplasms
Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ovarian Neoplasms
Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion.
Ovarian Neoplasms
Overexpression of CD147 in ovarian cancer is initiated by the hypoxic microenvironment.
Ovarian Neoplasms
Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.
Ovarian Neoplasms
Sorafenib controls the epithelial?mesenchymal transition of ovarian cancer cells via EGF and the CD44?HA signaling pathway in a cell type?dependent manner.
Ovarian Neoplasms
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer.
Ovarian Neoplasms
The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma.
Ovarian Neoplasms
The role of SDF-1/CXCR4 axis in ovarian cancer metastasis.
Ovarian Neoplasms
Tumor-associated macrophages promote invasion via Toll-like receptors signaling in patients with ovarian cancer.
Ovarian Neoplasms
Vacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer.
Ovarian Neoplasms
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Ovarian Neoplasms
[Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer]
Overnutrition
Postnatal early overnutrition dysregulates the intrarenal renin-angiotensin system and extracellular matrix-linked molecules in juvenile male rats.
Overweight
Association of MMP-8 with obesity, smoking and insulin resistance.
Overweight
Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women.
Overweight
Level of Adiponectin, Leptin and Selected Matrix Metalloproteinases in Female Overweight Patients with Primary Gonarthrosis.
Paget Disease, Extramammary
Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget's disease by receptor activator of nuclear factor kappa-B ligand (RANKL)/ RANK pathways.
Pancreatic Neoplasms
?-Mangostin suppresses lipopolysaccharide-induced invasion by inhibiting matrix metalloproteinase-2/9 and increasing E-cadherin expression through extracellular signal-regulated kinase signaling in pancreatic cancer cells.
Pancreatic Neoplasms
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.
Pancreatic Neoplasms
A phase II trial of marimastat in advanced pancreatic cancer.
Pancreatic Neoplasms
Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer.
Pancreatic Neoplasms
Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer.
Pancreatic Neoplasms
Biological approaches to therapy of pancreatic cancer.
Pancreatic Neoplasms
Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2.
Pancreatic Neoplasms
Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells.
Pancreatic Neoplasms
Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.
Pancreatic Neoplasms
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
Pancreatic Neoplasms
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Pancreatic Neoplasms
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
Pancreatic Neoplasms
Detection of matrix metalloproteinase activity in human pancreatic cancer.
Pancreatic Neoplasms
Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control.
Pancreatic Neoplasms
Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness.
Pancreatic Neoplasms
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Pancreatic Neoplasms
Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer.
Pancreatic Neoplasms
Expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in pancreatic neoplasm and pancreatic stellate cells.
Pancreatic Neoplasms
Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy.
Pancreatic Neoplasms
Gamma-Irradiation Enhances RECK Protein Levels in Panc-1 Pancreatic Cancer Cells.
Pancreatic Neoplasms
Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation.
Pancreatic Neoplasms
High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
Pancreatic Neoplasms
In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organs.
Pancreatic Neoplasms
Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells.
Pancreatic Neoplasms
Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
Pancreatic Neoplasms
Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
Pancreatic Neoplasms
Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer.
Pancreatic Neoplasms
Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design.
Pancreatic Neoplasms
Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Pancreatic Neoplasms
MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.
Pancreatic Neoplasms
Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin.
Pancreatic Neoplasms
Neurotransmitter Substance P Mediates Pancreatic Cancer Perineural Invasion via NK-1R in Cancer Cells.
Pancreatic Neoplasms
New target therapies in advanced pancreatic cancer.
Pancreatic Neoplasms
Novel approaches to target pancreatic cancer.
Pancreatic Neoplasms
Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
Pancreatic Neoplasms
Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1? in pancreatic cancer: Implications for tumor progression and prognosis.
Pancreatic Neoplasms
Pancreatic cancer: what the oncologist can offer for palliation.
Pancreatic Neoplasms
Pancreaticobiliary cancer: the future aspects of medical oncology.
Pancreatic Neoplasms
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Pancreatic Neoplasms
Prevention of early liver metastasis after pancreatectomy by perioperative administration of a nuclear factor-?B inhibitor in mice.
Pancreatic Neoplasms
Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1? and TGF? and Implications for Migration of Pancreatic Cancer Cells.
Pancreatic Neoplasms
Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023.
Pancreatic Neoplasms
Role of matrix metalloproteinases and their inhibitors in pancreatic cancer.
Pancreatic Neoplasms
Rosmarinic inhibits cell proliferation, invasion and migration via up-regulating miR-506 and suppressing MMP2/16 expression in pancreatic cancer.
Pancreatic Neoplasms
Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer.
Pancreatic Neoplasms
Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice.
Pancreatic Neoplasms
The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer.
Pancreatic Neoplasms
Thrombospondin-2 inhibits tumor cell invasion through the modulation of MMP-9 and uPA in pancreatic cancer cells.
Pancreatitis
Activated matrix metalloproteinase 8 in serum predicts severity of acute pancreatitis.
Pancreatitis
Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis.
Pancreatitis
Increased matrix metalloproteinase expression and activation following experimental acute pancreatitis.
Pancreatitis
Inhibition of Matrix Metalloproteinase with BB-94 Protects against Caerulein-Induced Pancreatitis via Modulating Neutrophil and Macrophage Activation.
Pancreatitis
Matrix metalloproteinase levels in acute aortic dissection, acute pancreatitis and other abdominal pain.
Pancreatitis
Role of TGF-beta1, extracellular matrix, and matrix metalloproteinase in the healing process of the pancreas after induction of acute necrotizing pancreatitis using arginine in rats.
Pancreatitis, Acute Necrotizing
Role of TGF-beta1, extracellular matrix, and matrix metalloproteinase in the healing process of the pancreas after induction of acute necrotizing pancreatitis using arginine in rats.
Pancreatitis, Chronic
Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Pancreatitis, Chronic
Role of matrix metalloproteinase 3 gene promoter polymorphism in chronic pancreatitis.
Papilloma
Increased expression of matrix metalloproteinase-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma.
Papilloma
Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Papilloma
Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
Papilloma, Inverted
Increased expression of matrix metalloproteinase-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma.
Papillomavirus Infections
Markers of squamocolumnar junction cells in normal tonsils and oropharyngeal cancer with and without HPV infection.
Papillomavirus Infections
Persistent Oral Human Papillomavirus (HPV) Infection is Associated with Low Salivary Levels of Matrix Metalloproteinase 8 (MMP-8).
Paralysis
Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis.
Paralysis
Mitochondrial dysfunction causes Ca2+ overload and ECM degradation-mediated muscle damage in C. elegans.
Paraparesis, Tropical Spastic
Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy.
Parasitic Diseases
Ecological Factors Mediate Immunity and Parasitic Co-Infection in Sea Fan Octocorals.
Parathyroid Neoplasms
Expression of matrix metalloproteinase gelatinase A messenger ribonucleic acid in parathyroid carcinomas.
Parkinson Disease
Exploring the Association Between Rosacea and Parkinson Disease: A Danish Nationwide Cohort Study.
Parkinson Disease
Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2 G2019S Parkinson's Disease Model Mice.
Parkinson Disease
Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and LRRK2 G2019S Parkinson's disease model mice challenged with lipopolysaccharide.
Parotitis
Decreased salivary matrix metalloproteinase-8 reflecting a defensive potential in juvenile parotitis.
Pediatric Obesity
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Pemphigoid, Benign Mucous Membrane
Neutrophil Collagenase, Gelatinase, and Myeloperoxidase in Tears of Patients with Stevens-Johnson Syndrome and Ocular Cicatricial Pemphigoid.
Pemphigoid, Bullous
Limbal Fibroblasts Maintain Normal Phenotype in 3D RAFT Tissue Equivalents Suggesting Potential for Safe Clinical Use in Treatment of Ocular Surface Failure.
Pemphigoid, Bullous
Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid.
Pemphigoid, Bullous
Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Penile Induration
Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie's plaque fibroblasts.
Penile Induration
Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.
Peptic Ulcer
Functionally significant polymorphisms of the MMP-9 gene are associated with peptic ulcer disease in the Caucasian population of Central Russia.
Peri-Implantitis
aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
Peri-Implantitis
An Unexplored Pharmacologic/Diagnostic Strategy for Peri-Implantitis: A Protocol Proposal.
Peri-Implantitis
Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases.
Peri-Implantitis
Assessment of matrix metalloproteinase-8 and -9 levels in the peri-implant sulcular fluid among waterpipe (narghile) smokers and never-smokers with peri-implantitis.
Peri-Implantitis
Biomarker levels in peri-implant crevicular fluid of healthy implants, untreated and non-surgically treated implants with peri-implantitis.
Peri-Implantitis
Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study.
Peri-Implantitis
Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines.
Peri-Implantitis
Cytokine and matrix metalloproteinase expression in fibroblasts from peri-implantitis lesions in response to viable Porphyromonas gingivalis.
Peri-Implantitis
Early intervention of peri-implantitis and periodontitis utilizing a mouse model.
Peri-Implantitis
Evaluation of Metalloproteinase-8 Levels in Crevicular Fluid of Patients with Healthy Implants or Periodontitis.
Peri-Implantitis
Histological evaluation of peri-implant mucosal and gingival tissues in peri-implantitis, peri-implant mucositis and periodontitis patients: a cross-sectional clinical study.
Peri-Implantitis
Host-Modulation Therapy and Chair-Side Diagnostics in the Treatment of Peri-Implantitis.
Peri-Implantitis
Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid.
Peri-Implantitis
Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
Peri-Implantitis
Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri-Implant Diseases.
Peri-Implantitis
Matrix metalloproteinase-8 is the major potential collagenase in active peri-implantitis.
Peri-Implantitis
Matrix metalloproteinase-8 levels in peri-implant sulcus fluid adjacent to titanium and zirconium nitride surfaces.
Peri-Implantitis
Matrix metalloproteinases (MMPs) in oral diseases.
Peri-Implantitis
MMP-8-Responsive Polyethylene Glycol Hydrogel for Intraoral Drug Delivery.
Peri-Implantitis
Peri-Implant Sulcus Fluid (PISF) Matrix Metalloproteinase (MMP) -8 Levels in Peri-Implantitis.
Peri-Implantitis
Periodontitis and peri-implantitis tissue levels of Treponema denticola-CTLP and its MMP-8 activating ability.
Peri-Implantitis
Salivary Diagnostics-Point-of-Care diagnostics of MMP-8 in dentistry and medicine.
Peri-Implantitis
Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease.
Peri-Implantitis
Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation.
Peri-Implantitis
Use of IL-1 ?, IL-6, TNF-?, and MMP-8 biomarkers to distinguish peri-implant diseases: A systematic review and meta-analysis.
Periapical Diseases
Sonic extracts from a bacterium related to periapical disease activate gelatinase A and inactivate tissue inhibitor of metalloproteinases TIMP-1 and TIMP-2.
Periapical Granuloma
Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions.
Periapical Granuloma
Expression of matrix metalloproteinase-8 and matrix metalloproteinase-13 in mast cells of human periapical lesions.
Periapical Granuloma
High matrix metalloproteinase activity is a hallmark of periapical granulomas.
Periapical Granuloma
Matrix metalloproteinase-8 (MMP-8) in pulpal and periapical inflammation and periapical root-canal exudates.
Periapical Periodontitis
Clinical Investigation of Matrix Metalloproteinases, Tissue Inhibitors of Matrix Metalloproteinases, and Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Complexes and Their Networks in Apical Periodontitis.
Periapical Periodontitis
Expression Levels of Matrix Metalloproteinase-9 and Gram-negative Bacteria in Symptomatic and Asymptomatic Periapical Lesions.
Periapical Periodontitis
Expression of Interleukin-1? and Matrix Metalloproteinase-8 in Cytolytic and Noncytolytic Enterococcus faecalis-induced Persistent Apical Periodontitis: A Comparative Study in the Rat.
Periapical Periodontitis
Expression of matrix metalloproteinase-8 and matrix metalloproteinase-13 in mast cells of human periapical lesions.
Periapical Periodontitis
Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases during Apical Periodontitis Development.
Periapical Periodontitis
Matrix metalloproteinase expression in teeth with apical periodontitis is differentially modulated by the modality of root canal treatment.
Periapical Periodontitis
The Expression of Semaphorin 7A in Human Periapical Lesions.
Pericardial Effusion
Lesions of the pericardium and their significance in the aetiology of heart failure in broiler chickens.
Perinatal Death
Gastric fluid versus amniotic fluid analysis for the identification of intra-amniotic infection due to Ureaplasma species.
Periodontal Attachment Loss
Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis.
Periodontal Attachment Loss
Collagenolytic enzymes in gingival crevicular fluid as diagnostic indicators of periodontitis.
Periodontal Diseases
A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.
Periodontal Diseases
A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies.
Periodontal Diseases
A Prototype Antibody-based Biosensor for Measurement of Salivary MMP-8 in Periodontitis using Surface Acoustic Wave Technology.
Periodontal Diseases
Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases.
Periodontal Diseases
Anti-rheumatic medication and salivary MMP-8, a biomarker for periodontal disease.
Periodontal Diseases
Application of quantitative proteomic analysis using tandem mass tags for discovery and identification of novel biomarkers in periodontal disease.
Periodontal Diseases
Areca nut extract represses migration and differentiation while activating matrix metalloproteinase-9 of normal gingival epithelial cells.
Periodontal Diseases
Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases.
Periodontal Diseases
Association between isotretinoin (Roaccutanne) use and changes in periodontal clinical parameters and MMP-8 and MMP-9 salivary levels.
Periodontal Diseases
Association between serum and oral matrix metalloproteinase-8 levels and periodontal health status.
Periodontal Diseases
Associations of oral fluid MMP-8 with periodontitis in Swiss adult subjects.
Periodontal Diseases
Biomarkers of periodontitis in oral fluids.
Periodontal Diseases
Changes in Inflammatory Cytokines in Saliva after Non-Surgical Periodontal Therapy: A Systematic Review and Meta-Analysis.
Periodontal Diseases
Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
Periodontal Diseases
Circulating Porphyromonas gingivalis lipopolysaccharide resets cardiac homeostasis in mice through a matrix metalloproteinase-9-dependent mechanism.
Periodontal Diseases
Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team.
Periodontal Diseases
Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Periodontal Diseases
Diagnostic sensitivity and specificity of host-derived salivary biomarkers in periodontal disease amongst adults: Systematic review.
Periodontal Diseases
Differential regulation of MMP-13 by chemical modified tetracyclines in osteoblasts.
Periodontal Diseases
Effect of smoking on periodontal health.
Periodontal Diseases
Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial.
Periodontal Diseases
Effects of Cigarette Smoke Condensate and Nicotine on Human Gingival Fibroblast-Mediated Collagen Degradation.
Periodontal Diseases
Effects of therapy with two combinations of antibiotics on the imbalance of MMP-2÷TIMP-2 in chronic periodontitis.
Periodontal Diseases
Epithelial barrier and oral bacterial infection.
Periodontal Diseases
Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases.
Periodontal Diseases
Evaluation of gingival crevicular fluid cyclophilin a and extracellular matrix metalloproteinase inducer levels in different periodontal diseases.
Periodontal Diseases
Evaluation of immunoassay-based MMP-8 detection in gingival crevicular fluid on a point-of-care platform.
Periodontal Diseases
Evaluation of salivary biomarkers for the diagnosis of periodontitis.
Periodontal Diseases
Functional polymorphisms in the matrix metalloproteinase-9 gene in relation to severity of chronic periodontitis.
Periodontal Diseases
Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Periodontal Diseases
Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease.
Periodontal Diseases
Gingival crevicular fluid semaphorin 4D and peptidylarginine deiminase-2 levels in periodontal health and disease.
Periodontal Diseases
Identification of pathogen and host-response markers correlated with periodontal disease.
Periodontal Diseases
Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis.
Periodontal Diseases
Increased local matrix metalloproteinase-8 expression in the periodontal connective tissues of smokers with periodontal disease.
Periodontal Diseases
Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease.
Periodontal Diseases
Inhibitory effect of flavonoid baicalin on degranulation of human polymorphonuclear leukocytes induced by interleukin-8: potential role in periodontal diseases.
Periodontal Diseases
Levels of gingival crevicular metalloproteinases-8 and -9 in periodontitis.
Periodontal Diseases
Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients.
Periodontal Diseases
Matrix metalloproteinase 8 (MMP8) gene polymorphisms in chronic periodontitis.
Periodontal Diseases
Matrix metalloproteinase-8 activity in gingival crevicular fluid: development of a novel assay.
Periodontal Diseases
Matrix metalloproteinase-8 analysis in patients with periodontal disease with prediabetes or type 2 diabetes mellitus: A systematic review.
Periodontal Diseases
Matrix metalloproteinase-8 concentration in shallow crevices associated with the extent of periodontal disease.
Periodontal Diseases
Matrix metalloproteinase-8 expression in periodontal tissues surgically removed from diabetic and non-diabetic patients with periodontal disease.
Periodontal Diseases
Matrix metalloproteinase-8 levels in periodontal disease patients: A systematic review.
Periodontal Diseases
Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae.
Periodontal Diseases
Microfluidic immunoassays as rapid saliva-based clinical diagnostics.
Periodontal Diseases
MMP-8, TRAP-5, and OPG Levels in GCF Diagnostic Potential to Discriminate between Healthy Patients', Mild and Severe Periodontitis Sites.
Periodontal Diseases
Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test.
Periodontal Diseases
Neutrophil elastase activity, levels of prostaglandin E2, and matrix metalloproteinase-8 in refractory periodontitis sites in smokers and non-smokers.
Periodontal Diseases
Non-proteolytic activation of latent human neutrophil collagenase and its role in matrix destruction in periodontal diseases.
Periodontal Diseases
Peri-Implantitis Diagnosis and Prognosis Using Biomarkers in Peri-Implant Crevicular Fluid: A Narrative Review.
Periodontal Diseases
Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease.
Periodontal Diseases
Periodontal Disease and Adverse Pregnancy Outcomes: A Prospective Study in a Low-Risk Population.
Periodontal Diseases
Porphyromonas gingivalis-mediated shedding of extracellular matrix metalloproteinase inducer (EMMPRIN) by oral epithelial cells: a potential role in inflammatory periodontal disease.
Periodontal Diseases
Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histiocytes.
Periodontal Diseases
Prediabetes/Diabetes Can Be Screened at the Dental Office by a Low-Cost and Fast Chair-Side/Point-of-Care aMMP-8 Immunotest.
Periodontal Diseases
Rapid assessment of salivary MMP-8 and periodontal disease using lateral flow immunoassay.
Periodontal Diseases
Relationship between TNF-?, MMP-8, and MMP-9 levels in gingival crevicular fluid and the subgingival microbiota in periodontal disease.
Periodontal Diseases
Rheumatoid arthritis and salivary biomarkers of periodontal disease.
Periodontal Diseases
Salivary biomarkers of existing periodontal disease: a cross-sectional study.
Periodontal Diseases
Salivary biomarkers: Relationship between oxidative stress and alveolar bone loss in chronic periodontitis.
Periodontal Diseases
Salivary IgA, Interleukin-1? and MMP-8 as Salivary Biomarkers in Chronic Periodontitis Patients.
Periodontal Diseases
Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus.
Periodontal Diseases
Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
Periodontal Diseases
Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease.
Periodontal Diseases
Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation.
Periodontal Diseases
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
Periodontal Diseases
The analysis of matrix metalloproteinase-8 in gingival crevicular fluid and periodontal diseases.
Periodontal Diseases
The effects of periodontal therapy on gingival crevicular fluid matrix metalloproteinase-8, interleukin-6 and prostaglandin E2 levels in patients with rheumatoid arthritis.
Periodontal Diseases
The influence of type 2 diabetes mellitus on salivary matrix metalloproteinase-8 levels and periodontal parameters: A study in an Indian population.
Periodontal Diseases
The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease.
Periodontal Diseases
Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment.
Periodontal Diseases
[Purification of human neutrophil collagenase, establishment of its monoclonal antibodies and application to gingival crevicular neutrophils]
Periodontal Pocket
Chlamydia pneumoniae together with collagenase-2 (MMP-8) in periodontal lesions.
Periodontal Pocket
Clinical Correlates of A Lateral Flow Immunoassay Oral Risk Indicator.
Periodontal Pocket
Collagenase activity in gingival crevicular fluid of patients with juvenile periodontitis.
Periodontal Pocket
Is the progression rate of periodontitis related to subgingival biofilm composition or gingival crevicular fluid IL-1? and MMP-8 concentrations?
Periodontal Pocket
Origin of MMP-8 and Lactoferrin levels from gingival crevicular fluid, salivary glands and whole saliva.
Periodontal Pocket
Periodontal Inflammatory Burden and Salivary Matrix Metalloproteinase-8 Concentration Among Patients With Chronic Kidney Disease at the Predialysis Stage.
Periodontal Pocket
Relationship of collagenase and cathepsin G activity in gingival crevicular fluid.
Periodontal Pocket
Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis.
Periodontal Pocket
The potential of salivary biomarkers for predicting the sensitivity and monitoring the response to nonsurgical periodontal therapy: A preliminary assessment.
Periodontitis
A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.
Periodontitis
A Prototype Antibody-based Biosensor for Measurement of Salivary MMP-8 in Periodontitis using Surface Acoustic Wave Technology.
Periodontitis
A Systems Biology Approach to Reveal Putative Host-Derived Biomarkers of Periodontitis by Network Topology Characterization of MMP-REDOX/NO and Apoptosis Integrated Pathways.
Periodontitis
Activation of neutrophil collagenase in periodontitis.
Periodontitis
Active Matrix Metalloproteinase-8 Point-of-Care (PoC)/Chairside Mouthrinse Test vs. Bleeding on Probing in Diagnosing Subclinical Periodontitis in Adolescents.
Periodontitis
Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
Periodontitis
Active MMP-8 Quantitative Test as an Adjunctive Tool for Early Diagnosis of Periodontitis.
Periodontitis
aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
Periodontitis
An aMMP-8 Point-of-Care and Questionnaire Based Real-Time Diagnostic Toolkit for Medical Practitioners.
Periodontitis
An Unexplored Pharmacologic/Diagnostic Strategy for Peri-Implantitis: A Protocol Proposal.
Periodontitis
Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down's syndrome.
Periodontitis
Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases.
Periodontitis
Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases.
Periodontitis
Assessment of MMP-1, MMP-8 and TIMP-2 in experimental periodontitis treated with kaempferol.
Periodontitis
Association between isotretinoin (Roaccutanne) use and changes in periodontal clinical parameters and MMP-8 and MMP-9 salivary levels.
Periodontitis
Association between serum and oral matrix metalloproteinase-8 levels and periodontal health status.
Periodontitis
Association of Common Variants in MMPs with Periodontitis Risk.
Periodontitis
Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study.
Periodontitis
Associations of oral fluid MMP-8 with periodontitis in Swiss adult subjects.
Periodontitis
Associations of periodontal microorganisms with salivary proteins and MMP-8 in gingival crevicular fluid.
Periodontitis
Biomarkers of periodontitis in oral fluids.
Periodontitis
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study.
Periodontitis
Changes in Inflammatory Cytokines in Saliva after Non-Surgical Periodontal Therapy: A Systematic Review and Meta-Analysis.
Periodontitis
Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study.
Periodontitis
Clinical Correlates of A Lateral Flow Immunoassay Oral Risk Indicator.
Periodontitis
Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue.
Periodontitis
Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines.
Periodontitis
Comparing periodontitis biomarkers in saliva, oral rinse and gingival crevicular fluid: A pilot study.
Periodontitis
Concentration of MMP-8 and IL-1? in gingival crevicular fluid in patients with chronic and aggressive periodontitis.
Periodontitis
Content of matrix metalloproteinase-8 and matrix metalloproteinase-9 in oral fluid of patients with chronic generalized periodontitis.
Periodontitis
Core-Shell poly-(D,l-Lactide-co-Glycolide)-chitosan Nanospheres with simvastatin-doxycycline for periodontal and osseous repair.
Periodontitis
Cross-sectional analysis of risk factors for subclinical periodontitis; active matrix metalloproteinase-8 as a potential indicator in initial periodontitis in adolescents.
Periodontitis
Cytokine-induced endogenous procollagenase stored in the extracellular matrix of soft connective tissue results in a burst of collagen breakdown following its activation.
Periodontitis
Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods.
Periodontitis
Diagnostic Ability of Salivary Matrix Metalloproteinase-9 Lateral-Flow-Test Point-of-Care Test for Periodontitis.
Periodontitis
Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease.
Periodontitis
Diagnostic and Prognostic ability of salivary MMP-9 and S100A8 for periodontitis.
Periodontitis
Diagnostic sensitivity and specificity of host-derived salivary biomarkers in periodontal disease amongst adults: Systematic review.
Periodontitis
Does Chemically Modified Curcumin Control the Progression of Periodontitis? A Systematic Review.
Periodontitis
Early intervention of peri-implantitis and periodontitis utilizing a mouse model.
Periodontitis
Early pregnancy levels of gingival crevicular fluid matrix metalloproteinases-8 and -9 are associated with the severity of periodontitis and the development of gestational diabetes mellitus.
Periodontitis
Efficacy test of horse chestnut leaf extract (ALH-L1005) as matrix metalloproteinase inhibitors in ligature-induced periodontitis in canine model.
Periodontitis
EMMPRIN-CypA contributes to the inflammatory processes in human periodontitis through infiltrating CD68+ inflammatory cells.
Periodontitis
EVALUATION OF BONE RESORPTIVE POTENTIAL IN THE TREATMENT OF GENERALIZED PERIODONTITIS.
Periodontitis
Evaluation of Metalloproteinase-8 Levels in Crevicular Fluid of Patients with Healthy Implants or Periodontitis.
Periodontitis
Evaluation of salivary biomarkers for the diagnosis of periodontitis.
Periodontitis
Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis.
Periodontitis
Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue.
Periodontitis
Expression profile of lipoxygenases in gingival tissues of human periodontitis.
Periodontitis
Extracellular ?-NAD(+) Inhibits Interleukin-1-Induced Matrix Metalloproteinase-1 and -3 Expression on Human Gingival Fibroblasts.
Periodontitis
Full-mouth profile of active MMP-8 in periodontitis patients.
Periodontitis
Genetic Factors and the Risk of Periodontitis Development: Findings from a Systematic Review Composed of 13 Studies of Meta-Analysis with 71,531 Participants.
Periodontitis
Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis.
Periodontitis
Gingival crevicular fluid levels of matrix metalloproteinases cross-sectionally related to periodontitis and metabolic syndrome in community Koreans.
Periodontitis
Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease.
Periodontitis
Gingival Tissue and Crevicular Fluid Co-operation in Adult Periodontitis.
Periodontitis
Gingival Tissue Inflammation Promotes Increased Matrix Metalloproteinase-12 Production by CD200R
Periodontitis
Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis.
Periodontitis
Histological evaluation of peri-implant mucosal and gingival tissues in peri-implantitis, peri-implant mucositis and periodontitis patients: a cross-sectional clinical study.
Periodontitis
Host-Modulation Therapy and Chair-Side Diagnostics in the Treatment of Peri-Implantitis.
Periodontitis
Human leukocyte antigens are associated with salivary level of active MMP-8.
Periodontitis
Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).
Periodontitis
Identification of pathogen and host-response markers correlated with periodontal disease.
Periodontitis
Implant-safe test in patients with peri-implantitis.
Periodontitis
Importance of MMP-8 in Salivary and Gingival Crevicular Fluids of Periodontitis Patients.
Periodontitis
Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Periodontitis
Increased local matrix metalloproteinase-8 expression in the periodontal connective tissues of smokers with periodontal disease.
Periodontitis
Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
Periodontitis
Interaction between the Wnt/?-catenin signaling pathway and the EMMPRIN/MMP-2, 9 route in periodontitis.
Periodontitis
Is the progression rate of periodontitis related to subgingival biofilm composition or gingival crevicular fluid IL-1? and MMP-8 concentrations?
Periodontitis
Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis.
Periodontitis
Langerhans cells express matrix metalloproteinases 9 and 2 and tissue inhibitors of metalloproteinases 1 and 2 in healthy human gingival tissue and in periodontitis.
Periodontitis
Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
Periodontitis
Levels of gingival crevicular metalloproteinases-8 and -9 in periodontitis.
Periodontitis
Levels of myeloid-related proteins in saliva for screening and monitoring of periodontal disease.
Periodontitis
Local administration of Tiludronic Acid downregulates important mediators involved in periodontal tissue destruction in experimental periodontitis in rats.
Periodontitis
Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis.
Periodontitis
Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis.
Periodontitis
Longitudinal evaluation of clinical, spectral and tissue degradation biomarkers in progression of periodontitis among cigarette and electronic cigarette smokers.
Periodontitis
Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis.
Periodontitis
Matrix metalloproteinase gene polymorphisms and periodontitis susceptibility: a meta-analysis involving 6,162 individuals.
Periodontitis
Matrix metalloproteinase-1 and -3 gene promoter polymorphisms in Japanese patients with periodontitis.
Periodontitis
Matrix metalloproteinase-1 and -8 in gingival crevicular fluid during orthodontic tooth movement: a pilot study during 1 month of follow-up after fixed appliance activation.
Periodontitis
Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.
Periodontitis
Matrix metalloproteinases (MMPs) in oral diseases.
Periodontitis
Matrix metalloproteinases and inflammatory cytokines in oral fluid of patients with chronic generalized periodontitis and various construction materials.
Periodontitis
Matrix metalloproteinases and inflammatory cytokines in the oral fluid of patients with chronic generalized periodontitis various structural materials restoration of teeth and dentition.
Periodontitis
Matrix metalloproteinases and inhibitors in dentistry.
Periodontitis
Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis.
Periodontitis
Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients.
Periodontitis
Matrix metalloproteinases and their inhibitors in gingival mast cells in persons with and without human immunodeficiency virus infection.
Periodontitis
Matrix Metalloproteinases, Tissue Inhibitor of Matrix Metalloproteinase-1, and Laminin-5 ?2 Chain Immunolocalization in Gingival Tissue of Endotoxin-Induced Periodontitis in Rats: Effects of Low-Dose Doxycycline and Alendronate.
Periodontitis
Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
Periodontitis
Meta-analysis of the association between serum and gingival crevicular fluid matrix metalloproteinase-9 and periodontitis.
Periodontitis
Microarray and quantitative RT-PCR analyses in calcium-channel blockers induced gingival overgrowth tissues of periodontitis patients.
Periodontitis
MMP-2, MMP-9 and TIMP-2 gene polymorphisms in Chinese patients with generalized aggressive periodontitis.
Periodontitis
MMP-8 -799 C>T genetic polymorphism is associated with the susceptibility to chronic and aggressive periodontitis in Taiwanese.
Periodontitis
MMP-8, TRAP-5, and OPG Levels in GCF Diagnostic Potential to Discriminate between Healthy Patients', Mild and Severe Periodontitis Sites.
Periodontitis
MMP-8-Responsive Polyethylene Glycol Hydrogel for Intraoral Drug Delivery.
Periodontitis
Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy.
Periodontitis
Modulation of Matrix Metalloproteinase and Cytokine Production by Licorice Isolates Licoricidin and Licorisoflavan A: Potential Therapeutic Approach for Periodontitis.
Periodontitis
Molecular forms and fragments of salivary MMP-8 in relation to periodontitis.
Periodontitis
Morphometric and histopathological evaluation of the effect of grape seed proanthocyanidin on alveolar bone loss in experimental diabetes and periodontitis.
Periodontitis
Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
Periodontitis
Neutrophil elastase activity, levels of prostaglandin E2, and matrix metalloproteinase-8 in refractory periodontitis sites in smokers and non-smokers.
Periodontitis
Non-Surgical Periodontal Therapy Reduces Saliva Adipokines and Matrix Metalloproteinases Levels in Periodontitis.
Periodontitis
Origin of MMP-8 and Lactoferrin levels from gingival crevicular fluid, salivary glands and whole saliva.
Periodontitis
Patterns of Salivary Analytes Provide Diagnostic Capacity for Distinguishing Chronic Adult Periodontitis from Health.
Periodontitis
Peri-Implant Sulcus Fluid (PISF) Matrix Metalloproteinase (MMP) -8 Levels in Peri-Implantitis.
Periodontitis
Periodontitis and Endothelial Dysfunction: Periodontal Clinical Parameters and Levels of Salivary Markers Interleukin-1?, Tumor Necrosis Factor-?, Matrix Metalloproteinase-2, Tissue Inhibitor of Metalloproteinases-2 Complex, and Nitric Oxide.
Periodontitis
Periodontitis and peri-implantitis tissue levels of Treponema denticola-CTLP and its MMP-8 activating ability.
Periodontitis
Pilot Study on Oral Health Status as Assessed by an Active Matrix Metalloproteinase-8 Chairside Mouthrinse Test in Adolescents.
Periodontitis
Pilot Study on the Genetic Background of an Active Matrix Metalloproteinase-8 Test in Finnish Adolescents.
Periodontitis
Porphyromonas gingivalis-mediated shedding of extracellular matrix metalloproteinase inducer (EMMPRIN) by oral epithelial cells: a potential role in inflammatory periodontal disease.
Periodontitis
Possible relationship between periodontitis and dementia in a North Indian old age population: a pilot study.
Periodontitis
Predictive Periodontitis: The Most Promising Salivary Biomarkers for Early Diagnosis of Periodontitis.
Periodontitis
Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats.
Periodontitis
Reduced expression of lipopolysaccharide-induced CXC chemokine in Porphyromonas gingivalis-induced experimental periodontitis in matrix metalloproteinase-8 null mice.
Periodontitis
Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans.
Periodontitis
Runt-related gene 2 is involved in the inhibition of matrix metalloproteinase-13 expression by roxithromycin in human gingival epithelial cell cultures.
Periodontitis
Saliva and serum biomarkers in periodontitis and coronary artery disease.
Periodontitis
Salivary biomarker combination prediction model for the diagnosis of periodontitis in a Taiwanese population.
Periodontitis
Salivary biomarkers for discriminating periodontitis in the presence of diabetes.
Periodontitis
Salivary biomarkers of existing periodontal disease: a cross-sectional study.
Periodontitis
Salivary Colony Stimulating Factor-1 and Interleukin-34 in Periodontal Disease.
Periodontitis
Salivary Diagnostics-Point-of-Care diagnostics of MMP-8 in dentistry and medicine.
Periodontitis
Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes.
Periodontitis
Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: A PRISMA-compliant systematic review and meta-analysis.
Periodontitis
Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus.
Periodontitis
Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
Periodontitis
Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease.
Periodontitis
Salivary MMP-13 gender differences in periodontitis: A cross-sectional study from Sweden.
Periodontitis
Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis.
Periodontitis
Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease.
Periodontitis
Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
Periodontitis
Smoking affects diagnostic salivary periodontal disease biomarker levels in adolescents.
Periodontitis
Smoking confounds the periodontal diagnostics using saliva biomarkers.
Periodontitis
Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues.
Periodontitis
Statin intake is associated with MMP-1 level in gingival crevicular fluid of patients with periodontitis.
Periodontitis
Targeted salivary biomarkers for discrimination of periodontal health and disease(s).
Periodontitis
Temporal expression of metalloproteinase-8 and -13 and their relationships with extracellular matrix metalloproteinase inducer in the development of ligature-induced periodontitis in rats.
Periodontitis
The analysis of matrix metalloproteinase-8 in gingival crevicular fluid and periodontal diseases.
Periodontitis
The Association of Matrix Metalloproteinase Gene Polymorphisms and Periodontitis: An Overview.
Periodontitis
The effect of smoking on the mRNA expression of MMPs and TIMP-1 in untreated chronic periodontitis patients: a cross-sectional study.
Periodontitis
The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid.
Periodontitis
The effects of periodontal therapy on gingival crevicular fluid matrix metalloproteinase-8, interleukin-6 and prostaglandin E2 levels in patients with rheumatoid arthritis.
Periodontitis
The Effects of Selective COX-2 Inhibitor/Celecoxib and Omega-3 Fatty Acid on Matrix Metalloproteinases, TIMP-1, and Laminin-5gamma2-Chain Immunolocalization in Experimental Periodontitis.
Periodontitis
The modulation of the TREM-1/PGLYRP1/MMP-8 axis in peri-implant diseases.
Periodontitis
The potential of salivary biomarkers for predicting the sensitivity and monitoring the response to nonsurgical periodontal therapy: A preliminary assessment.
Periodontitis
The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
Periodontitis
The Short-Term Effectiveness of Non-Surgical Treatment in Reducing Levels of Interleukin-1? and Proteases in Gingival Crevicular Fluid From Patients With Type 2 Diabetes Mellitus and Chronic Periodontitis.
Periodontitis
The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis.
Periodontitis
The temporal expression and localization of extracellular matrix metalloproteinase inducer (EMMPRIN) during the development of perio-dontitis in an animal model.
Periodontitis
Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation.
Periodontitis
Toll-like receptor (TLR) and matrix metalloproteinase (MMP) polymorphisms and periodontitis susceptibility: a meta-analysis.
Periodontitis
Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment.
Periodontitis
Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach.
Periodontitis
Validation of Periodontitis Screening Model Using Socio-Demographic, Systemic and Molecular Information in a Korean Population.
Periodontitis
[Detection and significance of IL-1beta and MMP-8 in patients with periodontitis of whole unstimulated saliva]
Peripheral Arterial Disease
Matrix metalloproteinase-2 dysregulation in type 1 diabetes.
Peripheral Nerve Injuries
Acute- and late-phase matrix metalloproteinase (MMP)-9 activity is comparable in female and male rats after peripheral nerve injury.
Peripheral Nerve Injuries
Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy.
Peritoneal Fibrosis
Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats.
Peritoneal Neoplasms
Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
Peritonitis
Collagenase 2/matrix metalloproteinase 8 in critically ill patients with secondary peritonitis.
Peritonitis
Colonic anastomotic strength and matrix metalloproteinase activity in an experimental model of bacterial peritonitis.
Peritonitis
Early diagnosis of CAPD peritonitis using a new test kit for detection of matrix metalloproteinase (MMP)-9.
Peritonitis
In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1?-induced peritonitis.
Peritonitis
Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis.
Peritonitis
Measurement of innate immune response biomarkers in peritoneal dialysis effluent using a rapid diagnostic point-of-care device as a diagnostic indicator of peritonitis.
Pheochromocytoma
A novel nerve growth factor-responsive element in the stromelysin-1 (transin) gene that is necessary and sufficient for gene expression in PC12 cells.
Pheochromocytoma
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Pheochromocytoma
The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae.
Pituitary Neoplasms
Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
Pituitary Neoplasms
Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
Pituitary Neoplasms
Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix.
Pituitary Neoplasms
The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma.
Placenta Accreta
Differential expression of growth-, angiogenesis- and invasion-related factors in the development of placenta accreta.
Placenta Previa
The frequency and clinical significance of intra-uterine infection and inflammation in patients with placenta previa and preterm labor and intact membranes.
Plasmacytoma
Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions.
Pleural Effusion
Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Pleural Effusion
Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
Pleural Effusion
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Pleural Effusion
Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.
Pleural Effusion
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
Pleural Effusion, Malignant
Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.
Pleurisy
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Pneumoconiosis
[Serum levels of matrix metalloproteinase 9 and 19 in the patients with pneumoconiosis].
Pneumonia
A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure.
Pneumonia
Activated protein C protection from lung inflammation in endotoxin-induced injury.
Pneumonia
Complex regulation of pulmonary inflammation and fibrosis by CCL18.
Pneumonia
Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activity.
Pneumonia
Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation.
Pneumonia
Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice.
Pneumonia
Matrix metalloproteinase-8: a useful biomarker to refine the diagnosis of community-acquired pneumonia upon intensive care unit admission?
Pneumonia
Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase.
Pneumonia
Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat.
Pneumonia
MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia.
Pneumonia
Nitrative stress in inflammatory lung diseases.
Pneumonia
Pretreatment of a matrix metalloproteases inhibitor and aprotinin attenuated the development of acute pancreatitis-induced lung injury in rat model.
Pneumonia
Pulmonary delivery of the broad-spectrum matrix metalloproteinase inhibitor marimastat diminishes multiwalled carbon nanotube-induced circulating bioactivity without reducing pulmonary inflammation.
Pneumonia
Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia.
Pneumonia
Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema.
Pneumoperitoneum
Effect of CO2 pneumoperitoneum on the proliferation of human ovarian cancer cell line SKOV-3 and the expression of NM23-H1 and MMP-2.
Pneumoperitoneum
Pneumoperitoneum augmented tumor invasiveness is abolished by matrix metalloproteinase blockade.
Polycystic Kidney Diseases
A possible role for metalloproteinases in renal cyst development.
Polycystic Kidney Diseases
Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic kidney disease.
Polycystic Kidney, Autosomal Dominant
Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models.
Polycystic Kidney, Autosomal Dominant
Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic kidney disease.
Polycystic Ovary Syndrome
Elevated matrix metalloproteinase-8 in saliva and serum in polycystic ovary syndrome and association with gingival inflammation.
Polycystic Ovary Syndrome
Increased Prolidase Activity and Oxidative Stress in PCOS.
Polycystic Ovary Syndrome
Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation.
Polyneuropathies
Collagen synthesis and degradation in polyneuropathy and myopathies.
Polyneuropathies
Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
Porcine Reproductive and Respiratory Syndrome
Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study.
Pouchitis
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.
Pre-Eclampsia
Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy.
Pre-Eclampsia
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Pre-Eclampsia
Effects of Matrix Metalloproteinase (MMP)-2 Polymorphisms on Responsiveness to Antihypertensive Therapy of Women with Hypertensive Disorders of Pregnancy.
Pre-Eclampsia
Elevated hyaluronan and extracellular matrix metalloproteinase inducer levels in women with preeclampsia.
Pre-Eclampsia
Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia.
Pre-Eclampsia
In vitro migration of cytotrophoblasts through a decidual endothelial cell monolayer: the role of matrix metalloproteinases.
Pre-Eclampsia
Interaction of cocultured decidual endothelial cells and cytotrophoblasts in preeclampsia.
Pre-Eclampsia
Interleukin-4 -590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9 -1562 (C>T) polymorphisms in pre-eclampsia.
Pre-Eclampsia
Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
Pre-Eclampsia
Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension.
Pre-Eclampsia
Matrix metalloproteinase multiplex screening identifies increased MMP-2 urine concentrations in women predicted to develop preeclampsia.
Pre-Eclampsia
Matrix metalloproteinase-2 C-735T and its interaction with matrix metalloproteinase-7 A-181G polymorphism are associated with the risk of preeclampsia: influence on total antioxidant capacity and blood pressure.
Pre-Eclampsia
MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia.
Pre-Eclampsia
MMP-8 C-799T and MMP-8 C+17G polymorphisms in mild and severe preeclampsia: Association between MMP-8 C-799T with susceptibility to severe preeclampsia.
Pre-Eclampsia
Modulation of matrix metalloproteinase secretion by adenosine A3 receptor in preeclamptic villous explants.
Pre-Eclampsia
Preeclampsia associates with RECK-dependent decrease in human trophoblasts migration and invasion.
Pre-Eclampsia
RNA interference-mediated silencing of laminin receptor 1 (LR1) suppresses migration and invasion and down-regulates matrix metalloproteinase (MMP)-2 and MMP-9 in trophoblast cells: implication in the pathogenesis of preeclampsia.
Pre-Eclampsia
The effect of serum from women with preeclampsia on JAR (trophoblast-like) cell line.
Pre-Eclampsia
[Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates]
Pre-Eclampsia
[Differences between the expression of matrix metalloproteinase-2, 9 in preeclampsia and normal placental tissues]
Pre-Eclampsia
[Differential expression of extracellular matrix metalloproteinase inducer in normal placenta and preeclampsia placenta]
Pre-Eclampsia
[Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
The Contribution of MMP-8 Promoter Genotypes to Childhood Leukemia.
Prediabetic State
Matrix metalloproteinase-8 analysis in patients with periodontal disease with prediabetes or type 2 diabetes mellitus: A systematic review.
Prediabetic State
Whole Salivary Interleukin-6 and Matrix Metalloproteinase-8 Levels in Chronic Periodontitis Patients With and Without Prediabetes.
Pregnancy Complications
Mapping themes trends and knowledge structure of trophoblastic invasion, a bibliometric analysis from 2012-2021.
Pregnancy Complications
Matrix metalloproteinase and tissue inhibitors of metalloproteinases gene polymorphisms in disorders that influence fertility and pregnancy complications: A systematic review and meta-analysis.
Prehypertension
Effects of androgen on vascular and inflammatory biomarkers in a female hypertensive population.
Premature Birth
About one-half of early spontaneous preterm deliveries can be identified by a rapid matrix metalloproteinase-8 (MMP-8) bedside test at the time of mid-trimester genetic amniocentesis.
Premature Birth
Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor.
Premature Birth
Class I to III Histone Deacetylases Differentially Regulate Inflammation-Induced Matrix Metalloproteinase 9 Expression in Primary Amnion Cells.
Premature Birth
Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency.
Premature Birth
Effect of clindamycin treatment on vaginal inflammatory markers in pregnant women with bacterial vaginosis and a positive fetal fibronectin test.
Premature Birth
Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes.
Premature Birth
Role of MMP-1, MMP-8 and MMP-9 gene polymorphisms in preterm birth.
Premature Birth
The Relationship Between Matrix Metalloproteinase-8 in After Birth Oral Fluid and Acute Histologic Chorioamnionitis in Preterm Delivery.
Presbyopia
Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail.
Pressure Ulcer
Involvement of proteolytic enzymes--plasminogen activators and matrix metalloproteinases--in the pathophysiology of pressure ulcers.
Pressure Ulcer
Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids.
Primary Myelofibrosis
Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis.
Prion Diseases
Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies.
Proctitis
Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer.
Prolactinoma
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas.
Prostatic Hyperplasia
Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism.
Prostatic Hyperplasia
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.
Prostatic Hyperplasia
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
Prostatic Neoplasms
A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis.
Prostatic Neoplasms
A Randomized Phase II Trial of the Matrix Metalloproteinase Inhibitor BMS-275291 in Hormone-Refractory Prostate Cancer Patients with Bone Metastases.
Prostatic Neoplasms
Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Prostatic Neoplasms
Anti-invasive activity of diallyl disulfide through tightening of tight junctions and inhibition of matrix metalloproteinase activities in LNCaP prostate cancer cells.
Prostatic Neoplasms
Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Prostatic Neoplasms
Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells.
Prostatic Neoplasms
Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.
Prostatic Neoplasms
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
Prostatic Neoplasms
Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer.
Prostatic Neoplasms
Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
Prostatic Neoplasms
EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer.
Prostatic Neoplasms
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Prostatic Neoplasms
Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
Prostatic Neoplasms
Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts.
Prostatic Neoplasms
Heterogeneous activation of MMP-9 due to prostate cancer-bone interaction.
Prostatic Neoplasms
High matrix metalloproteinase-to-E-cadherin ratio measured by bicolor fluorescent in situ hybridization is associated with lymphangiogenesis and lymph node metastasis in prostate cancer.
Prostatic Neoplasms
Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression.
Prostatic Neoplasms
Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer.
Prostatic Neoplasms
Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells.
Prostatic Neoplasms
Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Prostatic Neoplasms
Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events.
Prostatic Neoplasms
MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Prostatic Neoplasms
Matrilysin expression in the involuting rat ventral prostate.
Prostatic Neoplasms
Matrix metalloproteinase 9 and prostate-cancer risk : a meta-analysis of 1,059 participants.
Prostatic Neoplasms
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
Prostatic Neoplasms
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Prostatic Neoplasms
Matrix metalloproteinase and heparin-stimulated serine proteinase activities in post-prostate massage urine of men with prostate cancer.
Prostatic Neoplasms
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.
Prostatic Neoplasms
Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis.
Prostatic Neoplasms
miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer.
Prostatic Neoplasms
Modulation of prostate cancer growth in bone microenvironments.
Prostatic Neoplasms
National Cancer Institute intramural approach to advanced prostate cancer.
Prostatic Neoplasms
Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.
Prostatic Neoplasms
Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Prostatic Neoplasms
Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression.
Prostatic Neoplasms
Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment.
Prostatic Neoplasms
Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
Prostatic Neoplasms
Proanthocyanidins from the American Cranberry (Vaccinium macrocarpon) inhibit matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in human prostate cancer cells via alterations in multiple cellular signalling pathways.
Prostatic Neoplasms
Prostate cancer metastasis and soy isoflavones: a dogfight over a bone.
Prostatic Neoplasms
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy.
Prostatic Neoplasms
Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants.
Prostatic Neoplasms
RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer in vitro by modulating cathepsin B and MMP9 expression.
Prostatic Neoplasms
RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells.
Prostatic Neoplasms
Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.
Prostatic Neoplasms
Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.
Prostatic Neoplasms
Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.
Prostatic Neoplasms
Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection.
Prostatic Neoplasms
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.
Prostatic Neoplasms
The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patients.
Prostatic Neoplasms
The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy.
Prostatic Neoplasms
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
Prostatic Neoplasms
The role of the androgen receptor in prostate cancer-induced platelet aggregation and platelet-induced invasion.
Prostatic Neoplasms
Thymoquinone inhibits IL-7-induced tumor progression and metastatic invasion in prostate cancer cells by attenuating matrix metalloproteinase activity and Akt/NF-?B signaling.
Prostatic Neoplasms
Unripe Rubus coreanus Miquel suppresses migration and invasion of human prostate cancer cells by reducing matrix metalloproteinase expression.
Proteinuria
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Proteinuria
Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Pruritus
Evaluation of Association Between the Serum Levels of MMP-9 and MMP-9/TIMPs With Soluble Forms of Selectins and Itching Induced by Sulfur Mustard.
Pruritus
Matrix Metalloproteinase-8 Is Involved in Dermal Nerve Growth: Implications for Possible Application to Pruritus from In Vitro Models.
Pseudomonas Infections
Extracellular matrix metalloproteinase inducer enhances host resistance against pseudomonas aeruginosa infection through MAPK signaling pathway.
Psoriasis
Interleukin-17A enhances the production of CD147/extracellular matrix metalloproteinase inducer by monocytes from patients with psoriasis.
Psoriasis
Plasma TGF-beta(1), TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity.
Psoriasis
Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity.
Psoriasis
Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers.
Psoriasis
Serum of Patients with Psoriasis Modulates the Production of MMP-9 and TIMP-1 in Cells of Monocytic Lineage.
Psoriasis
Targeting miR-21 to treat psoriasis.
Psoriasis
[Expression of genes for metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis].
Pterygium
Continuous exposure of nicotine and cotinine retards human primary pterygium cell proliferation and migration.
Pterygium
Cyclosporine A Downregulates MMP-3 and MMP-13 Expression in Cultured Pterygium Fibroblasts.
Pterygium
Detection and comparison of matrix metalloproteinase in primary and recurrent pterygium fibroblasts.
Pterygium
Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.
Pterygium
Matrix metalloproteinase-9 expression in pterygium.
Pterygium
The Association of MMP-8 Genotypes with Pterygium.
Pulmonary Disease, Chronic Obstructive
Activity of matrix metalloproteinase in airway epithelial cells of COPD patients.
Pulmonary Disease, Chronic Obstructive
Association between the interleukin-13 gene and development of chronic obstructive pulmonary disease in southern Chinese Han population: a case-control study.
Pulmonary Disease, Chronic Obstructive
Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.
Pulmonary Disease, Chronic Obstructive
Cigarette smoke-induced epithelial expression of WNT-5B: implications for COPD.
Pulmonary Disease, Chronic Obstructive
Determination of enzyme matrix metalloproteinases-9 and immune status as indicators of development of the environmental diseases.
Pulmonary Disease, Chronic Obstructive
Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD.
Pulmonary Disease, Chronic Obstructive
Effects of resveratrol and genistein on nuclear factor??B, tumor necrosis factor?? and matrix metalloproteinase?9 in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
EMMPRIN (CD147) REGULATION OF MMP-9 IN BRONCHIAL EPITHELIAL CELLS IN COPD.
Pulmonary Disease, Chronic Obstructive
Evaluation of collagenase activity, matrix metalloproteinase-8, and matrix metalloproteinase-13 in horses with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Expression and localization of the MMP inhibitor RECK in a rat model of COPD: its involvement in the development of COPD.
Pulmonary Disease, Chronic Obstructive
Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation.
Pulmonary Disease, Chronic Obstructive
Gene-environment interaction between the MMP9 C-1562T promoter variant and cigarette smoke in the pathogenesis of chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Genetic Polymorphism of Matrix Metalloproteinase Family and Chronic Obstructive Pulmonary Disease Susceptibility: a Meta-analysis.
Pulmonary Disease, Chronic Obstructive
Genetic polymorphisms in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease?
Pulmonary Disease, Chronic Obstructive
Glucocorticosteroids Differentially Regulate MMP-9 and Neutrophil Elastase in COPD.
Pulmonary Disease, Chronic Obstructive
Human Rhinovirus Infection Upregulates MMP-9 Production in Airway Epithelial Cells via NF-{kappa}B.
Pulmonary Disease, Chronic Obstructive
Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways.
Pulmonary Disease, Chronic Obstructive
Increase in the expression of matrix metalloproteinase-12 in the airways of rats with allergic bronchial asthma.
Pulmonary Disease, Chronic Obstructive
Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.
Pulmonary Disease, Chronic Obstructive
Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Pulmonary Disease, Chronic Obstructive
Macrophages and the pathogenesis of COPD.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase-9 -1562C/T promoter polymorphism confers risk for COPD: a meta-analysis.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase-9 in lung remodeling.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinases -8 and -9 in the Airways, Blood and Urine During Exacerbations of COPD.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD.
Pulmonary Disease, Chronic Obstructive
Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat.
Pulmonary Disease, Chronic Obstructive
MMP-2 (-1306 C/T) Polymorphism Affects Serum Matrix Metalloproteinase (MMP)-2 Levels and Correlates with Chronic Obstructive Pulmonary Disease Severity: A Case-Control Study of MMP-1 and -2 in a Tunisian Population.
Pulmonary Disease, Chronic Obstructive
MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.
Pulmonary Disease, Chronic Obstructive
MMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD.
Pulmonary Disease, Chronic Obstructive
MMP-9 genetic polymorphism may confer susceptibility to COPD.
Pulmonary Disease, Chronic Obstructive
Nitrative stress in inflammatory lung diseases.
Pulmonary Disease, Chronic Obstructive
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Pulmonary Disease, Chronic Obstructive
Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Polymorphisms in Matrix Metalloproteinase-1, -9 and -12 Genes and the Risk of Chronic Obstructive Pulmonary Disease in a Korean Population.
Pulmonary Disease, Chronic Obstructive
Proteomic Analysis in Lung Tissue of Smokers and COPD Patients.
Pulmonary Disease, Chronic Obstructive
Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Pulmonary Disease, Chronic Obstructive
Relationship between expression of matrix metalloproteinase-9 and adenylyl cyclase-associated protein 1 in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
Pulmonary Disease, Chronic Obstructive
Rhinovirus-induces progression of lung disease in a mouse model of COPD via IL-33/ST2 signaling axis.
Pulmonary Disease, Chronic Obstructive
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.
Pulmonary Disease, Chronic Obstructive
Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.
Pulmonary Disease, Chronic Obstructive
Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation.
Pulmonary Disease, Chronic Obstructive
Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.
Pulmonary Disease, Chronic Obstructive
Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: Relationship to disease severity.
Pulmonary Disease, Chronic Obstructive
Sulphonamides: Deserving class as MMP inhibitors?
Pulmonary Disease, Chronic Obstructive
The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils.
Pulmonary Disease, Chronic Obstructive
The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro.
Pulmonary Disease, Chronic Obstructive
Tissue Inhibitor of Metalloproteinase-1 Promotes Polymorphonuclear Neutrophil (PMN) Pericellular Proteolysis by Anchoring Matrix Metalloproteinase-8 and -9 to PMN Surfaces.
Pulmonary Disease, Chronic Obstructive
TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin.
Pulmonary Disease, Chronic Obstructive
Transient elevation of neutrophil proteinases in induced sputum during COPD exacerbation.
Pulmonary Disease, Chronic Obstructive
Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD.
Pulmonary Disease, Chronic Obstructive
[Influence of N-acetylcysteine on the cytokines and matrix metalloproteinases in chronic obstructive pulmonary disease rat models]
Pulmonary Disease, Chronic Obstructive
[Markers of airway remodeling in induced sputum from healthy smokers]
Pulmonary Disease, Chronic Obstructive
[Study on effect of anemoside B4 in improving COPD rats by regulating IL-12/STAT4 and IL-4/STAT6 signaling pathways].
Pulmonary Disease, Chronic Obstructive
[The expressions of TNF-alpha and MMP-9 in serum and MMP-1 mRNA in the bone tissue in chronic obstructive pulmonary disease patients of cold dryness syndrome in northwest China].
Pulmonary Edema
Caspase-1 Inhibitor Prevents Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage in Mice.
Pulmonary Embolism
Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism.
Pulmonary Embolism
Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism.
Pulmonary Embolism
L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9.
Pulmonary Embolism
Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.
Pulmonary Embolism
Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism.
Pulmonary Emphysema
Liver growth factor treatment reverses emphysema previously established in a cigarette smoke exposure mouse model.
Pulmonary Emphysema
Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers.
Pulmonary Emphysema
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema.
Pulmonary Emphysema
Pulmonary emphysema and tumor microenvironment in primary lung cancer.
Pulmonary Emphysema
Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways.
Pulmonary Fibrosis
An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition.
Pulmonary Fibrosis
Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats.
Pulmonary Fibrosis
Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8.
Pulmonary Fibrosis
Gene expressions and roles of matrix metalloproteinases-8 and tissue inhibitor of metalloproteinases-1 in hyperoxia-induced pulmonary fibrosis in neonatal rats.
Pulmonary Fibrosis
Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in pulmonary fibrosis.
Pulmonary Fibrosis
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Pulmonary Fibrosis
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF.
Pulmonary Fibrosis
Upregulated miR-29c suppresses silica-induced lung fibrosis through the Wnt/?-catenin pathway in mice.
Pulmonary Fibrosis
[Effect of atorvastatin on MMP-9 and TIMP-1 levels in bronchoalvcolar lavage fluid and serum of rats with bleomycin-induced pulmonary fibrosis].
Pulmonary Fibrosis
[Feature changes of MMP-2/9 activities and TIMP-1/2 protein expressions during the progression of pulmonary fibrosis in rats]
Pulpitis
ASH1L Suppresses Matrix Metalloproteinase through Mitogen-activated Protein Kinase Signaling Pathway in Pulpitis.
Pulpitis
Comparison of Neurokinin A, Substance P, Interleukin 8, and Matrix Metalloproteinase-8 Changes in Pulp tissue and Gingival Crevicular Fluid Samples of Healthy and Symptomatic Irreversible Pulpitis Teeth.
Pulpitis
Erratum to Comparison of Neurokinin A, Substance P, Interleukin 8, and Matrix Metalloproteinase-8 Changes in Pulp tissue and Gingival Crevicular Fluid Samples of Healthy and Symptomatic Irreversible Pulpitis Teeth [J Endod 46 (2020) 1428-1437].
Pulpitis
Levels of matrix metalloproteinase-8 and cold test in reversible and irreversible pulpitis.
Pyelonephritis
Association of mRNA Levels of IL6, MMP-8, GSS in Saliva and Pyelonephritis in Children.
Radicular Cyst
Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors.
Radicular Cyst
Expression of matrix metalloproteinase-8 and matrix metalloproteinase-13 in mast cells of human periapical lesions.
Radicular Cyst
Modulation of Matrix Metalloproteinase 14, Tissue Inhibitor of Metalloproteinase 3, Tissue Inhibitor of Metalloproteinase 4, and Inducible Nitric Oxide Synthase in the Development of Periapical Lesions.
Rectal Neoplasms
Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Rectal Neoplasms
Effect of Conjugated Linoleic Acid Supplementation on Inflammatory Factors and Matrix Metalloproteinase Enzymes in Rectal Cancer Patients Undergoing Chemoradiotherapy.
Rectal Neoplasms
Effects of two conventional preoperative radiation schedules on anastomotic healing in the rat colon.
Refractive Errors
Association of matrix metalloproteinase gene polymorphisms with refractive error in Amish and Ashkenazi families.
Renal Insufficiency
Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
Renal Insufficiency
Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.
Renal Insufficiency, Chronic
Matrix metalloproteinase -2, -9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension.
Renal Insufficiency, Chronic
Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells.
Renal Insufficiency, Chronic
Periodontal Inflammatory Burden and Salivary Matrix Metalloproteinase-8 Concentration Among Patients With Chronic Kidney Disease at the Predialysis Stage.
Renal Insufficiency, Chronic
Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9.
Reperfusion Injury
Apelin-13 attenuates injury following ischemic stroke by targeting matrix metalloproteinases (MMP), endothelin- B receptor, occludin/claudin-5 and oxidative stress.
Reperfusion Injury
Effects of Novel Semiselective Matrix Metalloproteinase Inhibitors on Ex Vivo Cardiac Structure-Function.
Reperfusion Injury
Evaluation of matrix metalloproteinase, myeloperoxidase, and oxidative damage in mesenteric ischemia-reperfusion injury.
Reperfusion Injury
Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
Reperfusion Injury
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.
Reperfusion Injury
Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation.
Reperfusion Injury
Matrix metalloproteinase inhibition protects rat livers from prolonged cold ischemia-warm reperfusion injury.
Reperfusion Injury
Matrix metalloproteinase inhibitor (ONO-4817) attenuates ischemia-reperfusion injury in rat lung.
Reperfusion Injury
Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury.
Reperfusion Injury
Renal matrix metalloproteinase activity is unaffected by experimental ischemia-reperfusion injury and matrix metalloproteinase inhibition does not alter outcome of renal function.
Reperfusion Injury
Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation.
Reperfusion Injury
The role of matrix metalloproteinase inhibitors in ischemia-reperfusion injury in the liver.
Reperfusion Injury
[The impact of different duration of EA-pretreatment on expression of MMP-9 and VEGF in blood-brain barrier in rats with cerebral ischemia-reperfusion injury].
Reproductive Tract Infections
Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections.
Respiratory Distress Syndrome
Early Plasma Matrix Metalloproteinase Profiles Offer New Insight into the Biology and Prognosis of Pediatric Acute Respiratory Distress Syndrome.
Respiratory Distress Syndrome
Early Plasma Matrix Metalloproteinase Profiles: A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome.
Respiratory Distress Syndrome
Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.
Respiratory Distress Syndrome
Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress.
Respiratory Insufficiency
Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Respiratory Insufficiency
Serum MMP-8 and TIMP-1 in Critically Ill Patients with Acute Respiratory Failure: TIMP-1 Is Associated with Increased 90-Day Mortality.
Respiratory Tract Infections
Downregulation of miR?29b?3p promotes ??tubulin deacetylation by targeting the interaction of matrix metalloproteinase?9 with integrin ?1 in nasal polyps.
Respiratory Tract Infections
Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections.
Retinal Detachment
Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment.
Retinal Detachment
Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous.
Retinal Detachment
Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.
Retinal Detachment
The role and function of matrix metalloproteinase-8 in rhegmatogenous retinal detachment.
Retinal Diseases
The role and function of matrix metalloproteinase-8 in rhegmatogenous retinal detachment.
Retinal Hemorrhage
Insulin increases retinal hemorrhage in mild oxygen-induced retinopathy in the rat: inhibition by riluzole.
Retinal Neovascularization
ASSESSMENT OF GELATINASE AND TUMOR NECROSIS FACTOR-? LEVEL IN THE VITREOUS AND SERUM OF PATIENTS WITH EALES DISEASE: Role of Inflammation-Mediated Angiogenesis in the Pathogenesis of Eales Disease.
Retinal Neovascularization
Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 gene.
Retinal Neovascularization
Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
Retinal Neovascularization
Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization.
Retinal Neovascularization
Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.
Retinal Neovascularization
Synergism effect of swimming exercise and genistein on the inflammation, oxidative stress, and VEGF expression in the retina of diabetic-ovariectomized rats.
Retinal Vein Occlusion
Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.
Retinoblastoma
Differential roles of matrix metalloproteinase-9 and -2, depending on proliferation or differentiation of retinoblastoma cells.
Retinoblastoma
[Analysis of angiogenesis associated factors of retinoblastoma cell line and tumor tissues]
Retinoblastoma
[Anti-sense nucleic acid of CyclinD1 induces apoptosis of lung adenocarcinoma cancer cell A549.]
Retinopathy of Prematurity
An interplay of microglia and matrix metalloproteinase MMP9 under hypoxic stress regulates the opticin expression in retina.
Retinopathy of Prematurity
Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
Rhabdomyosarcoma
Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma.
Rheumatic Diseases
Association between Serum Matrix Metalloproteinase- (MMP-) 3 Levels and Systemic Lupus Erythematosus: A Meta-analysis.
Rheumatic Diseases
Matrix metalloproteinase inhibitors in rheumatic diseases.
Rheumatic Diseases
Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases.
Rheumatic Heart Disease
[Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases.]
Rheumatic Heart Disease
[Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function]
Rhinitis, Allergic
Nonasthmatic nasal polyposis patients with allergy exhibit greater epithelial MMP positivity.
Root Resorption
Expression of matrix metalloproteinases 2 and 9 in replanted teeth with external root resorption: A cross-sectional study.
Rosacea
Association of Rosacea With Risk for Glioma in a Danish Nationwide Cohort Study.
Rosacea
Elevated Expression and Activation of Matrix Metalloproteinase 8 in Tear Fluid in Atopic Blepharoconjunctivitis.
Rosacea
Exploring the Association Between Rosacea and Parkinson Disease: A Danish Nationwide Cohort Study.
Rosacea
Mast Cells Are Key Mediators of Cathelicidin-Initiated Skin Inflammation in Rosacea.
Salivary Gland Neoplasms
Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.
Salivary Gland Neoplasms
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Sarcoidosis
Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging.
Sarcoidosis
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF.
Sarcoma
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.
Sarcoma
Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
Sarcoma
Clinicopathologic significance of fascin, extracellular matrix metalloproteinase inducer, and ezrin expressions in colorectal adenocarcinoma.
Sarcoma
Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts.
Sarcoma
Effects of genistein on invasion and matrix metalloproteinase activities of HT1080 human fibrosarcoma cells.
Sarcoma
Expression of matrix metalloproteinases in feline vaccine site-associated sarcomas.
Sarcoma
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Sarcoma
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Sarcoma
Local activity of matrix metalloproteinases in a case of botryoid sarcoma.
Sarcoma
Matrix metalloproteinase expression in high grade soft tissue sarcomas.
Sarcoma
Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus.
Sarcoma
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Sarcoma
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
Sarcoma
Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
Sarcoma, Avian
Molecularly targeted therapy for gastrointestinal cancer.
Sarcoma, Avian
Resolution of TIMP-free and TIMP-complexed 70kDa progelatinase from culture medium of Rous sarcoma virus-transformed chicken embryo fibroblasts.
Sarcoma, Ewing
Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo.
Sarcoma, Kaposi
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
Sarcoma, Kaposi
Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
Scleroderma, Localized
Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts.
Scleroderma, Systemic
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.
Scleroderma, Systemic
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
Scleroderma, Systemic
Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis.
Scoliosis
Lack of Association Between the Promoter Polymorphisms of MMP-3 and IL-6 Genes and Adolescent Idiopathic Scoliosis: A Case-Control Study in a Chinese Han Population.
Seizures
Doxycycline could aggravate the absence-like epileptic seizures of WAG/Rij rats via matrix metalloproteinase inhibition.
Seizures
Matrix metalloproteinase-7 regulates cleavage of pro-nerve growth factor and is neuroprotective following kainic acid-induced seizures.
Seizures
The matrix metalloproteinase inhibitor marimastat inhibits seizures in a model of kainic acid-induced status epilepticus.
Seminoma
Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
Sepsis
A novel role for matrix metalloproteinase-8 in sepsis.
Sepsis
Data-Independent Acquisition-Based Quantitative Proteomic Analysis Reveals Differences in Host Immune Response of Peripheral Blood Mononuclear Cells to Sepsis.
Sepsis
Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8.
Sepsis
Effects of bromopride on expression of metalloproteinases and interleukins in left colonic anastomoses: an experimental study.
Sepsis
Elevated plasma matrix metalloproteinases and their tissue inhibitors in patients with severe sepsis.
Sepsis
Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis.
Sepsis
Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis.
Sepsis
LL-37 Exacerbates Local Inflammation in Sepsis-Induced Acute Lung Injury by Preventing Mitochondrial DNA (mtDNA) Degradation-Induced Autophagy.
Sepsis
Loss of matrix metalloproteinase-8 is associated with worsened recovery after ischemic kidney injury.
Sepsis
Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
Sepsis
Matrix Metalloproteinase-2 and Metalloproteinase-9 Activities are Associated with Blood-Brain Barrier Dysfunction in an Animal Model of Severe Sepsis.
Sepsis
Matrix metalloproteinase-8 as a potential drug target for the therapy of sepsis.
Sepsis
Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile Sepsis Model.
Sepsis
Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study.
Sepsis
Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?
Sepsis
Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.
Sepsis
Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients.
Sepsis
Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.
Sepsis
Serum MMP-8, -9 and TIMP-1 in sepsis: High serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.
Sepsis
Simultaneous Inhibition of Tumor Necrosis Factor Receptor 1 and Matrix Metalloproteinase 8 Completely Protects Against Acute Inflammation and Sepsis.
Sepsis
Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.
Sepsis
Targeting matrix metalloproteinases with intravenous doxycycline in severe sepsis--A randomised placebo-controlled pilot trial.
Sepsis
Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation.
Severe Combined Immunodeficiency
Expression of MTAP inhibits tumor-related phenotypes in HT1080 cells via a mechanism unrelated to its enzymatic function.
Severe Combined Immunodeficiency
Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Shock, Cardiogenic
High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction.
Shock, Septic
A novel role for matrix metalloproteinase-8 in sepsis.
Shock, Septic
Effect of a matrix metalloproteinase inhibitor on host resistance against Listeria monocytogenes infection.
Shock, Septic
Inhibition of Neutrophil Collagenase/MMP-8 and Gelatinase B/MMP-9 and Protection against Endotoxin Shock.
Shock, Septic
Targeting matrix metalloproteinases with intravenous doxycycline in severe sepsis--A randomised placebo-controlled pilot trial.
Shock, Septic
Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock.
Silicosis
Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis.
Sinus Thrombosis, Intracranial
Polymorphism in dural arteriovenous fistula: matrix metalloproteinase-2-1306 C/T as a potential risk factor for sinus thrombosis.
Skin Neoplasms
Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice.
Skin Neoplasms
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
Skin Neoplasms
Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8).
Skin Neoplasms
Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Skin Neoplasms
Matrix metalloproteinase-2 and -9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling.
Skin Neoplasms
Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk.
Skin Neoplasms
[Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Sleep Apnea, Obstructive
Matrix metalloproteinase 9 (MMP9) level and MMP9 -1562C>T in patients with obstructive sleep apnea: a systematic review and meta-analysis of case-control studies.
Small Cell Lung Carcinoma
Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells.
Small Cell Lung Carcinoma
Small cell lung cancer and targeted therapies.
Small Cell Lung Carcinoma
Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
Small Cell Lung Carcinoma
Transition from suspension to adherent growth is accompanied by tissue factor expression and matrix metalloproteinase secretion in a small cell lung cancer cell line.
Soft Tissue Neoplasms
Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities.
Spinal Cord Injuries
CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recovery.
Spinal Cord Injuries
Efficacy of a metalloproteinase inhibitor in spinal cord injured dogs.
Spinal Cord Injuries
Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury.
Spinal Cord Injuries
Expression of MMP-8 in Pressure Injuries in Spinal Cord Injury Patients Managed by Negative Pressure Wound Therapy or Conventional Wound Care: A Randomized Controlled Trial.
Spinal Cord Injuries
Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury.
Spinal Cord Injuries
Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.
Spinal Cord Injuries
Multiplex array proteomics detects increased MMP-8 in CSF after spinal cord injury.
Spinal Cord Injuries
Selective Inhibition of MMP-2 Does Not Alter Neurological Recovery after Spinal Cord Injury.
Spinal Cord Injuries
Type IV collagen and its degradation in paralyzed human muscle: effect of functional electrical stimulation.
Spondylarthropathies
Matrix metalloproteinase expression in the spondyloarthropathies.
Spondylitis, Ankylosing
Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis.
Spondylitis, Ankylosing
Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis.
Spondylitis, Ankylosing
MicroRNA let-7i-3p affects osteoblast differentiation in ankylosing spondylitis via targeting PDK1.
Spondylitis, Ankylosing
MMP-2 silencing reduces the osteogenic transformation of fibroblasts by inhibiting the activation of the BMP/Smad pathway in ankylosing spondylitis.
Spondylitis, Ankylosing
MMP-8 single-nucleotide polymorphisms are related to ankylosing spondylitis in Chinese Han population.
Spondylosis
[Effects of Chiropractics on Intervertebral Disk Extracell Matrix and Metabolic Enzymes in Rats with Cervical Spondylosis].
Squamous Cell Carcinoma of Head and Neck
A circular RNA derived from MMP9 facilitates oral squamous cell carcinoma metastasis through regulation of MMP9 mRNA stability.
Squamous Cell Carcinoma of Head and Neck
Acid-electrolyzed functional water induces extracellular matrix metalloproteinase inducer, a possible novel alarmin, secretion from oral squamous cell carcinoma cell lines.
Squamous Cell Carcinoma of Head and Neck
ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC.
Squamous Cell Carcinoma of Head and Neck
Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Anticancer Efficacy of Polyphenols and Their Combinations.
Squamous Cell Carcinoma of Head and Neck
Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Squamous Cell Carcinoma of Head and Neck
DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cells.
Squamous Cell Carcinoma of Head and Neck
Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
Squamous Cell Carcinoma of Head and Neck
EMMPRIN expression in oral SCC is regulated by FYN kinase.
Squamous Cell Carcinoma of Head and Neck
EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.
Squamous Cell Carcinoma of Head and Neck
Estimation of serum and salivary matrix metalloproteinase levels in oral squamous cell carcinoma patients: a systematic review and meta-analysis.
Squamous Cell Carcinoma of Head and Neck
Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
Squamous Cell Carcinoma of Head and Neck
Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma.
Squamous Cell Carcinoma of Head and Neck
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Squamous Cell Carcinoma of Head and Neck
Extracellular matrix metalloproteinase inducer expression in histological grades of oral squamous cell carcinoma - An immunohistochemical study.
Squamous Cell Carcinoma of Head and Neck
Fusobacteria modulate oral carcinogenesis and promote cancer progression.
Squamous Cell Carcinoma of Head and Neck
Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes.
Squamous Cell Carcinoma of Head and Neck
High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Human neutrophil peptide-1 affects matrix metalloproteinase-2, -8 and -9 secretions of oral squamous cell carcinoma cell lines in vitro.
Squamous Cell Carcinoma of Head and Neck
IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression.
Squamous Cell Carcinoma of Head and Neck
Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Squamous Cell Carcinoma of Head and Neck
Immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Immunohistochemical expression of MMP-2 and MMP-8 in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus.
Squamous Cell Carcinoma of Head and Neck
Molecular docking of alkaloid compounds with the matrix metalloproteinase 2.
Squamous Cell Carcinoma of Head and Neck
MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells.
Squamous Cell Carcinoma of Head and Neck
PKM2 enhances cancer invasion via ETS-1-dependent induction of matrix metalloproteinase in oral squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
Squamous Cell Carcinoma of Head and Neck
Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.
Squamous Cell Carcinoma of Head and Neck
Relationship between the Expression of Matrix Metalloproteinase and Clinicopathologic Features in Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
Squamous Cell Carcinoma of Head and Neck
The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The interplay of matrix metalloproteinase-8, transforming growth factor-?1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The matrix metalloproteinase system in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1.
Squamous Cell Carcinoma of Head and Neck
Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Ultrasound-guided intratumoral administration of collagenase-2 improved liposome drug accumulation in solid tumor xenografts.
Squamous Cell Carcinoma of Head and Neck
[Correlation of membrane type I matrix metalloproteinase (MT1-MMP) expression with clinicomorphological features of tumor front in squamous cell carcinoma of the larynx]
Squamous Cell Carcinoma of Head and Neck
[Expression of extracellular matrix metalloproteinase inducer in laryngeal squamous cell carcinoma]
Squamous Cell Carcinoma of Head and Neck
[Relationship between expression of MMP-2 and prognosis in human laryngeal squamous cell carcinoma].
ST Elevation Myocardial Infarction
Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction.
Status Asthmaticus
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
Status Epilepticus
Increased metalloproteinase activity in the hippocampus following status epilepticus.
Status Epilepticus
The matrix metalloproteinase inhibitor marimastat inhibits seizures in a model of kainic acid-induced status epilepticus.
Stevens-Johnson Syndrome
Neutrophil Collagenase, Gelatinase, and Myeloperoxidase in Tears of Patients with Stevens-Johnson Syndrome and Ocular Cicatricial Pemphigoid.
Stomach Neoplasms
A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer.
Stomach Neoplasms
Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-?B pathways.
Stomach Neoplasms
Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway.
Stomach Neoplasms
beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer.
Stomach Neoplasms
Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancer.
Stomach Neoplasms
Clinical Impact of MMP and TIMP Gene Polymorphisms in Gastric Cancer.
Stomach Neoplasms
Effect and prognostic significance of the KAI1 gene in human gastric carcinoma.
Stomach Neoplasms
Effect of a matrix metalloproteinase inhibitor on a lymph node metastatic model of gastric cancer cells passaged by orthotopic implantation.
Stomach Neoplasms
Effect of BRMS1 expression on proliferation, migration and adhesion of mouse forestomach carcinoma.
Stomach Neoplasms
Effect of glutamine-enriched nutritional support on intestinal mucosal barrier function, MMP-2, MMP-9 and immune function in patients with advanced gastric cancer during perioperative chemotherapy.
Stomach Neoplasms
Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10.
Stomach Neoplasms
Expression and clinical significance of matrix metalloproteinase-17 and -25 in gastric cancer.
Stomach Neoplasms
Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
Stomach Neoplasms
Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Stomach Neoplasms
HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9.
Stomach Neoplasms
Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.
Stomach Neoplasms
Matrix metalloproteinase expression and molecular interaction network analysis in gastric cancer.
Stomach Neoplasms
Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.
Stomach Neoplasms
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
Stomach Neoplasms
Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-?B pathway, and MMP-9 expression.
Stomach Neoplasms
miRNA-145 Targets v-ets Erythroblastosis Virus E26 Oncogene Homolog 1 to Suppress the Invasion, Metastasis, and Angiogenesis of Gastric Cancer Cells.
Stomach Neoplasms
MMP-2 as a putative biomarker for carcinomatosis in gastric cancer.
Stomach Neoplasms
p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer.
Stomach Neoplasms
Paclitaxel combined with harmine inhibits the migration and invasion of gastric cancer cells through downregulation of cyclooxygenase-2 expression.
Stomach Neoplasms
Paeonol exerts potential activities to inhibit the growth, migration and invasion of human gastric cancer BGC823 cells via downregulating MMP?2 and MMP?9.
Stomach Neoplasms
Preventive effect of matrix metalloproteinase inhibitor, R-94138, in combination with mitomycin C or cisplatin on peritoneal dissemination of human gastric cancer cell line TMK-1 in nude mice.
Stomach Neoplasms
Redox state of adipose tissue for patients with gastric cancer and its connection with the body mass index and distance from the tumor.
Stomach Neoplasms
Reduced angiogenesis in peritoneal dissemination of gastric cancer through gelatinase inhibition.
Stomach Neoplasms
Role of serum matrix metalloproteinase in the diagnosis of gastric cancer.
Stomach Neoplasms
Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.
Stomach Neoplasms
Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer.
Stomach Neoplasms
SPARC is associated with gastric cancer progression and poor survival of patients.
Stomach Neoplasms
The influence of transforming growth factor-?, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Stomach Neoplasms
Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo.
Stomach Neoplasms
Upregulated Expression of ADAM17 Is a Prognostic Marker for Patients With Gastric Cancer.
Stomach Neoplasms
Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer.
Stomach Neoplasms
[Antitumor effect of a matrix metalloproteinase inhibitor, TA-2516 (Marimastat), on a nude mouse model of intraperitoneal seeding of stomach cancer]
Stomach Neoplasms
[Therapeutic effect of matrix metalloproteinase inhibitor (R-94138) for peritoneal metastasis of stomach neoplasm models]
Stomach Ulcer
Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. Pylori infection.
Stomach Ulcer
Increased expression of matrix metalloproteinase-9 associated with gastric ulcer recurrence.
Stomach Ulcer
Matrix metalloproteinase gene expression in chronic gastric ulcer: a potential role of eosinophils in perforation.
Stomatitis, Aphthous
Clinical assessment of the effect of a matrix metalloproteinase inhibitor on aphthous ulcers.
Stomatitis, Aphthous
Effect of tetracyclines on collagenase activity in patients with recurrent aphthous ulcers.
Stroke
A Lipoxin A(4) Analog Ameliorates Blood-Brain Barrier Dysfunction and Reduces MMP-9 Expression in a Rat Model of Focal Cerebral Ischemia-Reperfusion Injury.
Stroke
A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
Stroke
Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats.
Stroke
Anti-arrhythmic and anti-heart failure effects of low-level electrical stimulation on aortic root ventricular ganglionated plexi.
Stroke
Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.
Stroke
Association of tumor necrosis factor-? and matrix metalloproteinase-3 gene variants with stroke.
Stroke
Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.
Stroke
Biomarkers of periodontitis and inflammation in ischemic stroke: A case-control study.
Stroke
Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.
Stroke
Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients.
Stroke
Causal associations of serum matrix metalloproteinase-8 level with ischaemic stroke and ischaemic stroke subtypes: a Mendelian randomization study.
Stroke
Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice.
Stroke
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events.
Stroke
Combination of endothelial progenitor cells and BB-94 significantly alleviates brain damage in a mouse model of diabetic ischemic stroke.
Stroke
Connective Tissue Growth Factor Is Associated With a Stable Atherosclerotic Plaque Phenotype and Is Involved in Plaque Stabilization After Stroke.
Stroke
Delayed Gelatinase Inhibition Induces Reticulon 4 Receptor Expression in the Peri-Infarct Cortex.
Stroke
Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.
Stroke
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.
Stroke
Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes.
Stroke
Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain.
Stroke
Endothelium-targeted pharmacotherapeutics for the treatment of stroke.
Stroke
Fisetin Prolongs Therapy Window of Brain Ischemic Stroke Using Tissue Plasminogen Activator: A Double-Blind Randomized Placebo-Controlled Clinical Trial.
Stroke
Ginsenoside Represses Symptomatic Intracerebral Hemorrhage after Recombinant Tissue Plasminogen Activator Therapy by Promoting Transforming Growth Factor-?1.
Stroke
Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke.
Stroke
Inhibition of Gelatinases (MMP-2 and MMP-9) by Withania somnifera Phytochemicals Confers Neuroprotection in Stroke: An In Silico Analysis.
Stroke
Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke.
Stroke
Matrix metalloproteinase (MMP) induction and inhibition at different doses of recombinant tissue plasminogen activator following experimental stroke.
Stroke
Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.
Stroke
Matrix metalloproteinase inhibition counteracts impairment of cortical experience-dependent plasticity after photothrombotic stroke.
Stroke
Matrix metalloproteinase inhibition in atherosclerosis and stroke.
Stroke
Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.
Stroke
Matrix metalloproteinases and atherosclerotic plaque instability.
Stroke
Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
Stroke
Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke.
Stroke
Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
Stroke
Reduced brain edema and matrix metalloproteinase (MMP) expression by pre-reperfusion infusion into ischemic territory in rat.
Stroke
Reperfusion and Neurovascular Dysfunction in Stroke: from Basic Mechanisms to Potential Strategies for Neuroprotection.
Stroke
Selective MMP-inhibition with Ro 28-2653 in acute experimental stroke - a magnetic resonance imaging efficacy study.
Stroke
Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke.
Stroke
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Stroke
Sonographic monitoring of mass effect in stroke patients treated with hypothermia. Correlation with intracranial pressure and matrix metalloproteinase 2 and 9 expression.
Stroke
Stroke Induces Mesenchymal Stem Cell Migration to Infarcted Brain Areas Via CXCR4 and C-Met Signaling.
Stroke
The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
Stroke
The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
Stroke
Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.
Stroke
True Effects or Bias? MMP-2 and MMP-9 Serum Concentrations after Acute Stroke.
Stroke
Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Stroke
White Matter Hyperintensity Volume Correlates with Matrix Metalloproteinase-2 in Acute Ischemic Stroke.
stromelysin 1 deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
Subarachnoid Hemorrhage
Effects of recombinant osteopontin on blood-brain barrier disruption after subarachnoid hemorrhage in rats.
Subdural Effusion
[Role of matrix metalloproteinase in transformation of subdural effusion into chronic subdural hematoma]
Suppuration
Biological response to peri-implantitis treatment.
Synovitis
Changes in MMP-2 and -9 activity and MMP-8 reactivity after amphotericin B induced synovitis and treatment with bufexamac.
Synovitis
Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction.
Synovitis
Effects of knockout of the receptor for advanced glycation end-products on bone mineral density and synovitis in mice with intra-articular fractures.
Synovitis
In vivo effects of meloxicam on inflammatory mediators, MMP activity and cartilage biomarkers in equine joints with acute synovitis.
Synovitis
In vivo effects of phenylbutazone on inflammation and cartilage-derived biomarkers in equine joints with acute synovitis.
Synovitis
Pathological features of established osteoarthritis with hydrathrosis are similar to rheumatoid arthritis.
Synovitis, Pigmented Villonodular
Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction.
Syphilis
Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis.
Telangiectasia, Hereditary Hemorrhagic
Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.
Telangiectasis
Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.
Temporomandibular Joint Disorders
Expression of collagenases (matrix metalloproteinase-1, 8, 13) and tissue inhibitor of metalloproteinase-1 of retrodiscal tissue in temporomandibular joint disorder patients.
Temporomandibular Joint Disorders
Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disorders.
Tendinopathy
Active expression of matrix metalloproteinase-13 mRNA in the granulation tissue of equine superficial digital flexor tendinitis.
Tendinopathy
Association of MMP-8 polymorphisms with tendinopathy of the primary posterior tibial tendon: a pilot study.
Tendinopathy
Efficacy of Combining PRP and MMP Inhibitors in Treating Moderately Damaged Tendons Ex Vivo.
Tendinopathy
Further characterisation of an experimental model of tendinopathy in the horse.
Tendinopathy
High-molecular-weight hyaluronic acid attenuated matrix metalloproteinase-1 and -3 expression via CD44 in tendinopathy.
Tendinopathy
Inhibition of CD44 induces apoptosis, inflammation, and matrix metalloproteinase expression in tendinopathy.
Tendinopathy
Matrix metalloproteinase inhibitors prevent a decrease in the mechanical properties of stress-deprived tendons: an in vitro experimental study.
Tendinopathy
MMP-8 polymorphism is genetic marker to tendinopathy primary posterior tibial tendon.
Tendinopathy
Photobiomodulation therapy on collagen type I and III, vascular endothelial growth factor, and metalloproteinase in experimentally induced tendinopathy in aged rats.
Tendinopathy
Preclinical and clinical studies of MMP inhibitors in cancer.
Tendinopathy
Statin treatment increases the clinical risk of tendinopathy through matrix metalloproteinase release - a cohort study design combined with an experimental study.
Tendinopathy
Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin.
Tendinopathy
Tendinosis: pathophysiology and nonoperative treatment.
Tendinopathy
TOL19-001 reduces inflammation and MMP expression in monolayer cultures of tendon cells.
Teratoma
Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells.
Thrombocytosis
Platelets prevent the development of monocrotaline-induced liver injury in mice.
Thrombosis
Breaking symmetry in protein dimers: designs and functions.
Thrombosis
Crucial Involvement of IL-6 in Thrombus Resolution in Mice via Macrophage Recruitment and the Induction of Proteolytic Enzymes.
Thrombosis
Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model.
Thrombosis
Enhanced matrix-degrading proteolytic activity within the thin thrombus-covered wall of human abdominal aortic aneurysms.
Thrombosis
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
Thrombosis
Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis.
Thrombosis
Granulocytes in coronary thrombus evolution after myocardial infarction - time-dependent changes in expression of matrix metalloproteinases.
Thrombosis
Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Thrombosis
Matrix Metalloproteinase-13 Predominates Over Matrix Metalloproteinase-8 as the Functional Interstitial Collagenase in Mouse Atheromata.
Thrombosis
Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.
Thrombosis
Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo.
Thrombosis
Rivaroxaban attenuates thrombosis by targeting the NF-?B signaling pathway in a rat model of deep venous thrombus.
Thrombosis
Specialized regulatory T cells control venous blood clot resolution through SPARC.
Thrombosis
Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity.
Thymoma
Activation of matrix metalloproteinase-2 is correlated with invasiveness in thymic epithelial tumors.
Thymoma
Analysis of salivary microRNA expression profiles and identification of novel biomarkers in esophageal cancer.
Thymoma
Clinical significance of tissue inhibitor of metalloproteinase and matrix metalloproteinase mRNA expression in thymoma.
Thyroid Cancer, Papillary
Clinical value of matrix metalloproteinase-2 and -9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma.
Thyroid Cancer, Papillary
EMMPRIN (CD147) expression and differentiation of papillary thyroid carcinoma: implications for immunocytochemistry in FNA cytology.
Thyroid Cancer, Papillary
Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Thyroid Cancer, Papillary
Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique.
Thyroid Carcinoma, Anaplastic
Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model.
Thyroid Neoplasms
Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.
Thyroid Neoplasms
Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study.
Thyroid Neoplasms
Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Thyroid Neoplasms
Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Thyroid Neoplasms
Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents.
Thyroid Neoplasms
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in thyroid C-cells and medullary thyroid carcinomas.
Thyroid Neoplasms
Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors.
Thyroid Neoplasms
Mutational analysis of the GNA11, MMP27, FGD1, TRRAP and GRM3 genes in thyroid cancer.
Thyroid Neoplasms
[Clinical significance of functional variants of matrix metalloproteinase genes in thyroid cancer]
Tongue Neoplasms
Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.
Tongue Neoplasms
Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
Tongue Neoplasms
The interplay of matrix metalloproteinase-8, transforming growth factor-?1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Tonsillitis
Systemic matrix metalloproteinase-8 response in chronic tonsillitis.
Tooth Mobility
Periodontal disease may induce liver fibrosis in an experimental study on Wistar rats.
Tooth, Nonvital
Matrix metalloproteinase-8 and substance P levels in gingival crevicular fluid during endodontic treatment of painful, nonvital teeth.
Toxocariasis
Matrix metalloproteinase-2 and matrix metalloproteinase-9 in mice with ocular toxocariasis.
Toxoplasmosis
Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-?B pathway in human astroglia infected with Toxoplasma gondii.
Trichiasis
Conjunctival expression of matrix metalloproteinase and pro-inflammatory cytokine genes following trichiasis surgery.
Trichiasis
Doxycycline prevents matrix remodeling and contraction by trichiasis-derived conjunctival fibroblasts.
Trichinellosis
Matrix metalloproteinase (MMP)-9: A realiable marker for inflammation in early human trichinellosis.
Triple Negative Breast Neoplasms
A novel regulatory function of CDKN1A/p21 in TNF?-induced matrix metalloproteinase 9-dependent migration and invasion of triple-negative breast cancer cells.
Triple Negative Breast Neoplasms
c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.
Triple Negative Breast Neoplasms
Corrigendum to 'A novel regulatory function of CDKN1A/p21 in TNF?-induced matrix metalloproteinase 9-dependent migration and invasion of triple-negative breast cancer cells' cellular signalling, volume 47, July 2018, Pages 27-36.
Triple Negative Breast Neoplasms
Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions.
Triple Negative Breast Neoplasms
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients.
Tuberculoma
DTI derived indices correlate with immunohistochemistry obtained matrix metalloproteinase (MMP-9) expression in cellular fraction of brain tuberculoma.
Tuberculosis
A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection.
Tuberculosis
Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
Tuberculosis
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
Tuberculosis
Batimastat reduces Mycobacterium tuberculosis-induced apoptosis in macrophages.
Tuberculosis
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.
Tuberculosis
Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis.
Tuberculosis
Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases.
Tuberculosis
Host gene-encoded severe lung TB: from genes to the potential pathways.
Tuberculosis
In an in vitro model of human tuberculosis, monocyte-microglial networks regulate matrix metalloproteinase-1 and -3 gene expression and secretion via a p38 mitogen activated protein kinase-dependent pathway.
Tuberculosis
Matrix Metalloproteinase Inhibition in a Murine Model of Cavitary Tuberculosis Paradoxically Worsens Pathology.
Tuberculosis
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis.
Tuberculosis
Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis.
Tuberculosis
Monocyte-astrocyte networks regulate matrix metalloproteinase gene expression and secretion in central nervous system tuberculosis in vitro and in vivo.
Tuberculosis
Procollagen III N-terminal Propeptide and Desmosine are Released by Matrix Destruction in Pulmonary Tuberculosis.
Tuberculosis
Regulation of matrix metalloproteinase-1, -3, and -9 in Mycobacterium tuberculosis-dependent respiratory networks by the rapamycin-sensitive PI3K/p70S6K cascade.
Tuberculosis
Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks.
Tuberculosis
[The system of matrix metalloproteinases and their role in patients with pulmonary tuberculosis].
Tuberculosis, Central Nervous System
Monocyte-astrocyte networks regulate matrix metalloproteinase gene expression and secretion in central nervous system tuberculosis in vitro and in vivo.
Tuberculosis, Meningeal
Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis.
Tuberculosis, Meningeal
Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.
Tuberculosis, Meningeal
Elevated Matrix Metalloproteinase Concentrations Offer Novel Insight Into Their Role in Pediatric Tuberculous Meningitis.
Tuberculosis, Meningeal
Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
Tuberculosis, Meningeal
Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
Tuberculosis, Pulmonary
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
Tuberculosis, Pulmonary
Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis.
Tuberculosis, Pulmonary
Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis.
Tuberculosis, Pulmonary
MMP-1(-1607G) polymorphism as a risk factor for fibrosis after pulmonary tuberculosis in Taiwan.
Tuberculosis, Pulmonary
Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis.
Tuberous Sclerosis
Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Ureteral Obstruction
Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model.
Ureteral Obstruction
Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.
Ureteral Obstruction
TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury.
Urinary Bladder Neck Obstruction
Effects of doxycycline on voiding behaviour of rats with bladder outlet obstruction.
Urinary Bladder Neoplasms
Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer.
Urinary Bladder Neoplasms
Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24.
Urinary Bladder Neoplasms
Antitumor effects of curcumin in human bladder cancer in vitro.
Urinary Bladder Neoplasms
Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer.
Urinary Bladder Neoplasms
Bacillus Calmette-Guérin enhances production and secretion of type IV collagenases in peripheral blood mononuclear cells.
Urinary Bladder Neoplasms
Clinical significance and prognostic value of S100A4 and matrix metalloproteinase-14 in patients with organ-confined bladder cancer.
Urinary Bladder Neoplasms
Comparison of p38MAPK (mitogene activated protein kinase), p65 NFkappaB (nuclear factor kappa b) and EMMPRIN (extracellular matrix metalloproteinase inducer) expressions with tumor grade and stage of superficial and invasive bladder tumors.
Urinary Bladder Neoplasms
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Urinary Bladder Neoplasms
Editorial Comment from Dr Miyata to Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: A mini-review.
Urinary Bladder Neoplasms
Editorial Comment from Dr Szarvas to Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: A mini-review.
Urinary Bladder Neoplasms
Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.
Urinary Bladder Neoplasms
Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: Correlation with clinicopathological characteristics.
Urinary Bladder Neoplasms
Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer.
Urinary Bladder Neoplasms
Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: A mini-review.
Urinary Bladder Neoplasms
Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase.
Urinary Bladder Neoplasms
Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells.
Urinary Bladder Neoplasms
Interleukin-20 Promotes Migration of Bladder Cancer Cells through Extracellular Signal-regulated Kinase (ERK)-mediated MMP-9 Protein Expression Leading to Nuclear Factor (NF-?B) Activation by Inducing the Up-regulation of p21WAF1 Protein Expression.
Urinary Bladder Neoplasms
Loss of GATA3 in bladder cancer promotes cell migration and invasion.
Urinary Bladder Neoplasms
Matrix metalloproteinase polymorphisms and bladder cancer risk.
Urinary Bladder Neoplasms
Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness.
Urinary Bladder Neoplasms
MMP-8 C-799?T, Lys460Thr, and Lys87Glu variants are not related to risk of cancer.
Urinary Bladder Neoplasms
Prognostic value of membrane type 1 and 2 matrix metalloproteinase expression and gelatinase A activity in bladder cancer.
Urinary Bladder Neoplasms
RhoGDI? promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation.
Urinary Bladder Neoplasms
Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation.
Urinary Bladder Neoplasms
The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.
Urinary Bladder Neoplasms
The role of matrix metalloproteinase MMP-9 and TIMP-2 tissue inhibitor of metalloproteinasas as serum markers of bladder cancer.
Urinary Bladder Neoplasms
Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.
Urinary Bladder Neoplasms
Urine: beyond cytology for detection of malignancy.
Urinary Incontinence
Effect of suburethral prolene mesh for suburethral function and histology in a stress urinary incontinence mouse model.
Urinary Incontinence
Elastin metabolism in pelvic tissues: is it modulated by reproductive hormones?
Urinary Incontinence
Signs of herniosis in women with vaginal prolapse and/or stress incontinence.
Urinary Incontinence
The role of neutrophil elastase in elastin metabolism of pelvic tissues from women with stress urinary incontinence.
Urinary Incontinence
[MMP-1 and MMP-3 gene encoding polymorphism and the risk of the development of pelvic organ prolapse and stress urinary incontinence].
Urinary Tract Infections
Urinary NGAL Measured after the First Year Post Kidney Transplantation Predicts Changes in Glomerular Filtration over One-Year Follow-Up.
Uterine Cervical Neoplasms
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Uterine Cervical Neoplasms
Ataxin-1 regulates epithelial-mesenchymal transition of cervical cancer cells.
Uterine Cervical Neoplasms
Baicalin Inhibits Human Cervical Cancer Cells by Suppressing Protein Kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) Signaling Pathway.
Uterine Cervical Neoplasms
Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
Uterine Cervical Neoplasms
Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
Uterine Cervical Neoplasms
Extracellular matrix metalloproteinase inducer (CD147/BSG/EMMPRIN)-induced radioresistance in cervical cancer by regulating the percentage of the cells in the G2/m phase of the cell cycle and the repair of DNA Double-strand Breaks (DSBs).
Uterine Cervical Neoplasms
Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells.
Uterine Cervical Neoplasms
Histone Deacetylase (HDAC) 10 Suppresses Cervical Cancer Metastasis through Inhibition of Matrix Metalloproteinase (MMP) 2 and 9 Expression.
Uterine Cervical Neoplasms
Inhibition of BAP31 expression inhibits cervical cancer progression by suppressing metastasis and inducing intrinsic and extrinsic apoptosis.
Uterine Cervical Neoplasms
Inhibition of lncRNA DCST1-AS1 suppresses proliferation, migration and invasion of cervical cancer cells by increasing miR-874-3p expression.
Uterine Cervical Neoplasms
Metastatic Inhibitory and Radical Scavenging Efficacies of Saponins Extracted from the Brittle Star (Ophiocoma erinaceus).
Uterine Cervical Neoplasms
No Association of Matrix Metalloproteinase [MMP]-2 (-735C > T) and Tissue Inhibitor of Metalloproteinase [TIMP]-2 (-418G > C) Gene Polymorphisms with Cervical Cancer Susceptibility.
Uterine Cervical Neoplasms
Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
Uterine Cervical Neoplasms
Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women.
Uterine Cervical Neoplasms
RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-?1.
Uterine Cervical Neoplasms
RNA interference targeting extracellular matrix metalloproteinase inducer (CD147) inhibits growth and increases chemosensitivity in human cervical cancer cells.
Uterine Cervical Neoplasms
Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer.
Uterine Cervical Neoplasms
The emerging role of KCl cotransport in tumor biology.
Uterine Cervical Neoplasms
[The Role and Mechanism of CXCR4 and Its Ligand SDF-1 in the Development of Cervical Cancer Metastasis.]
Uterine Hemorrhage
Expression of matrix metalloproteinase enzymes in endometrium of women with abnormal uterine bleeding.
Uveitis
Changes in Matrix Metalloproteinase Network in a Spontaneous Autoimmune Uveitis Model.
Uveitis
Elevated Expression and Activation of Matrix Metalloproteinase 8 in Tear Fluid in Atopic Blepharoconjunctivitis.
Vaginosis, Bacterial
Effect of clindamycin treatment on vaginal inflammatory markers in pregnant women with bacterial vaginosis and a positive fetal fibronectin test.
Vaginosis, Bacterial
Factors affecting matrix metalloproteinase-8 levels in the vaginal and cervical fluids in the first and second trimester of pregnancy.
Vaginosis, Bacterial
Vaginal matrix metalloproteinase levels in pregnant women with bacterial vaginosis.
Varicocele
Impact of micronised purified flavonoid fraction on increased malondialdehyde and decreased metalloproteinase-2 and metalloproteinase-9 levels in varicocele: outcome of an experimentally induced varicocele.
Varicose Ulcer
Matrix metalloproteinase (MMP)-1 and MMP-2, but not COX-2 serve as additional predictors for chronic venous ulcer healing.
Varicose Ulcer
Matrix Metalloproteinase Profiles in Chronic Venous Ulcer Wound Fluid of Inflammatory and Granulating Venous Leg Ulcers.
Varicose Ulcer
Role of matrix metalloproteinases in non-healing venous ulcers.
Varicose Ulcer
Venous ulcer: what is new?
Varicose Veins
Decreased production of collagen Type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3.
Varicose Veins
Effect of a Peptide Construct on Differentiated Macrophage MMP-2 and MMP-9 Levels of Varicose Patients.
Varicose Veins
Inhibitory Effect of TIMP Influences the Morphology of Varicose Veins.
Varicose Veins
Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation.
Varicose Veins
Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
Varicose Veins
Polymorphism of Matrix Metalloproteinases Genes MMP1, MMP2, MMP3, and MMP7 and the Risk of Varicose Veins of Lower Extremities.
Varicose Veins
[Lower extremity varicose veins in childhood and at a young age: Mechanism of development and specific features].
Vascular Calcification
Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells.
Vascular Calcification
Recombinant Human Thrombomodulin Suppresses Experimental Abdominal Aortic Aneurysms Induced by Calcium Chloride in Mice.
Vascular Diseases
Can proteomics yield insight into aging aorta?
Vascular Diseases
Causal associations of serum matrix metalloproteinase-8 level with ischaemic stroke and ischaemic stroke subtypes: a Mendelian randomization study.
Vascular Diseases
Chemical biology for understanding matrix metalloproteinase function.
Vascular Diseases
Elastase and matrix metalloproteinase activities are associated with pulmonary vascular disease in the nitrofen rat model of congenital diaphragmatic hernia.
Vascular Diseases
Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease.
Vascular Diseases
Genetic studies on the role of proteinases and growth factors in atherosclerosis and aneurysm formation.
Vascular Diseases
Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.
Vascular Diseases
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
Vascular Diseases
Lack of an association between matrix metalloproteinase polymorphisms and coronary heart disease in a Han Chinese population.
Vascular Diseases
Matrix metalloproteinase inhibition therapy for vascular diseases.
Vascular Diseases
Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
Vascular Diseases
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
Vascular Diseases
Matrix metalloproteinases and atherosclerotic plaque instability.
Vascular Diseases
Role of matrix metalloproteinases in early hypertensive vascular remodeling.
Vascular Diseases
Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
Vascular Diseases
The role of matrix metalloproteinases in vascular disease.
Vascular System Injuries
Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation.
Vascular System Injuries
Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.
Vascular System Injuries
Cisatracurium attenuates LPS-induced modulation of MMP3 and junctional protein expression in human microvascular endothelial cells.
Vascular System Injuries
Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
Vascular System Injuries
Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Vascular System Injuries
Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Vascular System Injuries
Metalloproteinase inhibition by batimastat does not reduce neointimal thickening in stented atherosclerotic porcine femoral arteries.
Vascular System Injuries
NPY promotes macrophage migration by upregulating matrix metalloproteinase-8 expression.
Vascular System Injuries
Regulation of MMP-9 expression by the A2b adenosine receptor and its dependency on TNF-? signaling.
Vascular System Injuries
Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
Vascular System Injuries
Temporal and topographic matrix metalloproteinase expression after vascular injury in mice.
Vascular System Injuries
Vascular Imaging of Matrix Metalloproteinase Activity as an Informative Preclinical Biomarker of Drug-induced Vascular Injury.
Vasculitis
Association between matrix metalloproteinase 9 promoter polymorphisms and Behçet's disease.
Vasculitis
Molecular imaging reveals time course of matrix metalloproteinase activity in acute cutaneous vasculitis in vivo.
Venous Thrombosis
Plasmin and matrix metalloproteinase system in deep venous thrombosis resolution.
Venous Thrombosis
Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.
Ventilator-Induced Lung Injury
Absence or Inhibition of Matrix Metalloproteinase-8 Decreases Ventilator-induced Lung Injury.
Ventilator-Induced Lung Injury
Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340).
Ventricular Dysfunction
Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.
Ventricular Dysfunction, Left
Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat.
Ventricular Dysfunction, Left
Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Ventricular Dysfunction, Left
Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
Ventricular Dysfunction, Right
Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.
Virus Diseases
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Virus Diseases
Association between matrix metalloproteinase (MMP)-2, MMP-9 and total antioxidant status of patients with asymptomatic hepatitis C virus infection.
Virus Diseases
Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection.
Virus Diseases
Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia.
Virus Diseases
Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection.
Virus Diseases
Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes?
Virus Diseases
The role of Smad1/5 in mantle immunity of the pearl oyster Pinctada fucata martensii.
Vitamin A Deficiency
Vitamin A deficiency disturbs collagen IV and laminin composition and decreases matrix metalloproteinase concentrations in rat lung. Partial reversibility by retinoic acid.
Vitamin D Deficiency
Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?
Vitamin D Deficiency
Vitamin D Inhibits Activities of Metalloproteinase-9/-13 in Articular Cartilage In Vivo and In Vitro.
Vitiligo
Matrix metalloproteinase in acral and non-acral vitiligo.
Vitreoretinopathy, Proliferative
Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: Correlations with extent, duration of RRD and PVR grade.
Vitreoretinopathy, Proliferative
Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment.
Vitreoretinopathy, Proliferative
Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade.
Vitreoretinopathy, Proliferative
Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy.
Vitreoretinopathy, Proliferative
The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy.
Vitreoretinopathy, Proliferative
[Progress in studies on effects of extracellular matrix in occurrence of proliferative vitreoretinopathy]
Waldenstrom Macroglobulinemia
Matrix Metalloproteinase-8 Is Overexpressed in Waldenström's Macroglobulinemia Cells, and Specific Inhibition of this Metalloproteinase Blocks Release of Soluble CD27.
Whooping Cough
Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes.
Whooping Cough
Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1.
Whooping Cough
Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells.
Whooping Cough
Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
Whooping Cough
Thymoquinone-induced Neu4 sialidase activates NF?B in macrophage cells and pro-inflammatory cytokines in vivo.
Wilms Tumor
A carcinogenic trigger to study the function of tumor suppressor genes in Schmidtea mediterranea.
Wound Infection
Nanocrystalline silver dressings in wound management: a review.
Xanthomatosis
Verruciform xanthoma of the oral cavity: clinicopathological study relating to pathogenesis. Report of three cases.
Xerophthalmia
The role and function of matrix metalloproteinase-8 in rhegmatogenous retinal detachment.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.